data_2kf3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kf3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.622 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.2 t . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 tt -169.78 160.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.4 -0.812 . . . . 0.0 109.219 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -147.26 30.33 0.94 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.339 -1.475 . . . . 0.0 111.129 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.9 p -104.86 156.25 18.18 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.744 0.783 . . . . 0.0 109.792 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.5 p90 -59.65 -61.38 2.66 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.729 -1.232 . . . . 0.0 110.143 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.642 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.74 -41.53 82.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.337 -0.852 . . . . 0.0 109.388 -179.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.5 -44.77 93.62 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.6 t -67.54 -41.66 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 121.43 -1.041 . . . . 0.0 108.662 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.47 -58.09 9.55 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.17 -54.86 14.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.362 -0.836 . . . . 0.0 109.633 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.519 ' CE1' ' HA ' ' A' ' 21' ' ' PRO . 34.1 t80 -57.6 -47.36 82.37 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.118 0.485 . . . . 0.0 110.754 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt -74.21 -44.37 53.52 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.246 -0.909 . . . . 0.0 110.717 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -62.98 -19.94 64.8 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.436 -1.415 . . . . 0.0 110.13 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.4 m -96.8 -43.33 7.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.987 -1.071 . . . . 0.0 111.01 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -107.77 13.12 26.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.153 -0.967 . . . . 0.0 111.894 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.2 m80 49.2 23.91 0.88 Allowed 'General case' 0 N--CA 1.508 2.426 0 O-C-N 120.692 -1.255 . . . . 0.0 109.902 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.469 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.5 pttp -141.48 153.63 45.06 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 mp -77.78 149.71 77.8 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.344 -0.847 . . . . 0.0 109.038 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.519 ' HA ' ' CE1' ' A' ' 13' ' ' TYR . 77.2 Cg_exo -39.34 151.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 123.133 2.555 . . . . 0.0 113.567 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -63.45 47.83 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.637 0.732 . . . . 0.0 110.538 179.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -169.88 26.95 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.846 -1.159 . . . . 0.0 110.328 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -118.48 114.01 22.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.482 -1.387 . . . . 0.0 110.227 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.421 HG22 HD12 ' A' ' 25' ' ' ILE . 35.4 pt -117.26 140.63 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.024 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.8 p -70.19 166.8 19.23 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.325 1.06 . . . . 0.0 111.684 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.577 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 20.6 mtmt -68.58 -35.57 77.55 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.73 -65.47 0.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.425 176.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.458 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.6 mt-10 -64.4 -52.02 60.3 Favored 'General case' 0 C--O 1.201 -1.466 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.624 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -41.71 -51.65 4.06 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.858 -1.152 . . . . 0.0 109.047 177.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -60.0 -56.73 18.08 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.372 -0.83 . . . . 0.0 110.895 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.9 -30.61 69.14 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.589 -1.319 . . . . 0.0 109.024 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.1 tp -63.48 -29.83 71.04 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.405 0.621 . . . . 0.0 109.439 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.34 55.01 0.15 Allowed Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.595 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -88.08 145.61 25.86 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.294 -1.121 . . . . 0.0 109.505 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -135.45 124.31 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.427 -0.795 . . . . 0.0 109.414 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.434 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -56.89 -53.21 60.54 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.708 -0.62 . . . . 0.0 109.716 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 81.0 p -68.54 48.53 0.06 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.462 -0.774 . . . . 0.0 109.834 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.641 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.4 ttpm? -178.29 -50.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.53 56.05 23.78 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.641 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -73.24 161.24 30.76 Favored 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.517 -0.99 . . . . 0.0 111.155 -178.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.526 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.5 tp -173.17 -68.18 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.117 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.51 -18.93 55.09 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.169 -0.957 . . . . 0.0 109.779 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.2 p-10 -78.38 -63.9 1.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.66 0.743 . . . . 0.0 109.36 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.43 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 26.6 m -75.6 -10.13 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.919 -0.488 . . . . 0.0 110.381 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.74 71.21 9.65 Favored Pre-proline 0 N--CA 1.486 1.346 0 O-C-N 121.514 -0.741 . . . . 0.0 109.589 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.9 124.37 16.08 Favored 'Trans proline' 0 N--CA 1.505 2.185 0 C-N-CA 123.517 2.812 . . . . 0.0 113.872 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.475 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 72.15 38.69 59.15 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.475 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.9 mmtm -137.02 171.25 14.79 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 121.691 0.758 . . . . 0.0 110.167 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.0 m -144.35 162.24 36.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.146 -0.971 . . . . 0.0 110.302 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.7 mm -84.63 127.87 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.631 0.729 . . . . 0.0 110.156 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.97 155.34 10.9 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.63 -15.94 9.71 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.695 -1.24 . . . . 0.0 111.053 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.46 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -71.75 -155.14 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.766 -1.432 . . . . 0.0 109.321 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.16 140.27 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.76 0.791 . . . . 0.0 110.393 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.615 ' C ' ' H ' ' A' ' 58' ' ' ASN . 9.7 t80 -105.61 91.16 3.64 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.55 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -60.52 36.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.605 -0.684 . . . . 0.0 110.828 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.615 ' H ' ' C ' ' A' ' 56' ' ' PHE . 51.7 t30 38.94 36.88 0.17 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.123 -0.985 . . . . 0.0 110.358 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.55 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.6 mtm180 -69.43 42.3 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.885 -1.134 . . . . 0.0 109.564 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.68 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 17.8 mt-10 -150.18 -15.46 0.25 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.411 -0.806 . . . . 0.0 110.254 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.43 32.1 83.08 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.68 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 7.1 mttp -113.63 6.53 16.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.717 -0.873 . . . . 0.0 109.304 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.7 144.01 51.66 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.659 -0.651 . . . . 0.0 109.39 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.48 124.52 14.38 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.984 2.456 . . . . 0.0 112.051 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.52 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.03 -172.5 28.81 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 68' ' ' GLY . 10.9 tttt 177.07 146.47 0.11 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.366 -1.079 . . . . 0.0 108.955 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 p -68.57 60.21 0.09 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.956 -1.09 . . . . 0.0 108.784 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 144.18 77.05 0.03 OUTLIER Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.541 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -173.69 167.29 4.51 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.586 -0.949 . . . . 0.0 109.208 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 92.4 m -143.81 156.67 44.56 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.23 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.707 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 22.6 m95 -127.11 138.21 53.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.052 -0.405 . . . . 0.0 109.947 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.533 ' HG2' ' NH1' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -130.04 154.19 47.67 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.89 -1.131 . . . . 0.0 109.733 179.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.577 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -118.28 166.9 12.07 Favored 'General case' 0 N--CA 1.509 2.488 0 CA-C-O 121.768 0.794 . . . . 0.0 112.064 -179.051 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.18 134.56 3.51 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.282 -0.886 . . . . 0.0 111.31 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.661 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.46 153.13 13.27 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.268 0.556 . . . . 0.0 111.372 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 76' ' ' ILE . 42.3 mm -135.98 143.45 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.769 -0.582 . . . . 0.0 109.977 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 57.96 69.75 0.71 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.497 0.665 . . . . 0.0 110.576 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.526 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 65.8 t80 -127.88 160.19 32.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.375 -0.828 . . . . 0.0 109.344 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.613 ' OG1' ' N ' ' A' ' 80' ' ' SER . 29.9 p -141.5 -78.94 0.26 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.613 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.4 OUTLIER -150.5 105.21 3.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.787 -0.571 . . . . 0.0 110.2 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.5 -98.85 0.17 Allowed Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.473 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 46.0 t80 -144.81 -169.86 3.27 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.605 -0.938 . . . . 0.0 109.379 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.641 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.8 mtm180 -72.0 -156.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.045 -1.034 . . . . 0.0 109.531 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -167.17 -151.7 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 p -99.25 -6.31 28.28 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.725 -1.234 . . . . 0.0 110.38 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.625 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -89.05 118.61 28.89 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.122 -0.986 . . . . 0.0 110.451 -178.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.804 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.77 150.46 43.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.755 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.7 tt -118.35 136.63 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -114.29 124.24 51.52 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.692 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -116.6 127.5 54.53 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.691 0.757 . . . . 0.0 109.09 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.707 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.9 p -93.69 157.96 15.91 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.143 0.973 . . . . 0.0 112.197 -178.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.1 p -68.86 -20.03 64.26 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.541 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -82.34 10.34 7.23 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.423 -0.798 . . . . 0.0 109.853 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.47 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.6 30.55 0.48 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.629 -0.669 . . . . 0.0 110.047 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.9 mt -102.79 138.68 39.36 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.384 -0.822 . . . . 0.0 109.94 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.464 HG23 HD12 ' A' ' 96' ' ' ILE . 33.4 mm -112.28 119.76 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.267 -0.896 . . . . 0.0 110.07 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.422 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.1 m-85 -119.95 142.61 48.59 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.625 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 9.3 tptp -130.62 147.67 52.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.761 . . . . 0.0 110.71 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.54 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.0 t -128.78 171.13 12.53 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.5 p -146.5 -2.62 0.66 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.36 -0.838 . . . . 0.0 110.488 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.2 p30 -115.63 19.34 15.37 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.653 -1.28 . . . . 0.0 108.549 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 78.97 62.01 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.534 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.668 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 21.5 m-85 69.89 -13.12 0.43 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.73 -0.606 . . . . 0.0 111.595 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -51.01 -72.39 0.05 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.735 -1.228 . . . . 0.0 109.557 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.413 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 34.5 p -99.96 -177.14 3.45 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.96 135.05 6.99 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.987 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.9 m -128.3 139.73 52.26 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.6 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 14.4 tttp -85.79 140.16 30.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.006 -1.059 . . . . 0.0 110.15 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.7 pt -113.23 -33.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.604 -0.685 . . . . 0.0 109.603 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.642 HH21 ' CG ' ' A' ' 8' ' ' ASP . 64.9 mtt180 . . . . . 0 N--CA 1.488 1.467 0 O-C-N 121.212 -0.93 . . . . 0.0 108.999 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.631 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.2 t . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 tt -171.31 161.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -145.94 28.2 1.15 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.43 -1.419 . . . . 0.0 111.083 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.5 p -104.16 156.12 18.15 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.729 0.776 . . . . 0.0 110.19 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.7 p90 -60.1 -60.78 3.28 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.758 -1.214 . . . . 0.0 110.759 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.629 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -58.57 -41.99 86.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 108.927 -179.381 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.19 -43.62 93.45 Favored Glycine 0 N--CA 1.501 2.993 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.5 t -68.78 -41.46 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.212 -1.169 . . . . 0.0 107.998 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.99 -59.1 5.91 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.61 -54.87 12.91 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.567 -0.708 . . . . 0.0 109.587 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.646 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 33.8 t80 -56.42 -49.51 74.35 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.174 0.511 . . . . 0.0 110.204 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.35 -47.41 56.57 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.164 -0.96 . . . . 0.0 111.567 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -61.4 -21.07 63.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.553 -1.342 . . . . 0.0 110.366 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 m -95.9 -41.01 9.02 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.986 -1.071 . . . . 0.0 111.652 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -110.8 16.2 21.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.457 -0.777 . . . . 0.0 111.566 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.6 m80 46.53 25.5 0.41 Allowed 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.563 -1.336 . . . . 0.0 110.248 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -142.95 152.62 42.2 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.203 -0.935 . . . . 0.0 110.695 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.3 mp -74.79 148.92 85.39 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.0 109.513 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.646 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 72.5 Cg_exo -40.48 151.56 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 123.4 2.734 . . . . 0.0 113.371 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.631 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -64.43 46.75 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 121.752 0.787 . . . . 0.0 110.997 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -167.62 24.87 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.937 -1.102 . . . . 0.0 110.545 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -116.27 116.02 27.01 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.692 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.462 HG22 HD12 ' A' ' 25' ' ' ILE . 28.8 pt -117.79 141.0 38.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.709 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.441 ' CB ' ' HG ' ' A' ' 28' ' ' SER . 6.9 p -71.83 167.54 19.77 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 120.858 -1.151 . . . . 0.0 110.524 -177.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.568 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 22.5 mtmt -68.23 -35.92 78.68 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.441 ' HG ' ' CB ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -41.01 -66.23 0.35 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 122.829 1.299 . . . . 0.0 108.472 178.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.548 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.9 mt-10 -65.65 -52.83 48.63 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.612 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.548 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -40.8 -50.86 3.17 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.324 -1.485 . . . . 0.0 107.397 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -58.57 -58.79 6.98 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 120.898 -1.126 . . . . 0.0 111.63 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.93 -29.77 67.35 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.1 -1.625 . . . . 0.0 110.163 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.9 tp -63.17 -25.01 68.15 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.96 50.49 0.26 Allowed Glycine 0 N--CA 1.501 2.992 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.588 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.49 146.12 30.38 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.094 -1.239 . . . . 0.0 109.661 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.42 125.8 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.565 -0.709 . . . . 0.0 109.214 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.96 -52.53 65.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.843 -0.536 . . . . 0.0 109.744 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.6 p -69.71 50.12 0.1 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.697 -1.252 . . . . 0.0 109.342 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.64 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -178.46 -50.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.18 56.38 24.11 Favored Glycine 0 N--CA 1.503 3.1 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.64 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -71.94 164.99 25.1 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.629 -0.924 . . . . 0.0 110.387 -178.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.512 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 60.6 tp -177.35 -69.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.726 -0.609 . . . . 0.0 110.214 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.87 -20.46 36.85 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.616 -1.302 . . . . 0.0 109.414 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 45' ' ' VAL . 4.5 p-10 -77.89 -63.08 1.47 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.424 1.107 . . . . 0.0 109.501 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.414 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 17.0 m -77.46 -7.25 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.17 -0.956 . . . . 0.0 110.259 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.47 70.53 7.46 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.464 -0.772 . . . . 0.0 109.076 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.39 125.97 20.8 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 123.358 2.705 . . . . 0.0 113.719 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.32 40.13 70.04 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -137.56 176.21 8.91 Favored 'General case' 0 N--CA 1.516 2.851 0 CA-C-O 122.592 1.187 . . . . 0.0 111.85 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.1 m -148.72 160.41 43.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.614 -1.304 . . . . 0.0 111.639 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.3 mm -83.24 127.76 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.436 -0.79 . . . . 0.0 109.833 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 170.44 153.23 8.59 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.71 -16.78 8.91 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.243 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.503 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 1.2 m-20 -70.48 -154.42 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.243 -1.151 . . . . 0.0 109.903 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mp -128.61 135.79 61.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.945 0.879 . . . . 0.0 110.202 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.617 ' C ' ' H ' ' A' ' 58' ' ' ASN . 10.9 t80 -101.75 91.16 4.28 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.52 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -60.57 37.27 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.632 -0.668 . . . . 0.0 110.456 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.617 ' H ' ' C ' ' A' ' 56' ' ' PHE . 56.3 t30 37.82 36.69 0.1 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.208 -0.932 . . . . 0.0 110.444 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.52 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.9 mtm180 -68.35 44.93 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.804 -1.185 . . . . 0.0 109.885 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.65 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 20.1 mt-10 -151.51 -25.64 0.2 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.511 -0.743 . . . . 0.0 110.055 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.86 29.47 59.12 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.68 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.5 mttp -112.89 9.16 18.86 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.535 -0.979 . . . . 0.0 109.468 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mt -131.95 143.92 51.05 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.755 -0.591 . . . . 0.0 109.41 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.57 124.19 13.74 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 122.729 2.286 . . . . 0.0 112.3 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.522 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -100.76 -172.83 29.21 Favored Glycine 0 N--CA 1.505 3.235 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 10.8 tttt 177.29 145.4 0.1 Allowed 'General case' 0 N--CA 1.508 2.465 0 O-C-N 121.559 -0.965 . . . . 0.0 108.73 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.6 p -67.62 56.88 0.06 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.016 -1.052 . . . . 0.0 109.104 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.511 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 147.31 77.9 0.02 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.533 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -173.97 168.35 4.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.566 -0.961 . . . . 0.0 108.839 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.443 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.8 m -143.97 156.38 44.39 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.967 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.701 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 20.6 m95 -127.76 137.21 52.35 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.54 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -128.83 157.57 41.15 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 120.969 -1.082 . . . . 0.0 109.73 179.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.568 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -121.52 167.66 12.6 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.271 -0.893 . . . . 0.0 111.565 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.95 136.63 4.24 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.245 -0.909 . . . . 0.0 111.151 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.696 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -59.0 151.72 21.43 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.557 -0.714 . . . . 0.0 111.724 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.402 ' HA ' HD12 ' A' ' 76' ' ' ILE . 46.3 mm -135.69 144.58 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.489 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 58.31 70.36 0.66 Allowed 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.393 0.616 . . . . 0.0 110.407 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.512 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 61.6 t80 -129.54 161.1 31.26 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.076 -1.015 . . . . 0.0 109.455 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.611 ' OG1' ' N ' ' A' ' 80' ' ' SER . 28.5 p -140.9 -77.74 0.29 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.611 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -149.18 110.89 4.52 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.31 -104.04 0.24 Allowed Glycine 0 N--CA 1.502 3.038 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 44.2 t80 -141.32 -167.63 2.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.918 -0.754 . . . . 0.0 109.183 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.633 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.6 mtm180 -73.04 -153.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.165 -0.96 . . . . 0.0 109.415 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -168.35 -151.35 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.1 p -99.45 -4.16 32.05 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.645 -1.285 . . . . 0.0 110.114 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.646 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -91.04 118.14 30.16 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.287 -0.883 . . . . 0.0 110.492 -178.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.796 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.66 148.88 39.86 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.354 -0.841 . . . . 0.0 109.481 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.3 tt -116.59 136.65 52.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -113.42 124.19 51.84 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.659 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -117.78 125.96 51.57 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.997 0.903 . . . . 0.0 109.466 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.701 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 5.1 p -92.12 158.54 16.14 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.852 0.834 . . . . 0.0 112.081 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.4 p -70.18 -19.69 63.17 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.533 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -82.43 10.12 7.78 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.347 -0.846 . . . . 0.0 109.928 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.453 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.85 30.22 0.47 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.712 -0.618 . . . . 0.0 110.099 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.6 mt -101.77 138.72 38.38 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.215 -0.928 . . . . 0.0 109.79 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.434 HG23 HD12 ' A' ' 96' ' ' ILE . 35.1 mm -113.23 119.51 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.469 -0.769 . . . . 0.0 110.024 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.423 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.9 m-85 -120.39 143.08 48.62 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.646 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 7.4 tptp -131.24 148.28 52.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.025 -1.047 . . . . 0.0 110.806 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.545 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.9 t -127.95 172.35 10.98 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.9 p -147.44 -1.45 0.62 Allowed 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.452 -0.78 . . . . 0.0 110.796 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.444 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.1 p30 -117.27 19.06 14.29 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.728 -1.232 . . . . 0.0 108.287 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 78.65 63.12 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.358 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.68 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 19.3 m-85 69.65 -13.23 0.41 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.873 -0.517 . . . . 0.0 111.334 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -50.72 -73.98 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.57 -1.331 . . . . 0.0 109.565 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.438 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 33.7 p -98.58 -177.42 3.67 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.67 134.81 7.15 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.968 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.4 m -128.39 139.0 52.6 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.606 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 15.7 tttp -86.26 140.21 30.32 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.937 -1.102 . . . . 0.0 109.904 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.8 pt -113.91 -31.26 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.689 -0.632 . . . . 0.0 109.642 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.629 HH21 ' CG ' ' A' ' 8' ' ' ASP . 66.7 mtt180 . . . . . 0 C--N 1.303 -1.426 0 O-C-N 121.126 -0.984 . . . . 0.0 108.846 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.621 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 20.2 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.399 0.618 . . . . 0.0 109.343 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 tt -170.13 159.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -146.17 30.14 1.05 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.766 -1.209 . . . . 0.0 111.306 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.4 p -104.8 158.14 16.73 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.594 0.712 . . . . 0.0 109.666 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.0 OUTLIER -60.68 -61.33 2.67 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.842 -1.161 . . . . 0.0 110.07 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.637 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.04 -41.48 78.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.213 -0.929 . . . . 0.0 109.659 -179.742 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.14 -44.83 94.62 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.3 t -67.31 -41.07 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.421 -1.047 . . . . 0.0 108.746 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.77 -57.86 9.45 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.17 -53.41 27.96 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.512 -0.742 . . . . 0.0 109.619 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.652 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 32.2 t80 -57.48 -50.6 72.52 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.454 0.645 . . . . 0.0 110.683 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tt -71.71 -45.14 62.75 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.3 -0.875 . . . . 0.0 110.886 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -62.12 -22.16 65.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.622 -1.299 . . . . 0.0 110.435 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 m -95.59 -40.93 9.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.077 -1.014 . . . . 0.0 111.021 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -110.28 17.06 21.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.958 -1.089 . . . . 0.0 112.002 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.2 m80 46.17 24.82 0.29 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.025 -1.047 . . . . 0.0 110.372 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.451 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.6 pttp -143.22 149.75 38.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.061 -1.024 . . . . 0.0 110.282 -178.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.63 150.15 88.72 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.249 -0.907 . . . . 0.0 108.827 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.652 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 50.9 Cg_exo -38.94 153.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.333 2.688 . . . . 0.0 114.092 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.621 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -68.53 50.24 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.197 0.999 . . . . 0.0 110.692 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -171.32 25.77 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 109.928 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -117.81 116.39 26.89 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.46 -1.4 . . . . 0.0 110.399 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.402 HD12 HG22 ' A' ' 25' ' ' ILE . 28.0 pt -118.99 136.13 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 CA-C-O 122.167 0.984 . . . . 0.0 109.659 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.7 p -65.49 166.89 9.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.05 -1.031 . . . . 0.0 111.545 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.614 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 22.5 mtmt -68.48 -36.72 79.35 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.44 -65.17 0.52 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.109 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.9 mt-10 -63.72 -53.86 44.53 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 119.067 -1.053 . . . . 0.0 108.983 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -40.72 -51.56 3.05 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.653 -1.28 . . . . 0.0 108.597 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -57.38 -58.8 6.68 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.965 -1.084 . . . . 0.0 111.502 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.37 -32.23 68.38 Favored 'General case' 0 N--CA 1.51 2.562 0 O-C-N 120.663 -1.273 . . . . 0.0 108.811 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.8 tp -61.35 -23.43 65.75 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.49 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.49 50.98 0.36 Allowed Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.562 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -82.99 146.71 28.62 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.152 -1.205 . . . . 0.0 109.343 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.3 t -135.75 123.93 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.472 -0.768 . . . . 0.0 109.388 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.427 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -57.25 -52.61 64.63 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.846 -0.534 . . . . 0.0 109.763 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.3 p -69.79 48.7 0.09 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.389 -0.819 . . . . 0.0 109.72 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.645 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.3 ttpm? -178.31 -50.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.63 57.4 17.95 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.645 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -72.5 162.09 29.94 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.747 -0.855 . . . . 0.0 110.56 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.619 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.7 tp -175.62 -66.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.443 -0.785 . . . . 0.0 109.937 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 80' ' ' SER . . . -61.72 -18.96 61.75 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.77 -1.207 . . . . 0.0 109.988 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 45' ' ' VAL . 4.5 p-10 -79.18 -64.63 1.14 Allowed 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.912 0.863 . . . . 0.0 109.063 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.507 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 31.6 m -74.48 -12.07 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.918 -0.489 . . . . 0.0 110.158 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.4 71.07 13.01 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.47 -0.769 . . . . 0.0 109.412 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.48 123.58 13.91 Favored 'Trans proline' 0 N--CA 1.509 2.395 0 C-N-CA 122.919 2.413 . . . . 0.0 113.991 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.49 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 71.57 41.0 58.45 Favored Glycine 0 N--CA 1.502 3.049 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.5 mmtt -139.07 170.82 15.28 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 122.031 0.919 . . . . 0.0 110.962 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.8 m -144.81 160.63 40.96 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.204 1.002 . . . . 0.0 110.554 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.8 mm -84.26 128.22 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.526 -0.734 . . . . 0.0 109.906 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.58 153.68 9.26 Favored Glycine 0 N--CA 1.499 2.88 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.75 -16.56 8.92 Favored Glycine 0 N--CA 1.5 2.925 0 C-N-CA 119.653 -1.26 . . . . 0.0 111.367 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -71.88 -150.64 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.795 -1.415 . . . . 0.0 110.037 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.93 140.7 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.561 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.624 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.3 t80 -106.68 90.1 3.22 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.514 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.3 p -60.0 38.22 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.388 0.613 . . . . 0.0 110.591 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 56' ' ' PHE . 63.8 t30 37.54 34.58 0.05 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.121 -0.987 . . . . 0.0 110.526 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.514 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.6 mtm180 -66.24 44.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.844 -1.16 . . . . 0.0 110.093 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.67 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 20.1 mt-10 -152.05 -26.42 0.18 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.483 -0.761 . . . . 0.0 109.918 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.6 28.08 62.0 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.671 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.0 mttp -110.31 5.11 21.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.527 -0.984 . . . . 0.0 109.102 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -127.98 144.46 51.57 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.792 -0.568 . . . . 0.0 109.673 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.52 124.89 15.02 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 123.048 2.499 . . . . 0.0 112.279 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.515 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.18 -173.94 28.8 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 68' ' ' GLY . 12.9 tttt 177.41 145.72 0.11 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.413 -1.051 . . . . 0.0 108.787 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 p -68.13 58.03 0.07 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.05 -1.031 . . . . 0.0 109.236 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 147.36 75.78 0.02 OUTLIER Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.531 ' NH2' ' OD1' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.46 169.92 5.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.684 -0.892 . . . . 0.0 109.225 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.454 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.9 m -145.23 155.39 43.22 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.829 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.704 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 20.3 m95 -126.13 138.78 53.7 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.546 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -129.35 155.8 45.05 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.789 -1.194 . . . . 0.0 109.58 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.614 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -120.28 166.25 13.75 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.255 -0.903 . . . . 0.0 111.551 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.53 134.66 3.34 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.197 -0.939 . . . . 0.0 110.69 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.696 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.91 152.14 16.71 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.359 0.599 . . . . 0.0 111.482 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.417 ' HA ' HD12 ' A' ' 76' ' ' ILE . 39.9 mm -134.9 142.85 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.559 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 57.8 71.69 0.56 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.288 0.566 . . . . 0.0 110.266 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.619 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 63.0 t80 -129.13 159.72 35.12 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.417 -0.802 . . . . 0.0 109.318 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.6 ' OG1' ' N ' ' A' ' 80' ' ' SER . 24.2 p -140.65 -78.33 0.29 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.6 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -150.05 107.58 3.65 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.66 -103.93 0.23 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.484 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 50.7 t80 -141.72 -170.02 3.03 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.638 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.5 mtm180 -70.41 -151.95 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.131 -0.981 . . . . 0.0 109.815 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -172.07 -151.89 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.8 p -98.9 -5.3 31.06 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.69 -1.256 . . . . 0.0 110.43 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.631 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -90.07 117.69 29.05 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.186 -0.946 . . . . 0.0 110.52 -178.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.806 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.31 149.64 43.03 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 tt -117.74 135.83 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -112.63 124.86 53.5 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.69 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.7 127.42 53.55 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.709 0.766 . . . . 0.0 109.205 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.704 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.1 p -94.35 158.95 15.33 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.173 0.987 . . . . 0.0 112.522 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.1 p -69.75 -19.08 63.54 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.531 ' OD1' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -83.24 10.46 8.4 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.762 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.443 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.46 29.97 0.52 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.634 -0.666 . . . . 0.0 110.025 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 23.4 mt -101.96 136.52 41.66 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.319 -0.863 . . . . 0.0 109.807 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.457 HG23 HD12 ' A' ' 96' ' ' ILE . 32.9 mm -110.38 119.92 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.576 -0.703 . . . . 0.0 110.251 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.426 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.3 m-85 -120.68 142.64 49.29 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.631 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 8.7 tptp -130.96 147.02 52.55 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.776 0.798 . . . . 0.0 111.005 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.564 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.4 t -127.51 171.53 11.52 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.6 p -146.85 -1.72 0.66 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.386 -0.821 . . . . 0.0 110.328 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 105' ' ' THR . 1.2 p30 -116.68 18.75 14.83 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.806 -1.184 . . . . 0.0 108.353 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 78.53 63.27 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.449 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.671 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 19.9 m-85 69.99 -14.12 0.39 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.774 -0.579 . . . . 0.0 111.614 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -51.39 -73.33 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.754 -1.216 . . . . 0.0 109.578 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.462 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 33.2 p -98.65 -178.08 3.87 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.85 133.53 6.25 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.935 -1.103 . . . . 0.0 109.847 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.7 m -127.87 140.05 52.25 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.629 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 16.3 tttp -86.01 139.71 30.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.123 -0.985 . . . . 0.0 109.971 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.0 pt -113.38 -32.43 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.637 HH21 ' CG ' ' A' ' 8' ' ' ASP . 62.2 mtt180 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.103 -0.998 . . . . 0.0 109.198 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.629 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 36.0 t . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 tt -171.52 158.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.0 p30 -146.08 29.97 1.07 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.472 -1.392 . . . . 0.0 111.241 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.9 p -105.69 155.94 18.77 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.2 p90 -58.66 -63.79 1.16 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.961 -1.087 . . . . 0.0 110.463 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.612 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -53.81 -43.46 69.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.516 -0.74 . . . . 0.0 109.449 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.39 -44.72 89.86 Favored Glycine 0 N--CA 1.5 2.965 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.2 t -67.3 -41.32 86.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 121.51 -0.994 . . . . 0.0 108.786 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.36 -58.84 6.19 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.82 -55.0 12.87 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.371 -0.83 . . . . 0.0 109.663 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.596 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 35.0 t80 -56.26 -50.76 70.43 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.284 0.564 . . . . 0.0 110.627 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.3 tt -72.26 -44.37 62.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.406 -0.809 . . . . 0.0 111.282 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -62.76 -21.31 65.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.605 -1.309 . . . . 0.0 110.08 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.0 m -95.9 -40.5 9.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.927 -1.108 . . . . 0.0 111.283 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -111.14 17.26 20.52 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.055 -1.028 . . . . 0.0 111.987 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.0 m80 45.78 25.01 0.25 Allowed 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.845 -1.159 . . . . 0.0 110.271 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.4 pttp -141.88 152.51 43.67 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.075 -1.016 . . . . 0.0 110.898 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.3 mp -76.78 148.73 79.72 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.224 -0.922 . . . . 0.0 109.303 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.596 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 73.7 Cg_exo -38.23 152.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 122.904 2.403 . . . . 0.0 114.428 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -66.06 48.52 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 122.122 0.963 . . . . 0.0 110.094 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -169.23 24.16 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.671 -1.268 . . . . 0.0 110.126 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -117.39 116.25 26.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.968 -1.082 . . . . 0.0 110.86 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.45 HD12 HG22 ' A' ' 25' ' ' ILE . 34.4 pt -118.03 141.01 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.833 0.825 . . . . 0.0 109.312 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.2 p -70.98 166.29 21.61 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.967 -1.083 . . . . 0.0 111.479 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.568 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 20.2 mtmt -67.19 -36.39 81.64 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.78 -65.08 0.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.6 177.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.46 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.2 mt-10 -63.34 -52.47 61.66 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.025 -1.07 . . . . 0.0 108.342 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -41.69 -49.78 4.22 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.174 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -60.81 -55.72 29.69 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.36 -0.837 . . . . 0.0 111.755 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.49 -31.8 70.82 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.669 -1.269 . . . . 0.0 109.276 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 20.2 tp -60.83 -31.36 70.78 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.96 52.09 0.15 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.677 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -83.77 146.39 28.18 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.083 -1.245 . . . . 0.0 109.888 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -137.56 125.86 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.274 -0.891 . . . . 0.0 109.373 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.431 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -57.27 -53.28 59.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.924 -0.485 . . . . 0.0 110.501 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.7 p -69.08 48.75 0.07 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.979 -1.076 . . . . 0.0 109.716 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.572 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -178.81 -49.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.52 55.37 29.25 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.677 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -70.8 160.17 33.22 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 121.64 -0.918 . . . . 0.0 110.458 -179.063 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.516 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 58.9 tp -174.98 -67.29 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.497 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.52 -20.19 43.94 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.339 -0.851 . . . . 0.0 110.093 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.8 p-10 -79.63 -65.39 1.01 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.678 0.752 . . . . 0.0 109.874 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.495 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 28.9 m -75.98 -6.82 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.799 -0.563 . . . . 0.0 110.708 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.0 69.03 9.04 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -57.69 122.32 11.55 Favored 'Trans proline' 0 N--CA 1.508 2.324 0 C-N-CA 123.595 2.863 . . . . 0.0 113.853 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.95 38.99 55.61 Favored Glycine 0 N--CA 1.501 3.016 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -138.38 178.16 7.34 Favored 'General case' 0 N--CA 1.51 2.546 0 CA-C-O 122.248 1.023 . . . . 0.0 111.455 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 63.9 m -150.53 161.0 43.38 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.857 -1.152 . . . . 0.0 111.417 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.8 mm -83.37 126.17 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.092 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.72 152.97 8.74 Favored Glycine 0 N--CA 1.499 2.842 0 C-N-CA 119.981 -1.104 . . . . 0.0 110.38 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.43 -17.35 8.42 Favored Glycine 0 N--CA 1.498 2.778 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.052 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -69.95 -153.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.633 -1.51 . . . . 0.0 109.752 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.95 138.42 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.43 -0.794 . . . . 0.0 110.399 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.641 ' O ' ' N ' ' A' ' 58' ' ' ASN . 10.0 t80 -104.36 89.77 3.34 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.546 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -59.5 39.17 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.529 -0.732 . . . . 0.0 110.682 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.641 ' N ' ' O ' ' A' ' 56' ' ' PHE . 59.5 t30 36.83 34.88 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.069 -1.02 . . . . 0.0 110.483 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.546 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.2 mtm180 -66.71 45.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.822 -1.174 . . . . 0.0 109.602 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.665 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 18.9 mt-10 -151.74 -26.84 0.19 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.467 -0.771 . . . . 0.0 110.028 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.27 27.9 61.0 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.669 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.7 mttp -110.69 5.7 21.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.66 -0.906 . . . . 0.0 109.468 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.93 143.6 49.31 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.8 124.42 14.04 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.637 2.224 . . . . 0.0 112.239 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.498 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -99.81 -173.82 30.62 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 68' ' ' GLY . 11.1 tttt 177.92 146.27 0.13 Allowed 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.456 -1.026 . . . . 0.0 108.834 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.4 p -68.01 58.18 0.07 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.975 -1.078 . . . . 0.0 109.031 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 146.86 76.69 0.02 OUTLIER Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.542 ' NH2' ' OD1' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -173.35 168.89 4.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.597 -0.943 . . . . 0.0 109.161 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.454 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.3 m -145.65 155.2 42.85 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.834 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.708 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 21.5 m95 -125.39 138.8 54.04 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.536 ' HG2' ' NH1' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -129.72 156.06 44.9 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.798 -1.189 . . . . 0.0 109.517 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.568 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -120.03 167.54 12.07 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.3 -0.875 . . . . 0.0 112.136 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.46 135.59 3.62 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.237 -0.915 . . . . 0.0 111.153 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.675 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.93 154.7 11.88 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.743 -0.598 . . . . 0.0 111.546 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.2 mm -136.87 143.5 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.518 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 57.62 70.01 0.69 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.192 0.52 . . . . 0.0 110.589 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.496 ' CG ' ' N ' ' A' ' 79' ' ' THR . 59.5 t80 -128.37 161.33 29.68 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.02 -1.05 . . . . 0.0 109.331 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.608 ' OG1' ' N ' ' A' ' 80' ' ' SER . 26.9 p -141.43 -76.69 0.29 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.608 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -150.47 110.33 4.09 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.73 -103.67 0.24 Allowed Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 45.4 t80 -142.46 -169.96 3.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.89 -0.77 . . . . 0.0 109.156 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.657 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.2 mtm180 -71.47 -158.09 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.24 -0.912 . . . . 0.0 109.159 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -166.33 -150.9 0.12 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.8 p -99.0 -6.38 28.67 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.404 -1.435 . . . . 0.0 110.391 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.628 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -89.11 118.02 28.52 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.099 -1.001 . . . . 0.0 110.992 -178.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.804 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.03 149.97 42.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 0.0 109.685 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.2 tt -118.15 137.42 52.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -113.85 124.88 53.29 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.63 127.67 53.81 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.724 0.773 . . . . 0.0 109.213 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.708 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.0 p -94.13 158.37 15.64 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 122.449 1.119 . . . . 0.0 112.382 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.8 p -68.93 -20.3 64.21 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.542 ' OD1' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -83.1 11.04 6.87 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.062 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.448 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.62 29.63 0.52 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.601 -0.687 . . . . 0.0 110.42 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 23.1 mt -102.78 136.86 41.83 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.459 HG23 HD12 ' A' ' 96' ' ' ILE . 31.7 mm -110.84 119.7 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.523 -0.736 . . . . 0.0 110.104 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.448 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.2 m-85 -119.88 142.81 48.34 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.628 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 8.2 tptp -130.7 147.29 52.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.847 -1.158 . . . . 0.0 110.691 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.484 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.5 t -128.46 171.43 12.08 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 76.5 p -146.51 -3.63 0.62 Allowed 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.491 -0.756 . . . . 0.0 110.459 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' A' ' 105' ' ' THR . 1.1 p30 -114.36 19.52 16.19 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.792 -1.192 . . . . 0.0 108.455 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 78.11 62.41 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.15 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.669 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 21.6 m-85 70.36 -14.57 0.39 Allowed 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.826 -0.546 . . . . 0.0 111.66 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -49.98 -72.88 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.661 -1.275 . . . . 0.0 109.886 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.458 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 42.0 p -100.42 -178.31 3.77 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.65 135.19 8.39 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.045 -1.034 . . . . 0.0 110.332 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.1 m -128.13 139.14 52.66 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.642 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 15.8 tttp -86.02 139.15 31.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.835 -1.166 . . . . 0.0 110.003 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.8 pt -111.96 -32.91 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.63 -0.669 . . . . 0.0 109.791 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.642 ' C ' ' HZ3' ' A' ' 108' ' ' LYS . 69.0 mtt180 . . . . . 0 N--CA 1.487 1.412 0 O-C-N 121.281 -0.887 . . . . 0.0 108.678 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.633 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.8 t . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 tt -171.15 158.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -145.4 29.67 1.15 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.411 -1.431 . . . . 0.0 111.466 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.7 p -103.67 157.15 17.26 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.436 -0.79 . . . . 0.0 109.762 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.4 p90 -59.87 -63.13 1.41 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.211 -0.93 . . . . 0.0 109.897 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.588 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.8 OUTLIER -56.01 -42.25 76.15 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.165 -0.959 . . . . 0.0 109.679 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.4 -44.98 85.07 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.3 t -67.93 -42.51 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.24 -58.6 7.65 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.9 -53.13 27.92 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.766 -1.209 . . . . 0.0 110.103 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.626 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 36.6 t80 -57.24 -48.61 78.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.669 -0.644 . . . . 0.0 110.418 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -73.91 -43.89 56.94 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.493 -0.755 . . . . 0.0 110.974 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -63.7 -20.04 65.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.443 -1.411 . . . . 0.0 109.981 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 m -98.12 -40.29 8.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.697 -1.252 . . . . 0.0 110.544 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -109.66 14.62 23.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 112.022 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.8 m80 46.77 24.98 0.39 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.668 -1.27 . . . . 0.0 110.41 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.464 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 3.8 pttp -143.57 149.82 37.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.177 -0.952 . . . . 0.0 110.828 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp -72.72 149.48 90.52 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 120.98 -1.075 . . . . 0.0 109.565 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.626 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 51.3 Cg_exo -40.36 150.8 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 123.189 2.592 . . . . 0.0 113.716 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.633 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -63.95 48.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.541 0.686 . . . . 0.0 110.489 -179.205 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -171.43 28.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.02 -1.05 . . . . 0.0 110.67 179.103 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -119.11 115.08 23.53 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.191 -0.943 . . . . 0.0 110.719 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.5 pt -117.38 140.32 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.462 ' CB ' ' HG ' ' A' ' 28' ' ' SER . 11.5 p -70.82 167.26 19.28 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.054 0.93 . . . . 0.0 111.75 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.568 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 23.6 mtmt -68.49 -37.32 80.01 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.462 ' HG ' ' CB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -40.43 -67.83 0.21 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 113.873 -1.512 . . . . 0.0 108.217 177.187 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.515 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.0 mt-10 -63.57 -54.43 36.14 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.233 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.515 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -39.18 -51.84 1.94 Allowed 'General case' 0 CA--C 1.566 1.569 0 O-C-N 120.318 -1.489 . . . . 0.0 109.033 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.425 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 41.2 mt-30 -58.93 -57.69 11.93 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.661 -0.649 . . . . 0.0 111.219 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.15 -32.84 71.41 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.819 -1.175 . . . . 0.0 110.006 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.1 tp -59.45 -27.78 66.38 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.96 52.5 0.21 Allowed Glycine 0 N--CA 1.502 3.09 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.605 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -85.04 146.2 27.3 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.549 -0.971 . . . . 0.0 111.007 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.6 t -137.14 124.59 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 O-C-N 121.394 -0.816 . . . . 0.0 109.79 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.425 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -57.27 -50.87 71.52 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 122.037 -0.414 . . . . 0.0 110.369 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.3 p -70.06 49.06 0.1 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.3 -0.875 . . . . 0.0 109.443 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.567 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -179.13 -52.97 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.69 57.05 13.5 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.605 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -71.79 162.29 29.68 Favored 'General case' 0 C--N 1.289 -2.058 0 O-C-N 121.728 -0.866 . . . . 0.0 111.067 -178.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.581 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 64.6 tp -174.44 -67.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.772 -1.205 . . . . 0.0 109.995 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 80' ' ' SER . . . -61.33 -18.96 61.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.509 -0.744 . . . . 0.0 109.827 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 3.9 p-10 -80.22 -62.1 1.78 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.091 0.948 . . . . 0.0 108.742 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.427 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 16.3 m -75.65 -11.35 14.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.663 -1.273 . . . . 0.0 109.293 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.78 72.6 10.5 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 120.996 -1.065 . . . . 0.0 109.855 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.61 125.76 19.29 Favored 'Trans proline' 0 N--CA 1.509 2.415 0 C-N-CA 123.051 2.5 . . . . 0.0 114.323 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.571 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 72.74 40.15 53.67 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.571 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.8 mmtm -141.41 170.8 15.04 Favored 'General case' 0 N--CA 1.508 2.426 0 CA-C-O 121.674 0.749 . . . . 0.0 111.567 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.5 m -144.32 162.58 36.07 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 122.794 1.283 . . . . 0.0 110.935 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.6 mm -83.81 126.26 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.923 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 172.85 153.05 9.11 Favored Glycine 0 N--CA 1.501 3.021 0 O-C-N 120.575 -1.328 . . . . 0.0 109.98 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.38 -15.39 9.98 Favored Glycine 0 N--CA 1.499 2.866 0 O-C-N 121.145 -1.209 . . . . 0.0 111.166 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 1.6 m-20 -70.49 -154.9 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.547 -1.56 . . . . 0.0 109.473 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.0 mp -129.29 135.74 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 122.055 0.931 . . . . 0.0 110.169 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.582 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.7 t80 -101.8 89.16 3.58 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.67 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 2.2 p -59.3 40.25 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 121.306 0.574 . . . . 0.0 110.766 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.582 ' N ' ' O ' ' A' ' 56' ' ' PHE . 61.5 t30 34.13 37.12 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.372 -0.83 . . . . 0.0 110.4 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.67 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.1 mtm180 -68.02 40.1 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -0.951 . . . . 0.0 109.929 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.655 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 21.6 mt-10 -148.98 -19.38 0.3 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.024 -1.047 . . . . 0.0 110.44 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.45 31.45 68.35 Favored Glycine 0 N--CA 1.499 2.871 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.684 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.7 mttp -114.3 8.28 16.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.575 -0.956 . . . . 0.0 108.932 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mt -131.96 143.99 51.33 Favored Pre-proline 0 N--CA 1.491 1.583 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -63.37 124.3 13.57 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.681 2.254 . . . . 0.0 112.005 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.526 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -100.39 -172.04 29.56 Favored Glycine 0 N--CA 1.499 2.851 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 68' ' ' GLY . 10.3 tttt 177.03 146.55 0.1 Allowed 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.678 -0.895 . . . . 0.0 108.938 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.8 p -68.19 58.32 0.08 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.91 -1.119 . . . . 0.0 109.281 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 145.52 76.66 0.03 OUTLIER Glycine 0 N--CA 1.5 2.946 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.536 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.09 165.8 6.15 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.657 -0.908 . . . . 0.0 109.239 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.0 m -142.18 154.01 44.49 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.378 -0.826 . . . . 0.0 109.69 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.688 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 19.2 m95 -125.42 139.3 53.77 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.514 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -129.97 155.28 46.35 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.295 -0.878 . . . . 0.0 109.918 179.612 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.568 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -119.2 166.52 12.86 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.227 -0.921 . . . . 0.0 111.295 -179.144 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.85 134.8 3.19 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.182 -0.949 . . . . 0.0 110.955 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.661 ' HA ' ' NE ' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -57.04 152.43 13.21 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.457 0.646 . . . . 0.0 111.548 -179.338 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.407 ' HA ' HD12 ' A' ' 76' ' ' ILE . 42.0 mm -135.53 142.58 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.08 -1.013 . . . . 0.0 110.084 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 58.62 71.24 0.59 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.403 0.621 . . . . 0.0 110.517 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.581 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 65.1 t80 -129.59 159.3 36.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.354 -0.841 . . . . 0.0 109.382 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 80' ' ' SER . 29.4 p -139.87 -78.94 0.31 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.642 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -149.86 106.65 3.54 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.84 -102.78 0.21 Allowed Glycine 0 N--CA 1.5 2.926 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.482 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 52.4 t80 -142.38 -168.0 2.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.86 -0.788 . . . . 0.0 108.977 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.652 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.8 mtm180 -73.09 -152.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.823 -1.173 . . . . 0.0 109.807 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -170.48 -150.61 0.07 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.6 p -100.75 -5.77 25.91 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.754 -1.216 . . . . 0.0 110.345 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.62 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -90.44 118.81 30.21 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.906 -1.121 . . . . 0.0 110.272 -178.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.812 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.52 150.42 42.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.187 -0.946 . . . . 0.0 109.346 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.6 tt -117.29 138.83 46.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -114.84 123.51 49.37 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.664 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -116.71 126.87 53.8 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.561 0.696 . . . . 0.0 109.357 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.688 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 3.1 p -93.07 158.94 15.52 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.163 0.983 . . . . 0.0 111.929 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.9 p -70.03 -20.33 63.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.446 -0.784 . . . . 0.0 108.913 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.536 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.47 10.2 6.19 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.468 -0.77 . . . . 0.0 109.867 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.475 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.76 30.07 0.48 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.654 -0.654 . . . . 0.0 110.148 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.5 mt -102.45 137.48 40.63 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.313 -0.867 . . . . 0.0 110.121 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.46 HG23 HD12 ' A' ' 96' ' ' ILE . 30.8 mm -110.75 119.14 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.28 -0.888 . . . . 0.0 110.951 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.444 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.5 m-85 -119.82 143.44 47.87 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.62 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 7.3 tptp -132.47 148.03 52.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.185 -0.947 . . . . 0.0 110.816 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.522 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.2 t -127.61 171.85 11.28 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.5 p -146.74 -1.82 0.67 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.274 -0.891 . . . . 0.0 110.358 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.449 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.2 p30 -117.36 19.31 14.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.823 -1.173 . . . . 0.0 108.681 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 78.94 61.63 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.237 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.684 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 19.6 m-85 70.01 -13.8 0.41 Allowed 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.711 -0.618 . . . . 0.0 111.529 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -49.83 -72.97 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.734 -1.228 . . . . 0.0 109.437 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.441 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 34.5 p -99.5 -176.18 3.21 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.8 135.07 6.28 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.174 -0.953 . . . . 0.0 109.666 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 55.0 m -128.33 140.7 51.72 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.605 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 15.4 tttp -87.25 139.91 30.08 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.7 -1.25 . . . . 0.0 110.306 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.6 pt -113.22 -32.72 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.485 -0.76 . . . . 0.0 109.75 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.605 ' C ' ' HZ3' ' A' ' 108' ' ' LYS . 60.5 mtt180 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 118.292 -0.861 . . . . 0.0 109.528 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.626 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.0 t . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 tt -170.8 159.87 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -144.46 27.74 1.37 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.793 -1.192 . . . . 0.0 111.501 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.0 p -105.54 158.03 16.97 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.859 0.837 . . . . 0.0 110.761 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.7 p90 -60.02 -61.16 2.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.595 -1.316 . . . . 0.0 110.997 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.646 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.81 -39.83 78.51 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.0 -1.062 . . . . 0.0 110.102 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.44 -44.25 96.81 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.66 -41.73 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.313 -1.11 . . . . 0.0 108.535 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.33 -58.94 5.86 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.98 -54.21 16.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.421 -0.8 . . . . 0.0 109.861 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.632 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 35.4 t80 -57.35 -49.62 75.55 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.569 -0.707 . . . . 0.0 110.737 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.89 -45.14 62.32 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.125 -0.985 . . . . 0.0 110.631 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -62.71 -20.11 64.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.23 -1.544 . . . . 0.0 110.615 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.0 m -98.07 -39.33 8.97 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.954 -1.091 . . . . 0.0 110.977 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -111.34 15.79 21.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.796 -1.19 . . . . 0.0 111.967 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.8 m80 46.75 23.74 0.28 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.109 -0.994 . . . . 0.0 110.867 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.2 pttp -141.16 150.81 43.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 109.792 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.7 mp -73.87 150.13 88.17 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.803 -1.186 . . . . 0.0 108.901 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.632 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 51.3 Cg_exo -38.07 150.66 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 124.016 3.144 . . . . 0.0 113.701 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.626 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -65.77 46.73 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.747 0.784 . . . . 0.0 111.405 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -169.82 26.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 109.818 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -117.9 119.72 35.69 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.836 -1.165 . . . . 0.0 110.622 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.1 pt -121.12 139.52 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.818 0.818 . . . . 0.0 109.194 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.1 p -69.78 167.63 16.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.893 -1.129 . . . . 0.0 111.094 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.554 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 19.1 mtmt -68.22 -33.04 73.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.12 -63.65 0.93 Allowed 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.493 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.7 mt-10 -66.44 -51.58 55.37 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -41.35 -51.41 3.68 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.662 -1.215 . . . . 0.0 108.686 177.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -60.14 -56.38 22.26 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.399 -0.813 . . . . 0.0 111.201 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.13 -27.85 68.68 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.263 -1.523 . . . . 0.0 109.147 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.1 tp -64.74 -23.35 67.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.706 -0.621 . . . . 0.0 110.233 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.4 51.78 0.28 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.603 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -84.43 144.18 28.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.29 -1.123 . . . . 0.0 109.853 179.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.2 t -136.14 125.18 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.226 -0.921 . . . . 0.0 109.627 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -56.5 -51.46 68.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.967 -0.458 . . . . 0.0 110.547 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.7 p -71.55 48.32 0.14 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.96 -1.088 . . . . 0.0 109.777 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.577 ' HZ1' ' CG ' ' A' ' 41' ' ' ASN . 1.4 ttpm? -177.44 -49.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.76 54.79 31.08 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.603 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -71.21 160.27 33.14 Favored 'General case' 0 C--N 1.29 -2.021 0 O-C-N 121.479 -1.012 . . . . 0.0 110.311 -178.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.575 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 64.9 tp -174.94 -67.26 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.581 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.49 -21.29 51.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.817 -1.177 . . . . 0.0 109.467 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 3.2 p-10 -77.86 -63.42 1.39 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.684 0.754 . . . . 0.0 109.441 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.431 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 22.5 m -76.21 -8.78 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.724 -0.61 . . . . 0.0 109.734 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.13 68.79 8.87 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.148 -0.97 . . . . 0.0 109.292 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -57.26 124.51 16.34 Favored 'Trans proline' 0 N--CA 1.506 2.259 0 C-N-CA 123.306 2.67 . . . . 0.0 113.511 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.538 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 69.86 41.05 74.15 Favored Glycine 0 N--CA 1.501 3.033 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.4 mmtm -139.56 175.85 9.22 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.647 -0.914 . . . . 0.0 110.533 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.1 m -148.74 160.62 43.01 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.493 1.139 . . . . 0.0 110.957 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.0 mm -82.02 127.15 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.786 0.803 . . . . 0.0 110.493 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.33 153.55 9.08 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.31 -17.48 8.47 Favored Glycine 0 N--CA 1.507 3.433 0 O-C-N 121.57 -0.959 . . . . 0.0 110.799 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 1.2 m-20 -69.71 -156.21 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.629 -1.512 . . . . 0.0 109.619 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.83 140.72 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-O 121.604 0.716 . . . . 0.0 110.435 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.668 ' O ' ' N ' ' A' ' 58' ' ' ASN . 9.2 t80 -107.03 88.54 2.76 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.556 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -58.03 38.72 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.826 -0.546 . . . . 0.0 110.675 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.668 ' N ' ' O ' ' A' ' 56' ' ' PHE . 59.9 t30 35.76 38.75 0.06 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.074 -1.016 . . . . 0.0 110.001 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.556 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.2 mtm180 -69.61 41.79 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.745 -1.222 . . . . 0.0 109.832 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.668 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 17.5 mt-10 -148.0 -24.56 0.35 Allowed 'General case' 0 N--CA 1.485 1.285 0 O-C-N 120.698 -1.251 . . . . 0.0 109.717 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.3 27.66 61.37 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.68 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.8 mttp -111.84 7.51 20.15 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.921 -0.752 . . . . 0.0 109.637 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -129.61 143.79 50.36 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.83 123.54 12.48 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 122.613 2.209 . . . . 0.0 112.886 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.506 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -97.94 -174.17 33.3 Favored Glycine 0 N--CA 1.506 3.341 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 68' ' ' GLY . 11.1 tttt 177.62 145.82 0.12 Allowed 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.447 -1.031 . . . . 0.0 108.707 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.0 p -68.71 58.85 0.09 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.888 -1.133 . . . . 0.0 108.767 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 146.67 74.39 0.02 OUTLIER Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.538 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -171.82 167.86 6.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.509 -0.995 . . . . 0.0 109.193 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.455 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 93.0 m -144.06 155.6 44.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 110.331 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.724 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 20.7 m95 -125.41 137.59 54.01 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.559 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -127.57 156.28 42.5 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.869 -1.144 . . . . 0.0 109.054 179.515 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.554 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -121.18 166.86 13.36 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.089 -1.007 . . . . 0.0 111.306 -179.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.52 134.71 3.36 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.313 -0.867 . . . . 0.0 110.979 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.641 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -56.23 152.23 11.27 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.611 0.719 . . . . 0.0 111.449 179.416 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.3 mm -135.5 143.58 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.563 -0.711 . . . . 0.0 110.106 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 58.41 69.47 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.365 0.603 . . . . 0.0 110.497 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.575 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 69.4 t80 -128.24 160.16 32.97 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.244 -0.91 . . . . 0.0 109.631 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 80' ' ' SER . 25.1 p -142.23 -78.5 0.25 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.597 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -148.67 107.95 3.93 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.85 -102.06 0.2 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 51.4 t80 -143.0 -168.52 2.81 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.635 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.4 mtm180 -72.99 -150.61 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.688 -1.257 . . . . 0.0 109.314 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.596 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 10.4 p30 -171.52 -151.28 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.6 p -99.83 -7.23 25.65 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.673 -1.267 . . . . 0.0 110.201 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.606 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -88.51 118.78 28.39 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.132 -0.98 . . . . 0.0 110.276 -178.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.807 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.77 150.32 43.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.429 -0.795 . . . . 0.0 110.014 179.038 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.0 tt -117.02 136.76 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 108.983 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -112.89 124.7 53.2 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.679 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.36 126.72 52.68 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.11 0.957 . . . . 0.0 109.494 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.724 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.7 p -94.39 158.34 15.61 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 122.292 1.044 . . . . 0.0 112.085 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.5 p -68.53 -21.17 64.58 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.538 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.61 10.77 5.45 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.196 -0.94 . . . . 0.0 110.144 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.435 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 76.97 31.12 0.53 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.927 -0.483 . . . . 0.0 110.051 179.513 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.8 mt -103.48 136.26 43.54 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.279 -0.888 . . . . 0.0 109.816 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.437 HG23 HD12 ' A' ' 96' ' ' ILE . 34.1 mm -110.37 120.02 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.248 -0.907 . . . . 0.0 110.204 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.441 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.3 m-85 -120.17 143.47 48.21 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.606 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 7.7 tptp -131.74 147.41 52.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 110.967 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.549 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.2 t -127.79 169.9 13.36 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.1 p -144.79 -2.99 0.8 Allowed 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.663 -0.648 . . . . 0.0 110.22 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.469 ' CG ' ' H ' ' A' ' 105' ' ' THR . 1.1 p30 -115.37 18.79 15.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.596 -1.315 . . . . 0.0 108.566 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 78.9 63.55 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.167 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.68 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 18.0 m-85 69.09 -13.64 0.34 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.899 -0.501 . . . . 0.0 111.736 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -51.46 -73.5 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.384 -1.448 . . . . 0.0 109.8 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.469 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 36.3 p -99.03 -178.48 3.95 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.32 134.24 7.15 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.845 -1.159 . . . . 0.0 110.0 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 78.3 m -127.38 140.66 52.03 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.633 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 15.8 tttp -86.22 139.33 31.14 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.063 -1.023 . . . . 0.0 109.928 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.2 pt -112.43 -31.66 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.695 -0.628 . . . . 0.0 109.728 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.646 HH21 ' CG ' ' A' ' 8' ' ' ASP . 61.8 mtt180 . . . . . 0 C--N 1.306 -1.298 0 O-C-N 120.962 -1.086 . . . . 0.0 108.756 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.638 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 24.1 t . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 tt -171.06 160.84 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -145.98 29.52 1.09 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.473 -1.392 . . . . 0.0 111.465 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.0 p -106.18 156.84 18.04 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.785 0.802 . . . . 0.0 110.05 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.7 p90 -59.91 -62.45 1.86 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.899 -1.126 . . . . 0.0 110.745 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.65 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -55.74 -42.7 75.78 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.35 -0.844 . . . . 0.0 109.565 179.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.0 -44.75 87.96 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.0 t -68.22 -41.05 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 O-C-N 121.58 -0.953 . . . . 0.0 108.771 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.2 -58.29 8.32 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.26 -54.3 17.49 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.402 -0.811 . . . . 0.0 110.087 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.611 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 38.8 t80 -57.32 -50.1 74.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.911 -0.493 . . . . 0.0 110.429 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.85 -43.48 65.42 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.537 -0.727 . . . . 0.0 111.189 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -63.54 -20.1 65.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.31 -1.494 . . . . 0.0 110.314 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.5 m -97.28 -39.9 9.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.048 -1.032 . . . . 0.0 111.219 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.9 16.47 20.35 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.213 -0.93 . . . . 0.0 111.953 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.5 m80 46.82 24.38 0.34 Allowed 'General case' 0 N--CA 1.511 2.606 0 O-C-N 120.414 -1.429 . . . . 0.0 110.599 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 pttp -142.5 152.57 42.82 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.041 -1.037 . . . . 0.0 110.999 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mp -75.45 148.53 83.29 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.313 -0.867 . . . . 0.0 109.442 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.611 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 54.0 Cg_exo -38.74 150.0 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.623 2.882 . . . . 0.0 113.58 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -63.64 46.62 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.572 0.701 . . . . 0.0 110.883 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -169.6 27.22 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.108 -0.995 . . . . 0.0 110.342 179.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -117.56 116.41 27.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.004 -1.06 . . . . 0.0 110.616 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.407 HG22 HD12 ' A' ' 25' ' ' ILE . 31.0 pt -119.11 139.36 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.313 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.1 p -70.33 166.35 20.41 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.056 -1.028 . . . . 0.0 111.206 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.55 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 20.5 mtmt -67.19 -37.41 83.64 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -40.91 -67.08 0.27 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.482 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.9 mt-10 -62.49 -54.46 39.61 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.297 -0.961 . . . . 0.0 108.994 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -39.18 -51.41 1.94 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.699 -1.251 . . . . 0.0 109.136 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.39 -57.63 12.16 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.549 -0.719 . . . . 0.0 111.019 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.9 -30.35 70.12 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 120.545 -1.347 . . . . 0.0 109.13 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.8 tp -61.51 -25.66 67.41 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.672 -0.642 . . . . 0.0 109.517 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.27 49.56 0.27 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.574 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -82.53 144.77 30.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -1.162 . . . . 0.0 109.72 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.0 t -136.73 125.21 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.34 -0.85 . . . . 0.0 109.392 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -57.19 -53.08 62.18 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.2 p -68.07 48.84 0.06 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.061 -1.025 . . . . 0.0 110.211 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.543 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -179.71 -51.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.91 58.15 11.83 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.574 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -72.85 161.98 30.05 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.714 -0.874 . . . . 0.0 110.782 -178.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.541 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.5 tp -174.85 -68.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.372 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.72 -18.65 60.52 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.721 -1.237 . . . . 0.0 109.793 -178.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.9 p-10 -79.56 -60.86 2.19 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.842 0.829 . . . . 0.0 109.285 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.428 ' H ' HG23 ' A' ' 45' ' ' VAL . 12.6 m -75.53 -13.24 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.85 -0.531 . . . . 0.0 109.983 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.57 72.62 9.83 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.46 -0.775 . . . . 0.0 110.011 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.29 124.72 16.83 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.809 2.34 . . . . 0.0 114.407 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.06 39.66 58.1 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -138.65 172.69 12.51 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 122.195 0.998 . . . . 0.0 110.717 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.1 m -146.46 163.05 36.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.631 -1.293 . . . . 0.0 111.273 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.2 mm -83.8 130.02 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.452 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 167.81 154.35 8.62 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.67 -15.03 11.54 Favored Glycine 0 N--CA 1.501 3.031 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.269 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.472 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -72.93 -154.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.63 -1.512 . . . . 0.0 108.585 178.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -126.27 141.85 44.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.34 -0.85 . . . . 0.0 110.732 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.598 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.9 t80 -106.59 90.84 3.46 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.585 0.707 . . . . 0.0 109.106 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.508 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.5 p -61.34 38.94 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.579 0.704 . . . . 0.0 110.741 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.598 ' N ' ' O ' ' A' ' 56' ' ' PHE . 56.9 t30 36.33 35.73 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.131 -0.981 . . . . 0.0 110.505 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.508 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.5 mtm180 -67.17 43.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.915 -1.116 . . . . 0.0 109.872 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.67 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 18.2 mt-10 -150.58 -25.43 0.23 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.468 -0.77 . . . . 0.0 109.943 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.86 27.77 62.06 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.679 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.0 mttp -110.77 6.8 21.74 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.747 -0.855 . . . . 0.0 109.615 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mt -129.76 143.67 49.95 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.547 -0.721 . . . . 0.0 109.69 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.41 123.79 13.07 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.782 2.321 . . . . 0.0 111.913 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -100.48 -172.22 29.48 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 68' ' ' GLY . 9.8 tttt 177.37 146.63 0.12 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.624 -0.927 . . . . 0.0 109.092 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.7 p -68.07 58.7 0.07 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.83 -1.169 . . . . 0.0 109.155 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 144.26 77.47 0.03 OUTLIER Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -171.82 168.04 6.19 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.701 -0.881 . . . . 0.0 108.988 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.442 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 86.6 m -144.18 154.53 43.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.454 -0.779 . . . . 0.0 110.116 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.686 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 18.5 m95 -125.4 139.21 53.86 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.522 ' HG2' ' NH1' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -130.21 155.06 46.89 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 121.01 -1.057 . . . . 0.0 109.578 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.55 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -119.74 167.85 11.65 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.088 -1.008 . . . . 0.0 111.761 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.59 136.21 3.71 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.746 -1.221 . . . . 0.0 110.753 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.689 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -59.19 152.49 20.46 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.236 0.541 . . . . 0.0 111.605 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.415 ' HA ' HD12 ' A' ' 76' ' ' ILE . 42.6 mm -135.74 144.95 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.595 -0.69 . . . . 0.0 110.462 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 57.35 68.53 0.84 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.523 0.677 . . . . 0.0 110.696 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.541 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 66.9 t80 -127.86 159.34 35.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.251 -0.906 . . . . 0.0 109.511 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.613 ' OG1' ' N ' ' A' ' 80' ' ' SER . 26.1 p -140.7 -77.35 0.3 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.613 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -150.09 108.23 3.75 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.19 -102.33 0.21 Allowed Glycine 0 N--CA 1.501 3.028 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.484 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 48.4 t80 -144.04 -169.78 3.19 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.646 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.9 mtm180 -71.66 -156.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.702 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -166.91 -150.06 0.1 Allowed 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.1 p -100.39 -6.84 25.1 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.646 -1.284 . . . . 0.0 110.151 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.671 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -88.03 117.53 26.96 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.285 -0.884 . . . . 0.0 110.764 -178.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.803 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.89 149.12 41.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.74 179.259 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.4 tt -117.56 137.39 51.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -113.97 125.44 54.02 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.682 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -117.92 126.48 52.45 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.791 0.805 . . . . 0.0 108.914 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.686 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 2.1 p -92.43 157.03 16.8 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.985 0.898 . . . . 0.0 111.298 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.1 p -69.92 -19.45 63.39 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.528 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.31 10.43 5.6 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.237 -0.914 . . . . 0.0 109.781 179.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.455 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.0 30.85 0.43 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.881 -0.512 . . . . 0.0 110.004 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 25.8 mt -103.26 138.68 39.71 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.134 -0.979 . . . . 0.0 109.938 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.469 HG23 HD12 ' A' ' 96' ' ' ILE . 32.0 mm -112.63 120.15 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.417 -0.802 . . . . 0.0 110.058 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.437 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.7 m-85 -120.36 142.96 48.68 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.671 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 8.5 tptp -131.0 147.78 52.67 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.167 -0.958 . . . . 0.0 110.835 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.508 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -128.22 171.14 12.24 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.9 p -146.69 -2.63 0.64 Allowed 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.443 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.45 ' CG ' ' H ' ' A' ' 105' ' ' THR . 1.2 p30 -115.95 20.02 14.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.741 -1.224 . . . . 0.0 108.397 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 78.14 61.75 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.619 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.679 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 20.0 m-85 70.45 -13.52 0.45 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.67 -0.644 . . . . 0.0 111.343 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -50.8 -73.62 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.517 -1.365 . . . . 0.0 109.31 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.45 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 37.1 p -99.11 -178.08 3.82 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.3 134.77 7.48 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.167 -0.958 . . . . 0.0 110.028 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 57.8 m -127.67 139.77 52.5 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.624 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 14.2 tttp -85.83 140.05 30.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.803 -1.185 . . . . 0.0 110.416 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.4 pt -113.2 -32.42 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.63 -0.669 . . . . 0.0 109.922 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.65 HH21 ' CG ' ' A' ' 8' ' ' ASP . 69.6 mtt180 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 109.112 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.577 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 39.9 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 tt -171.23 159.69 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -146.77 29.38 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.368 -1.458 . . . . 0.0 110.61 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.9 p -105.48 157.42 17.37 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.545 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -60.06 -61.89 2.27 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.85 -1.156 . . . . 0.0 110.43 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.618 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.51 -40.75 79.41 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.053 -1.029 . . . . 0.0 109.317 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.13 -45.13 94.35 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 68.8 t -66.55 -40.73 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.388 -1.066 . . . . 0.0 109.179 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -63.06 -57.38 10.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.72 -0.612 . . . . 0.0 109.392 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.82 -52.1 51.71 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.627 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 33.3 t80 -58.45 -49.67 76.47 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.333 0.587 . . . . 0.0 111.188 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.2 tt -72.25 -45.89 58.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.561 -0.712 . . . . 0.0 110.749 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 11' ' ' ALA . 64.2 mt-30 -61.0 -20.05 62.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.354 -1.466 . . . . 0.0 110.587 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 m -97.97 -40.77 8.31 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.486 -1.384 . . . . 0.0 111.194 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -110.36 16.12 21.84 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.781 -1.199 . . . . 0.0 111.714 -177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.0 m80 46.03 24.61 0.26 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.367 -0.833 . . . . 0.0 110.643 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 3.8 pttp -142.41 154.33 44.5 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.688 0.756 . . . . 0.0 110.511 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.2 149.28 79.18 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.707 -0.62 . . . . 0.0 109.686 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.627 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 51.6 Cg_exo -39.67 147.68 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.556 2.837 . . . . 0.0 113.718 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -63.8 47.55 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.084 0.945 . . . . 0.0 110.936 -177.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.478 ' HB2' ' HA ' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -169.11 27.08 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.087 -1.008 . . . . 0.0 110.811 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -117.99 118.26 31.46 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.705 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.463 HG22 HD12 ' A' ' 25' ' ' ILE . 28.8 pt -120.12 137.39 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.44 ' CB ' ' HG ' ' A' ' 28' ' ' SER . 7.2 p -67.78 169.8 9.04 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.498 1.142 . . . . 0.0 111.259 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.557 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 24.1 mtmt -71.61 -37.53 70.93 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -39.67 -70.43 0.1 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 175.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.522 ' O ' ' C ' ' A' ' 30' ' ' ALA . 3.5 mt-10 -58.57 -58.76 7.15 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.63 -51.55 1.21 Allowed 'General case' 0 N--CA 1.508 2.46 0 O-C-N 119.075 -2.265 . . . . 0.0 110.348 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -58.15 -58.64 7.55 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.091 -1.006 . . . . 0.0 110.171 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.48 69.81 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 121.119 -0.988 . . . . 0.0 110.452 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.6 tp -55.12 -28.61 53.93 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.504 0.669 . . . . 0.0 110.23 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.29 51.05 0.25 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.534 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.71 144.94 30.79 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.277 -1.131 . . . . 0.0 109.375 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.8 t -137.45 127.03 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.556 -0.715 . . . . 0.0 110.132 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -56.98 -52.55 64.82 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.991 -0.443 . . . . 0.0 110.581 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.6 p -70.05 47.31 0.08 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.196 -0.94 . . . . 0.0 110.377 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.624 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.5 ttpm? -176.35 -51.1 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.16 56.43 20.46 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.624 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -69.92 161.77 29.32 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.659 -0.907 . . . . 0.0 110.521 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.523 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 60.1 tp -176.26 -65.95 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.557 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.17 -19.4 63.05 Favored 'General case' 0 C--O 1.197 -1.666 0 O-C-N 121.305 -0.872 . . . . 0.0 109.504 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.6 p-10 -80.06 -64.42 1.19 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.993 0.902 . . . . 0.0 108.637 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.452 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 30.5 m -73.89 -11.45 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.705 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.57 72.15 11.68 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.506 -0.746 . . . . 0.0 109.939 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.4 122.43 11.66 Favored 'Trans proline' 0 N--CA 1.512 2.601 0 C-N-CA 123.472 2.781 . . . . 0.0 114.219 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.418 ' C ' ' HG2' ' A' ' 49' ' ' LYS . . . 73.41 39.46 50.83 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 8.6 mmtm -138.68 176.44 8.7 Favored 'General case' 0 N--CA 1.512 2.669 0 CA-C-O 122.513 1.149 . . . . 0.0 111.009 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.1 m -148.57 162.91 38.71 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 120.203 -1.56 . . . . 0.0 110.783 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.1 mm -85.59 125.31 40.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.128 -0.983 . . . . 0.0 109.77 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.22 154.02 10.45 Favored Glycine 0 N--CA 1.503 3.138 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.42 -17.42 8.41 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.906 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -69.79 -154.49 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.839 -1.389 . . . . 0.0 109.835 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.9 mp -127.69 139.8 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 121.805 0.812 . . . . 0.0 110.855 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.628 ' C ' ' H ' ' A' ' 58' ' ' ASN . 9.0 t80 -105.2 90.05 3.31 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.38 -0.825 . . . . 0.0 108.816 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.541 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.5 p -59.34 36.04 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 121.393 0.616 . . . . 0.0 110.524 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.628 ' H ' ' C ' ' A' ' 56' ' ' PHE . 59.2 t30 39.38 34.68 0.14 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.075 -1.016 . . . . 0.0 110.325 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.541 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.3 mtm180 -66.58 45.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.547 -1.345 . . . . 0.0 110.066 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.661 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 18.5 mt-10 -151.53 -27.07 0.19 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.526 -0.733 . . . . 0.0 110.142 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.32 27.76 59.11 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.674 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.6 mttp -111.13 7.79 21.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.723 -0.869 . . . . 0.0 109.757 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.31 144.88 55.04 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.608 -0.683 . . . . 0.0 109.247 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.57 125.15 14.97 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.672 2.248 . . . . 0.0 112.289 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.541 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.82 -171.41 27.7 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 68' ' ' GLY . 12.1 tttt 176.37 146.67 0.09 Allowed 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.405 -1.056 . . . . 0.0 109.144 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.1 p -68.88 61.29 0.1 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.763 -1.211 . . . . 0.0 108.951 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 142.99 76.73 0.04 OUTLIER Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.568 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.92 168.25 4.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.54 -0.976 . . . . 0.0 109.195 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.446 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 93.4 m -144.5 155.86 43.9 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.463 -0.773 . . . . 0.0 109.897 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.693 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 19.8 m95 -126.55 137.6 53.37 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.553 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -128.84 156.55 43.46 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.993 -1.067 . . . . 0.0 109.091 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.557 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -121.28 167.4 12.77 Favored 'General case' 0 N--CA 1.513 2.676 0 CA-C-O 122.274 1.035 . . . . 0.0 111.402 -179.322 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -166.29 136.84 3.42 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.276 -0.89 . . . . 0.0 111.308 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.677 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -59.5 153.69 18.93 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.648 0.737 . . . . 0.0 111.584 -179.344 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.408 ' HA ' HD12 ' A' ' 76' ' ' ILE . 40.6 mm -136.76 142.84 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.77 -0.581 . . . . 0.0 110.764 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 59.26 65.79 1.13 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.436 0.636 . . . . 0.0 110.665 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.523 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 63.1 t80 -125.2 159.78 30.75 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.298 -0.876 . . . . 0.0 109.566 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' A' ' 80' ' ' SER . 28.1 p -139.99 -77.38 0.32 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.583 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.1 OUTLIER -149.53 112.12 4.76 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.06 -104.83 0.26 Allowed Glycine 0 N--CA 1.502 3.049 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.462 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 44.3 t80 -141.43 -169.77 2.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.861 -0.787 . . . . 0.0 109.286 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.651 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.7 mtm180 -71.1 -155.0 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 O-C-N 120.81 -1.181 . . . . 0.0 109.539 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -168.77 -151.99 0.1 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.5 p -99.72 -3.5 32.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.62 -1.3 . . . . 0.0 110.335 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.604 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -91.28 117.07 29.34 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.251 -0.906 . . . . 0.0 110.283 -179.134 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.802 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.1 150.22 44.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.329 -0.857 . . . . 0.0 109.56 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.2 tt -119.06 137.38 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -114.47 125.72 54.14 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.7 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.56 127.83 53.99 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.752 0.786 . . . . 0.0 109.279 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.693 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.5 p -94.12 159.14 15.28 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.282 1.039 . . . . 0.0 112.329 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.5 p -69.87 -19.52 63.43 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.568 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -83.16 10.44 8.28 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.732 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.464 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.39 31.29 0.48 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.726 -0.609 . . . . 0.0 109.988 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.1 mt -103.43 138.34 40.29 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.46 -0.775 . . . . 0.0 109.833 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.447 HG23 HD12 ' A' ' 96' ' ' ILE . 31.9 mm -112.35 119.51 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.794 -0.566 . . . . 0.0 110.139 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.408 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.0 m-85 -120.62 143.55 48.61 Favored 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.604 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 7.7 tptp -131.12 148.09 52.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.02 -1.05 . . . . 0.0 110.299 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.553 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -127.68 171.9 11.26 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.3 p -146.73 -1.85 0.67 Allowed 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.147 -0.971 . . . . 0.0 110.281 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.2 p30 -117.13 20.27 13.83 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.717 -1.239 . . . . 0.0 108.433 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 77.07 64.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.409 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.674 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 18.9 m-85 68.96 -12.87 0.37 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 122.195 -0.316 . . . . 0.0 111.793 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -51.66 -72.75 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.478 -1.389 . . . . 0.0 109.58 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.432 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 37.3 p -100.07 -179.12 4.05 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.12 135.42 9.1 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.038 -1.039 . . . . 0.0 109.954 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 64.0 m -128.8 139.51 52.15 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.62 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 15.5 tttp -86.1 139.19 31.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.839 -1.163 . . . . 0.0 110.314 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.5 pt -112.7 -31.55 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.831 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.62 ' C ' ' HZ3' ' A' ' 108' ' ' LYS . 68.2 mtt180 . . . . . 0 C--N 1.306 -1.298 0 O-C-N 121.131 -0.981 . . . . 0.0 109.167 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.592 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 22.0 t . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 tt -169.94 160.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -146.53 30.2 1.01 Allowed 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.255 -1.528 . . . . 0.0 111.637 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.3 p -104.16 158.32 16.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.517 -0.739 . . . . 0.0 109.526 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.7 p90 -60.35 -61.67 2.43 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.617 -1.302 . . . . 0.0 110.872 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.615 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -56.69 -41.67 77.74 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.145 -0.972 . . . . 0.0 109.618 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.27 -45.21 94.46 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.72 -41.5 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 O-C-N 121.109 -1.23 . . . . 0.0 108.101 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.36 -59.38 5.37 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.48 -52.17 31.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.058 -1.026 . . . . 0.0 109.973 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.645 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 36.3 t80 -59.58 -47.98 83.46 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.291 -0.881 . . . . 0.0 110.628 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.7 tt -72.9 -44.38 61.34 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.382 -0.824 . . . . 0.0 110.841 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -62.73 -22.62 66.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.554 -1.341 . . . . 0.0 110.379 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.2 m -94.88 -42.11 8.85 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.957 -1.089 . . . . 0.0 111.048 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -109.49 16.83 21.98 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.127 -0.983 . . . . 0.0 112.214 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 m80 46.84 24.35 0.34 Allowed 'General case' 0 N--CA 1.51 2.56 0 O-C-N 120.94 -1.1 . . . . 0.0 110.584 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.2 pttp -141.39 151.45 43.49 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.241 1.02 . . . . 0.0 110.296 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp -75.44 150.39 84.75 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.033 -1.042 . . . . 0.0 108.725 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.645 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 50.7 Cg_exo -40.33 151.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 123.344 2.696 . . . . 0.0 114.35 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -66.38 47.6 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.6 0.714 . . . . 0.0 111.312 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.419 ' HB2' ' HA ' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -170.22 27.65 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 109.189 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -119.25 118.26 30.8 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.714 -1.241 . . . . 0.0 110.098 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 25' ' ' ILE . 33.8 pt -119.89 138.73 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.307 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.0 p -69.01 166.97 16.91 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.936 -1.102 . . . . 0.0 110.875 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.591 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 22.9 mtmt -70.38 -34.59 72.75 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.31 -66.99 0.32 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' ' 30' ' ' ALA . 3.4 mt-10 -60.35 -58.3 9.1 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.439 -1.304 . . . . 0.0 108.288 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.66 -52.46 1.23 Allowed 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.007 -1.058 . . . . 0.0 109.241 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -59.0 -55.98 28.15 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.563 -0.711 . . . . 0.0 110.511 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.26 -29.1 70.17 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 120.652 -1.28 . . . . 0.0 108.964 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.9 tp -62.38 -27.36 69.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.648 -0.657 . . . . 0.0 109.471 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.84 52.73 0.23 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.557 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -83.07 146.77 28.51 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.317 -1.108 . . . . 0.0 109.693 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -135.77 125.16 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.325 -0.859 . . . . 0.0 109.187 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -58.82 -52.56 65.21 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.831 -0.543 . . . . 0.0 109.724 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.9 p -70.37 50.98 0.12 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.001 -1.062 . . . . 0.0 109.412 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.645 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -179.69 -50.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.41 56.99 20.29 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.645 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -72.14 164.42 26.22 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.834 -0.803 . . . . 0.0 110.784 -178.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.612 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 66.6 tp -178.64 -66.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.001 -1.062 . . . . 0.0 110.004 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.98 -23.12 63.36 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.098 -1.001 . . . . 0.0 109.711 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 45' ' ' VAL . 5.5 p-10 -76.39 -64.11 1.18 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.003 0.906 . . . . 0.0 109.497 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.448 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 15.3 m -76.21 -10.92 13.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.853 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.62 70.14 11.41 Favored Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.348 -0.845 . . . . 0.0 109.431 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -57.04 123.57 14.16 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 123.182 2.588 . . . . 0.0 113.673 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.487 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 73.88 36.45 52.51 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.487 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 8.5 mmtm -138.57 168.97 18.63 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 121.885 0.85 . . . . 0.0 111.205 -178.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.3 m -142.48 162.02 36.56 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.277 1.037 . . . . 0.0 111.089 -177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.1 mm -84.47 126.93 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 122.1 0.952 . . . . 0.0 110.327 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.36 153.74 9.24 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.57 -20.46 7.82 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.329 -1.415 . . . . 0.0 110.782 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.449 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -68.33 -154.42 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 118.686 1.243 . . . . 0.0 109.01 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.66 139.65 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-O 121.864 0.84 . . . . 0.0 111.219 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.625 ' C ' ' H ' ' A' ' 58' ' ' ASN . 8.5 t80 -104.05 89.96 3.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.341 -0.85 . . . . 0.0 109.304 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.505 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.3 p -58.99 35.16 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.603 -0.686 . . . . 0.0 110.888 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.625 ' H ' ' C ' ' A' ' 56' ' ' PHE . 55.2 t30 38.34 39.7 0.3 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.107 -0.996 . . . . 0.0 109.878 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.505 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 8.9 mtm180 -70.29 43.33 0.06 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.562 -1.336 . . . . 0.0 110.087 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.66 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 21.7 mt-10 -149.38 -25.32 0.28 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.332 -0.855 . . . . 0.0 109.943 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.59 28.74 58.92 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.66 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 8.5 mttp -111.3 7.93 21.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.508 -0.995 . . . . 0.0 109.713 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mt -131.0 144.04 51.91 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.602 -0.686 . . . . 0.0 109.493 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.33 124.98 15.8 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.819 2.346 . . . . 0.0 112.408 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.543 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.1 -173.22 28.82 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 68' ' ' GLY . 11.0 tttt 177.29 144.24 0.09 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.375 -1.074 . . . . 0.0 108.656 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.2 p -68.1 58.58 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.936 -1.102 . . . . 0.0 109.172 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 147.64 75.51 0.02 OUTLIER Glycine 0 N--CA 1.5 2.913 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.564 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.56 168.11 5.37 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.711 -0.876 . . . . 0.0 109.33 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 87.9 m -143.39 155.09 44.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.486 -0.759 . . . . 0.0 110.039 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.699 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 17.9 m95 -125.21 138.34 54.12 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.558 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -129.47 156.14 44.59 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 120.747 -1.221 . . . . 0.0 109.586 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.591 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -120.47 167.66 12.13 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.259 -0.901 . . . . 0.0 112.026 -179.37 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -166.65 135.71 2.94 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.135 -0.978 . . . . 0.0 110.714 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.633 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -58.59 153.33 16.53 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.343 0.592 . . . . 0.0 111.676 -179.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.9 mm -136.02 140.67 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.49 0.662 . . . . 0.0 110.37 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 60.49 68.98 0.72 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.679 -0.638 . . . . 0.0 110.403 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.612 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 61.2 t80 -126.13 159.45 32.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.349 -0.844 . . . . 0.0 109.636 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.601 ' OG1' ' N ' ' A' ' 80' ' ' SER . 31.2 p -139.8 -78.25 0.32 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.601 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -150.84 107.44 3.51 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.94 -107.41 0.31 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 52.1 t80 -139.29 -166.93 2.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.734 -0.862 . . . . 0.0 108.843 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.648 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.3 mtm180 -73.91 -157.31 0.05 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.0 -1.062 . . . . 0.0 109.53 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -166.64 -153.14 0.15 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 100' ' ' THR . 50.7 p -98.22 -9.64 25.3 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.457 -1.402 . . . . 0.0 110.727 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.64 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -86.06 117.71 25.07 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.066 -1.021 . . . . 0.0 111.096 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.784 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.65 148.45 42.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.405 -0.81 . . . . 0.0 109.552 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.5 tt -115.93 139.54 42.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -116.05 125.43 52.42 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.671 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -117.55 127.52 54.06 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.856 0.836 . . . . 0.0 109.355 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.699 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 8.6 p -94.58 157.7 15.86 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.122 0.963 . . . . 0.0 111.944 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.1 p -69.01 -20.1 64.14 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.564 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -82.18 9.72 8.15 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.3 -0.875 . . . . 0.0 110.033 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.451 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.25 29.35 0.45 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.714 -0.616 . . . . 0.0 110.449 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.2 mt -101.87 135.99 42.47 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.437 -0.79 . . . . 0.0 109.985 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.469 HG23 HD12 ' A' ' 96' ' ' ILE . 31.4 mm -110.2 119.74 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.515 -0.74 . . . . 0.0 110.115 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.433 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.3 m-85 -119.04 143.14 47.27 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.64 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 8.5 tptp -132.45 147.49 52.37 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.823 -1.173 . . . . 0.0 110.537 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.476 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.5 t -129.39 171.04 12.92 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.403 ' O ' ' OG ' ' A' ' 85' ' ' SER . 72.3 p -145.22 -3.65 0.74 Allowed 'General case' 0 N--CA 1.508 2.472 0 O-C-N 121.45 -0.781 . . . . 0.0 110.234 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.2 p30 -114.53 19.37 16.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.756 -1.215 . . . . 0.0 108.924 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 77.87 63.69 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.054 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.648 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 18.5 m-85 69.5 -14.48 0.33 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.813 -0.554 . . . . 0.0 111.87 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -49.96 -74.27 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.538 -1.351 . . . . 0.0 109.314 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.419 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 38.0 p -99.03 -177.17 3.54 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.791 -1.193 . . . . 0.0 108.319 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.23 134.33 7.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -0.983 . . . . 0.0 110.236 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.6 m -127.3 139.99 52.51 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.606 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 15.2 tttp -86.37 140.21 30.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.8 -1.187 . . . . 0.0 110.364 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.6 pt -113.68 -31.71 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.438 -0.788 . . . . 0.0 110.074 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.615 HH21 ' CG ' ' A' ' 8' ' ' ASP . 67.6 mtt180 . . . . . 0 N--CA 1.485 1.317 0 O-C-N 121.068 -1.02 . . . . 0.0 108.659 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.638 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.8 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 tt -169.4 159.69 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.365 -0.835 . . . . 0.0 109.342 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -146.67 31.07 0.97 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.512 -1.368 . . . . 0.0 111.357 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.7 p -106.08 155.97 18.88 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.599 -0.688 . . . . 0.0 109.865 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.3 p90 -58.44 -62.18 2.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.195 -0.941 . . . . 0.0 110.725 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.621 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.9 OUTLIER -58.15 -41.13 83.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.353 -0.842 . . . . 0.0 109.526 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.92 -44.91 87.56 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.3 t -67.95 -41.99 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.46 -57.02 12.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.473 -0.767 . . . . 0.0 109.21 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.08 -55.22 15.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.474 -0.766 . . . . 0.0 109.692 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.638 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 33.9 t80 -56.45 -49.88 73.32 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.249 0.547 . . . . 0.0 110.802 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -73.22 -44.55 59.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.376 -0.828 . . . . 0.0 110.709 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -62.26 -21.12 64.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.566 -1.334 . . . . 0.0 110.298 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.6 m -97.26 -40.92 8.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.174 -0.954 . . . . 0.0 110.742 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -109.16 14.42 23.9 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.118 -0.989 . . . . 0.0 111.908 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.1 m80 46.51 25.57 0.41 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 120.864 -1.147 . . . . 0.0 109.669 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.592 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 5.0 pttp -142.27 152.2 42.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.315 -0.866 . . . . 0.0 110.004 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp -76.88 149.36 80.24 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 109.066 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.638 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 66.1 Cg_exo -40.76 150.71 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.734 2.289 . . . . 0.0 113.23 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -62.59 47.14 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.601 0.715 . . . . 0.0 111.12 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -168.42 26.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.6 -1.313 . . . . 0.0 110.286 179.121 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -116.69 113.05 22.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.88 -1.137 . . . . 0.0 110.886 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.478 HG22 HD12 ' A' ' 25' ' ' ILE . 28.3 pt -116.18 138.59 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.325 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.454 ' CB ' ' HG ' ' A' ' 28' ' ' SER . 4.4 p -69.73 166.62 18.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.018 -1.051 . . . . 0.0 110.37 -176.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.586 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 18.7 mtmt -66.29 -35.4 80.29 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.454 ' HG ' ' CB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -41.89 -66.33 0.36 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.625 178.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.4 mt-10 -65.33 -49.3 69.95 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.301 -0.959 . . . . 0.0 109.192 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -44.24 -50.0 9.04 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.79 -1.194 . . . . 0.0 107.997 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -59.2 -57.6 12.33 Favored 'General case' 0 N--CA 1.509 2.506 0 O-C-N 121.36 -0.838 . . . . 0.0 110.733 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.34 -30.91 69.83 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.994 -1.066 . . . . 0.0 109.807 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.0 tp -63.11 -25.82 68.54 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.96 50.16 0.23 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.593 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.91 144.1 31.2 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.369 -1.077 . . . . 0.0 110.146 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.0 t -134.52 125.3 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.174 -0.954 . . . . 0.0 109.699 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -58.73 -52.83 64.02 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.55 -0.719 . . . . 0.0 109.812 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 59.6 p -68.56 50.2 0.07 Allowed 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.982 -1.073 . . . . 0.0 109.133 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.567 ' HZ1' ' CG ' ' A' ' 41' ' ' ASN . 1.0 OUTLIER -179.34 -50.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -0.774 . . . . 0.0 108.964 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.95 56.86 18.4 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.593 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -74.27 162.76 28.59 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.443 -1.034 . . . . 0.0 110.773 -178.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.604 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 65.4 tp -176.12 -67.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.547 -0.72 . . . . 0.0 109.798 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HB3' ' HA ' ' A' ' 80' ' ' SER . . . -60.63 -18.86 55.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.962 -1.086 . . . . 0.0 109.935 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.8 p-10 -79.45 -65.1 1.04 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.843 0.83 . . . . 0.0 109.552 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.49 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 30.7 m -73.33 -10.89 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 O-C-N 121.743 -0.598 . . . . 0.0 110.353 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.83 71.87 9.59 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 109.785 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.36 122.56 12.0 Favored 'Trans proline' 0 N--CA 1.509 2.392 0 C-N-CA 123.977 3.118 . . . . 0.0 113.562 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.74 39.76 59.46 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 7.2 mmtt -136.6 176.08 9.03 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.052 0.929 . . . . 0.0 110.597 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.0 m -150.13 158.82 44.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.785 -1.197 . . . . 0.0 111.167 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.3 mm -82.45 130.37 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.548 0.69 . . . . 0.0 110.121 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.4 154.83 8.5 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.89 -16.53 10.2 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 120.293 -0.956 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.411 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -70.55 -152.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.748 -1.443 . . . . 0.0 109.603 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -128.93 138.84 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.522 0.677 . . . . 0.0 110.821 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.605 ' C ' ' H ' ' A' ' 58' ' ' ASN . 11.0 t80 -104.09 90.31 3.55 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.661 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.3 36.2 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.47 0.653 . . . . 0.0 111.182 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.605 ' H ' ' C ' ' A' ' 56' ' ' PHE . 53.5 t30 36.58 38.4 0.08 Allowed 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.94 -1.1 . . . . 0.0 110.541 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.661 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.8 mtm180 -69.51 39.07 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.672 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 18.9 mt-10 -149.05 -10.9 0.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.182 -0.949 . . . . 0.0 110.246 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.78 33.23 84.53 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.672 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 7.1 mttp -115.1 8.6 15.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.613 -0.934 . . . . 0.0 109.446 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -132.81 142.94 46.59 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.446 -0.784 . . . . 0.0 109.349 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.86 125.99 17.84 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.885 2.39 . . . . 0.0 112.394 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.539 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.0 -170.99 28.63 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.559 ' O ' ' N ' ' A' ' 68' ' ' GLY . 11.1 tttt 175.52 144.08 0.07 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.149 -1.206 . . . . 0.0 108.269 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.2 p -66.09 57.05 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.838 -1.164 . . . . 0.0 108.427 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 147.63 77.34 0.02 OUTLIER Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.539 ' NH1' ' O ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -173.54 167.78 4.56 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.551 -0.97 . . . . 0.0 108.974 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.431 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 85.6 m -144.36 155.87 43.98 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.811 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.717 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 25.6 m95 -126.32 138.73 53.61 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.585 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.38 154.31 47.81 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.544 -1.347 . . . . 0.0 109.606 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.586 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -118.35 167.0 11.97 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.195 -0.94 . . . . 0.0 111.815 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.13 136.13 3.97 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.797 0.808 . . . . 0.0 110.967 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.664 ' CG ' ' HE ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -60.73 151.69 28.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.613 -0.679 . . . . 0.0 111.938 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.453 HG13 ' HB ' ' A' ' 88' ' ' ILE . 40.4 mm -137.15 143.82 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 121.476 0.655 . . . . 0.0 110.18 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 60.25 66.08 1.0 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.234 0.54 . . . . 0.0 110.576 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.604 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 58.0 t80 -126.79 161.63 27.74 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.156 -0.965 . . . . 0.0 109.122 178.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.634 ' OG1' ' N ' ' A' ' 80' ' ' SER . 27.2 p -141.38 -78.96 0.26 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.634 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.1 OUTLIER -149.27 106.08 3.56 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.51 -107.09 0.3 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 49.1 t80 -135.82 -166.02 1.79 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.721 -0.87 . . . . 0.0 108.771 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.658 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.8 mtm180 -75.16 -153.04 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.916 -1.115 . . . . 0.0 109.077 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -168.41 -150.3 0.09 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.3 p -100.87 -8.36 22.64 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.464 -1.397 . . . . 0.0 110.335 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.625 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -86.5 116.75 24.85 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.386 -0.821 . . . . 0.0 110.741 -178.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.8 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.22 149.47 44.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.251 -0.906 . . . . 0.0 109.698 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.453 ' HB ' HG13 ' A' ' 76' ' ' ILE . 10.5 tt -119.64 136.1 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.621 0.724 . . . . 0.0 109.125 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -112.66 124.65 53.03 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -116.69 127.84 54.78 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.691 0.758 . . . . 0.0 109.002 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.717 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 5.7 p -93.78 158.72 15.53 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.995 0.903 . . . . 0.0 111.91 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.7 p -69.39 -19.94 63.81 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.524 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.72 9.28 8.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.471 -0.768 . . . . 0.0 109.898 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.78 30.32 0.47 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.621 -0.674 . . . . 0.0 110.024 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.8 mt -102.87 137.57 40.9 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.342 -0.849 . . . . 0.0 110.388 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.413 HG23 HD12 ' A' ' 96' ' ' ILE . 35.9 mm -110.42 118.95 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.306 -0.872 . . . . 0.0 110.691 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.455 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 6.9 m-85 -119.09 141.61 48.61 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.625 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 6.2 tptp -131.37 148.26 52.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.417 -0.802 . . . . 0.0 110.896 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.518 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.7 t -128.66 172.46 11.2 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.9 p -146.87 -3.21 0.6 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.523 -0.735 . . . . 0.0 110.487 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 105' ' ' THR . 1.3 p30 -115.54 22.5 13.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.785 -1.197 . . . . 0.0 108.296 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 75.76 62.17 0.05 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.495 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.67 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 17.6 m-85 69.59 -10.87 0.55 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.701 -0.624 . . . . 0.0 111.414 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.72 -72.87 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.695 -1.253 . . . . 0.0 109.213 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.471 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 34.9 p -99.39 -178.37 3.88 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.65 133.48 6.41 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.071 -1.018 . . . . 0.0 109.794 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.9 m -127.28 141.49 51.7 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.618 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 13.5 tttp -86.77 139.03 31.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.873 -1.142 . . . . 0.0 110.093 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.3 pt -112.11 -32.26 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.606 -0.684 . . . . 0.0 109.432 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.621 HH21 ' CG ' ' A' ' 8' ' ' ASP . 56.3 mtt180 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 118.086 -0.959 . . . . 0.0 109.049 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.622 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.2 t . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 tt -169.78 160.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.4 -0.812 . . . . 0.0 109.219 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -147.26 30.33 0.94 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.339 -1.475 . . . . 0.0 111.129 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.9 p -104.86 156.25 18.18 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.744 0.783 . . . . 0.0 109.792 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.5 p90 -59.65 -61.38 2.66 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.729 -1.232 . . . . 0.0 110.143 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.642 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.74 -41.53 82.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.337 -0.852 . . . . 0.0 109.388 -179.597 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.5 -44.77 93.62 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.6 t -67.54 -41.66 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 121.43 -1.041 . . . . 0.0 108.662 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.47 -58.09 9.55 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.17 -54.86 14.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.362 -0.836 . . . . 0.0 109.633 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.519 ' CE1' ' HA ' ' A' ' 21' ' ' PRO . 34.1 t80 -57.6 -47.36 82.37 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.118 0.485 . . . . 0.0 110.754 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt -74.21 -44.37 53.52 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.246 -0.909 . . . . 0.0 110.717 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -62.98 -19.94 64.8 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.436 -1.415 . . . . 0.0 110.13 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.4 m -96.8 -43.33 7.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.987 -1.071 . . . . 0.0 111.01 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -107.77 13.12 26.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.153 -0.967 . . . . 0.0 111.894 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.2 m80 49.2 23.91 0.88 Allowed 'General case' 0 N--CA 1.508 2.426 0 O-C-N 120.692 -1.255 . . . . 0.0 109.902 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.469 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.5 pttp -141.48 153.63 45.06 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.2 mp -77.78 149.71 77.8 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.344 -0.847 . . . . 0.0 109.038 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.519 ' HA ' ' CE1' ' A' ' 13' ' ' TYR . 77.2 Cg_exo -39.34 151.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 123.133 2.555 . . . . 0.0 113.567 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -63.45 47.83 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.637 0.732 . . . . 0.0 110.538 179.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -169.88 26.95 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.846 -1.159 . . . . 0.0 110.328 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -118.48 114.01 22.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.482 -1.387 . . . . 0.0 110.227 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.421 HG22 HD12 ' A' ' 25' ' ' ILE . 35.4 pt -117.26 140.63 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.024 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.8 p -70.19 166.8 19.23 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.325 1.06 . . . . 0.0 111.684 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.577 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 20.6 mtmt -68.58 -35.57 77.55 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.73 -65.47 0.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.425 176.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.458 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.6 mt-10 -64.4 -52.02 60.3 Favored 'General case' 0 C--O 1.201 -1.466 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.624 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -41.71 -51.65 4.06 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.858 -1.152 . . . . 0.0 109.047 177.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -60.0 -56.73 18.08 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.372 -0.83 . . . . 0.0 110.895 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.9 -30.61 69.14 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.589 -1.319 . . . . 0.0 109.024 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.1 tp -63.48 -29.83 71.04 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.405 0.621 . . . . 0.0 109.439 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.34 55.01 0.15 Allowed Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.595 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -88.08 145.61 25.86 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.294 -1.121 . . . . 0.0 109.505 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -135.45 124.31 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.427 -0.795 . . . . 0.0 109.414 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.434 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -56.89 -53.21 60.54 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.708 -0.62 . . . . 0.0 109.716 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 81.0 p -68.54 48.53 0.06 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.462 -0.774 . . . . 0.0 109.834 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.641 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.4 ttpm? -178.29 -50.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.53 56.05 23.78 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.641 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -73.24 161.24 30.76 Favored 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.517 -0.99 . . . . 0.0 111.155 -178.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.526 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.5 tp -173.17 -68.18 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.117 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.51 -18.93 55.09 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.169 -0.957 . . . . 0.0 109.779 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.2 p-10 -78.38 -63.9 1.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.66 0.743 . . . . 0.0 109.36 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.43 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 26.6 m -75.6 -10.13 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.919 -0.488 . . . . 0.0 110.381 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.74 71.21 9.65 Favored Pre-proline 0 N--CA 1.486 1.346 0 O-C-N 121.514 -0.741 . . . . 0.0 109.589 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.9 124.37 16.08 Favored 'Trans proline' 0 N--CA 1.505 2.185 0 C-N-CA 123.517 2.812 . . . . 0.0 113.872 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.475 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 72.15 38.69 59.15 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.475 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.9 mmtm -137.02 171.25 14.79 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 121.691 0.758 . . . . 0.0 110.167 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.0 m -144.35 162.24 36.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.146 -0.971 . . . . 0.0 110.302 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.7 mm -84.63 127.87 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.631 0.729 . . . . 0.0 110.156 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.97 155.34 10.9 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.63 -15.94 9.71 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.695 -1.24 . . . . 0.0 111.053 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.46 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -71.75 -155.14 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.766 -1.432 . . . . 0.0 109.321 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.16 140.27 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.76 0.791 . . . . 0.0 110.393 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.615 ' C ' ' H ' ' A' ' 58' ' ' ASN . 9.7 t80 -105.61 91.16 3.64 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.55 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -60.52 36.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.605 -0.684 . . . . 0.0 110.828 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.615 ' H ' ' C ' ' A' ' 56' ' ' PHE . 51.7 t30 38.94 36.88 0.17 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.123 -0.985 . . . . 0.0 110.358 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.55 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.6 mtm180 -69.43 42.3 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.885 -1.134 . . . . 0.0 109.564 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.68 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 17.8 mt-10 -150.18 -15.46 0.25 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.411 -0.806 . . . . 0.0 110.254 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.43 32.1 83.08 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.68 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 7.1 mttp -113.63 6.53 16.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.717 -0.873 . . . . 0.0 109.304 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.7 144.01 51.66 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.659 -0.651 . . . . 0.0 109.39 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.48 124.52 14.38 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.984 2.456 . . . . 0.0 112.051 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.52 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.03 -172.5 28.81 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 68' ' ' GLY . 10.9 tttt 177.07 146.47 0.11 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.366 -1.079 . . . . 0.0 108.955 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.2 p -68.57 60.21 0.09 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.956 -1.09 . . . . 0.0 108.784 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 144.18 77.05 0.03 OUTLIER Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.541 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -173.69 167.29 4.51 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.586 -0.949 . . . . 0.0 109.208 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 92.4 m -143.81 156.67 44.56 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.23 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.707 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 22.6 m95 -127.11 138.21 53.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.052 -0.405 . . . . 0.0 109.947 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.533 ' HG2' ' NH1' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -130.04 154.19 47.67 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.89 -1.131 . . . . 0.0 109.733 179.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.577 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -118.28 166.9 12.07 Favored 'General case' 0 N--CA 1.509 2.488 0 CA-C-O 121.768 0.794 . . . . 0.0 112.064 -179.051 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.18 134.56 3.51 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.282 -0.886 . . . . 0.0 111.31 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.661 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.46 153.13 13.27 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.268 0.556 . . . . 0.0 111.372 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.401 HD12 ' HA ' ' A' ' 76' ' ' ILE . 42.3 mm -135.98 143.45 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.769 -0.582 . . . . 0.0 109.977 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 57.96 69.75 0.71 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.497 0.665 . . . . 0.0 110.576 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.526 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 65.8 t80 -127.88 160.19 32.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.375 -0.828 . . . . 0.0 109.344 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.613 ' OG1' ' N ' ' A' ' 80' ' ' SER . 29.9 p -141.5 -78.94 0.26 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.613 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.4 OUTLIER -150.5 105.21 3.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.787 -0.571 . . . . 0.0 110.2 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.5 -98.85 0.17 Allowed Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.473 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 46.0 t80 -144.81 -169.86 3.27 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.605 -0.938 . . . . 0.0 109.379 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.641 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.8 mtm180 -72.0 -156.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.045 -1.034 . . . . 0.0 109.531 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -167.17 -151.7 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 p -99.25 -6.31 28.28 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.725 -1.234 . . . . 0.0 110.38 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.625 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -89.05 118.61 28.89 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.122 -0.986 . . . . 0.0 110.451 -178.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.804 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.77 150.46 43.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.755 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.7 tt -118.35 136.63 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -114.29 124.24 51.52 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.692 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -116.6 127.5 54.53 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.691 0.757 . . . . 0.0 109.09 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.707 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.9 p -93.69 157.96 15.91 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.143 0.973 . . . . 0.0 112.197 -178.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.1 p -68.86 -20.03 64.26 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.541 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -82.34 10.34 7.23 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.423 -0.798 . . . . 0.0 109.853 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.47 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.6 30.55 0.48 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.629 -0.669 . . . . 0.0 110.047 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.9 mt -102.79 138.68 39.36 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.384 -0.822 . . . . 0.0 109.94 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.464 HG23 HD12 ' A' ' 96' ' ' ILE . 33.4 mm -112.28 119.76 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.267 -0.896 . . . . 0.0 110.07 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.422 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.1 m-85 -119.95 142.61 48.59 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.625 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 9.3 tptp -130.62 147.67 52.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.761 . . . . 0.0 110.71 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.54 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.0 t -128.78 171.13 12.53 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.5 p -146.5 -2.62 0.66 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.36 -0.838 . . . . 0.0 110.488 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.2 p30 -115.63 19.34 15.37 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.653 -1.28 . . . . 0.0 108.549 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 78.97 62.01 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.534 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.668 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 21.5 m-85 69.89 -13.12 0.43 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.73 -0.606 . . . . 0.0 111.595 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -51.01 -72.39 0.05 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.735 -1.228 . . . . 0.0 109.557 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.413 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 34.5 p -99.96 -177.14 3.45 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.96 135.05 6.99 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.987 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.9 m -128.3 139.73 52.26 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.6 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 14.4 tttp -85.79 140.16 30.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.006 -1.059 . . . . 0.0 110.15 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.7 pt -113.23 -33.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.604 -0.685 . . . . 0.0 109.603 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.642 HH21 ' CG ' ' A' ' 8' ' ' ASP . 64.9 mtt180 . . . . . 0 N--CA 1.488 1.467 0 O-C-N 121.212 -0.93 . . . . 0.0 108.999 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.631 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.2 t . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 tt -171.31 161.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -145.94 28.2 1.15 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.43 -1.419 . . . . 0.0 111.083 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.5 p -104.16 156.12 18.15 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.729 0.776 . . . . 0.0 110.19 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.7 p90 -60.1 -60.78 3.28 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.758 -1.214 . . . . 0.0 110.759 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.629 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -58.57 -41.99 86.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 108.927 -179.381 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.19 -43.62 93.45 Favored Glycine 0 N--CA 1.501 2.993 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.5 t -68.78 -41.46 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.212 -1.169 . . . . 0.0 107.998 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.99 -59.1 5.91 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.61 -54.87 12.91 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.567 -0.708 . . . . 0.0 109.587 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.646 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 33.8 t80 -56.42 -49.51 74.35 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.174 0.511 . . . . 0.0 110.204 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.35 -47.41 56.57 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.164 -0.96 . . . . 0.0 111.567 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -61.4 -21.07 63.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.553 -1.342 . . . . 0.0 110.366 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 m -95.9 -41.01 9.02 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.986 -1.071 . . . . 0.0 111.652 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -110.8 16.2 21.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.457 -0.777 . . . . 0.0 111.566 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.6 m80 46.53 25.5 0.41 Allowed 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.563 -1.336 . . . . 0.0 110.248 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -142.95 152.62 42.2 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.203 -0.935 . . . . 0.0 110.695 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.3 mp -74.79 148.92 85.39 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.0 109.513 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.646 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 72.5 Cg_exo -40.48 151.56 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 123.4 2.734 . . . . 0.0 113.371 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.631 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -64.43 46.75 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 121.752 0.787 . . . . 0.0 110.997 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -167.62 24.87 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.937 -1.102 . . . . 0.0 110.545 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -116.27 116.02 27.01 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.692 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.462 HG22 HD12 ' A' ' 25' ' ' ILE . 28.8 pt -117.79 141.0 38.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.709 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.441 ' CB ' ' HG ' ' A' ' 28' ' ' SER . 6.9 p -71.83 167.54 19.77 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 120.858 -1.151 . . . . 0.0 110.524 -177.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.568 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 22.5 mtmt -68.23 -35.92 78.68 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.441 ' HG ' ' CB ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -41.01 -66.23 0.35 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 122.829 1.299 . . . . 0.0 108.472 178.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.548 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.9 mt-10 -65.65 -52.83 48.63 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.612 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.548 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -40.8 -50.86 3.17 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.324 -1.485 . . . . 0.0 107.397 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -58.57 -58.79 6.98 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 120.898 -1.126 . . . . 0.0 111.63 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.93 -29.77 67.35 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.1 -1.625 . . . . 0.0 110.163 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.9 tp -63.17 -25.01 68.15 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.96 50.49 0.26 Allowed Glycine 0 N--CA 1.501 2.992 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.588 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.49 146.12 30.38 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.094 -1.239 . . . . 0.0 109.661 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.42 125.8 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.565 -0.709 . . . . 0.0 109.214 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.96 -52.53 65.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.843 -0.536 . . . . 0.0 109.744 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.6 p -69.71 50.12 0.1 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.697 -1.252 . . . . 0.0 109.342 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.64 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -178.46 -50.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.18 56.38 24.11 Favored Glycine 0 N--CA 1.503 3.1 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.64 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -71.94 164.99 25.1 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.629 -0.924 . . . . 0.0 110.387 -178.761 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.512 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 60.6 tp -177.35 -69.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.726 -0.609 . . . . 0.0 110.214 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.87 -20.46 36.85 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.616 -1.302 . . . . 0.0 109.414 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' A' ' 45' ' ' VAL . 4.5 p-10 -77.89 -63.08 1.47 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.424 1.107 . . . . 0.0 109.501 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.414 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 17.0 m -77.46 -7.25 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.17 -0.956 . . . . 0.0 110.259 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.47 70.53 7.46 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.464 -0.772 . . . . 0.0 109.076 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.39 125.97 20.8 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 123.358 2.705 . . . . 0.0 113.719 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.32 40.13 70.04 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -137.56 176.21 8.91 Favored 'General case' 0 N--CA 1.516 2.851 0 CA-C-O 122.592 1.187 . . . . 0.0 111.85 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.1 m -148.72 160.41 43.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.614 -1.304 . . . . 0.0 111.639 -177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.3 mm -83.24 127.76 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.436 -0.79 . . . . 0.0 109.833 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 170.44 153.23 8.59 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.71 -16.78 8.91 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.243 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.503 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 1.2 m-20 -70.48 -154.42 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.243 -1.151 . . . . 0.0 109.903 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mp -128.61 135.79 61.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.945 0.879 . . . . 0.0 110.202 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.617 ' C ' ' H ' ' A' ' 58' ' ' ASN . 10.9 t80 -101.75 91.16 4.28 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.52 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -60.57 37.27 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.632 -0.668 . . . . 0.0 110.456 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.617 ' H ' ' C ' ' A' ' 56' ' ' PHE . 56.3 t30 37.82 36.69 0.1 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.208 -0.932 . . . . 0.0 110.444 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.52 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.9 mtm180 -68.35 44.93 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.804 -1.185 . . . . 0.0 109.885 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.65 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 20.1 mt-10 -151.51 -25.64 0.2 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.511 -0.743 . . . . 0.0 110.055 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.86 29.47 59.12 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.68 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.5 mttp -112.89 9.16 18.86 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.535 -0.979 . . . . 0.0 109.468 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mt -131.95 143.92 51.05 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.755 -0.591 . . . . 0.0 109.41 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.57 124.19 13.74 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 122.729 2.286 . . . . 0.0 112.3 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.522 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -100.76 -172.83 29.21 Favored Glycine 0 N--CA 1.505 3.235 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 10.8 tttt 177.29 145.4 0.1 Allowed 'General case' 0 N--CA 1.508 2.465 0 O-C-N 121.559 -0.965 . . . . 0.0 108.73 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.6 p -67.62 56.88 0.06 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.016 -1.052 . . . . 0.0 109.104 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.511 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 147.31 77.9 0.02 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.533 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -173.97 168.35 4.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.566 -0.961 . . . . 0.0 108.839 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.443 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.8 m -143.97 156.38 44.39 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.967 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.701 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 20.6 m95 -127.76 137.21 52.35 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.54 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -128.83 157.57 41.15 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 120.969 -1.082 . . . . 0.0 109.73 179.253 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.568 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -121.52 167.66 12.6 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.271 -0.893 . . . . 0.0 111.565 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.95 136.63 4.24 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.245 -0.909 . . . . 0.0 111.151 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.696 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -59.0 151.72 21.43 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.557 -0.714 . . . . 0.0 111.724 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.402 ' HA ' HD12 ' A' ' 76' ' ' ILE . 46.3 mm -135.69 144.58 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.489 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 58.31 70.36 0.66 Allowed 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.393 0.616 . . . . 0.0 110.407 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.512 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 61.6 t80 -129.54 161.1 31.26 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.076 -1.015 . . . . 0.0 109.455 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.611 ' OG1' ' N ' ' A' ' 80' ' ' SER . 28.5 p -140.9 -77.74 0.29 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.611 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -149.18 110.89 4.52 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.31 -104.04 0.24 Allowed Glycine 0 N--CA 1.502 3.038 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 44.2 t80 -141.32 -167.63 2.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.918 -0.754 . . . . 0.0 109.183 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.633 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.6 mtm180 -73.04 -153.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.165 -0.96 . . . . 0.0 109.415 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -168.35 -151.35 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.1 p -99.45 -4.16 32.05 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.645 -1.285 . . . . 0.0 110.114 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.646 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -91.04 118.14 30.16 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.287 -0.883 . . . . 0.0 110.492 -178.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.796 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.66 148.88 39.86 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.354 -0.841 . . . . 0.0 109.481 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.3 tt -116.59 136.65 52.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -113.42 124.19 51.84 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.659 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -117.78 125.96 51.57 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.997 0.903 . . . . 0.0 109.466 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.701 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 5.1 p -92.12 158.54 16.14 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.852 0.834 . . . . 0.0 112.081 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.4 p -70.18 -19.69 63.17 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.533 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -82.43 10.12 7.78 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.347 -0.846 . . . . 0.0 109.928 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.453 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.85 30.22 0.47 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.712 -0.618 . . . . 0.0 110.099 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.6 mt -101.77 138.72 38.38 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.215 -0.928 . . . . 0.0 109.79 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.434 HG23 HD12 ' A' ' 96' ' ' ILE . 35.1 mm -113.23 119.51 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.469 -0.769 . . . . 0.0 110.024 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.423 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.9 m-85 -120.39 143.08 48.62 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.646 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 7.4 tptp -131.24 148.28 52.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.025 -1.047 . . . . 0.0 110.806 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.545 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.9 t -127.95 172.35 10.98 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.9 p -147.44 -1.45 0.62 Allowed 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.452 -0.78 . . . . 0.0 110.796 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.444 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.1 p30 -117.27 19.06 14.29 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.728 -1.232 . . . . 0.0 108.287 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 78.65 63.12 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.358 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.68 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 19.3 m-85 69.65 -13.23 0.41 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.873 -0.517 . . . . 0.0 111.334 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -50.72 -73.98 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.57 -1.331 . . . . 0.0 109.565 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.438 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 33.7 p -98.58 -177.42 3.67 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.67 134.81 7.15 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.968 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.4 m -128.39 139.0 52.6 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.606 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 15.7 tttp -86.26 140.21 30.32 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.937 -1.102 . . . . 0.0 109.904 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.8 pt -113.91 -31.26 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.689 -0.632 . . . . 0.0 109.642 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.629 HH21 ' CG ' ' A' ' 8' ' ' ASP . 66.7 mtt180 . . . . . 0 C--N 1.303 -1.426 0 O-C-N 121.126 -0.984 . . . . 0.0 108.846 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.621 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 20.2 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.399 0.618 . . . . 0.0 109.343 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 tt -170.13 159.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -146.17 30.14 1.05 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.766 -1.209 . . . . 0.0 111.306 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.4 p -104.8 158.14 16.73 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.594 0.712 . . . . 0.0 109.666 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.0 OUTLIER -60.68 -61.33 2.67 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.842 -1.161 . . . . 0.0 110.07 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.637 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.04 -41.48 78.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.213 -0.929 . . . . 0.0 109.659 -179.742 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.14 -44.83 94.62 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.3 t -67.31 -41.07 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.421 -1.047 . . . . 0.0 108.746 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.77 -57.86 9.45 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.17 -53.41 27.96 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.512 -0.742 . . . . 0.0 109.619 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.652 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 32.2 t80 -57.48 -50.6 72.52 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.454 0.645 . . . . 0.0 110.683 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tt -71.71 -45.14 62.75 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.3 -0.875 . . . . 0.0 110.886 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -62.12 -22.16 65.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.622 -1.299 . . . . 0.0 110.435 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 m -95.59 -40.93 9.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.077 -1.014 . . . . 0.0 111.021 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -110.28 17.06 21.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.958 -1.089 . . . . 0.0 112.002 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.2 m80 46.17 24.82 0.29 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.025 -1.047 . . . . 0.0 110.372 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.6 pttp -143.22 149.75 38.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.061 -1.024 . . . . 0.0 110.282 -178.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp -73.63 150.15 88.72 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.249 -0.907 . . . . 0.0 108.827 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.652 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 50.9 Cg_exo -38.94 153.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.333 2.688 . . . . 0.0 114.092 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.621 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -68.53 50.24 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.197 0.999 . . . . 0.0 110.692 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -171.32 25.77 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 109.928 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -117.81 116.39 26.89 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.46 -1.4 . . . . 0.0 110.399 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.402 HD12 HG22 ' A' ' 25' ' ' ILE . 28.0 pt -118.99 136.13 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 CA-C-O 122.167 0.984 . . . . 0.0 109.659 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.7 p -65.49 166.89 9.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.05 -1.031 . . . . 0.0 111.545 -177.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.614 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 22.5 mtmt -68.48 -36.72 79.35 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.44 -65.17 0.52 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.109 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.9 mt-10 -63.72 -53.86 44.53 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 119.067 -1.053 . . . . 0.0 108.983 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -40.72 -51.56 3.05 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.653 -1.28 . . . . 0.0 108.597 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -57.38 -58.8 6.68 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.965 -1.084 . . . . 0.0 111.502 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.37 -32.23 68.38 Favored 'General case' 0 N--CA 1.51 2.562 0 O-C-N 120.663 -1.273 . . . . 0.0 108.811 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.8 tp -61.35 -23.43 65.75 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.49 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.49 50.98 0.36 Allowed Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.562 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -82.99 146.71 28.62 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.152 -1.205 . . . . 0.0 109.343 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.3 t -135.75 123.93 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.472 -0.768 . . . . 0.0 109.388 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.427 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -57.25 -52.61 64.63 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.846 -0.534 . . . . 0.0 109.763 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.3 p -69.79 48.7 0.09 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.389 -0.819 . . . . 0.0 109.72 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.645 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.3 ttpm? -178.31 -50.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.63 57.4 17.95 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.645 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -72.5 162.09 29.94 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.747 -0.855 . . . . 0.0 110.56 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.619 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.7 tp -175.62 -66.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.443 -0.785 . . . . 0.0 109.937 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 80' ' ' SER . . . -61.72 -18.96 61.75 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.77 -1.207 . . . . 0.0 109.988 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 45' ' ' VAL . 4.5 p-10 -79.18 -64.63 1.14 Allowed 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.912 0.863 . . . . 0.0 109.063 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.507 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 31.6 m -74.48 -12.07 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.918 -0.489 . . . . 0.0 110.158 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.4 71.07 13.01 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.47 -0.769 . . . . 0.0 109.412 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.48 123.58 13.91 Favored 'Trans proline' 0 N--CA 1.509 2.395 0 C-N-CA 122.919 2.413 . . . . 0.0 113.991 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.49 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 71.57 41.0 58.45 Favored Glycine 0 N--CA 1.502 3.049 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.5 mmtt -139.07 170.82 15.28 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 122.031 0.919 . . . . 0.0 110.962 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.8 m -144.81 160.63 40.96 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.204 1.002 . . . . 0.0 110.554 -177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.8 mm -84.26 128.22 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.526 -0.734 . . . . 0.0 109.906 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.58 153.68 9.26 Favored Glycine 0 N--CA 1.499 2.88 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.75 -16.56 8.92 Favored Glycine 0 N--CA 1.5 2.925 0 C-N-CA 119.653 -1.26 . . . . 0.0 111.367 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -71.88 -150.64 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.795 -1.415 . . . . 0.0 110.037 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.93 140.7 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.561 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.624 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.3 t80 -106.68 90.1 3.22 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.514 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.3 p -60.0 38.22 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.388 0.613 . . . . 0.0 110.591 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 56' ' ' PHE . 63.8 t30 37.54 34.58 0.05 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.121 -0.987 . . . . 0.0 110.526 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.514 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.6 mtm180 -66.24 44.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.844 -1.16 . . . . 0.0 110.093 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.67 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 20.1 mt-10 -152.05 -26.42 0.18 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.483 -0.761 . . . . 0.0 109.918 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.6 28.08 62.0 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.671 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.0 mttp -110.31 5.11 21.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.527 -0.984 . . . . 0.0 109.102 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -127.98 144.46 51.57 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.792 -0.568 . . . . 0.0 109.673 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.52 124.89 15.02 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 123.048 2.499 . . . . 0.0 112.279 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.515 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.18 -173.94 28.8 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 68' ' ' GLY . 12.9 tttt 177.41 145.72 0.11 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.413 -1.051 . . . . 0.0 108.787 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 p -68.13 58.03 0.07 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.05 -1.031 . . . . 0.0 109.236 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 147.36 75.78 0.02 OUTLIER Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.531 ' NH2' ' OD1' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.46 169.92 5.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.684 -0.892 . . . . 0.0 109.225 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.454 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.9 m -145.23 155.39 43.22 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.829 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.704 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 20.3 m95 -126.13 138.78 53.7 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.546 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -129.35 155.8 45.05 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.789 -1.194 . . . . 0.0 109.58 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.614 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -120.28 166.25 13.75 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.255 -0.903 . . . . 0.0 111.551 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.53 134.66 3.34 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.197 -0.939 . . . . 0.0 110.69 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.696 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.91 152.14 16.71 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.359 0.599 . . . . 0.0 111.482 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.417 ' HA ' HD12 ' A' ' 76' ' ' ILE . 39.9 mm -134.9 142.85 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.559 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 57.8 71.69 0.56 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.288 0.566 . . . . 0.0 110.266 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.619 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 63.0 t80 -129.13 159.72 35.12 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.417 -0.802 . . . . 0.0 109.318 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.6 ' OG1' ' N ' ' A' ' 80' ' ' SER . 24.2 p -140.65 -78.33 0.29 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.6 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -150.05 107.58 3.65 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.66 -103.93 0.23 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.484 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 50.7 t80 -141.72 -170.02 3.03 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.638 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.5 mtm180 -70.41 -151.95 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.131 -0.981 . . . . 0.0 109.815 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -172.07 -151.89 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.8 p -98.9 -5.3 31.06 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.69 -1.256 . . . . 0.0 110.43 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.631 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -90.07 117.69 29.05 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.186 -0.946 . . . . 0.0 110.52 -178.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.806 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.31 149.64 43.03 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 tt -117.74 135.83 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -112.63 124.86 53.5 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.69 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.7 127.42 53.55 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.709 0.766 . . . . 0.0 109.205 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.704 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.1 p -94.35 158.95 15.33 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.173 0.987 . . . . 0.0 112.522 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.1 p -69.75 -19.08 63.54 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.531 ' OD1' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -83.24 10.46 8.4 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.762 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.443 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.46 29.97 0.52 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.634 -0.666 . . . . 0.0 110.025 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 23.4 mt -101.96 136.52 41.66 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.319 -0.863 . . . . 0.0 109.807 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.457 HG23 HD12 ' A' ' 96' ' ' ILE . 32.9 mm -110.38 119.92 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.576 -0.703 . . . . 0.0 110.251 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.426 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.3 m-85 -120.68 142.64 49.29 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.631 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 8.7 tptp -130.96 147.02 52.55 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.776 0.798 . . . . 0.0 111.005 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.564 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.4 t -127.51 171.53 11.52 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 74.6 p -146.85 -1.72 0.66 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.386 -0.821 . . . . 0.0 110.328 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.462 ' CG ' ' H ' ' A' ' 105' ' ' THR . 1.2 p30 -116.68 18.75 14.83 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.806 -1.184 . . . . 0.0 108.353 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 78.53 63.27 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.449 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.671 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 19.9 m-85 69.99 -14.12 0.39 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.774 -0.579 . . . . 0.0 111.614 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -51.39 -73.33 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.754 -1.216 . . . . 0.0 109.578 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.462 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 33.2 p -98.65 -178.08 3.87 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.85 133.53 6.25 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.935 -1.103 . . . . 0.0 109.847 -179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.7 m -127.87 140.05 52.25 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.629 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 16.3 tttp -86.01 139.71 30.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.123 -0.985 . . . . 0.0 109.971 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.0 pt -113.38 -32.43 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.637 HH21 ' CG ' ' A' ' 8' ' ' ASP . 62.2 mtt180 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.103 -0.998 . . . . 0.0 109.198 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.629 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 36.0 t . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 tt -171.52 158.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.0 p30 -146.08 29.97 1.07 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.472 -1.392 . . . . 0.0 111.241 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.9 p -105.69 155.94 18.77 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.2 p90 -58.66 -63.79 1.16 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.961 -1.087 . . . . 0.0 110.463 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.612 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -53.81 -43.46 69.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.516 -0.74 . . . . 0.0 109.449 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.39 -44.72 89.86 Favored Glycine 0 N--CA 1.5 2.965 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 63.2 t -67.3 -41.32 86.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 121.51 -0.994 . . . . 0.0 108.786 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.36 -58.84 6.19 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.82 -55.0 12.87 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.371 -0.83 . . . . 0.0 109.663 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.596 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 35.0 t80 -56.26 -50.76 70.43 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.284 0.564 . . . . 0.0 110.627 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.3 tt -72.26 -44.37 62.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.406 -0.809 . . . . 0.0 111.282 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -62.76 -21.31 65.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.605 -1.309 . . . . 0.0 110.08 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.0 m -95.9 -40.5 9.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.927 -1.108 . . . . 0.0 111.283 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -111.14 17.26 20.52 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.055 -1.028 . . . . 0.0 111.987 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.0 m80 45.78 25.01 0.25 Allowed 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.845 -1.159 . . . . 0.0 110.271 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.4 pttp -141.88 152.51 43.67 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.075 -1.016 . . . . 0.0 110.898 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.3 mp -76.78 148.73 79.72 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.224 -0.922 . . . . 0.0 109.303 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.596 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 73.7 Cg_exo -38.23 152.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 122.904 2.403 . . . . 0.0 114.428 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -66.06 48.52 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 122.122 0.963 . . . . 0.0 110.094 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -169.23 24.16 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.671 -1.268 . . . . 0.0 110.126 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -117.39 116.25 26.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.968 -1.082 . . . . 0.0 110.86 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.45 HD12 HG22 ' A' ' 25' ' ' ILE . 34.4 pt -118.03 141.01 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.833 0.825 . . . . 0.0 109.312 179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.2 p -70.98 166.29 21.61 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.967 -1.083 . . . . 0.0 111.479 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.568 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 20.2 mtmt -67.19 -36.39 81.64 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.78 -65.08 0.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.6 177.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.46 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.2 mt-10 -63.34 -52.47 61.66 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.025 -1.07 . . . . 0.0 108.342 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -41.69 -49.78 4.22 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.174 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -60.81 -55.72 29.69 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.36 -0.837 . . . . 0.0 111.755 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.49 -31.8 70.82 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.669 -1.269 . . . . 0.0 109.276 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 20.2 tp -60.83 -31.36 70.78 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.96 52.09 0.15 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.677 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -83.77 146.39 28.18 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.083 -1.245 . . . . 0.0 109.888 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -137.56 125.86 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.274 -0.891 . . . . 0.0 109.373 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.431 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -57.27 -53.28 59.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.924 -0.485 . . . . 0.0 110.501 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.7 p -69.08 48.75 0.07 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.979 -1.076 . . . . 0.0 109.716 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.572 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -178.81 -49.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.52 55.37 29.25 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.677 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -70.8 160.17 33.22 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 121.64 -0.918 . . . . 0.0 110.458 -179.063 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.516 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 58.9 tp -174.98 -67.29 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.497 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.52 -20.19 43.94 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.339 -0.851 . . . . 0.0 110.093 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.8 p-10 -79.63 -65.39 1.01 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.678 0.752 . . . . 0.0 109.874 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.495 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 28.9 m -75.98 -6.82 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.799 -0.563 . . . . 0.0 110.708 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.0 69.03 9.04 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -57.69 122.32 11.55 Favored 'Trans proline' 0 N--CA 1.508 2.324 0 C-N-CA 123.595 2.863 . . . . 0.0 113.853 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.95 38.99 55.61 Favored Glycine 0 N--CA 1.501 3.016 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.7 mmtm -138.38 178.16 7.34 Favored 'General case' 0 N--CA 1.51 2.546 0 CA-C-O 122.248 1.023 . . . . 0.0 111.455 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 63.9 m -150.53 161.0 43.38 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.857 -1.152 . . . . 0.0 111.417 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.8 mm -83.37 126.17 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.092 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.72 152.97 8.74 Favored Glycine 0 N--CA 1.499 2.842 0 C-N-CA 119.981 -1.104 . . . . 0.0 110.38 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.43 -17.35 8.42 Favored Glycine 0 N--CA 1.498 2.778 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.052 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -69.95 -153.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.633 -1.51 . . . . 0.0 109.752 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.95 138.42 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.43 -0.794 . . . . 0.0 110.399 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.641 ' O ' ' N ' ' A' ' 58' ' ' ASN . 10.0 t80 -104.36 89.77 3.34 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.546 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -59.5 39.17 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.529 -0.732 . . . . 0.0 110.682 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.641 ' N ' ' O ' ' A' ' 56' ' ' PHE . 59.5 t30 36.83 34.88 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.069 -1.02 . . . . 0.0 110.483 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.546 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.2 mtm180 -66.71 45.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.822 -1.174 . . . . 0.0 109.602 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.665 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 18.9 mt-10 -151.74 -26.84 0.19 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.467 -0.771 . . . . 0.0 110.028 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.27 27.9 61.0 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.669 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.7 mttp -110.69 5.7 21.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.66 -0.906 . . . . 0.0 109.468 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.93 143.6 49.31 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.8 124.42 14.04 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.637 2.224 . . . . 0.0 112.239 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.498 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -99.81 -173.82 30.62 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 68' ' ' GLY . 11.1 tttt 177.92 146.27 0.13 Allowed 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.456 -1.026 . . . . 0.0 108.834 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.4 p -68.01 58.18 0.07 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.975 -1.078 . . . . 0.0 109.031 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 146.86 76.69 0.02 OUTLIER Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.542 ' NH2' ' OD1' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -173.35 168.89 4.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.597 -0.943 . . . . 0.0 109.161 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.454 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.3 m -145.65 155.2 42.85 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.834 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.708 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 21.5 m95 -125.39 138.8 54.04 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.536 ' HG2' ' NH1' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -129.72 156.06 44.9 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.798 -1.189 . . . . 0.0 109.517 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.568 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -120.03 167.54 12.07 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.3 -0.875 . . . . 0.0 112.136 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.46 135.59 3.62 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.237 -0.915 . . . . 0.0 111.153 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.675 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.93 154.7 11.88 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.743 -0.598 . . . . 0.0 111.546 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.2 mm -136.87 143.5 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.518 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 57.62 70.01 0.69 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.192 0.52 . . . . 0.0 110.589 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.496 ' CG ' ' N ' ' A' ' 79' ' ' THR . 59.5 t80 -128.37 161.33 29.68 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.02 -1.05 . . . . 0.0 109.331 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.608 ' OG1' ' N ' ' A' ' 80' ' ' SER . 26.9 p -141.43 -76.69 0.29 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.608 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -150.47 110.33 4.09 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.73 -103.67 0.24 Allowed Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 45.4 t80 -142.46 -169.96 3.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.89 -0.77 . . . . 0.0 109.156 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.657 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.2 mtm180 -71.47 -158.09 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.24 -0.912 . . . . 0.0 109.159 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -166.33 -150.9 0.12 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 53.8 p -99.0 -6.38 28.67 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.404 -1.435 . . . . 0.0 110.391 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.628 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -89.11 118.02 28.52 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.099 -1.001 . . . . 0.0 110.992 -178.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.804 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.03 149.97 42.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 0.0 109.685 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.2 tt -118.15 137.42 52.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -113.85 124.88 53.29 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.63 127.67 53.81 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.724 0.773 . . . . 0.0 109.213 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.708 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.0 p -94.13 158.37 15.64 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 122.449 1.119 . . . . 0.0 112.382 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.8 p -68.93 -20.3 64.21 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.542 ' OD1' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -83.1 11.04 6.87 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.062 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.448 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.62 29.63 0.52 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.601 -0.687 . . . . 0.0 110.42 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 23.1 mt -102.78 136.86 41.83 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.459 HG23 HD12 ' A' ' 96' ' ' ILE . 31.7 mm -110.84 119.7 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.523 -0.736 . . . . 0.0 110.104 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.448 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.2 m-85 -119.88 142.81 48.34 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.628 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 8.2 tptp -130.7 147.29 52.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.847 -1.158 . . . . 0.0 110.691 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.484 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.5 t -128.46 171.43 12.08 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 76.5 p -146.51 -3.63 0.62 Allowed 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.491 -0.756 . . . . 0.0 110.459 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.458 ' CG ' ' H ' ' A' ' 105' ' ' THR . 1.1 p30 -114.36 19.52 16.19 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.792 -1.192 . . . . 0.0 108.455 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 78.11 62.41 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.15 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.669 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 21.6 m-85 70.36 -14.57 0.39 Allowed 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.826 -0.546 . . . . 0.0 111.66 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -49.98 -72.88 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.661 -1.275 . . . . 0.0 109.886 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.458 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 42.0 p -100.42 -178.31 3.77 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.65 135.19 8.39 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.045 -1.034 . . . . 0.0 110.332 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.1 m -128.13 139.14 52.66 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.642 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 15.8 tttp -86.02 139.15 31.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.835 -1.166 . . . . 0.0 110.003 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.8 pt -111.96 -32.91 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.63 -0.669 . . . . 0.0 109.791 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.642 ' C ' ' HZ3' ' A' ' 108' ' ' LYS . 69.0 mtt180 . . . . . 0 N--CA 1.487 1.412 0 O-C-N 121.281 -0.887 . . . . 0.0 108.678 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.633 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.8 t . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 tt -171.15 158.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -145.4 29.67 1.15 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.411 -1.431 . . . . 0.0 111.466 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.7 p -103.67 157.15 17.26 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.436 -0.79 . . . . 0.0 109.762 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.4 p90 -59.87 -63.13 1.41 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.211 -0.93 . . . . 0.0 109.897 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.588 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.8 OUTLIER -56.01 -42.25 76.15 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.165 -0.959 . . . . 0.0 109.679 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.4 -44.98 85.07 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.3 t -67.93 -42.51 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.24 -58.6 7.65 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.9 -53.13 27.92 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.766 -1.209 . . . . 0.0 110.103 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.626 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 36.6 t80 -57.24 -48.61 78.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.669 -0.644 . . . . 0.0 110.418 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -73.91 -43.89 56.94 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.493 -0.755 . . . . 0.0 110.974 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -63.7 -20.04 65.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.443 -1.411 . . . . 0.0 109.981 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 m -98.12 -40.29 8.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.697 -1.252 . . . . 0.0 110.544 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -109.66 14.62 23.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 112.022 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.8 m80 46.77 24.98 0.39 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.668 -1.27 . . . . 0.0 110.41 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.464 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 3.8 pttp -143.57 149.82 37.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.177 -0.952 . . . . 0.0 110.828 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp -72.72 149.48 90.52 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 120.98 -1.075 . . . . 0.0 109.565 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.626 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 51.3 Cg_exo -40.36 150.8 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 123.189 2.592 . . . . 0.0 113.716 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.633 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -63.95 48.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.541 0.686 . . . . 0.0 110.489 -179.205 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -171.43 28.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.02 -1.05 . . . . 0.0 110.67 179.103 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -119.11 115.08 23.53 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.191 -0.943 . . . . 0.0 110.719 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.5 pt -117.38 140.32 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.462 ' CB ' ' HG ' ' A' ' 28' ' ' SER . 11.5 p -70.82 167.26 19.28 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.054 0.93 . . . . 0.0 111.75 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.568 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 23.6 mtmt -68.49 -37.32 80.01 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.462 ' HG ' ' CB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -40.43 -67.83 0.21 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 113.873 -1.512 . . . . 0.0 108.217 177.187 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.515 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.0 mt-10 -63.57 -54.43 36.14 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.233 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.515 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -39.18 -51.84 1.94 Allowed 'General case' 0 CA--C 1.566 1.569 0 O-C-N 120.318 -1.489 . . . . 0.0 109.033 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.425 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 41.2 mt-30 -58.93 -57.69 11.93 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.661 -0.649 . . . . 0.0 111.219 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.15 -32.84 71.41 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.819 -1.175 . . . . 0.0 110.006 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.1 tp -59.45 -27.78 66.38 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.96 52.5 0.21 Allowed Glycine 0 N--CA 1.502 3.09 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.605 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -85.04 146.2 27.3 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.549 -0.971 . . . . 0.0 111.007 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.6 t -137.14 124.59 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 O-C-N 121.394 -0.816 . . . . 0.0 109.79 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.425 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -57.27 -50.87 71.52 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 122.037 -0.414 . . . . 0.0 110.369 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.3 p -70.06 49.06 0.1 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.3 -0.875 . . . . 0.0 109.443 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.567 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -179.13 -52.97 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.69 57.05 13.5 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.605 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -71.79 162.29 29.68 Favored 'General case' 0 C--N 1.289 -2.058 0 O-C-N 121.728 -0.866 . . . . 0.0 111.067 -178.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.581 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 64.6 tp -174.44 -67.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.772 -1.205 . . . . 0.0 109.995 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.424 ' HB3' ' HA ' ' A' ' 80' ' ' SER . . . -61.33 -18.96 61.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.509 -0.744 . . . . 0.0 109.827 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 3.9 p-10 -80.22 -62.1 1.78 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.091 0.948 . . . . 0.0 108.742 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.427 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 16.3 m -75.65 -11.35 14.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.663 -1.273 . . . . 0.0 109.293 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.78 72.6 10.5 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 120.996 -1.065 . . . . 0.0 109.855 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.61 125.76 19.29 Favored 'Trans proline' 0 N--CA 1.509 2.415 0 C-N-CA 123.051 2.5 . . . . 0.0 114.323 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.571 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 72.74 40.15 53.67 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.571 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.8 mmtm -141.41 170.8 15.04 Favored 'General case' 0 N--CA 1.508 2.426 0 CA-C-O 121.674 0.749 . . . . 0.0 111.567 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 72.5 m -144.32 162.58 36.07 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 122.794 1.283 . . . . 0.0 110.935 -177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.6 mm -83.81 126.26 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.923 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 172.85 153.05 9.11 Favored Glycine 0 N--CA 1.501 3.021 0 O-C-N 120.575 -1.328 . . . . 0.0 109.98 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.38 -15.39 9.98 Favored Glycine 0 N--CA 1.499 2.866 0 O-C-N 121.145 -1.209 . . . . 0.0 111.166 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 1.6 m-20 -70.49 -154.9 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.547 -1.56 . . . . 0.0 109.473 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.0 mp -129.29 135.74 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 122.055 0.931 . . . . 0.0 110.169 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.582 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.7 t80 -101.8 89.16 3.58 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.67 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 2.2 p -59.3 40.25 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 121.306 0.574 . . . . 0.0 110.766 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.582 ' N ' ' O ' ' A' ' 56' ' ' PHE . 61.5 t30 34.13 37.12 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.372 -0.83 . . . . 0.0 110.4 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.67 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.1 mtm180 -68.02 40.1 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -0.951 . . . . 0.0 109.929 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.655 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 21.6 mt-10 -148.98 -19.38 0.3 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.024 -1.047 . . . . 0.0 110.44 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.45 31.45 68.35 Favored Glycine 0 N--CA 1.499 2.871 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.684 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.7 mttp -114.3 8.28 16.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.575 -0.956 . . . . 0.0 108.932 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mt -131.96 143.99 51.33 Favored Pre-proline 0 N--CA 1.491 1.583 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -63.37 124.3 13.57 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.681 2.254 . . . . 0.0 112.005 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.526 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -100.39 -172.04 29.56 Favored Glycine 0 N--CA 1.499 2.851 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 68' ' ' GLY . 10.3 tttt 177.03 146.55 0.1 Allowed 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.678 -0.895 . . . . 0.0 108.938 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.8 p -68.19 58.32 0.08 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.91 -1.119 . . . . 0.0 109.281 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 145.52 76.66 0.03 OUTLIER Glycine 0 N--CA 1.5 2.946 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.536 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.09 165.8 6.15 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.657 -0.908 . . . . 0.0 109.239 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.0 m -142.18 154.01 44.49 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.378 -0.826 . . . . 0.0 109.69 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.688 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 19.2 m95 -125.42 139.3 53.77 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.514 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -129.97 155.28 46.35 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.295 -0.878 . . . . 0.0 109.918 179.612 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.568 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -119.2 166.52 12.86 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.227 -0.921 . . . . 0.0 111.295 -179.144 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.85 134.8 3.19 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.182 -0.949 . . . . 0.0 110.955 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.661 ' HA ' ' NE ' ' A' ' 87' ' ' ARG . 0.5 OUTLIER -57.04 152.43 13.21 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.457 0.646 . . . . 0.0 111.548 -179.338 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.407 ' HA ' HD12 ' A' ' 76' ' ' ILE . 42.0 mm -135.53 142.58 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.08 -1.013 . . . . 0.0 110.084 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 58.62 71.24 0.59 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.403 0.621 . . . . 0.0 110.517 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.581 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 65.1 t80 -129.59 159.3 36.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.354 -0.841 . . . . 0.0 109.382 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 80' ' ' SER . 29.4 p -139.87 -78.94 0.31 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.642 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -149.86 106.65 3.54 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.84 -102.78 0.21 Allowed Glycine 0 N--CA 1.5 2.926 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.482 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 52.4 t80 -142.38 -168.0 2.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.86 -0.788 . . . . 0.0 108.977 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.652 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.8 mtm180 -73.09 -152.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.823 -1.173 . . . . 0.0 109.807 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -170.48 -150.61 0.07 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.6 p -100.75 -5.77 25.91 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.754 -1.216 . . . . 0.0 110.345 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.62 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -90.44 118.81 30.21 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.906 -1.121 . . . . 0.0 110.272 -178.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.812 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.52 150.42 42.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.187 -0.946 . . . . 0.0 109.346 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.6 tt -117.29 138.83 46.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -114.84 123.51 49.37 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.664 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -116.71 126.87 53.8 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.561 0.696 . . . . 0.0 109.357 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.688 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 3.1 p -93.07 158.94 15.52 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.163 0.983 . . . . 0.0 111.929 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.9 p -70.03 -20.33 63.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.446 -0.784 . . . . 0.0 108.913 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.536 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.47 10.2 6.19 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.468 -0.77 . . . . 0.0 109.867 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.475 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.76 30.07 0.48 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.654 -0.654 . . . . 0.0 110.148 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.5 mt -102.45 137.48 40.63 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.313 -0.867 . . . . 0.0 110.121 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.46 HG23 HD12 ' A' ' 96' ' ' ILE . 30.8 mm -110.75 119.14 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.28 -0.888 . . . . 0.0 110.951 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.444 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.5 m-85 -119.82 143.44 47.87 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.62 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 7.3 tptp -132.47 148.03 52.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.185 -0.947 . . . . 0.0 110.816 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.522 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.2 t -127.61 171.85 11.28 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.5 p -146.74 -1.82 0.67 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.274 -0.891 . . . . 0.0 110.358 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.449 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.2 p30 -117.36 19.31 14.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.823 -1.173 . . . . 0.0 108.681 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 78.94 61.63 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.237 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.684 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 19.6 m-85 70.01 -13.8 0.41 Allowed 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.711 -0.618 . . . . 0.0 111.529 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -49.83 -72.97 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.734 -1.228 . . . . 0.0 109.437 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.441 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 34.5 p -99.5 -176.18 3.21 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -161.8 135.07 6.28 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.174 -0.953 . . . . 0.0 109.666 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 55.0 m -128.33 140.7 51.72 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.605 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 15.4 tttp -87.25 139.91 30.08 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.7 -1.25 . . . . 0.0 110.306 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.6 pt -113.22 -32.72 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.485 -0.76 . . . . 0.0 109.75 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.605 ' C ' ' HZ3' ' A' ' 108' ' ' LYS . 60.5 mtt180 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 118.292 -0.861 . . . . 0.0 109.528 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.626 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.0 t . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.7 tt -170.8 159.87 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -144.46 27.74 1.37 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.793 -1.192 . . . . 0.0 111.501 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.0 p -105.54 158.03 16.97 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.859 0.837 . . . . 0.0 110.761 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.7 p90 -60.02 -61.16 2.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.595 -1.316 . . . . 0.0 110.997 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.646 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.81 -39.83 78.51 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.0 -1.062 . . . . 0.0 110.102 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.44 -44.25 96.81 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.66 -41.73 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.313 -1.11 . . . . 0.0 108.535 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.33 -58.94 5.86 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.98 -54.21 16.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.421 -0.8 . . . . 0.0 109.861 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.632 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 35.4 t80 -57.35 -49.62 75.55 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.569 -0.707 . . . . 0.0 110.737 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.89 -45.14 62.32 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.125 -0.985 . . . . 0.0 110.631 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -62.71 -20.11 64.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.23 -1.544 . . . . 0.0 110.615 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.0 m -98.07 -39.33 8.97 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.954 -1.091 . . . . 0.0 110.977 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -111.34 15.79 21.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.796 -1.19 . . . . 0.0 111.967 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.8 m80 46.75 23.74 0.28 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.109 -0.994 . . . . 0.0 110.867 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.2 pttp -141.16 150.81 43.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 109.792 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.7 mp -73.87 150.13 88.17 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.803 -1.186 . . . . 0.0 108.901 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.632 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 51.3 Cg_exo -38.07 150.66 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 124.016 3.144 . . . . 0.0 113.701 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.626 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -65.77 46.73 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.747 0.784 . . . . 0.0 111.405 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -169.82 26.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 109.818 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -117.9 119.72 35.69 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.836 -1.165 . . . . 0.0 110.622 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.1 pt -121.12 139.52 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.818 0.818 . . . . 0.0 109.194 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.1 p -69.78 167.63 16.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.893 -1.129 . . . . 0.0 111.094 -177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.554 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 19.1 mtmt -68.22 -33.04 73.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.12 -63.65 0.93 Allowed 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.493 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.7 mt-10 -66.44 -51.58 55.37 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -41.35 -51.41 3.68 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.662 -1.215 . . . . 0.0 108.686 177.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -60.14 -56.38 22.26 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.399 -0.813 . . . . 0.0 111.201 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.13 -27.85 68.68 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.263 -1.523 . . . . 0.0 109.147 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.1 tp -64.74 -23.35 67.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.706 -0.621 . . . . 0.0 110.233 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.4 51.78 0.28 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.603 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -84.43 144.18 28.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.29 -1.123 . . . . 0.0 109.853 179.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.2 t -136.14 125.18 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.226 -0.921 . . . . 0.0 109.627 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -56.5 -51.46 68.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.967 -0.458 . . . . 0.0 110.547 -179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.7 p -71.55 48.32 0.14 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.96 -1.088 . . . . 0.0 109.777 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.577 ' HZ1' ' CG ' ' A' ' 41' ' ' ASN . 1.4 ttpm? -177.44 -49.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.76 54.79 31.08 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.603 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -71.21 160.27 33.14 Favored 'General case' 0 C--N 1.29 -2.021 0 O-C-N 121.479 -1.012 . . . . 0.0 110.311 -178.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.575 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 64.9 tp -174.94 -67.26 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.581 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -58.49 -21.29 51.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.817 -1.177 . . . . 0.0 109.467 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 3.2 p-10 -77.86 -63.42 1.39 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.684 0.754 . . . . 0.0 109.441 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.431 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 22.5 m -76.21 -8.78 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.724 -0.61 . . . . 0.0 109.734 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.13 68.79 8.87 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.148 -0.97 . . . . 0.0 109.292 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -57.26 124.51 16.34 Favored 'Trans proline' 0 N--CA 1.506 2.259 0 C-N-CA 123.306 2.67 . . . . 0.0 113.511 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.538 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 69.86 41.05 74.15 Favored Glycine 0 N--CA 1.501 3.033 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.4 mmtm -139.56 175.85 9.22 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.647 -0.914 . . . . 0.0 110.533 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.1 m -148.74 160.62 43.01 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.493 1.139 . . . . 0.0 110.957 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.0 mm -82.02 127.15 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.786 0.803 . . . . 0.0 110.493 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.33 153.55 9.08 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.31 -17.48 8.47 Favored Glycine 0 N--CA 1.507 3.433 0 O-C-N 121.57 -0.959 . . . . 0.0 110.799 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 1.2 m-20 -69.71 -156.21 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.629 -1.512 . . . . 0.0 109.619 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.83 140.72 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-O 121.604 0.716 . . . . 0.0 110.435 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.668 ' O ' ' N ' ' A' ' 58' ' ' ASN . 9.2 t80 -107.03 88.54 2.76 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.556 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -58.03 38.72 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.826 -0.546 . . . . 0.0 110.675 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.668 ' N ' ' O ' ' A' ' 56' ' ' PHE . 59.9 t30 35.76 38.75 0.06 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.074 -1.016 . . . . 0.0 110.001 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.556 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.2 mtm180 -69.61 41.79 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.745 -1.222 . . . . 0.0 109.832 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.668 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 17.5 mt-10 -148.0 -24.56 0.35 Allowed 'General case' 0 N--CA 1.485 1.285 0 O-C-N 120.698 -1.251 . . . . 0.0 109.717 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.3 27.66 61.37 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.68 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.8 mttp -111.84 7.51 20.15 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.921 -0.752 . . . . 0.0 109.637 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -129.61 143.79 50.36 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.83 123.54 12.48 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 122.613 2.209 . . . . 0.0 112.886 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.506 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -97.94 -174.17 33.3 Favored Glycine 0 N--CA 1.506 3.341 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 68' ' ' GLY . 11.1 tttt 177.62 145.82 0.12 Allowed 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.447 -1.031 . . . . 0.0 108.707 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.0 p -68.71 58.85 0.09 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.888 -1.133 . . . . 0.0 108.767 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 146.67 74.39 0.02 OUTLIER Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.538 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -171.82 167.86 6.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.509 -0.995 . . . . 0.0 109.193 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.455 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 93.0 m -144.06 155.6 44.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 110.331 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.724 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 20.7 m95 -125.41 137.59 54.01 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.559 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -127.57 156.28 42.5 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.869 -1.144 . . . . 0.0 109.054 179.515 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.554 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -121.18 166.86 13.36 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.089 -1.007 . . . . 0.0 111.306 -179.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.52 134.71 3.36 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.313 -0.867 . . . . 0.0 110.979 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.641 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -56.23 152.23 11.27 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.611 0.719 . . . . 0.0 111.449 179.416 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.3 mm -135.5 143.58 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.563 -0.711 . . . . 0.0 110.106 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 58.41 69.47 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.365 0.603 . . . . 0.0 110.497 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.575 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 69.4 t80 -128.24 160.16 32.97 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.244 -0.91 . . . . 0.0 109.631 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 80' ' ' SER . 25.1 p -142.23 -78.5 0.25 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.597 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -148.67 107.95 3.93 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.85 -102.06 0.2 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 51.4 t80 -143.0 -168.52 2.81 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.635 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.4 mtm180 -72.99 -150.61 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.688 -1.257 . . . . 0.0 109.314 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.596 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 10.4 p30 -171.52 -151.28 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.6 p -99.83 -7.23 25.65 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.673 -1.267 . . . . 0.0 110.201 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.606 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -88.51 118.78 28.39 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.132 -0.98 . . . . 0.0 110.276 -178.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.807 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.77 150.32 43.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.429 -0.795 . . . . 0.0 110.014 179.038 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.0 tt -117.02 136.76 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 108.983 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -112.89 124.7 53.2 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.679 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.36 126.72 52.68 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.11 0.957 . . . . 0.0 109.494 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.724 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.7 p -94.39 158.34 15.61 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 122.292 1.044 . . . . 0.0 112.085 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.5 p -68.53 -21.17 64.58 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.538 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.61 10.77 5.45 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.196 -0.94 . . . . 0.0 110.144 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.435 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 76.97 31.12 0.53 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.927 -0.483 . . . . 0.0 110.051 179.513 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.8 mt -103.48 136.26 43.54 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.279 -0.888 . . . . 0.0 109.816 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.437 HG23 HD12 ' A' ' 96' ' ' ILE . 34.1 mm -110.37 120.02 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.248 -0.907 . . . . 0.0 110.204 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.441 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.3 m-85 -120.17 143.47 48.21 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.606 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 7.7 tptp -131.74 147.41 52.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 110.967 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.549 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.2 t -127.79 169.9 13.36 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.1 p -144.79 -2.99 0.8 Allowed 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.663 -0.648 . . . . 0.0 110.22 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.469 ' CG ' ' H ' ' A' ' 105' ' ' THR . 1.1 p30 -115.37 18.79 15.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.596 -1.315 . . . . 0.0 108.566 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 78.9 63.55 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.167 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.68 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 18.0 m-85 69.09 -13.64 0.34 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.899 -0.501 . . . . 0.0 111.736 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -51.46 -73.5 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.384 -1.448 . . . . 0.0 109.8 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.469 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 36.3 p -99.03 -178.48 3.95 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.32 134.24 7.15 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.845 -1.159 . . . . 0.0 110.0 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 78.3 m -127.38 140.66 52.03 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.633 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 15.8 tttp -86.22 139.33 31.14 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.063 -1.023 . . . . 0.0 109.928 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.2 pt -112.43 -31.66 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.695 -0.628 . . . . 0.0 109.728 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.646 HH21 ' CG ' ' A' ' 8' ' ' ASP . 61.8 mtt180 . . . . . 0 C--N 1.306 -1.298 0 O-C-N 120.962 -1.086 . . . . 0.0 108.756 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.638 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 24.1 t . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 tt -171.06 160.84 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -145.98 29.52 1.09 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.473 -1.392 . . . . 0.0 111.465 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.0 p -106.18 156.84 18.04 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.785 0.802 . . . . 0.0 110.05 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.7 p90 -59.91 -62.45 1.86 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.899 -1.126 . . . . 0.0 110.745 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.65 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -55.74 -42.7 75.78 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.35 -0.844 . . . . 0.0 109.565 179.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.0 -44.75 87.96 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.0 t -68.22 -41.05 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 O-C-N 121.58 -0.953 . . . . 0.0 108.771 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.2 -58.29 8.32 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.26 -54.3 17.49 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.402 -0.811 . . . . 0.0 110.087 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.611 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 38.8 t80 -57.32 -50.1 74.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.911 -0.493 . . . . 0.0 110.429 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.85 -43.48 65.42 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.537 -0.727 . . . . 0.0 111.189 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -63.54 -20.1 65.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.31 -1.494 . . . . 0.0 110.314 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.5 m -97.28 -39.9 9.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.048 -1.032 . . . . 0.0 111.219 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.9 16.47 20.35 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.213 -0.93 . . . . 0.0 111.953 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.5 m80 46.82 24.38 0.34 Allowed 'General case' 0 N--CA 1.511 2.606 0 O-C-N 120.414 -1.429 . . . . 0.0 110.599 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 pttp -142.5 152.57 42.82 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.041 -1.037 . . . . 0.0 110.999 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mp -75.45 148.53 83.29 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.313 -0.867 . . . . 0.0 109.442 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.611 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 54.0 Cg_exo -38.74 150.0 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.623 2.882 . . . . 0.0 113.58 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -63.64 46.62 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.572 0.701 . . . . 0.0 110.883 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.414 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -169.6 27.22 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.108 -0.995 . . . . 0.0 110.342 179.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -117.56 116.41 27.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.004 -1.06 . . . . 0.0 110.616 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.407 HG22 HD12 ' A' ' 25' ' ' ILE . 31.0 pt -119.11 139.36 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.313 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.1 p -70.33 166.35 20.41 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.056 -1.028 . . . . 0.0 111.206 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.55 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 20.5 mtmt -67.19 -37.41 83.64 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -40.91 -67.08 0.27 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.482 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.9 mt-10 -62.49 -54.46 39.61 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.297 -0.961 . . . . 0.0 108.994 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -39.18 -51.41 1.94 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.699 -1.251 . . . . 0.0 109.136 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.39 -57.63 12.16 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.549 -0.719 . . . . 0.0 111.019 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.9 -30.35 70.12 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 120.545 -1.347 . . . . 0.0 109.13 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.8 tp -61.51 -25.66 67.41 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.672 -0.642 . . . . 0.0 109.517 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.27 49.56 0.27 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.574 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -82.53 144.77 30.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -1.162 . . . . 0.0 109.72 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.0 t -136.73 125.21 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.34 -0.85 . . . . 0.0 109.392 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -57.19 -53.08 62.18 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.2 p -68.07 48.84 0.06 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.061 -1.025 . . . . 0.0 110.211 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.543 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -179.71 -51.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.91 58.15 11.83 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.574 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -72.85 161.98 30.05 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.714 -0.874 . . . . 0.0 110.782 -178.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.541 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.5 tp -174.85 -68.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.372 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.72 -18.65 60.52 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.721 -1.237 . . . . 0.0 109.793 -178.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.9 p-10 -79.56 -60.86 2.19 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.842 0.829 . . . . 0.0 109.285 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.428 ' H ' HG23 ' A' ' 45' ' ' VAL . 12.6 m -75.53 -13.24 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.85 -0.531 . . . . 0.0 109.983 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.57 72.62 9.83 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.46 -0.775 . . . . 0.0 110.011 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.29 124.72 16.83 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.809 2.34 . . . . 0.0 114.407 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.06 39.66 58.1 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -138.65 172.69 12.51 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 122.195 0.998 . . . . 0.0 110.717 -179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.1 m -146.46 163.05 36.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.631 -1.293 . . . . 0.0 111.273 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.2 mm -83.8 130.02 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.452 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 167.81 154.35 8.62 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.67 -15.03 11.54 Favored Glycine 0 N--CA 1.501 3.031 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.269 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.472 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -72.93 -154.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.63 -1.512 . . . . 0.0 108.585 178.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -126.27 141.85 44.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.34 -0.85 . . . . 0.0 110.732 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.598 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.9 t80 -106.59 90.84 3.46 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.585 0.707 . . . . 0.0 109.106 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.508 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.5 p -61.34 38.94 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.579 0.704 . . . . 0.0 110.741 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.598 ' N ' ' O ' ' A' ' 56' ' ' PHE . 56.9 t30 36.33 35.73 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.131 -0.981 . . . . 0.0 110.505 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.508 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.5 mtm180 -67.17 43.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.915 -1.116 . . . . 0.0 109.872 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.67 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 18.2 mt-10 -150.58 -25.43 0.23 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.468 -0.77 . . . . 0.0 109.943 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.86 27.77 62.06 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.679 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.0 mttp -110.77 6.8 21.74 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.747 -0.855 . . . . 0.0 109.615 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mt -129.76 143.67 49.95 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.547 -0.721 . . . . 0.0 109.69 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.41 123.79 13.07 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.782 2.321 . . . . 0.0 111.913 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -100.48 -172.22 29.48 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 68' ' ' GLY . 9.8 tttt 177.37 146.63 0.12 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.624 -0.927 . . . . 0.0 109.092 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.7 p -68.07 58.7 0.07 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.83 -1.169 . . . . 0.0 109.155 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 144.26 77.47 0.03 OUTLIER Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -171.82 168.04 6.19 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.701 -0.881 . . . . 0.0 108.988 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.442 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 86.6 m -144.18 154.53 43.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.454 -0.779 . . . . 0.0 110.116 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.686 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 18.5 m95 -125.4 139.21 53.86 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.522 ' HG2' ' NH1' ' A' ' 72' ' ' ARG . 0.1 OUTLIER -130.21 155.06 46.89 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 121.01 -1.057 . . . . 0.0 109.578 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.55 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -119.74 167.85 11.65 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.088 -1.008 . . . . 0.0 111.761 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.59 136.21 3.71 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.746 -1.221 . . . . 0.0 110.753 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.689 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -59.19 152.49 20.46 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.236 0.541 . . . . 0.0 111.605 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.415 ' HA ' HD12 ' A' ' 76' ' ' ILE . 42.6 mm -135.74 144.95 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.595 -0.69 . . . . 0.0 110.462 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 57.35 68.53 0.84 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.523 0.677 . . . . 0.0 110.696 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.541 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 66.9 t80 -127.86 159.34 35.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.251 -0.906 . . . . 0.0 109.511 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.613 ' OG1' ' N ' ' A' ' 80' ' ' SER . 26.1 p -140.7 -77.35 0.3 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.613 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -150.09 108.23 3.75 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.19 -102.33 0.21 Allowed Glycine 0 N--CA 1.501 3.028 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.484 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 48.4 t80 -144.04 -169.78 3.19 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.646 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.9 mtm180 -71.66 -156.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.702 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -166.91 -150.06 0.1 Allowed 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.1 p -100.39 -6.84 25.1 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.646 -1.284 . . . . 0.0 110.151 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.671 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -88.03 117.53 26.96 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.285 -0.884 . . . . 0.0 110.764 -178.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.803 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.89 149.12 41.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.74 179.259 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.4 tt -117.56 137.39 51.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -113.97 125.44 54.02 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.682 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -117.92 126.48 52.45 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.791 0.805 . . . . 0.0 108.914 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.686 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 2.1 p -92.43 157.03 16.8 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.985 0.898 . . . . 0.0 111.298 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.1 p -69.92 -19.45 63.39 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.528 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.31 10.43 5.6 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.237 -0.914 . . . . 0.0 109.781 179.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.455 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.0 30.85 0.43 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.881 -0.512 . . . . 0.0 110.004 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 25.8 mt -103.26 138.68 39.71 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.134 -0.979 . . . . 0.0 109.938 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.469 HG23 HD12 ' A' ' 96' ' ' ILE . 32.0 mm -112.63 120.15 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.417 -0.802 . . . . 0.0 110.058 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.437 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.7 m-85 -120.36 142.96 48.68 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.671 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 8.5 tptp -131.0 147.78 52.67 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.167 -0.958 . . . . 0.0 110.835 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.508 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -128.22 171.14 12.24 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.9 p -146.69 -2.63 0.64 Allowed 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.443 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.45 ' CG ' ' H ' ' A' ' 105' ' ' THR . 1.2 p30 -115.95 20.02 14.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.741 -1.224 . . . . 0.0 108.397 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 78.14 61.75 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.619 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.679 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 20.0 m-85 70.45 -13.52 0.45 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.67 -0.644 . . . . 0.0 111.343 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -50.8 -73.62 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.517 -1.365 . . . . 0.0 109.31 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.45 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 37.1 p -99.11 -178.08 3.82 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.3 134.77 7.48 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.167 -0.958 . . . . 0.0 110.028 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 57.8 m -127.67 139.77 52.5 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.624 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 14.2 tttp -85.83 140.05 30.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.803 -1.185 . . . . 0.0 110.416 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.4 pt -113.2 -32.42 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.63 -0.669 . . . . 0.0 109.922 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.65 HH21 ' CG ' ' A' ' 8' ' ' ASP . 69.6 mtt180 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 109.112 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.577 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 39.9 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 tt -171.23 159.69 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -146.77 29.38 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.368 -1.458 . . . . 0.0 110.61 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.9 p -105.48 157.42 17.37 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.545 -178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -60.06 -61.89 2.27 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.85 -1.156 . . . . 0.0 110.43 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.618 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.51 -40.75 79.41 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.053 -1.029 . . . . 0.0 109.317 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.13 -45.13 94.35 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 68.8 t -66.55 -40.73 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.388 -1.066 . . . . 0.0 109.179 178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -63.06 -57.38 10.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.72 -0.612 . . . . 0.0 109.392 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.82 -52.1 51.71 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.627 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 33.3 t80 -58.45 -49.67 76.47 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.333 0.587 . . . . 0.0 111.188 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.2 tt -72.25 -45.89 58.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.561 -0.712 . . . . 0.0 110.749 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.48 ' N ' ' O ' ' A' ' 11' ' ' ALA . 64.2 mt-30 -61.0 -20.05 62.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.354 -1.466 . . . . 0.0 110.587 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 m -97.97 -40.77 8.31 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.486 -1.384 . . . . 0.0 111.194 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -110.36 16.12 21.84 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.781 -1.199 . . . . 0.0 111.714 -177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.0 m80 46.03 24.61 0.26 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.367 -0.833 . . . . 0.0 110.643 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 3.8 pttp -142.41 154.33 44.5 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.688 0.756 . . . . 0.0 110.511 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mp -77.2 149.28 79.18 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.707 -0.62 . . . . 0.0 109.686 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.627 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 51.6 Cg_exo -39.67 147.68 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.556 2.837 . . . . 0.0 113.718 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -63.8 47.55 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.084 0.945 . . . . 0.0 110.936 -177.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.478 ' HB2' ' HA ' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -169.11 27.08 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.087 -1.008 . . . . 0.0 110.811 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -117.99 118.26 31.46 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.705 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.463 HG22 HD12 ' A' ' 25' ' ' ILE . 28.8 pt -120.12 137.39 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.44 ' CB ' ' HG ' ' A' ' 28' ' ' SER . 7.2 p -67.78 169.8 9.04 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.498 1.142 . . . . 0.0 111.259 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.557 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 24.1 mtmt -71.61 -37.53 70.93 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -39.67 -70.43 0.1 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 175.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.522 ' O ' ' C ' ' A' ' 30' ' ' ALA . 3.5 mt-10 -58.57 -58.76 7.15 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.63 -51.55 1.21 Allowed 'General case' 0 N--CA 1.508 2.46 0 O-C-N 119.075 -2.265 . . . . 0.0 110.348 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -58.15 -58.64 7.55 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.091 -1.006 . . . . 0.0 110.171 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.48 69.81 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 121.119 -0.988 . . . . 0.0 110.452 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.6 tp -55.12 -28.61 53.93 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.504 0.669 . . . . 0.0 110.23 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.29 51.05 0.25 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.534 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.71 144.94 30.79 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.277 -1.131 . . . . 0.0 109.375 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.8 t -137.45 127.03 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.556 -0.715 . . . . 0.0 110.132 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -56.98 -52.55 64.82 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.991 -0.443 . . . . 0.0 110.581 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.6 p -70.05 47.31 0.08 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.196 -0.94 . . . . 0.0 110.377 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.624 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.5 ttpm? -176.35 -51.1 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.16 56.43 20.46 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.624 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -69.92 161.77 29.32 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.659 -0.907 . . . . 0.0 110.521 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.523 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 60.1 tp -176.26 -65.95 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.557 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.17 -19.4 63.05 Favored 'General case' 0 C--O 1.197 -1.666 0 O-C-N 121.305 -0.872 . . . . 0.0 109.504 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.6 p-10 -80.06 -64.42 1.19 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.993 0.902 . . . . 0.0 108.637 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.452 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 30.5 m -73.89 -11.45 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.705 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.57 72.15 11.68 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.506 -0.746 . . . . 0.0 109.939 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.4 122.43 11.66 Favored 'Trans proline' 0 N--CA 1.512 2.601 0 C-N-CA 123.472 2.781 . . . . 0.0 114.219 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.418 ' C ' ' HG2' ' A' ' 49' ' ' LYS . . . 73.41 39.46 50.83 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 8.6 mmtm -138.68 176.44 8.7 Favored 'General case' 0 N--CA 1.512 2.669 0 CA-C-O 122.513 1.149 . . . . 0.0 111.009 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.1 m -148.57 162.91 38.71 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 120.203 -1.56 . . . . 0.0 110.783 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.1 mm -85.59 125.31 40.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.128 -0.983 . . . . 0.0 109.77 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.22 154.02 10.45 Favored Glycine 0 N--CA 1.503 3.138 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.42 -17.42 8.41 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.906 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -69.79 -154.49 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.839 -1.389 . . . . 0.0 109.835 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.9 mp -127.69 139.8 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 121.805 0.812 . . . . 0.0 110.855 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.628 ' C ' ' H ' ' A' ' 58' ' ' ASN . 9.0 t80 -105.2 90.05 3.31 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.38 -0.825 . . . . 0.0 108.816 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.541 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.5 p -59.34 36.04 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 121.393 0.616 . . . . 0.0 110.524 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.628 ' H ' ' C ' ' A' ' 56' ' ' PHE . 59.2 t30 39.38 34.68 0.14 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.075 -1.016 . . . . 0.0 110.325 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.541 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.3 mtm180 -66.58 45.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.547 -1.345 . . . . 0.0 110.066 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.661 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 18.5 mt-10 -151.53 -27.07 0.19 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.526 -0.733 . . . . 0.0 110.142 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.32 27.76 59.11 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.674 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.6 mttp -111.13 7.79 21.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.723 -0.869 . . . . 0.0 109.757 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.31 144.88 55.04 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.608 -0.683 . . . . 0.0 109.247 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.57 125.15 14.97 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.672 2.248 . . . . 0.0 112.289 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.541 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.82 -171.41 27.7 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 68' ' ' GLY . 12.1 tttt 176.37 146.67 0.09 Allowed 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.405 -1.056 . . . . 0.0 109.144 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.1 p -68.88 61.29 0.1 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.763 -1.211 . . . . 0.0 108.951 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 142.99 76.73 0.04 OUTLIER Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.568 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.92 168.25 4.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.54 -0.976 . . . . 0.0 109.195 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.446 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 93.4 m -144.5 155.86 43.9 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.463 -0.773 . . . . 0.0 109.897 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.693 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 19.8 m95 -126.55 137.6 53.37 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.553 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -128.84 156.55 43.46 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.993 -1.067 . . . . 0.0 109.091 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.557 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -121.28 167.4 12.77 Favored 'General case' 0 N--CA 1.513 2.676 0 CA-C-O 122.274 1.035 . . . . 0.0 111.402 -179.322 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -166.29 136.84 3.42 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.276 -0.89 . . . . 0.0 111.308 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.677 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -59.5 153.69 18.93 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.648 0.737 . . . . 0.0 111.584 -179.344 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.408 ' HA ' HD12 ' A' ' 76' ' ' ILE . 40.6 mm -136.76 142.84 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.77 -0.581 . . . . 0.0 110.764 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 59.26 65.79 1.13 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.436 0.636 . . . . 0.0 110.665 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.523 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 63.1 t80 -125.2 159.78 30.75 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.298 -0.876 . . . . 0.0 109.566 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' A' ' 80' ' ' SER . 28.1 p -139.99 -77.38 0.32 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.583 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.1 OUTLIER -149.53 112.12 4.76 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.06 -104.83 0.26 Allowed Glycine 0 N--CA 1.502 3.049 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.462 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 44.3 t80 -141.43 -169.77 2.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.861 -0.787 . . . . 0.0 109.286 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.651 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.7 mtm180 -71.1 -155.0 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 O-C-N 120.81 -1.181 . . . . 0.0 109.539 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -168.77 -151.99 0.1 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.5 p -99.72 -3.5 32.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.62 -1.3 . . . . 0.0 110.335 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.604 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -91.28 117.07 29.34 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.251 -0.906 . . . . 0.0 110.283 -179.134 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.802 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.1 150.22 44.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.329 -0.857 . . . . 0.0 109.56 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.2 tt -119.06 137.38 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -114.47 125.72 54.14 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.7 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.56 127.83 53.99 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.752 0.786 . . . . 0.0 109.279 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.693 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.5 p -94.12 159.14 15.28 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.282 1.039 . . . . 0.0 112.329 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.5 p -69.87 -19.52 63.43 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.568 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -83.16 10.44 8.28 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.732 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.464 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.39 31.29 0.48 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.726 -0.609 . . . . 0.0 109.988 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.1 mt -103.43 138.34 40.29 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.46 -0.775 . . . . 0.0 109.833 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.447 HG23 HD12 ' A' ' 96' ' ' ILE . 31.9 mm -112.35 119.51 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.794 -0.566 . . . . 0.0 110.139 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.408 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.0 m-85 -120.62 143.55 48.61 Favored 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.604 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 7.7 tptp -131.12 148.09 52.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.02 -1.05 . . . . 0.0 110.299 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.553 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -127.68 171.9 11.26 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.3 p -146.73 -1.85 0.67 Allowed 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.147 -0.971 . . . . 0.0 110.281 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.437 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.2 p30 -117.13 20.27 13.83 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.717 -1.239 . . . . 0.0 108.433 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 77.07 64.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.409 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.674 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 18.9 m-85 68.96 -12.87 0.37 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 122.195 -0.316 . . . . 0.0 111.793 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -51.66 -72.75 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.478 -1.389 . . . . 0.0 109.58 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.432 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 37.3 p -100.07 -179.12 4.05 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.12 135.42 9.1 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.038 -1.039 . . . . 0.0 109.954 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 64.0 m -128.8 139.51 52.15 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.62 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 15.5 tttp -86.1 139.19 31.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.839 -1.163 . . . . 0.0 110.314 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.5 pt -112.7 -31.55 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.831 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.62 ' C ' ' HZ3' ' A' ' 108' ' ' LYS . 68.2 mtt180 . . . . . 0 C--N 1.306 -1.298 0 O-C-N 121.131 -0.981 . . . . 0.0 109.167 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.592 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 22.0 t . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 tt -169.94 160.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -146.53 30.2 1.01 Allowed 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.255 -1.528 . . . . 0.0 111.637 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.3 p -104.16 158.32 16.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.517 -0.739 . . . . 0.0 109.526 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.7 p90 -60.35 -61.67 2.43 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.617 -1.302 . . . . 0.0 110.872 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.615 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -56.69 -41.67 77.74 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.145 -0.972 . . . . 0.0 109.618 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.27 -45.21 94.46 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.72 -41.5 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 O-C-N 121.109 -1.23 . . . . 0.0 108.101 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.36 -59.38 5.37 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.48 -52.17 31.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.058 -1.026 . . . . 0.0 109.973 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.645 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 36.3 t80 -59.58 -47.98 83.46 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.291 -0.881 . . . . 0.0 110.628 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.7 tt -72.9 -44.38 61.34 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.382 -0.824 . . . . 0.0 110.841 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -62.73 -22.62 66.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.554 -1.341 . . . . 0.0 110.379 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.2 m -94.88 -42.11 8.85 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.957 -1.089 . . . . 0.0 111.048 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -109.49 16.83 21.98 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.127 -0.983 . . . . 0.0 112.214 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 m80 46.84 24.35 0.34 Allowed 'General case' 0 N--CA 1.51 2.56 0 O-C-N 120.94 -1.1 . . . . 0.0 110.584 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.2 pttp -141.39 151.45 43.49 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.241 1.02 . . . . 0.0 110.296 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp -75.44 150.39 84.75 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.033 -1.042 . . . . 0.0 108.725 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.645 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 50.7 Cg_exo -40.33 151.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 123.344 2.696 . . . . 0.0 114.35 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -66.38 47.6 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.6 0.714 . . . . 0.0 111.312 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.419 ' HB2' ' HA ' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -170.22 27.65 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 109.189 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -119.25 118.26 30.8 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.714 -1.241 . . . . 0.0 110.098 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 25' ' ' ILE . 33.8 pt -119.89 138.73 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.307 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.0 p -69.01 166.97 16.91 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.936 -1.102 . . . . 0.0 110.875 -177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.591 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 22.9 mtmt -70.38 -34.59 72.75 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.31 -66.99 0.32 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' ' 30' ' ' ALA . 3.4 mt-10 -60.35 -58.3 9.1 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.439 -1.304 . . . . 0.0 108.288 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.66 -52.46 1.23 Allowed 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.007 -1.058 . . . . 0.0 109.241 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -59.0 -55.98 28.15 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.563 -0.711 . . . . 0.0 110.511 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.26 -29.1 70.17 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 120.652 -1.28 . . . . 0.0 108.964 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.9 tp -62.38 -27.36 69.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.648 -0.657 . . . . 0.0 109.471 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.84 52.73 0.23 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.557 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -83.07 146.77 28.51 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.317 -1.108 . . . . 0.0 109.693 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -135.77 125.16 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.325 -0.859 . . . . 0.0 109.187 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -58.82 -52.56 65.21 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.831 -0.543 . . . . 0.0 109.724 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.9 p -70.37 50.98 0.12 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.001 -1.062 . . . . 0.0 109.412 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.645 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -179.69 -50.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.41 56.99 20.29 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.645 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -72.14 164.42 26.22 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.834 -0.803 . . . . 0.0 110.784 -178.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.612 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 66.6 tp -178.64 -66.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.001 -1.062 . . . . 0.0 110.004 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.98 -23.12 63.36 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.098 -1.001 . . . . 0.0 109.711 -178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 45' ' ' VAL . 5.5 p-10 -76.39 -64.11 1.18 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.003 0.906 . . . . 0.0 109.497 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.448 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 15.3 m -76.21 -10.92 13.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.853 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.62 70.14 11.41 Favored Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.348 -0.845 . . . . 0.0 109.431 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -57.04 123.57 14.16 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 123.182 2.588 . . . . 0.0 113.673 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.487 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 73.88 36.45 52.51 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.487 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 8.5 mmtm -138.57 168.97 18.63 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 121.885 0.85 . . . . 0.0 111.205 -178.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.3 m -142.48 162.02 36.56 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.277 1.037 . . . . 0.0 111.089 -177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.1 mm -84.47 126.93 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 122.1 0.952 . . . . 0.0 110.327 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.36 153.74 9.24 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.57 -20.46 7.82 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.329 -1.415 . . . . 0.0 110.782 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.449 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -68.33 -154.42 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 118.686 1.243 . . . . 0.0 109.01 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.66 139.65 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-O 121.864 0.84 . . . . 0.0 111.219 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.625 ' C ' ' H ' ' A' ' 58' ' ' ASN . 8.5 t80 -104.05 89.96 3.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.341 -0.85 . . . . 0.0 109.304 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.505 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.3 p -58.99 35.16 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.603 -0.686 . . . . 0.0 110.888 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.625 ' H ' ' C ' ' A' ' 56' ' ' PHE . 55.2 t30 38.34 39.7 0.3 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.107 -0.996 . . . . 0.0 109.878 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.505 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 8.9 mtm180 -70.29 43.33 0.06 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.562 -1.336 . . . . 0.0 110.087 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.66 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 21.7 mt-10 -149.38 -25.32 0.28 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.332 -0.855 . . . . 0.0 109.943 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.59 28.74 58.92 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.66 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 8.5 mttp -111.3 7.93 21.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.508 -0.995 . . . . 0.0 109.713 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mt -131.0 144.04 51.91 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.602 -0.686 . . . . 0.0 109.493 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.33 124.98 15.8 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.819 2.346 . . . . 0.0 112.408 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.543 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.1 -173.22 28.82 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 68' ' ' GLY . 11.0 tttt 177.29 144.24 0.09 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.375 -1.074 . . . . 0.0 108.656 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.2 p -68.1 58.58 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.936 -1.102 . . . . 0.0 109.172 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 147.64 75.51 0.02 OUTLIER Glycine 0 N--CA 1.5 2.913 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.564 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.56 168.11 5.37 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.711 -0.876 . . . . 0.0 109.33 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 87.9 m -143.39 155.09 44.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.486 -0.759 . . . . 0.0 110.039 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.699 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 17.9 m95 -125.21 138.34 54.12 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.558 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -129.47 156.14 44.59 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 120.747 -1.221 . . . . 0.0 109.586 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.591 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -120.47 167.66 12.13 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.259 -0.901 . . . . 0.0 112.026 -179.37 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -166.65 135.71 2.94 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.135 -0.978 . . . . 0.0 110.714 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.633 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -58.59 153.33 16.53 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.343 0.592 . . . . 0.0 111.676 -179.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.9 mm -136.02 140.67 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.49 0.662 . . . . 0.0 110.37 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 60.49 68.98 0.72 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.679 -0.638 . . . . 0.0 110.403 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.612 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 61.2 t80 -126.13 159.45 32.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.349 -0.844 . . . . 0.0 109.636 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.601 ' OG1' ' N ' ' A' ' 80' ' ' SER . 31.2 p -139.8 -78.25 0.32 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.601 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -150.84 107.44 3.51 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.94 -107.41 0.31 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 52.1 t80 -139.29 -166.93 2.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.734 -0.862 . . . . 0.0 108.843 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.648 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.3 mtm180 -73.91 -157.31 0.05 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.0 -1.062 . . . . 0.0 109.53 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -166.64 -153.14 0.15 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 100' ' ' THR . 50.7 p -98.22 -9.64 25.3 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.457 -1.402 . . . . 0.0 110.727 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.64 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -86.06 117.71 25.07 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.066 -1.021 . . . . 0.0 111.096 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.784 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.65 148.45 42.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.405 -0.81 . . . . 0.0 109.552 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.5 tt -115.93 139.54 42.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -116.05 125.43 52.42 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.671 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -117.55 127.52 54.06 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.856 0.836 . . . . 0.0 109.355 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.699 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 8.6 p -94.58 157.7 15.86 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.122 0.963 . . . . 0.0 111.944 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.1 p -69.01 -20.1 64.14 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.564 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -82.18 9.72 8.15 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.3 -0.875 . . . . 0.0 110.033 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.451 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.25 29.35 0.45 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.714 -0.616 . . . . 0.0 110.449 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.2 mt -101.87 135.99 42.47 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.437 -0.79 . . . . 0.0 109.985 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.469 HG23 HD12 ' A' ' 96' ' ' ILE . 31.4 mm -110.2 119.74 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.515 -0.74 . . . . 0.0 110.115 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.433 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.3 m-85 -119.04 143.14 47.27 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.64 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 8.5 tptp -132.45 147.49 52.37 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.823 -1.173 . . . . 0.0 110.537 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.476 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.5 t -129.39 171.04 12.92 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.403 ' O ' ' OG ' ' A' ' 85' ' ' SER . 72.3 p -145.22 -3.65 0.74 Allowed 'General case' 0 N--CA 1.508 2.472 0 O-C-N 121.45 -0.781 . . . . 0.0 110.234 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.2 p30 -114.53 19.37 16.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.756 -1.215 . . . . 0.0 108.924 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 77.87 63.69 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.054 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.648 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 18.5 m-85 69.5 -14.48 0.33 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.813 -0.554 . . . . 0.0 111.87 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -49.96 -74.27 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.538 -1.351 . . . . 0.0 109.314 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.419 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 38.0 p -99.03 -177.17 3.54 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.791 -1.193 . . . . 0.0 108.319 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.23 134.33 7.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -0.983 . . . . 0.0 110.236 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.6 m -127.3 139.99 52.51 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.606 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 15.2 tttp -86.37 140.21 30.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.8 -1.187 . . . . 0.0 110.364 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.6 pt -113.68 -31.71 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.438 -0.788 . . . . 0.0 110.074 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.615 HH21 ' CG ' ' A' ' 8' ' ' ASP . 67.6 mtt180 . . . . . 0 N--CA 1.485 1.317 0 O-C-N 121.068 -1.02 . . . . 0.0 108.659 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.638 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.8 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 tt -169.4 159.69 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.365 -0.835 . . . . 0.0 109.342 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -146.67 31.07 0.97 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.512 -1.368 . . . . 0.0 111.357 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.7 p -106.08 155.97 18.88 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.599 -0.688 . . . . 0.0 109.865 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.3 p90 -58.44 -62.18 2.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.195 -0.941 . . . . 0.0 110.725 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.621 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.9 OUTLIER -58.15 -41.13 83.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.353 -0.842 . . . . 0.0 109.526 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.92 -44.91 87.56 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.3 t -67.95 -41.99 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.46 -57.02 12.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.473 -0.767 . . . . 0.0 109.21 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.08 -55.22 15.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.474 -0.766 . . . . 0.0 109.692 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.638 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 33.9 t80 -56.45 -49.88 73.32 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.249 0.547 . . . . 0.0 110.802 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -73.22 -44.55 59.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.376 -0.828 . . . . 0.0 110.709 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -62.26 -21.12 64.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.566 -1.334 . . . . 0.0 110.298 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.6 m -97.26 -40.92 8.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.174 -0.954 . . . . 0.0 110.742 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -109.16 14.42 23.9 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.118 -0.989 . . . . 0.0 111.908 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.1 m80 46.51 25.57 0.41 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 120.864 -1.147 . . . . 0.0 109.669 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.592 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 5.0 pttp -142.27 152.2 42.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.315 -0.866 . . . . 0.0 110.004 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp -76.88 149.36 80.24 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 109.066 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.638 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 66.1 Cg_exo -40.76 150.71 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.734 2.289 . . . . 0.0 113.23 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -62.59 47.14 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.601 0.715 . . . . 0.0 111.12 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -168.42 26.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.6 -1.313 . . . . 0.0 110.286 179.121 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -116.69 113.05 22.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.88 -1.137 . . . . 0.0 110.886 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.478 HG22 HD12 ' A' ' 25' ' ' ILE . 28.3 pt -116.18 138.59 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.325 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.454 ' CB ' ' HG ' ' A' ' 28' ' ' SER . 4.4 p -69.73 166.62 18.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.018 -1.051 . . . . 0.0 110.37 -176.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.586 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 18.7 mtmt -66.29 -35.4 80.29 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.454 ' HG ' ' CB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -41.89 -66.33 0.36 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.625 178.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.4 mt-10 -65.33 -49.3 69.95 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.301 -0.959 . . . . 0.0 109.192 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -44.24 -50.0 9.04 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.79 -1.194 . . . . 0.0 107.997 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -59.2 -57.6 12.33 Favored 'General case' 0 N--CA 1.509 2.506 0 O-C-N 121.36 -0.838 . . . . 0.0 110.733 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.34 -30.91 69.83 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.994 -1.066 . . . . 0.0 109.807 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.0 tp -63.11 -25.82 68.54 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.96 50.16 0.23 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.593 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.91 144.1 31.2 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.369 -1.077 . . . . 0.0 110.146 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.0 t -134.52 125.3 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.174 -0.954 . . . . 0.0 109.699 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -58.73 -52.83 64.02 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.55 -0.719 . . . . 0.0 109.812 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 59.6 p -68.56 50.2 0.07 Allowed 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.982 -1.073 . . . . 0.0 109.133 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.567 ' HZ1' ' CG ' ' A' ' 41' ' ' ASN . 1.0 OUTLIER -179.34 -50.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -0.774 . . . . 0.0 108.964 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.95 56.86 18.4 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.593 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -74.27 162.76 28.59 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.443 -1.034 . . . . 0.0 110.773 -178.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.604 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 65.4 tp -176.12 -67.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.547 -0.72 . . . . 0.0 109.798 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.407 ' HB3' ' HA ' ' A' ' 80' ' ' SER . . . -60.63 -18.86 55.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.962 -1.086 . . . . 0.0 109.935 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.8 p-10 -79.45 -65.1 1.04 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.843 0.83 . . . . 0.0 109.552 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.49 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 30.7 m -73.33 -10.89 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 O-C-N 121.743 -0.598 . . . . 0.0 110.353 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.83 71.87 9.59 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 109.785 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.36 122.56 12.0 Favored 'Trans proline' 0 N--CA 1.509 2.392 0 C-N-CA 123.977 3.118 . . . . 0.0 113.562 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.74 39.76 59.46 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 7.2 mmtt -136.6 176.08 9.03 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.052 0.929 . . . . 0.0 110.597 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.0 m -150.13 158.82 44.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.785 -1.197 . . . . 0.0 111.167 -177.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.3 mm -82.45 130.37 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.548 0.69 . . . . 0.0 110.121 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.4 154.83 8.5 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.89 -16.53 10.2 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 120.293 -0.956 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.411 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -70.55 -152.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.748 -1.443 . . . . 0.0 109.603 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -128.93 138.84 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.522 0.677 . . . . 0.0 110.821 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.605 ' C ' ' H ' ' A' ' 58' ' ' ASN . 11.0 t80 -104.09 90.31 3.55 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.661 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.3 36.2 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.47 0.653 . . . . 0.0 111.182 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.605 ' H ' ' C ' ' A' ' 56' ' ' PHE . 53.5 t30 36.58 38.4 0.08 Allowed 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.94 -1.1 . . . . 0.0 110.541 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.661 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.8 mtm180 -69.51 39.07 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.672 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 18.9 mt-10 -149.05 -10.9 0.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.182 -0.949 . . . . 0.0 110.246 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.78 33.23 84.53 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.672 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 7.1 mttp -115.1 8.6 15.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.613 -0.934 . . . . 0.0 109.446 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -132.81 142.94 46.59 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.446 -0.784 . . . . 0.0 109.349 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.86 125.99 17.84 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.885 2.39 . . . . 0.0 112.394 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.539 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.0 -170.99 28.63 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.559 ' O ' ' N ' ' A' ' 68' ' ' GLY . 11.1 tttt 175.52 144.08 0.07 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.149 -1.206 . . . . 0.0 108.269 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.2 p -66.09 57.05 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.838 -1.164 . . . . 0.0 108.427 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 147.63 77.34 0.02 OUTLIER Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.539 ' NH1' ' O ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -173.54 167.78 4.56 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.551 -0.97 . . . . 0.0 108.974 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.431 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 85.6 m -144.36 155.87 43.98 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.811 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.717 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 25.6 m95 -126.32 138.73 53.61 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.585 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.38 154.31 47.81 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.544 -1.347 . . . . 0.0 109.606 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.586 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -118.35 167.0 11.97 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.195 -0.94 . . . . 0.0 111.815 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.13 136.13 3.97 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.797 0.808 . . . . 0.0 110.967 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.664 ' CG ' ' HE ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -60.73 151.69 28.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.613 -0.679 . . . . 0.0 111.938 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.453 HG13 ' HB ' ' A' ' 88' ' ' ILE . 40.4 mm -137.15 143.82 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 121.476 0.655 . . . . 0.0 110.18 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 60.25 66.08 1.0 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.234 0.54 . . . . 0.0 110.576 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.604 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 58.0 t80 -126.79 161.63 27.74 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.156 -0.965 . . . . 0.0 109.122 178.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.634 ' OG1' ' N ' ' A' ' 80' ' ' SER . 27.2 p -141.38 -78.96 0.26 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.634 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.1 OUTLIER -149.27 106.08 3.56 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.51 -107.09 0.3 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 49.1 t80 -135.82 -166.02 1.79 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.721 -0.87 . . . . 0.0 108.771 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.658 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.8 mtm180 -75.16 -153.04 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.916 -1.115 . . . . 0.0 109.077 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -168.41 -150.3 0.09 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.3 p -100.87 -8.36 22.64 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.464 -1.397 . . . . 0.0 110.335 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.625 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -86.5 116.75 24.85 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.386 -0.821 . . . . 0.0 110.741 -178.887 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.8 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.22 149.47 44.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.251 -0.906 . . . . 0.0 109.698 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.453 ' HB ' HG13 ' A' ' 76' ' ' ILE . 10.5 tt -119.64 136.1 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.621 0.724 . . . . 0.0 109.125 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -112.66 124.65 53.03 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -116.69 127.84 54.78 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.691 0.758 . . . . 0.0 109.002 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.717 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 5.7 p -93.78 158.72 15.53 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.995 0.903 . . . . 0.0 111.91 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.7 p -69.39 -19.94 63.81 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.524 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.72 9.28 8.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.471 -0.768 . . . . 0.0 109.898 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.78 30.32 0.47 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.621 -0.674 . . . . 0.0 110.024 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.8 mt -102.87 137.57 40.9 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.342 -0.849 . . . . 0.0 110.388 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.413 HG23 HD12 ' A' ' 96' ' ' ILE . 35.9 mm -110.42 118.95 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.306 -0.872 . . . . 0.0 110.691 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.455 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 6.9 m-85 -119.09 141.61 48.61 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.625 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 6.2 tptp -131.37 148.26 52.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.417 -0.802 . . . . 0.0 110.896 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.518 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.7 t -128.66 172.46 11.2 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.9 p -146.87 -3.21 0.6 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.523 -0.735 . . . . 0.0 110.487 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 105' ' ' THR . 1.3 p30 -115.54 22.5 13.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.785 -1.197 . . . . 0.0 108.296 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 75.76 62.17 0.05 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.495 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.67 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 17.6 m-85 69.59 -10.87 0.55 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.701 -0.624 . . . . 0.0 111.414 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.72 -72.87 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.695 -1.253 . . . . 0.0 109.213 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.471 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 34.9 p -99.39 -178.37 3.88 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -160.65 133.48 6.41 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.071 -1.018 . . . . 0.0 109.794 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.9 m -127.28 141.49 51.7 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.618 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 13.5 tttp -86.77 139.03 31.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.873 -1.142 . . . . 0.0 110.093 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.3 pt -112.11 -32.26 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.606 -0.684 . . . . 0.0 109.432 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.621 HH21 ' CG ' ' A' ' 8' ' ' ASP . 56.3 mtt180 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 118.086 -0.959 . . . . 0.0 109.049 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.622 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.2 t . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 tt -169.78 160.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.4 -0.812 . . . . 0.0 109.219 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -147.26 30.33 0.94 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.339 -1.475 . . . . 0.0 111.129 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 10' ' ' VAL . 19.9 p -104.86 156.25 18.18 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.744 0.783 . . . . 0.0 109.792 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.5 p90 -59.65 -61.38 2.66 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.729 -1.232 . . . . 0.0 110.143 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.647 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.74 -41.53 82.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.337 -0.852 . . . . 0.0 109.388 -179.597 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.5 -44.77 93.62 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.642 HG22 ' HG2' ' A' ' 21' ' ' PRO . 60.6 t -67.54 -41.66 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 121.43 -1.041 . . . . 0.0 108.662 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.47 -58.09 9.55 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.17 -54.86 14.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.362 -0.836 . . . . 0.0 109.633 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.571 ' CE1' ' HA ' ' A' ' 21' ' ' PRO . 34.1 t80 -57.6 -47.36 82.37 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.118 0.485 . . . . 0.0 110.754 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.2 tt -74.21 -44.37 53.52 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.246 -0.909 . . . . 0.0 110.717 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -62.98 -19.94 64.8 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.436 -1.415 . . . . 0.0 110.13 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.4 m -96.8 -43.33 7.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.987 -1.071 . . . . 0.0 111.01 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -107.77 13.12 26.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.153 -0.967 . . . . 0.0 111.894 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.2 m80 49.2 23.91 0.88 Allowed 'General case' 0 N--CA 1.508 2.426 0 O-C-N 120.692 -1.255 . . . . 0.0 109.902 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.487 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.5 pttp -141.48 153.63 45.06 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.526 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.2 mp -77.78 149.71 77.8 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.344 -0.847 . . . . 0.0 109.038 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.642 ' HG2' HG22 ' A' ' 10' ' ' VAL . 77.2 Cg_exo -39.34 151.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 123.133 2.555 . . . . 0.0 113.567 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -63.45 47.83 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.637 0.732 . . . . 0.0 110.538 179.581 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -169.88 26.95 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.846 -1.159 . . . . 0.0 110.328 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -118.48 114.01 22.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.482 -1.387 . . . . 0.0 110.227 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 35.4 pt -117.26 140.63 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.024 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.638 HG22 ' HA3' ' A' ' 53' ' ' GLY . 6.8 p -70.19 166.8 19.23 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.325 1.06 . . . . 0.0 111.684 -177.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.577 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 20.6 mtmt -68.58 -35.57 77.55 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.73 -65.47 0.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.425 176.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.458 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.6 mt-10 -64.4 -52.02 60.3 Favored 'General case' 0 C--O 1.201 -1.466 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.624 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -41.71 -51.65 4.06 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.858 -1.152 . . . . 0.0 109.047 177.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -60.0 -56.73 18.08 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.372 -0.83 . . . . 0.0 110.895 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.9 -30.61 69.14 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.589 -1.319 . . . . 0.0 109.024 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.1 tp -63.48 -29.83 71.04 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.405 0.621 . . . . 0.0 109.439 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.34 55.01 0.15 Allowed Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.595 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -88.08 145.61 25.86 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.294 -1.121 . . . . 0.0 109.505 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -135.45 124.31 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.427 -0.795 . . . . 0.0 109.414 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -56.89 -53.21 60.54 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.708 -0.62 . . . . 0.0 109.716 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 81.0 p -68.54 48.53 0.06 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.462 -0.774 . . . . 0.0 109.834 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.648 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.4 ttpm? -178.29 -50.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.53 56.05 23.78 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.648 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -73.24 161.24 30.76 Favored 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.517 -0.99 . . . . 0.0 111.155 -178.764 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.828 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.5 tp -173.17 -68.18 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.117 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.602 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.51 -18.93 55.09 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.169 -0.957 . . . . 0.0 109.779 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.2 p-10 -78.38 -63.9 1.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.66 0.743 . . . . 0.0 109.36 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.6 m -75.6 -10.13 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.919 -0.488 . . . . 0.0 110.381 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.74 71.21 9.65 Favored Pre-proline 0 N--CA 1.486 1.346 0 O-C-N 121.514 -0.741 . . . . 0.0 109.589 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.9 124.37 16.08 Favored 'Trans proline' 0 N--CA 1.505 2.185 0 C-N-CA 123.517 2.812 . . . . 0.0 113.872 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.536 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 72.15 38.69 59.15 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.9 mmtm -137.02 171.25 14.79 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 121.691 0.758 . . . . 0.0 110.167 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.0 m -144.35 162.24 36.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.146 -0.971 . . . . 0.0 110.302 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.7 mm -84.63 127.87 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.631 0.729 . . . . 0.0 110.156 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.97 155.34 10.9 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.638 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 120.63 -15.94 9.71 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.695 -1.24 . . . . 0.0 111.053 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -71.75 -155.14 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.766 -1.432 . . . . 0.0 109.321 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.16 140.27 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.76 0.791 . . . . 0.0 110.393 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.597 ' O ' ' N ' ' A' ' 58' ' ' ASN . 9.7 t80 -105.61 91.16 3.64 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.55 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -60.52 36.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.605 -0.684 . . . . 0.0 110.828 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 56' ' ' PHE . 51.7 t30 38.94 36.88 0.17 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.123 -0.985 . . . . 0.0 110.358 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.55 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.6 mtm180 -69.43 42.3 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.885 -1.134 . . . . 0.0 109.564 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.621 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 17.8 mt-10 -150.18 -15.46 0.25 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.411 -0.806 . . . . 0.0 110.254 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.43 32.1 83.08 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.668 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.1 mttp -113.63 6.53 16.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.717 -0.873 . . . . 0.0 109.304 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.7 144.01 51.66 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.659 -0.651 . . . . 0.0 109.39 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.48 124.52 14.38 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.984 2.456 . . . . 0.0 112.051 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.521 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -101.03 -172.5 28.81 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 68' ' ' GLY . 10.9 tttt 177.07 146.47 0.11 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.366 -1.079 . . . . 0.0 108.955 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 67' ' ' SER . 24.2 p -68.57 60.21 0.09 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.956 -1.09 . . . . 0.0 108.784 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 144.18 77.05 0.03 OUTLIER Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.541 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -173.69 167.29 4.51 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.586 -0.949 . . . . 0.0 109.208 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 92.4 m -143.81 156.67 44.56 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.23 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.727 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 22.6 m95 -127.11 138.21 53.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.052 -0.405 . . . . 0.0 109.947 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.561 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.04 154.19 47.67 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.89 -1.131 . . . . 0.0 109.733 179.32 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.577 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -118.28 166.9 12.07 Favored 'General case' 0 N--CA 1.509 2.488 0 CA-C-O 121.768 0.794 . . . . 0.0 112.064 -179.051 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.18 134.56 3.51 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.282 -0.886 . . . . 0.0 111.31 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.678 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.46 153.13 13.27 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.268 0.556 . . . . 0.0 111.372 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.726 HD11 ' CG2' ' A' ' 88' ' ' ILE . 42.3 mm -135.98 143.45 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.769 -0.582 . . . . 0.0 109.977 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 57.96 69.75 0.71 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.497 0.665 . . . . 0.0 110.576 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.828 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 65.8 t80 -127.88 160.19 32.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.375 -0.828 . . . . 0.0 109.344 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.613 ' OG1' ' N ' ' A' ' 80' ' ' SER . 29.9 p -141.5 -78.94 0.26 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.613 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.4 OUTLIER -150.5 105.21 3.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.787 -0.571 . . . . 0.0 110.2 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.5 -98.85 0.17 Allowed Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.473 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 46.0 t80 -144.81 -169.86 3.27 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.605 -0.938 . . . . 0.0 109.379 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.641 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.8 mtm180 -72.0 -156.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.045 -1.034 . . . . 0.0 109.531 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -167.17 -151.7 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 p -99.25 -6.31 28.28 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.725 -1.234 . . . . 0.0 110.38 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.466 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -89.05 118.61 28.89 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.122 -0.986 . . . . 0.0 110.451 -178.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.857 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.77 150.46 43.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.755 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.726 ' CG2' HD11 ' A' ' 76' ' ' ILE . 3.7 tt -118.35 136.63 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 72' ' ' ARG . 2.4 mm? -114.29 124.24 51.52 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.692 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -116.6 127.5 54.53 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.691 0.757 . . . . 0.0 109.09 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.727 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.9 p -93.69 157.96 15.91 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.143 0.973 . . . . 0.0 112.197 -178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.1 p -68.86 -20.03 64.26 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.541 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -82.34 10.34 7.23 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.423 -0.798 . . . . 0.0 109.853 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.47 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.6 30.55 0.48 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.629 -0.669 . . . . 0.0 110.047 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.9 mt -102.79 138.68 39.36 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.384 -0.822 . . . . 0.0 109.94 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.468 HG22 HD11 ' A' ' 109' ' ' ILE . 33.4 mm -112.28 119.76 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.267 -0.896 . . . . 0.0 110.07 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.427 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.1 m-85 -119.95 142.61 48.59 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.466 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 9.3 tptp -130.62 147.67 52.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.761 . . . . 0.0 110.71 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.549 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.0 t -128.78 171.13 12.53 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.5 p -146.5 -2.62 0.66 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.36 -0.838 . . . . 0.0 110.488 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.636 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -115.63 19.34 15.37 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.653 -1.28 . . . . 0.0 108.549 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.97 62.01 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.534 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.668 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 21.5 m-85 69.89 -13.12 0.43 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.73 -0.606 . . . . 0.0 111.595 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -51.01 -72.39 0.05 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.735 -1.228 . . . . 0.0 109.557 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.458 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 34.5 p -99.96 -177.14 3.45 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -160.96 135.05 6.99 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.987 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.9 m -128.3 139.73 52.26 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.611 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 14.4 tttp -85.79 140.16 30.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.006 -1.059 . . . . 0.0 110.15 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.468 HD11 HG22 ' A' ' 96' ' ' ILE . 11.7 pt -113.23 -33.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.604 -0.685 . . . . 0.0 109.603 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.647 HH21 ' CG ' ' A' ' 8' ' ' ASP . 64.9 mtt180 . . . . . 0 N--CA 1.488 1.467 0 O-C-N 121.212 -0.93 . . . . 0.0 108.999 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.631 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.2 t . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 tt -171.31 161.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -145.94 28.2 1.15 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.43 -1.419 . . . . 0.0 111.083 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.5 p -104.16 156.12 18.15 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.729 0.776 . . . . 0.0 110.19 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.7 p90 -60.1 -60.78 3.28 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.758 -1.214 . . . . 0.0 110.759 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.63 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -58.57 -41.99 86.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 108.927 -179.381 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.19 -43.62 93.45 Favored Glycine 0 N--CA 1.501 2.993 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.733 HG22 ' HG2' ' A' ' 21' ' ' PRO . 50.5 t -68.78 -41.46 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.212 -1.169 . . . . 0.0 107.998 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.99 -59.1 5.91 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.61 -54.87 12.91 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.567 -0.708 . . . . 0.0 109.587 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.689 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 33.8 t80 -56.42 -49.51 74.35 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.174 0.511 . . . . 0.0 110.204 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.35 -47.41 56.57 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.164 -0.96 . . . . 0.0 111.567 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -61.4 -21.07 63.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.553 -1.342 . . . . 0.0 110.366 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 m -95.9 -41.01 9.02 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.986 -1.071 . . . . 0.0 111.652 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -110.8 16.2 21.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.457 -0.777 . . . . 0.0 111.566 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.6 m80 46.53 25.5 0.41 Allowed 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.563 -1.336 . . . . 0.0 110.248 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -142.95 152.62 42.2 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.203 -0.935 . . . . 0.0 110.695 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.551 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.3 mp -74.79 148.92 85.39 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.0 109.513 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.733 ' HG2' HG22 ' A' ' 10' ' ' VAL . 72.5 Cg_exo -40.48 151.56 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 123.4 2.734 . . . . 0.0 113.371 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.631 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -64.43 46.75 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 121.752 0.787 . . . . 0.0 110.997 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -167.62 24.87 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.937 -1.102 . . . . 0.0 110.545 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -116.27 116.02 27.01 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.692 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.8 pt -117.79 141.0 38.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.709 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.603 HG22 ' HA3' ' A' ' 53' ' ' GLY . 6.9 p -71.83 167.54 19.77 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 120.858 -1.151 . . . . 0.0 110.524 -177.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.568 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 22.5 mtmt -68.23 -35.92 78.68 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.414 ' HG ' ' CB ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -41.01 -66.23 0.35 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 122.829 1.299 . . . . 0.0 108.472 178.355 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.548 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.9 mt-10 -65.65 -52.83 48.63 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.612 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.548 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -40.8 -50.86 3.17 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.324 -1.485 . . . . 0.0 107.397 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -58.57 -58.79 6.98 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 120.898 -1.126 . . . . 0.0 111.63 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.93 -29.77 67.35 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.1 -1.625 . . . . 0.0 110.163 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.9 tp -63.17 -25.01 68.15 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.96 50.49 0.26 Allowed Glycine 0 N--CA 1.501 2.992 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.588 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.49 146.12 30.38 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.094 -1.239 . . . . 0.0 109.661 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.42 125.8 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.565 -0.709 . . . . 0.0 109.214 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -58.96 -52.53 65.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.843 -0.536 . . . . 0.0 109.744 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.6 p -69.71 50.12 0.1 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.697 -1.252 . . . . 0.0 109.342 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.64 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -178.46 -50.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.18 56.38 24.11 Favored Glycine 0 N--CA 1.503 3.1 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.64 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -71.94 164.99 25.1 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.629 -0.924 . . . . 0.0 110.387 -178.761 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.792 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 60.6 tp -177.35 -69.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.726 -0.609 . . . . 0.0 110.214 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -57.87 -20.46 36.85 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.616 -1.302 . . . . 0.0 109.414 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.5 p-10 -77.89 -63.08 1.47 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.424 1.107 . . . . 0.0 109.501 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.451 HG22 ' H ' ' A' ' 45' ' ' VAL . 17.0 m -77.46 -7.25 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.17 -0.956 . . . . 0.0 110.259 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.47 70.53 7.46 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.464 -0.772 . . . . 0.0 109.076 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.39 125.97 20.8 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 123.358 2.705 . . . . 0.0 113.719 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.32 40.13 70.04 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -137.56 176.21 8.91 Favored 'General case' 0 N--CA 1.516 2.851 0 CA-C-O 122.592 1.187 . . . . 0.0 111.85 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.404 ' HG ' ' HD2' ' A' ' 78' ' ' TYR . 73.1 m -148.72 160.41 43.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.614 -1.304 . . . . 0.0 111.639 -177.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.3 mm -83.24 127.76 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.436 -0.79 . . . . 0.0 109.833 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 170.44 153.23 8.59 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.603 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 121.71 -16.78 8.91 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.243 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.522 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 1.2 m-20 -70.48 -154.42 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.243 -1.151 . . . . 0.0 109.903 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mp -128.61 135.79 61.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.945 0.879 . . . . 0.0 110.202 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.606 ' O ' ' N ' ' A' ' 58' ' ' ASN . 10.9 t80 -101.75 91.16 4.28 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.654 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -60.57 37.27 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.632 -0.668 . . . . 0.0 110.456 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 56' ' ' PHE . 56.3 t30 37.82 36.69 0.1 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.208 -0.932 . . . . 0.0 110.444 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.654 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.9 mtm180 -68.35 44.93 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.804 -1.185 . . . . 0.0 109.885 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.62 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 20.1 mt-10 -151.51 -25.64 0.2 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.511 -0.743 . . . . 0.0 110.055 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.86 29.47 59.12 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.68 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.5 mttp -112.89 9.16 18.86 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.535 -0.979 . . . . 0.0 109.468 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mt -131.95 143.92 51.05 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.755 -0.591 . . . . 0.0 109.41 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.57 124.19 13.74 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 122.729 2.286 . . . . 0.0 112.3 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.541 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -100.76 -172.83 29.21 Favored Glycine 0 N--CA 1.505 3.235 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 68' ' ' GLY . 10.8 tttt 177.29 145.4 0.1 Allowed 'General case' 0 N--CA 1.508 2.465 0 O-C-N 121.559 -0.965 . . . . 0.0 108.73 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' A' ' 67' ' ' SER . 24.6 p -67.62 56.88 0.06 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.016 -1.052 . . . . 0.0 109.104 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 147.31 77.9 0.02 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.541 HH11 ' C ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -173.97 168.35 4.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.566 -0.961 . . . . 0.0 108.839 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.443 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.8 m -143.97 156.38 44.39 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.967 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.721 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 20.6 m95 -127.76 137.21 52.35 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.567 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -128.83 157.57 41.15 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 120.969 -1.082 . . . . 0.0 109.73 179.253 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.568 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -121.52 167.66 12.6 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.271 -0.893 . . . . 0.0 111.565 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.95 136.63 4.24 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.245 -0.909 . . . . 0.0 111.151 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.716 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -59.0 151.72 21.43 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.557 -0.714 . . . . 0.0 111.724 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.633 HD11 ' CG2' ' A' ' 88' ' ' ILE . 46.3 mm -135.69 144.58 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.489 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 58.31 70.36 0.66 Allowed 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.393 0.616 . . . . 0.0 110.407 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.792 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 61.6 t80 -129.54 161.1 31.26 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.076 -1.015 . . . . 0.0 109.455 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.611 ' OG1' ' N ' ' A' ' 80' ' ' SER . 28.5 p -140.9 -77.74 0.29 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.611 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -149.18 110.89 4.52 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.31 -104.04 0.24 Allowed Glycine 0 N--CA 1.502 3.038 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 44.2 t80 -141.32 -167.63 2.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.918 -0.754 . . . . 0.0 109.183 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.633 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.6 mtm180 -73.04 -153.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.165 -0.96 . . . . 0.0 109.415 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -168.35 -151.35 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.52 ' OG ' ' O ' ' A' ' 100' ' ' THR . 43.1 p -99.45 -4.16 32.05 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.645 -1.285 . . . . 0.0 110.114 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.457 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -91.04 118.14 30.16 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.287 -0.883 . . . . 0.0 110.492 -178.805 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.842 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.66 148.88 39.86 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.354 -0.841 . . . . 0.0 109.481 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.633 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.3 tt -116.59 136.65 52.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 72' ' ' ARG . 1.9 mm? -113.42 124.19 51.84 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.659 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -117.78 125.96 51.57 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.997 0.903 . . . . 0.0 109.466 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.721 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 5.1 p -92.12 158.54 16.14 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.852 0.834 . . . . 0.0 112.081 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.4 p -70.18 -19.69 63.17 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.533 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -82.43 10.12 7.78 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.347 -0.846 . . . . 0.0 109.928 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.453 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.85 30.22 0.47 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.712 -0.618 . . . . 0.0 110.099 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.423 HD12 HH21 ' A' ' 69' ' ' ARG . 29.6 mt -101.77 138.72 38.38 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.215 -0.928 . . . . 0.0 109.79 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.446 ' CG2' HD11 ' A' ' 109' ' ' ILE . 35.1 mm -113.23 119.51 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.469 -0.769 . . . . 0.0 110.024 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.428 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.9 m-85 -120.39 143.08 48.62 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.457 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 7.4 tptp -131.24 148.28 52.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.025 -1.047 . . . . 0.0 110.806 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.551 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.9 t -127.95 172.35 10.98 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.52 ' O ' ' OG ' ' A' ' 85' ' ' SER . 67.9 p -147.44 -1.45 0.62 Allowed 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.452 -0.78 . . . . 0.0 110.796 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.634 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -117.27 19.06 14.29 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.728 -1.232 . . . . 0.0 108.287 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.65 63.12 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.358 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.68 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 19.3 m-85 69.65 -13.23 0.41 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.873 -0.517 . . . . 0.0 111.334 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -50.72 -73.98 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.57 -1.331 . . . . 0.0 109.565 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.481 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 33.7 p -98.58 -177.42 3.67 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.67 134.81 7.15 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.968 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.4 m -128.39 139.0 52.6 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.615 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.7 tttp -86.26 140.21 30.32 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.937 -1.102 . . . . 0.0 109.904 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.446 HD11 ' CG2' ' A' ' 96' ' ' ILE . 12.8 pt -113.91 -31.26 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.689 -0.632 . . . . 0.0 109.642 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.63 HH21 ' CG ' ' A' ' 8' ' ' ASP . 66.7 mtt180 . . . . . 0 C--N 1.303 -1.426 0 O-C-N 121.126 -0.984 . . . . 0.0 108.846 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.621 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 20.2 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.399 0.618 . . . . 0.0 109.343 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 tt -170.13 159.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -146.17 30.14 1.05 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.766 -1.209 . . . . 0.0 111.306 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.4 p -104.8 158.14 16.73 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.594 0.712 . . . . 0.0 109.666 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.0 OUTLIER -60.68 -61.33 2.67 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.842 -1.161 . . . . 0.0 110.07 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.637 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.04 -41.48 78.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.213 -0.929 . . . . 0.0 109.659 -179.742 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.14 -44.83 94.62 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.676 HG22 ' HG2' ' A' ' 21' ' ' PRO . 53.3 t -67.31 -41.07 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.421 -1.047 . . . . 0.0 108.746 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.77 -57.86 9.45 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.17 -53.41 27.96 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.512 -0.742 . . . . 0.0 109.619 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.697 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 32.2 t80 -57.48 -50.6 72.52 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.454 0.645 . . . . 0.0 110.683 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tt -71.71 -45.14 62.75 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.3 -0.875 . . . . 0.0 110.886 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -62.12 -22.16 65.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.622 -1.299 . . . . 0.0 110.435 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 m -95.59 -40.93 9.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.077 -1.014 . . . . 0.0 111.021 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -110.28 17.06 21.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.958 -1.089 . . . . 0.0 112.002 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.2 m80 46.17 24.82 0.29 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.025 -1.047 . . . . 0.0 110.372 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.451 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.6 pttp -143.22 149.75 38.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.061 -1.024 . . . . 0.0 110.282 -178.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.6 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.6 mp -73.63 150.15 88.72 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.249 -0.907 . . . . 0.0 108.827 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.697 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 50.9 Cg_exo -38.94 153.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.333 2.688 . . . . 0.0 114.092 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.621 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -68.53 50.24 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.197 0.999 . . . . 0.0 110.692 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -171.32 25.77 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 109.928 179.015 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -117.81 116.39 26.89 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.46 -1.4 . . . . 0.0 110.399 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.0 pt -118.99 136.13 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 CA-C-O 122.167 0.984 . . . . 0.0 109.659 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.545 HG22 ' HA3' ' A' ' 53' ' ' GLY . 7.7 p -65.49 166.89 9.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.05 -1.031 . . . . 0.0 111.545 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.616 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 22.5 mtmt -68.48 -36.72 79.35 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.44 -65.17 0.52 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.109 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.9 mt-10 -63.72 -53.86 44.53 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 119.067 -1.053 . . . . 0.0 108.983 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -40.72 -51.56 3.05 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.653 -1.28 . . . . 0.0 108.597 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -57.38 -58.8 6.68 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.965 -1.084 . . . . 0.0 111.502 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.37 -32.23 68.38 Favored 'General case' 0 N--CA 1.51 2.562 0 O-C-N 120.663 -1.273 . . . . 0.0 108.811 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.412 HD21 ' HB ' ' A' ' 45' ' ' VAL . 27.8 tp -61.35 -23.43 65.75 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.49 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.49 50.98 0.36 Allowed Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.562 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -82.99 146.71 28.62 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.152 -1.205 . . . . 0.0 109.343 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.3 t -135.75 123.93 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.472 -0.768 . . . . 0.0 109.388 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -57.25 -52.61 64.63 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.846 -0.534 . . . . 0.0 109.763 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.3 p -69.79 48.7 0.09 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.389 -0.819 . . . . 0.0 109.72 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.645 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.3 ttpm? -178.31 -50.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.63 57.4 17.95 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.645 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -72.5 162.09 29.94 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.747 -0.855 . . . . 0.0 110.56 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.875 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.7 tp -175.62 -66.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.443 -0.785 . . . . 0.0 109.937 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.642 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -61.72 -18.96 61.75 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.77 -1.207 . . . . 0.0 109.988 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 45' ' ' VAL . 4.5 p-10 -79.18 -64.63 1.14 Allowed 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.912 0.863 . . . . 0.0 109.063 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.478 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 31.6 m -74.48 -12.07 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.918 -0.489 . . . . 0.0 110.158 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.4 71.07 13.01 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.47 -0.769 . . . . 0.0 109.412 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.48 123.58 13.91 Favored 'Trans proline' 0 N--CA 1.509 2.395 0 C-N-CA 122.919 2.413 . . . . 0.0 113.991 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.49 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 71.57 41.0 58.45 Favored Glycine 0 N--CA 1.502 3.049 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.5 mmtt -139.07 170.82 15.28 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 122.031 0.919 . . . . 0.0 110.962 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.417 ' HA ' HD21 ' A' ' 42' ' ' LEU . 74.8 m -144.81 160.63 40.96 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.204 1.002 . . . . 0.0 110.554 -177.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.8 mm -84.26 128.22 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.526 -0.734 . . . . 0.0 109.906 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.58 153.68 9.26 Favored Glycine 0 N--CA 1.499 2.88 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.545 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 121.75 -16.56 8.92 Favored Glycine 0 N--CA 1.5 2.925 0 C-N-CA 119.653 -1.26 . . . . 0.0 111.367 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -71.88 -150.64 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.795 -1.415 . . . . 0.0 110.037 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.93 140.7 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.561 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.624 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.3 t80 -106.68 90.1 3.22 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.514 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.3 p -60.0 38.22 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.388 0.613 . . . . 0.0 110.591 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 56' ' ' PHE . 63.8 t30 37.54 34.58 0.05 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.121 -0.987 . . . . 0.0 110.526 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.514 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.6 mtm180 -66.24 44.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.844 -1.16 . . . . 0.0 110.093 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.616 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 20.1 mt-10 -152.05 -26.42 0.18 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.483 -0.761 . . . . 0.0 109.918 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.6 28.08 62.0 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.671 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.0 mttp -110.31 5.11 21.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.527 -0.984 . . . . 0.0 109.102 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -127.98 144.46 51.57 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.792 -0.568 . . . . 0.0 109.673 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.52 124.89 15.02 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 123.048 2.499 . . . . 0.0 112.279 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.527 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -101.18 -173.94 28.8 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 68' ' ' GLY . 12.9 tttt 177.41 145.72 0.11 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.413 -1.051 . . . . 0.0 108.787 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 p -68.13 58.03 0.07 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.05 -1.031 . . . . 0.0 109.236 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 147.36 75.78 0.02 OUTLIER Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.531 ' NH2' ' OD1' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.46 169.92 5.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.684 -0.892 . . . . 0.0 109.225 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.454 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.9 m -145.23 155.39 43.22 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.829 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.721 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 20.3 m95 -126.13 138.78 53.7 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.573 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -129.35 155.8 45.05 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.789 -1.194 . . . . 0.0 109.58 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.616 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -120.28 166.25 13.75 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.255 -0.903 . . . . 0.0 111.551 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.53 134.66 3.34 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.197 -0.939 . . . . 0.0 110.69 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.712 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.91 152.14 16.71 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.359 0.599 . . . . 0.0 111.482 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.724 HD11 ' CG2' ' A' ' 88' ' ' ILE . 39.9 mm -134.9 142.85 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.559 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 57.8 71.69 0.56 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.288 0.566 . . . . 0.0 110.266 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.875 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 63.0 t80 -129.13 159.72 35.12 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.417 -0.802 . . . . 0.0 109.318 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.6 ' OG1' ' N ' ' A' ' 80' ' ' SER . 24.2 p -140.65 -78.33 0.29 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.642 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -150.05 107.58 3.65 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.66 -103.93 0.23 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.484 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 50.7 t80 -141.72 -170.02 3.03 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.638 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.5 mtm180 -70.41 -151.95 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.131 -0.981 . . . . 0.0 109.815 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -172.07 -151.89 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 100' ' ' THR . 43.8 p -98.9 -5.3 31.06 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.69 -1.256 . . . . 0.0 110.43 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -90.07 117.69 29.05 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.186 -0.946 . . . . 0.0 110.52 -178.638 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.856 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.31 149.64 43.03 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.724 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.8 tt -117.74 135.83 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.434 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.0 mm? -112.63 124.86 53.5 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.69 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.7 127.42 53.55 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.709 0.766 . . . . 0.0 109.205 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.721 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.1 p -94.35 158.95 15.33 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.173 0.987 . . . . 0.0 112.522 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.1 p -69.75 -19.08 63.54 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.531 ' OD1' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -83.24 10.46 8.4 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.762 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.443 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.46 29.97 0.52 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.634 -0.666 . . . . 0.0 110.025 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.41 HD12 HH21 ' A' ' 69' ' ' ARG . 23.4 mt -101.96 136.52 41.66 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.319 -0.863 . . . . 0.0 109.807 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.459 HG22 HD11 ' A' ' 109' ' ' ILE . 32.9 mm -110.38 119.92 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.576 -0.703 . . . . 0.0 110.251 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.429 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.3 m-85 -120.68 142.64 49.29 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.458 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 8.7 tptp -130.96 147.02 52.55 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.776 0.798 . . . . 0.0 111.005 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.573 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.4 t -127.51 171.53 11.52 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.442 ' O ' ' OG ' ' A' ' 85' ' ' SER . 74.6 p -146.85 -1.72 0.66 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.386 -0.821 . . . . 0.0 110.328 178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.627 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -116.68 18.75 14.83 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.806 -1.184 . . . . 0.0 108.353 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.53 63.27 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.449 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.671 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 19.9 m-85 69.99 -14.12 0.39 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.774 -0.579 . . . . 0.0 111.614 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -51.39 -73.33 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.754 -1.216 . . . . 0.0 109.578 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.504 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 33.2 p -98.65 -178.08 3.87 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.434 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -160.85 133.53 6.25 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.935 -1.103 . . . . 0.0 109.847 -179.245 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.7 m -127.87 140.05 52.25 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.615 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 16.3 tttp -86.01 139.71 30.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.123 -0.985 . . . . 0.0 109.971 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.459 HD11 HG22 ' A' ' 96' ' ' ILE . 12.0 pt -113.38 -32.43 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.637 HH21 ' CG ' ' A' ' 8' ' ' ASP . 62.2 mtt180 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.103 -0.998 . . . . 0.0 109.198 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.629 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 36.0 t . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 4' ' ' ILE . 1.6 tt -171.52 158.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.0 p30 -146.08 29.97 1.07 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.472 -1.392 . . . . 0.0 111.241 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 10' ' ' VAL . 24.9 p -105.69 155.94 18.77 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.2 p90 -58.66 -63.79 1.16 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.961 -1.087 . . . . 0.0 110.463 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.614 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -53.81 -43.46 69.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.516 -0.74 . . . . 0.0 109.449 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.39 -44.72 89.86 Favored Glycine 0 N--CA 1.5 2.965 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.682 HG22 ' HG2' ' A' ' 21' ' ' PRO . 63.2 t -67.3 -41.32 86.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 121.51 -0.994 . . . . 0.0 108.786 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.36 -58.84 6.19 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.82 -55.0 12.87 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.371 -0.83 . . . . 0.0 109.663 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.646 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 35.0 t80 -56.26 -50.76 70.43 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.284 0.564 . . . . 0.0 110.627 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.3 tt -72.26 -44.37 62.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.406 -0.809 . . . . 0.0 111.282 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -62.76 -21.31 65.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.605 -1.309 . . . . 0.0 110.08 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.0 m -95.9 -40.5 9.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.927 -1.108 . . . . 0.0 111.283 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -111.14 17.26 20.52 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.055 -1.028 . . . . 0.0 111.987 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.0 m80 45.78 25.01 0.25 Allowed 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.845 -1.159 . . . . 0.0 110.271 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.4 pttp -141.88 152.51 43.67 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.075 -1.016 . . . . 0.0 110.898 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.543 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.3 mp -76.78 148.73 79.72 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.224 -0.922 . . . . 0.0 109.303 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HG2' HG22 ' A' ' 10' ' ' VAL . 73.7 Cg_exo -38.23 152.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 122.904 2.403 . . . . 0.0 114.428 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -66.06 48.52 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 122.122 0.963 . . . . 0.0 110.094 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.7 OUTLIER -169.23 24.16 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.671 -1.268 . . . . 0.0 110.126 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -117.39 116.25 26.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.968 -1.082 . . . . 0.0 110.86 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.4 pt -118.03 141.01 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.833 0.825 . . . . 0.0 109.312 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.626 HG22 ' HA3' ' A' ' 53' ' ' GLY . 6.2 p -70.98 166.29 21.61 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.967 -1.083 . . . . 0.0 111.479 -177.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.629 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 20.2 mtmt -67.19 -36.39 81.64 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.78 -65.08 0.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.6 177.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.46 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.2 mt-10 -63.34 -52.47 61.66 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.025 -1.07 . . . . 0.0 108.342 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -41.69 -49.78 4.22 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.174 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 37.8 mt-30 -60.81 -55.72 29.69 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.36 -0.837 . . . . 0.0 111.755 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.49 -31.8 70.82 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.669 -1.269 . . . . 0.0 109.276 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 20.2 tp -60.83 -31.36 70.78 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.96 52.09 0.15 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.677 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -83.77 146.39 28.18 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.083 -1.245 . . . . 0.0 109.888 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -137.56 125.86 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.274 -0.891 . . . . 0.0 109.373 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -57.27 -53.28 59.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.924 -0.485 . . . . 0.0 110.501 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.7 p -69.08 48.75 0.07 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.979 -1.076 . . . . 0.0 109.716 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.648 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -178.81 -49.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.52 55.37 29.25 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.677 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -70.8 160.17 33.22 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 121.64 -0.918 . . . . 0.0 110.458 -179.063 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.813 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 58.9 tp -174.98 -67.29 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.497 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.653 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -58.52 -20.19 43.94 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.339 -0.851 . . . . 0.0 110.093 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.8 p-10 -79.63 -65.39 1.01 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.678 0.752 . . . . 0.0 109.874 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.457 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 28.9 m -75.98 -6.82 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.799 -0.563 . . . . 0.0 110.708 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.0 69.03 9.04 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -57.69 122.32 11.55 Favored 'Trans proline' 0 N--CA 1.508 2.324 0 C-N-CA 123.595 2.863 . . . . 0.0 113.853 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.95 38.99 55.61 Favored Glycine 0 N--CA 1.501 3.016 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 8.7 mmtm -138.38 178.16 7.34 Favored 'General case' 0 N--CA 1.51 2.546 0 CA-C-O 122.248 1.023 . . . . 0.0 111.455 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.419 ' HG ' ' HD2' ' A' ' 78' ' ' TYR . 63.9 m -150.53 161.0 43.38 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.857 -1.152 . . . . 0.0 111.417 -177.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.8 mm -83.37 126.17 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.092 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.72 152.97 8.74 Favored Glycine 0 N--CA 1.499 2.842 0 C-N-CA 119.981 -1.104 . . . . 0.0 110.38 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.626 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 122.43 -17.35 8.42 Favored Glycine 0 N--CA 1.498 2.778 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.052 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -69.95 -153.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.633 -1.51 . . . . 0.0 109.752 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.95 138.42 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.43 -0.794 . . . . 0.0 110.399 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.641 ' O ' ' N ' ' A' ' 58' ' ' ASN . 10.0 t80 -104.36 89.77 3.34 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.546 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -59.5 39.17 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.529 -0.732 . . . . 0.0 110.682 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.641 ' N ' ' O ' ' A' ' 56' ' ' PHE . 59.5 t30 36.83 34.88 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.069 -1.02 . . . . 0.0 110.483 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.546 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.2 mtm180 -66.71 45.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.822 -1.174 . . . . 0.0 109.602 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.61 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 18.9 mt-10 -151.74 -26.84 0.19 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.467 -0.771 . . . . 0.0 110.028 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.27 27.9 61.0 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.669 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.7 mttp -110.69 5.7 21.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.66 -0.906 . . . . 0.0 109.468 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.93 143.6 49.31 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.8 124.42 14.04 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.637 2.224 . . . . 0.0 112.239 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.519 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -99.81 -173.82 30.62 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 68' ' ' GLY . 11.1 tttt 177.92 146.27 0.13 Allowed 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.456 -1.026 . . . . 0.0 108.834 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.4 p -68.01 58.18 0.07 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.975 -1.078 . . . . 0.0 109.031 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 146.86 76.69 0.02 OUTLIER Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.542 ' NH2' ' OD1' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -173.35 168.89 4.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.597 -0.943 . . . . 0.0 109.161 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.454 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.3 m -145.65 155.2 42.85 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.834 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.726 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 21.5 m95 -125.39 138.8 54.04 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.558 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -129.72 156.06 44.9 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.798 -1.189 . . . . 0.0 109.517 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.629 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -120.03 167.54 12.07 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.3 -0.875 . . . . 0.0 112.136 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.46 135.59 3.62 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.237 -0.915 . . . . 0.0 111.153 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.692 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.93 154.7 11.88 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.743 -0.598 . . . . 0.0 111.546 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.706 HD11 ' CG2' ' A' ' 88' ' ' ILE . 45.2 mm -136.87 143.5 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.518 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 57.62 70.01 0.69 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.192 0.52 . . . . 0.0 110.589 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.813 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 59.5 t80 -128.37 161.33 29.68 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.02 -1.05 . . . . 0.0 109.331 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.608 ' OG1' ' N ' ' A' ' 80' ' ' SER . 26.9 p -141.43 -76.69 0.29 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.653 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -150.47 110.33 4.09 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.73 -103.67 0.24 Allowed Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 45.4 t80 -142.46 -169.96 3.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.89 -0.77 . . . . 0.0 109.156 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.657 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.2 mtm180 -71.47 -158.09 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.24 -0.912 . . . . 0.0 109.159 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -166.33 -150.9 0.12 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.505 ' OG ' ' O ' ' A' ' 100' ' ' THR . 53.8 p -99.0 -6.38 28.67 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.404 -1.435 . . . . 0.0 110.391 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.47 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -89.11 118.02 28.52 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.099 -1.001 . . . . 0.0 110.992 -178.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.857 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.03 149.97 42.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 0.0 109.685 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.706 ' CG2' HD11 ' A' ' 76' ' ' ILE . 5.2 tt -118.15 137.42 52.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 72' ' ' ARG . 1.9 mm? -113.85 124.88 53.29 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.63 127.67 53.81 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.724 0.773 . . . . 0.0 109.213 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.726 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.0 p -94.13 158.37 15.64 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 122.449 1.119 . . . . 0.0 112.382 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.8 p -68.93 -20.3 64.21 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.542 ' OD1' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -83.1 11.04 6.87 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.062 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.448 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.62 29.63 0.52 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.601 -0.687 . . . . 0.0 110.42 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.407 HD12 HH21 ' A' ' 69' ' ' ARG . 23.1 mt -102.78 136.86 41.83 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.501 HG22 HD11 ' A' ' 109' ' ' ILE . 31.7 mm -110.84 119.7 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.523 -0.736 . . . . 0.0 110.104 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.455 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.2 m-85 -119.88 142.81 48.34 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.47 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 8.2 tptp -130.7 147.29 52.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.847 -1.158 . . . . 0.0 110.691 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.493 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.5 t -128.46 171.43 12.08 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.505 ' O ' ' OG ' ' A' ' 85' ' ' SER . 76.5 p -146.51 -3.63 0.62 Allowed 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.491 -0.756 . . . . 0.0 110.459 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.639 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -114.36 19.52 16.19 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.792 -1.192 . . . . 0.0 108.455 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.11 62.41 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.15 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.669 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 21.6 m-85 70.36 -14.57 0.39 Allowed 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.826 -0.546 . . . . 0.0 111.66 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -49.98 -72.88 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.661 -1.275 . . . . 0.0 109.886 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.502 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 42.0 p -100.42 -178.31 3.77 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.65 135.19 8.39 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.045 -1.034 . . . . 0.0 110.332 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.1 m -128.13 139.14 52.66 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.601 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.8 tttp -86.02 139.15 31.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.835 -1.166 . . . . 0.0 110.003 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.501 HD11 HG22 ' A' ' 96' ' ' ILE . 10.8 pt -111.96 -32.91 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.63 -0.669 . . . . 0.0 109.791 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.614 HH21 ' CG ' ' A' ' 8' ' ' ASP . 69.0 mtt180 . . . . . 0 N--CA 1.487 1.412 0 O-C-N 121.281 -0.887 . . . . 0.0 108.678 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.633 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.8 t . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 tt -171.15 158.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -145.4 29.67 1.15 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.411 -1.431 . . . . 0.0 111.466 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.7 p -103.67 157.15 17.26 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.436 -0.79 . . . . 0.0 109.762 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.4 p90 -59.87 -63.13 1.41 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.211 -0.93 . . . . 0.0 109.897 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.586 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.8 OUTLIER -56.01 -42.25 76.15 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.165 -0.959 . . . . 0.0 109.679 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.4 -44.98 85.07 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.772 HG22 ' HG2' ' A' ' 21' ' ' PRO . 53.3 t -67.93 -42.51 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.24 -58.6 7.65 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.9 -53.13 27.92 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.766 -1.209 . . . . 0.0 110.103 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.672 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 36.6 t80 -57.24 -48.61 78.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.669 -0.644 . . . . 0.0 110.418 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -73.91 -43.89 56.94 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.493 -0.755 . . . . 0.0 110.974 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -63.7 -20.04 65.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.443 -1.411 . . . . 0.0 109.981 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 m -98.12 -40.29 8.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.697 -1.252 . . . . 0.0 110.544 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -109.66 14.62 23.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 112.022 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.8 m80 46.77 24.98 0.39 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.668 -1.27 . . . . 0.0 110.41 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -143.57 149.82 37.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.177 -0.952 . . . . 0.0 110.828 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.587 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.5 mp -72.72 149.48 90.52 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 120.98 -1.075 . . . . 0.0 109.565 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.772 ' HG2' HG22 ' A' ' 10' ' ' VAL . 51.3 Cg_exo -40.36 150.8 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 123.189 2.592 . . . . 0.0 113.716 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.633 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -63.95 48.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.541 0.686 . . . . 0.0 110.489 -179.205 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -171.43 28.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.02 -1.05 . . . . 0.0 110.67 179.103 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -119.11 115.08 23.53 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.191 -0.943 . . . . 0.0 110.719 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.5 pt -117.38 140.32 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.53 HG22 ' HA3' ' A' ' 53' ' ' GLY . 11.5 p -70.82 167.26 19.28 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.054 0.93 . . . . 0.0 111.75 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.568 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 23.6 mtmt -68.49 -37.32 80.01 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.406 ' HG ' ' CB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -40.43 -67.83 0.21 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 113.873 -1.512 . . . . 0.0 108.217 177.187 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.515 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.0 mt-10 -63.57 -54.43 36.14 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.233 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.515 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -39.18 -51.84 1.94 Allowed 'General case' 0 CA--C 1.566 1.569 0 O-C-N 120.318 -1.489 . . . . 0.0 109.033 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.439 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 41.2 mt-30 -58.93 -57.69 11.93 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.661 -0.649 . . . . 0.0 111.219 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.15 -32.84 71.41 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.819 -1.175 . . . . 0.0 110.006 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.1 tp -59.45 -27.78 66.38 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.96 52.5 0.21 Allowed Glycine 0 N--CA 1.502 3.09 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.605 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -85.04 146.2 27.3 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.549 -0.971 . . . . 0.0 111.007 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.6 t -137.14 124.59 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 O-C-N 121.394 -0.816 . . . . 0.0 109.79 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -57.27 -50.87 71.52 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 122.037 -0.414 . . . . 0.0 110.369 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.3 p -70.06 49.06 0.1 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.3 -0.875 . . . . 0.0 109.443 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.646 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -179.13 -52.97 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.69 57.05 13.5 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.646 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -71.79 162.29 29.68 Favored 'General case' 0 C--N 1.289 -2.058 0 O-C-N 121.728 -0.866 . . . . 0.0 111.067 -178.723 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.819 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 64.6 tp -174.44 -67.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.772 -1.205 . . . . 0.0 109.995 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -61.33 -18.96 61.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.509 -0.744 . . . . 0.0 109.827 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 3.9 p-10 -80.22 -62.1 1.78 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.091 0.948 . . . . 0.0 108.742 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 45' ' ' VAL . 16.3 m -75.65 -11.35 14.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.663 -1.273 . . . . 0.0 109.293 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.78 72.6 10.5 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 120.996 -1.065 . . . . 0.0 109.855 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.61 125.76 19.29 Favored 'Trans proline' 0 N--CA 1.509 2.415 0 C-N-CA 123.051 2.5 . . . . 0.0 114.323 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.571 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 72.74 40.15 53.67 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.571 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.8 mmtm -141.41 170.8 15.04 Favored 'General case' 0 N--CA 1.508 2.426 0 CA-C-O 121.674 0.749 . . . . 0.0 111.567 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.478 ' HG ' ' HD2' ' A' ' 78' ' ' TYR . 72.5 m -144.32 162.58 36.07 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 122.794 1.283 . . . . 0.0 110.935 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.6 mm -83.81 126.26 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.923 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 172.85 153.05 9.11 Favored Glycine 0 N--CA 1.501 3.021 0 O-C-N 120.575 -1.328 . . . . 0.0 109.98 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.53 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 120.38 -15.39 9.98 Favored Glycine 0 N--CA 1.499 2.866 0 O-C-N 121.145 -1.209 . . . . 0.0 111.166 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 1.6 m-20 -70.49 -154.9 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.547 -1.56 . . . . 0.0 109.473 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.0 mp -129.29 135.74 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 122.055 0.931 . . . . 0.0 110.169 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.633 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.7 t80 -101.8 89.16 3.58 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.67 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 2.2 p -59.3 40.25 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 121.306 0.574 . . . . 0.0 110.766 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.633 ' N ' ' O ' ' A' ' 56' ' ' PHE . 61.5 t30 34.13 37.12 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.372 -0.83 . . . . 0.0 110.4 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.67 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.1 mtm180 -68.02 40.1 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -0.951 . . . . 0.0 109.929 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.603 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 21.6 mt-10 -148.98 -19.38 0.3 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.024 -1.047 . . . . 0.0 110.44 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.45 31.45 68.35 Favored Glycine 0 N--CA 1.499 2.871 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.684 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.7 mttp -114.3 8.28 16.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.575 -0.956 . . . . 0.0 108.932 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mt -131.96 143.99 51.33 Favored Pre-proline 0 N--CA 1.491 1.583 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -63.37 124.3 13.57 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.681 2.254 . . . . 0.0 112.005 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.532 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -100.39 -172.04 29.56 Favored Glycine 0 N--CA 1.499 2.851 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 68' ' ' GLY . 10.3 tttt 177.03 146.55 0.1 Allowed 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.678 -0.895 . . . . 0.0 108.938 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.8 p -68.19 58.32 0.08 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.91 -1.119 . . . . 0.0 109.281 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 145.52 76.66 0.03 OUTLIER Glycine 0 N--CA 1.5 2.946 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.536 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.09 165.8 6.15 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.657 -0.908 . . . . 0.0 109.239 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.0 m -142.18 154.01 44.49 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.378 -0.826 . . . . 0.0 109.69 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.705 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 19.2 m95 -125.42 139.3 53.77 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.537 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -129.97 155.28 46.35 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.295 -0.878 . . . . 0.0 109.918 179.612 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.568 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -119.2 166.52 12.86 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.227 -0.921 . . . . 0.0 111.295 -179.144 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.85 134.8 3.19 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.182 -0.949 . . . . 0.0 110.955 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.703 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -57.04 152.43 13.21 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.457 0.646 . . . . 0.0 111.548 -179.338 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 75' ' ' ASP . 42.0 mm -135.53 142.58 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.08 -1.013 . . . . 0.0 110.084 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 58.62 71.24 0.59 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.403 0.621 . . . . 0.0 110.517 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.819 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 65.1 t80 -129.59 159.3 36.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.354 -0.841 . . . . 0.0 109.382 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 80' ' ' SER . 29.4 p -139.87 -78.94 0.31 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.642 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -149.86 106.65 3.54 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.84 -102.78 0.21 Allowed Glycine 0 N--CA 1.5 2.926 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.482 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 52.4 t80 -142.38 -168.0 2.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.86 -0.788 . . . . 0.0 108.977 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.652 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.8 mtm180 -73.09 -152.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.823 -1.173 . . . . 0.0 109.807 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -170.48 -150.61 0.07 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 100' ' ' THR . 40.6 p -100.75 -5.77 25.91 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.754 -1.216 . . . . 0.0 110.345 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.5 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -90.44 118.81 30.21 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.906 -1.121 . . . . 0.0 110.272 -178.706 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.865 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.52 150.42 42.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.187 -0.946 . . . . 0.0 109.346 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.662 ' CG2' HD11 ' A' ' 76' ' ' ILE . 3.6 tt -117.29 138.83 46.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.462 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.2 mm? -114.84 123.51 49.37 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.664 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -116.71 126.87 53.8 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.561 0.696 . . . . 0.0 109.357 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.705 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 3.1 p -93.07 158.94 15.52 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.163 0.983 . . . . 0.0 111.929 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.9 p -70.03 -20.33 63.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.446 -0.784 . . . . 0.0 108.913 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.536 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.47 10.2 6.19 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.468 -0.77 . . . . 0.0 109.867 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.475 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.76 30.07 0.48 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.654 -0.654 . . . . 0.0 110.148 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.4 HD12 HH21 ' A' ' 69' ' ' ARG . 26.5 mt -102.45 137.48 40.63 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.313 -0.867 . . . . 0.0 110.121 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.48 HG22 HD11 ' A' ' 109' ' ' ILE . 30.8 mm -110.75 119.14 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.28 -0.888 . . . . 0.0 110.951 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.448 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.5 m-85 -119.82 143.44 47.87 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.5 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 7.3 tptp -132.47 148.03 52.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.185 -0.947 . . . . 0.0 110.816 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.529 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.2 t -127.61 171.85 11.28 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.459 ' O ' ' OG ' ' A' ' 85' ' ' SER . 73.5 p -146.74 -1.82 0.67 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.274 -0.891 . . . . 0.0 110.358 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.631 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -117.36 19.31 14.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.823 -1.173 . . . . 0.0 108.681 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.94 61.63 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.237 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.684 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 19.6 m-85 70.01 -13.8 0.41 Allowed 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.711 -0.618 . . . . 0.0 111.529 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -49.83 -72.97 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.734 -1.228 . . . . 0.0 109.437 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.485 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 34.5 p -99.5 -176.18 3.21 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.462 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -161.8 135.07 6.28 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.174 -0.953 . . . . 0.0 109.666 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 55.0 m -128.33 140.7 51.72 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.615 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.4 tttp -87.25 139.91 30.08 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.7 -1.25 . . . . 0.0 110.306 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.48 HD11 HG22 ' A' ' 96' ' ' ILE . 13.6 pt -113.22 -32.72 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.485 -0.76 . . . . 0.0 109.75 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.615 ' O ' ' NZ ' ' A' ' 108' ' ' LYS . 60.5 mtt180 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 118.292 -0.861 . . . . 0.0 109.528 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.626 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.0 t . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 4' ' ' ILE . 1.7 tt -170.8 159.87 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -144.46 27.74 1.37 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.793 -1.192 . . . . 0.0 111.501 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 10' ' ' VAL . 18.0 p -105.54 158.03 16.97 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.859 0.837 . . . . 0.0 110.761 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.7 p90 -60.02 -61.16 2.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.595 -1.316 . . . . 0.0 110.997 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.651 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.81 -39.83 78.51 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.0 -1.062 . . . . 0.0 110.102 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.44 -44.25 96.81 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.667 HG22 ' HG2' ' A' ' 21' ' ' PRO . 54.5 t -67.66 -41.73 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.313 -1.11 . . . . 0.0 108.535 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.33 -58.94 5.86 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.98 -54.21 16.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.421 -0.8 . . . . 0.0 109.861 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.689 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 35.4 t80 -57.35 -49.62 75.55 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.569 -0.707 . . . . 0.0 110.737 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.89 -45.14 62.32 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.125 -0.985 . . . . 0.0 110.631 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -62.71 -20.11 64.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.23 -1.544 . . . . 0.0 110.615 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.0 m -98.07 -39.33 8.97 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.954 -1.091 . . . . 0.0 110.977 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -111.34 15.79 21.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.796 -1.19 . . . . 0.0 111.967 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.8 m80 46.75 23.74 0.28 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.109 -0.994 . . . . 0.0 110.867 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.2 pttp -141.16 150.81 43.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 109.792 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.568 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.7 mp -73.87 150.13 88.17 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.803 -1.186 . . . . 0.0 108.901 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.689 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 51.3 Cg_exo -38.07 150.66 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 124.016 3.144 . . . . 0.0 113.701 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.626 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -65.77 46.73 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.747 0.784 . . . . 0.0 111.405 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.7 OUTLIER -169.82 26.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 109.818 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -117.9 119.72 35.69 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.836 -1.165 . . . . 0.0 110.622 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.1 pt -121.12 139.52 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.818 0.818 . . . . 0.0 109.194 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.696 HG22 ' HA3' ' A' ' 53' ' ' GLY . 6.1 p -69.78 167.63 16.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.893 -1.129 . . . . 0.0 111.094 -177.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.554 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 19.1 mtmt -68.22 -33.04 73.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.12 -63.65 0.93 Allowed 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.493 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.7 mt-10 -66.44 -51.58 55.37 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -41.35 -51.41 3.68 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.662 -1.215 . . . . 0.0 108.686 177.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.415 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 39.3 mt-30 -60.14 -56.38 22.26 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.399 -0.813 . . . . 0.0 111.201 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.13 -27.85 68.68 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.263 -1.523 . . . . 0.0 109.147 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.1 tp -64.74 -23.35 67.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.706 -0.621 . . . . 0.0 110.233 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.4 51.78 0.28 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -84.43 144.18 28.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.29 -1.123 . . . . 0.0 109.853 179.393 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.2 t -136.14 125.18 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.226 -0.921 . . . . 0.0 109.627 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.5 -51.46 68.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.967 -0.458 . . . . 0.0 110.547 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.7 p -71.55 48.32 0.14 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.96 -1.088 . . . . 0.0 109.777 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.637 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.4 ttpm? -177.44 -49.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.76 54.79 31.08 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.637 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -71.21 160.27 33.14 Favored 'General case' 0 C--N 1.29 -2.021 0 O-C-N 121.479 -1.012 . . . . 0.0 110.311 -178.448 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.84 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 64.9 tp -174.94 -67.26 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.581 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.635 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -58.49 -21.29 51.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.817 -1.177 . . . . 0.0 109.467 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 3.2 p-10 -77.86 -63.42 1.39 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.684 0.754 . . . . 0.0 109.441 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.402 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 22.5 m -76.21 -8.78 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.724 -0.61 . . . . 0.0 109.734 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.13 68.79 8.87 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.148 -0.97 . . . . 0.0 109.292 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -57.26 124.51 16.34 Favored 'Trans proline' 0 N--CA 1.506 2.259 0 C-N-CA 123.306 2.67 . . . . 0.0 113.511 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.538 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 69.86 41.05 74.15 Favored Glycine 0 N--CA 1.501 3.033 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.4 mmtm -139.56 175.85 9.22 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.647 -0.914 . . . . 0.0 110.533 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.1 m -148.74 160.62 43.01 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.493 1.139 . . . . 0.0 110.957 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.0 mm -82.02 127.15 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.786 0.803 . . . . 0.0 110.493 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.33 153.55 9.08 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.696 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 122.31 -17.48 8.47 Favored Glycine 0 N--CA 1.507 3.433 0 O-C-N 121.57 -0.959 . . . . 0.0 110.799 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 1.2 m-20 -69.71 -156.21 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.629 -1.512 . . . . 0.0 109.619 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.83 140.72 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-O 121.604 0.716 . . . . 0.0 110.435 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.668 ' O ' ' N ' ' A' ' 58' ' ' ASN . 9.2 t80 -107.03 88.54 2.76 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.687 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -58.03 38.72 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.826 -0.546 . . . . 0.0 110.675 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.668 ' N ' ' O ' ' A' ' 56' ' ' PHE . 59.9 t30 35.76 38.75 0.06 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.074 -1.016 . . . . 0.0 110.001 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.687 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.2 mtm180 -69.61 41.79 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.745 -1.222 . . . . 0.0 109.832 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.611 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 17.5 mt-10 -148.0 -24.56 0.35 Allowed 'General case' 0 N--CA 1.485 1.285 0 O-C-N 120.698 -1.251 . . . . 0.0 109.717 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.3 27.66 61.37 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.68 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.8 mttp -111.84 7.51 20.15 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.921 -0.752 . . . . 0.0 109.637 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -129.61 143.79 50.36 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.83 123.54 12.48 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 122.613 2.209 . . . . 0.0 112.886 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.527 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -97.94 -174.17 33.3 Favored Glycine 0 N--CA 1.506 3.341 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.549 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 11.1 tttt 177.62 145.82 0.12 Allowed 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.447 -1.031 . . . . 0.0 108.707 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.0 p -68.71 58.85 0.09 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.888 -1.133 . . . . 0.0 108.767 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.549 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 146.67 74.39 0.02 OUTLIER Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.538 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -171.82 167.86 6.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.509 -0.995 . . . . 0.0 109.193 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.455 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 93.0 m -144.06 155.6 44.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 110.331 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.74 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 20.7 m95 -125.41 137.59 54.01 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.588 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -127.57 156.28 42.5 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.869 -1.144 . . . . 0.0 109.054 179.515 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.554 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -121.18 166.86 13.36 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.089 -1.007 . . . . 0.0 111.306 -179.613 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.52 134.71 3.36 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.313 -0.867 . . . . 0.0 110.979 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.66 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -56.23 152.23 11.27 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.611 0.719 . . . . 0.0 111.449 179.416 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.717 HD11 ' CG2' ' A' ' 88' ' ' ILE . 38.3 mm -135.5 143.58 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.563 -0.711 . . . . 0.0 110.106 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 58.41 69.47 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.365 0.603 . . . . 0.0 110.497 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.84 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 69.4 t80 -128.24 160.16 32.97 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.244 -0.91 . . . . 0.0 109.631 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.617 ' OG1' ' N ' ' A' ' 80' ' ' SER . 25.1 p -142.23 -78.5 0.25 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.635 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -148.67 107.95 3.93 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.85 -102.06 0.2 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 51.4 t80 -143.0 -168.52 2.81 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.635 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.4 mtm180 -72.99 -150.61 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.688 -1.257 . . . . 0.0 109.314 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.596 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 10.4 p30 -171.52 -151.28 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.6 p -99.83 -7.23 25.65 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.673 -1.267 . . . . 0.0 110.201 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.472 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -88.51 118.78 28.39 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.132 -0.98 . . . . 0.0 110.276 -178.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.859 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.77 150.32 43.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.429 -0.795 . . . . 0.0 110.014 179.038 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.717 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.0 tt -117.02 136.76 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 108.983 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.406 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.9 mm? -112.89 124.7 53.2 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.679 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.36 126.72 52.68 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.11 0.957 . . . . 0.0 109.494 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.74 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.7 p -94.39 158.34 15.61 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 122.292 1.044 . . . . 0.0 112.085 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.5 p -68.53 -21.17 64.58 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.538 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.61 10.77 5.45 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.196 -0.94 . . . . 0.0 110.144 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.435 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 76.97 31.12 0.53 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.927 -0.483 . . . . 0.0 110.051 179.513 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.409 HD12 HH21 ' A' ' 69' ' ' ARG . 26.8 mt -103.48 136.26 43.54 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.279 -0.888 . . . . 0.0 109.816 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.458 HG22 HD11 ' A' ' 109' ' ' ILE . 34.1 mm -110.37 120.02 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.248 -0.907 . . . . 0.0 110.204 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.448 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.3 m-85 -120.17 143.47 48.21 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.472 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 7.7 tptp -131.74 147.41 52.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 110.967 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.558 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.2 t -127.79 169.9 13.36 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.1 p -144.79 -2.99 0.8 Allowed 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.663 -0.648 . . . . 0.0 110.22 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.631 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -115.37 18.79 15.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.596 -1.315 . . . . 0.0 108.566 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.9 63.55 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.167 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.68 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 18.0 m-85 69.09 -13.64 0.34 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.899 -0.501 . . . . 0.0 111.736 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -51.46 -73.5 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.384 -1.448 . . . . 0.0 109.8 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.509 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 36.3 p -99.03 -178.48 3.95 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.32 134.24 7.15 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.845 -1.159 . . . . 0.0 110.0 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 78.3 m -127.38 140.66 52.03 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.628 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.8 tttp -86.22 139.33 31.14 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.063 -1.023 . . . . 0.0 109.928 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.458 HD11 HG22 ' A' ' 96' ' ' ILE . 13.2 pt -112.43 -31.66 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.695 -0.628 . . . . 0.0 109.728 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.651 HH21 ' CG ' ' A' ' 8' ' ' ASP . 61.8 mtt180 . . . . . 0 C--N 1.306 -1.298 0 O-C-N 120.962 -1.086 . . . . 0.0 108.756 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.638 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 24.1 t . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 tt -171.06 160.84 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -145.98 29.52 1.09 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.473 -1.392 . . . . 0.0 111.465 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 10' ' ' VAL . 22.0 p -106.18 156.84 18.04 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.785 0.802 . . . . 0.0 110.05 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.504 ' HA ' HD12 ' A' ' 88' ' ' ILE . 1.7 p90 -59.91 -62.45 1.86 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.899 -1.126 . . . . 0.0 110.745 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.653 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -55.74 -42.7 75.78 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.35 -0.844 . . . . 0.0 109.565 179.49 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.0 -44.75 87.96 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.678 HG22 ' HG2' ' A' ' 21' ' ' PRO . 75.0 t -68.22 -41.05 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 O-C-N 121.58 -0.953 . . . . 0.0 108.771 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.2 -58.29 8.32 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.26 -54.3 17.49 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.402 -0.811 . . . . 0.0 110.087 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.655 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 38.8 t80 -57.32 -50.1 74.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.911 -0.493 . . . . 0.0 110.429 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.85 -43.48 65.42 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.537 -0.727 . . . . 0.0 111.189 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -63.54 -20.1 65.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.31 -1.494 . . . . 0.0 110.314 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.5 m -97.28 -39.9 9.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.048 -1.032 . . . . 0.0 111.219 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.9 16.47 20.35 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.213 -0.93 . . . . 0.0 111.953 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.5 m80 46.82 24.38 0.34 Allowed 'General case' 0 N--CA 1.511 2.606 0 O-C-N 120.414 -1.429 . . . . 0.0 110.599 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 pttp -142.5 152.57 42.82 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.041 -1.037 . . . . 0.0 110.999 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.519 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.4 mp -75.45 148.53 83.29 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.313 -0.867 . . . . 0.0 109.442 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.678 ' HG2' HG22 ' A' ' 10' ' ' VAL . 54.0 Cg_exo -38.74 150.0 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.623 2.882 . . . . 0.0 113.58 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -63.64 46.62 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.572 0.701 . . . . 0.0 110.883 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -169.6 27.22 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.108 -0.995 . . . . 0.0 110.342 179.496 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -117.56 116.41 27.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.004 -1.06 . . . . 0.0 110.616 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 31.0 pt -119.11 139.36 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.313 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.581 HG22 ' HA3' ' A' ' 53' ' ' GLY . 5.1 p -70.33 166.35 20.41 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.056 -1.028 . . . . 0.0 111.206 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.604 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 20.5 mtmt -67.19 -37.41 83.64 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -40.91 -67.08 0.27 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.482 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.9 mt-10 -62.49 -54.46 39.61 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.297 -0.961 . . . . 0.0 108.994 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -39.18 -51.41 1.94 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.699 -1.251 . . . . 0.0 109.136 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.39 -57.63 12.16 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.549 -0.719 . . . . 0.0 111.019 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.9 -30.35 70.12 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 120.545 -1.347 . . . . 0.0 109.13 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.8 tp -61.51 -25.66 67.41 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.672 -0.642 . . . . 0.0 109.517 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.27 49.56 0.27 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.574 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -82.53 144.77 30.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -1.162 . . . . 0.0 109.72 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.0 t -136.73 125.21 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.34 -0.85 . . . . 0.0 109.392 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -57.19 -53.08 62.18 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.2 p -68.07 48.84 0.06 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.061 -1.025 . . . . 0.0 110.211 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.631 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -179.71 -51.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.91 58.15 11.83 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.631 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -72.85 161.98 30.05 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.714 -0.874 . . . . 0.0 110.782 -178.421 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.822 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.5 tp -174.85 -68.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.372 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -61.72 -18.65 60.52 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.721 -1.237 . . . . 0.0 109.793 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.9 p-10 -79.56 -60.86 2.19 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.842 0.829 . . . . 0.0 109.285 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.6 m -75.53 -13.24 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.85 -0.531 . . . . 0.0 109.983 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.57 72.62 9.83 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.46 -0.775 . . . . 0.0 110.011 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.29 124.72 16.83 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.809 2.34 . . . . 0.0 114.407 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.06 39.66 58.1 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 8.3 mmtt -138.65 172.69 12.51 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 122.195 0.998 . . . . 0.0 110.717 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.1 m -146.46 163.05 36.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.631 -1.293 . . . . 0.0 111.273 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.2 mm -83.8 130.02 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.452 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 167.81 154.35 8.62 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.581 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 118.67 -15.03 11.54 Favored Glycine 0 N--CA 1.501 3.031 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.269 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.488 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -72.93 -154.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.63 -1.512 . . . . 0.0 108.585 178.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -126.27 141.85 44.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.34 -0.85 . . . . 0.0 110.732 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.598 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.9 t80 -106.59 90.84 3.46 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.585 0.707 . . . . 0.0 109.106 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.508 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.5 p -61.34 38.94 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.579 0.704 . . . . 0.0 110.741 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.598 ' N ' ' O ' ' A' ' 56' ' ' PHE . 56.9 t30 36.33 35.73 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.131 -0.981 . . . . 0.0 110.505 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.508 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.5 mtm180 -67.17 43.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.915 -1.116 . . . . 0.0 109.872 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.61 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 18.2 mt-10 -150.58 -25.43 0.23 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.468 -0.77 . . . . 0.0 109.943 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.86 27.77 62.06 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.679 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.0 mttp -110.77 6.8 21.74 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.747 -0.855 . . . . 0.0 109.615 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mt -129.76 143.67 49.95 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.547 -0.721 . . . . 0.0 109.69 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.41 123.79 13.07 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.782 2.321 . . . . 0.0 111.913 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -100.48 -172.22 29.48 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 68' ' ' GLY . 9.8 tttt 177.37 146.63 0.12 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.624 -0.927 . . . . 0.0 109.092 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' A' ' 67' ' ' SER . 24.7 p -68.07 58.7 0.07 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.83 -1.169 . . . . 0.0 109.155 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 144.26 77.47 0.03 OUTLIER Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -171.82 168.04 6.19 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.701 -0.881 . . . . 0.0 108.988 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.442 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 86.6 m -144.18 154.53 43.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.454 -0.779 . . . . 0.0 110.116 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.703 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 18.5 m95 -125.4 139.21 53.86 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.531 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.21 155.06 46.89 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 121.01 -1.057 . . . . 0.0 109.578 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.604 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -119.74 167.85 11.65 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.088 -1.008 . . . . 0.0 111.761 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.59 136.21 3.71 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.746 -1.221 . . . . 0.0 110.753 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.705 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -59.19 152.49 20.46 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.236 0.541 . . . . 0.0 111.605 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.662 HD11 ' CG2' ' A' ' 88' ' ' ILE . 42.6 mm -135.74 144.95 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.595 -0.69 . . . . 0.0 110.462 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 57.35 68.53 0.84 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.523 0.677 . . . . 0.0 110.696 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.822 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 66.9 t80 -127.86 159.34 35.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.251 -0.906 . . . . 0.0 109.511 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.613 ' OG1' ' N ' ' A' ' 80' ' ' SER . 26.1 p -140.7 -77.35 0.3 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.613 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -150.09 108.23 3.75 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.19 -102.33 0.21 Allowed Glycine 0 N--CA 1.501 3.028 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.484 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 48.4 t80 -144.04 -169.78 3.19 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.646 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.9 mtm180 -71.66 -156.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.702 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -166.91 -150.06 0.1 Allowed 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 100' ' ' THR . 48.1 p -100.39 -6.84 25.1 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.646 -1.284 . . . . 0.0 110.151 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.46 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -88.03 117.53 26.96 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.285 -0.884 . . . . 0.0 110.764 -178.677 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.856 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.89 149.12 41.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.74 179.259 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.662 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.4 tt -117.56 137.39 51.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.465 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.1 mm? -113.97 125.44 54.02 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.682 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -117.92 126.48 52.45 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.791 0.805 . . . . 0.0 108.914 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.703 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 2.1 p -92.43 157.03 16.8 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.985 0.898 . . . . 0.0 111.298 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.1 p -69.92 -19.45 63.39 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.528 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.31 10.43 5.6 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.237 -0.914 . . . . 0.0 109.781 179.643 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.455 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.0 30.85 0.43 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.881 -0.512 . . . . 0.0 110.004 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.408 HD12 HH21 ' A' ' 69' ' ' ARG . 25.8 mt -103.26 138.68 39.71 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.134 -0.979 . . . . 0.0 109.938 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.0 mm -112.63 120.15 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.417 -0.802 . . . . 0.0 110.058 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.441 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.7 m-85 -120.36 142.96 48.68 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.46 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 8.5 tptp -131.0 147.78 52.67 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.167 -0.958 . . . . 0.0 110.835 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.516 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -128.22 171.14 12.24 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.442 ' O ' ' OG ' ' A' ' 85' ' ' SER . 73.9 p -146.69 -2.63 0.64 Allowed 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.443 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.638 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -115.95 20.02 14.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.741 -1.224 . . . . 0.0 108.397 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.14 61.75 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.619 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.679 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 20.0 m-85 70.45 -13.52 0.45 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.67 -0.644 . . . . 0.0 111.343 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -50.8 -73.62 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.517 -1.365 . . . . 0.0 109.31 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.494 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 37.1 p -99.11 -178.08 3.82 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.465 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -160.3 134.77 7.48 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.167 -0.958 . . . . 0.0 110.028 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 57.8 m -127.67 139.77 52.5 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.602 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 14.2 tttp -85.83 140.05 30.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.803 -1.185 . . . . 0.0 110.416 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.4 pt -113.2 -32.42 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.63 -0.669 . . . . 0.0 109.922 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.653 HH21 ' CG ' ' A' ' 8' ' ' ASP . 69.6 mtt180 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 109.112 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.577 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 39.9 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 tt -171.23 159.69 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -146.77 29.38 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.368 -1.458 . . . . 0.0 110.61 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 10' ' ' VAL . 24.9 p -105.48 157.42 17.37 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.545 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -60.06 -61.89 2.27 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.85 -1.156 . . . . 0.0 110.43 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.62 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.51 -40.75 79.41 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.053 -1.029 . . . . 0.0 109.317 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.13 -45.13 94.35 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.707 HG22 ' HG2' ' A' ' 21' ' ' PRO . 68.8 t -66.55 -40.73 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.388 -1.066 . . . . 0.0 109.179 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.06 -57.38 10.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.72 -0.612 . . . . 0.0 109.392 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.82 -52.1 51.71 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.672 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 33.3 t80 -58.45 -49.67 76.47 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.333 0.587 . . . . 0.0 111.188 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.2 tt -72.25 -45.89 58.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.561 -0.712 . . . . 0.0 110.749 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -61.0 -20.05 62.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.354 -1.466 . . . . 0.0 110.587 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 m -97.97 -40.77 8.31 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.486 -1.384 . . . . 0.0 111.194 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -110.36 16.12 21.84 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.781 -1.199 . . . . 0.0 111.714 -177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.0 m80 46.03 24.61 0.26 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.367 -0.833 . . . . 0.0 110.643 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 3.8 pttp -142.41 154.33 44.5 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.688 0.756 . . . . 0.0 110.511 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.473 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.4 mp -77.2 149.28 79.18 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.707 -0.62 . . . . 0.0 109.686 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.707 ' HG2' HG22 ' A' ' 10' ' ' VAL . 51.6 Cg_exo -39.67 147.68 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.556 2.837 . . . . 0.0 113.718 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -63.8 47.55 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.084 0.945 . . . . 0.0 110.936 -177.5 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -169.11 27.08 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.087 -1.008 . . . . 0.0 110.811 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -117.99 118.26 31.46 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.705 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.8 pt -120.12 137.39 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.566 HG22 ' HA3' ' A' ' 53' ' ' GLY . 7.2 p -67.78 169.8 9.04 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.498 1.142 . . . . 0.0 111.259 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.537 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 24.1 mtmt -71.61 -37.53 70.93 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -39.67 -70.43 0.1 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 175.376 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.522 ' O ' ' C ' ' A' ' 30' ' ' ALA . 3.5 mt-10 -58.57 -58.76 7.15 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.63 -51.55 1.21 Allowed 'General case' 0 N--CA 1.508 2.46 0 O-C-N 119.075 -2.265 . . . . 0.0 110.348 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -58.15 -58.64 7.55 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.091 -1.006 . . . . 0.0 110.171 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.48 69.81 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 121.119 -0.988 . . . . 0.0 110.452 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.6 tp -55.12 -28.61 53.93 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.504 0.669 . . . . 0.0 110.23 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.29 51.05 0.25 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.534 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.71 144.94 30.79 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.277 -1.131 . . . . 0.0 109.375 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.8 t -137.45 127.03 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.556 -0.715 . . . . 0.0 110.132 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -56.98 -52.55 64.82 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.991 -0.443 . . . . 0.0 110.581 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.6 p -70.05 47.31 0.08 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.196 -0.94 . . . . 0.0 110.377 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.631 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.5 ttpm? -176.35 -51.1 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.16 56.43 20.46 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.631 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -69.92 161.77 29.32 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.659 -0.907 . . . . 0.0 110.521 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.792 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 60.1 tp -176.26 -65.95 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.557 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -62.17 -19.4 63.05 Favored 'General case' 0 C--O 1.197 -1.666 0 O-C-N 121.305 -0.872 . . . . 0.0 109.504 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.6 p-10 -80.06 -64.42 1.19 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.993 0.902 . . . . 0.0 108.637 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.419 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 30.5 m -73.89 -11.45 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.705 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.57 72.15 11.68 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.506 -0.746 . . . . 0.0 109.939 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.4 122.43 11.66 Favored 'Trans proline' 0 N--CA 1.512 2.601 0 C-N-CA 123.472 2.781 . . . . 0.0 114.219 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.409 ' C ' ' HG2' ' A' ' 49' ' ' LYS . . . 73.41 39.46 50.83 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.49 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 8.6 mmtm -138.68 176.44 8.7 Favored 'General case' 0 N--CA 1.512 2.669 0 CA-C-O 122.513 1.149 . . . . 0.0 111.009 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.1 m -148.57 162.91 38.71 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 120.203 -1.56 . . . . 0.0 110.783 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.1 mm -85.59 125.31 40.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.128 -0.983 . . . . 0.0 109.77 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.22 154.02 10.45 Favored Glycine 0 N--CA 1.503 3.138 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.566 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 122.42 -17.42 8.41 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.906 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -69.79 -154.49 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.839 -1.389 . . . . 0.0 109.835 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.9 mp -127.69 139.8 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 121.805 0.812 . . . . 0.0 110.855 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.614 ' O ' ' N ' ' A' ' 58' ' ' ASN . 9.0 t80 -105.2 90.05 3.31 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.38 -0.825 . . . . 0.0 108.816 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.541 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.5 p -59.34 36.04 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 121.393 0.616 . . . . 0.0 110.524 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.614 ' N ' ' O ' ' A' ' 56' ' ' PHE . 59.2 t30 39.38 34.68 0.14 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.075 -1.016 . . . . 0.0 110.325 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.541 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.3 mtm180 -66.58 45.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.547 -1.345 . . . . 0.0 110.066 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.616 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 18.5 mt-10 -151.53 -27.07 0.19 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.526 -0.733 . . . . 0.0 110.142 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.32 27.76 59.11 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.674 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.6 mttp -111.13 7.79 21.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.723 -0.869 . . . . 0.0 109.757 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.31 144.88 55.04 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.608 -0.683 . . . . 0.0 109.247 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.57 125.15 14.97 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.672 2.248 . . . . 0.0 112.289 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.541 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.82 -171.41 27.7 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 68' ' ' GLY . 12.1 tttt 176.37 146.67 0.09 Allowed 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.405 -1.056 . . . . 0.0 109.144 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 67' ' ' SER . 24.1 p -68.88 61.29 0.1 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.763 -1.211 . . . . 0.0 108.951 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 142.99 76.73 0.04 OUTLIER Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.568 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.92 168.25 4.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.54 -0.976 . . . . 0.0 109.195 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.446 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 93.4 m -144.5 155.86 43.9 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.463 -0.773 . . . . 0.0 109.897 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.708 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 19.8 m95 -126.55 137.6 53.37 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.579 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -128.84 156.55 43.46 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.993 -1.067 . . . . 0.0 109.091 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.538 ' O ' ' OH ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -121.28 167.4 12.77 Favored 'General case' 0 N--CA 1.513 2.676 0 CA-C-O 122.274 1.035 . . . . 0.0 111.402 -179.322 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -166.29 136.84 3.42 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.276 -0.89 . . . . 0.0 111.308 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.693 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -59.5 153.69 18.93 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.648 0.737 . . . . 0.0 111.584 -179.344 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.649 HD11 ' CG2' ' A' ' 88' ' ' ILE . 40.6 mm -136.76 142.84 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.77 -0.581 . . . . 0.0 110.764 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 59.26 65.79 1.13 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.436 0.636 . . . . 0.0 110.665 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.792 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 63.1 t80 -125.2 159.78 30.75 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.298 -0.876 . . . . 0.0 109.566 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' A' ' 80' ' ' SER . 28.1 p -139.99 -77.38 0.32 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.594 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -149.53 112.12 4.76 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.06 -104.83 0.26 Allowed Glycine 0 N--CA 1.502 3.049 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.462 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 44.3 t80 -141.43 -169.77 2.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.861 -0.787 . . . . 0.0 109.286 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.668 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.7 mtm180 -71.1 -155.0 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 O-C-N 120.81 -1.181 . . . . 0.0 109.539 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -168.77 -151.99 0.1 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.5 p -99.72 -3.5 32.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.62 -1.3 . . . . 0.0 110.335 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.527 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -91.28 117.07 29.34 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.251 -0.906 . . . . 0.0 110.283 -179.134 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.853 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.1 150.22 44.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.329 -0.857 . . . . 0.0 109.56 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.649 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.2 tt -119.06 137.38 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 72' ' ' ARG . 2.2 mm? -114.47 125.72 54.14 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.7 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.56 127.83 53.99 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.752 0.786 . . . . 0.0 109.279 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.708 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.5 p -94.12 159.14 15.28 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.282 1.039 . . . . 0.0 112.329 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.5 p -69.87 -19.52 63.43 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.568 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -83.16 10.44 8.28 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.732 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.464 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.39 31.29 0.48 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.726 -0.609 . . . . 0.0 109.988 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.413 HD12 HH21 ' A' ' 69' ' ' ARG . 27.1 mt -103.43 138.34 40.29 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.46 -0.775 . . . . 0.0 109.833 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 109' ' ' ILE . 31.9 mm -112.35 119.51 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.794 -0.566 . . . . 0.0 110.139 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.413 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.0 m-85 -120.62 143.55 48.61 Favored 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.527 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 7.7 tptp -131.12 148.09 52.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.02 -1.05 . . . . 0.0 110.299 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.562 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -127.68 171.9 11.26 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.3 p -146.73 -1.85 0.67 Allowed 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.147 -0.971 . . . . 0.0 110.281 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.627 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -117.13 20.27 13.83 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.717 -1.239 . . . . 0.0 108.433 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 77.07 64.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.409 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.674 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 18.9 m-85 68.96 -12.87 0.37 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 122.195 -0.316 . . . . 0.0 111.793 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -51.66 -72.75 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.478 -1.389 . . . . 0.0 109.58 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.474 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 37.3 p -100.07 -179.12 4.05 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.415 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -159.12 135.42 9.1 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.038 -1.039 . . . . 0.0 109.954 -179.209 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 64.0 m -128.8 139.51 52.15 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.613 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.5 tttp -86.1 139.19 31.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.839 -1.163 . . . . 0.0 110.314 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 96' ' ' ILE . 13.5 pt -112.7 -31.55 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.831 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.62 HH21 ' CG ' ' A' ' 8' ' ' ASP . 68.2 mtt180 . . . . . 0 C--N 1.306 -1.298 0 O-C-N 121.131 -0.981 . . . . 0.0 109.167 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.592 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 22.0 t . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 tt -169.94 160.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -146.53 30.2 1.01 Allowed 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.255 -1.528 . . . . 0.0 111.637 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 10' ' ' VAL . 28.3 p -104.16 158.32 16.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.517 -0.739 . . . . 0.0 109.526 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.7 p90 -60.35 -61.67 2.43 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.617 -1.302 . . . . 0.0 110.872 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.617 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -56.69 -41.67 77.74 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.145 -0.972 . . . . 0.0 109.618 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.27 -45.21 94.46 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.676 HG22 ' HG2' ' A' ' 21' ' ' PRO . 54.7 t -66.72 -41.5 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 O-C-N 121.109 -1.23 . . . . 0.0 108.101 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.36 -59.38 5.37 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.48 -52.17 31.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.058 -1.026 . . . . 0.0 109.973 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.695 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 36.3 t80 -59.58 -47.98 83.46 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.291 -0.881 . . . . 0.0 110.628 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.7 tt -72.9 -44.38 61.34 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.382 -0.824 . . . . 0.0 110.841 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -62.73 -22.62 66.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.554 -1.341 . . . . 0.0 110.379 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.2 m -94.88 -42.11 8.85 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.957 -1.089 . . . . 0.0 111.048 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -109.49 16.83 21.98 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.127 -0.983 . . . . 0.0 112.214 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 m80 46.84 24.35 0.34 Allowed 'General case' 0 N--CA 1.51 2.56 0 O-C-N 120.94 -1.1 . . . . 0.0 110.584 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.2 pttp -141.39 151.45 43.49 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.241 1.02 . . . . 0.0 110.296 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.527 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.5 mp -75.44 150.39 84.75 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.033 -1.042 . . . . 0.0 108.725 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.695 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 50.7 Cg_exo -40.33 151.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 123.344 2.696 . . . . 0.0 114.35 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -66.38 47.6 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.6 0.714 . . . . 0.0 111.312 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -170.22 27.65 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 109.189 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -119.25 118.26 30.8 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.714 -1.241 . . . . 0.0 110.098 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.8 pt -119.89 138.73 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.307 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.54 HG22 ' HA3' ' A' ' 53' ' ' GLY . 12.0 p -69.01 166.97 16.91 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.936 -1.102 . . . . 0.0 110.875 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.591 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 22.9 mtmt -70.38 -34.59 72.75 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.31 -66.99 0.32 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' ' 30' ' ' ALA . 3.4 mt-10 -60.35 -58.3 9.1 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.439 -1.304 . . . . 0.0 108.288 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.66 -52.46 1.23 Allowed 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.007 -1.058 . . . . 0.0 109.241 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -59.0 -55.98 28.15 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.563 -0.711 . . . . 0.0 110.511 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.26 -29.1 70.17 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 120.652 -1.28 . . . . 0.0 108.964 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.413 HD21 ' HB ' ' A' ' 45' ' ' VAL . 33.9 tp -62.38 -27.36 69.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.648 -0.657 . . . . 0.0 109.471 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.84 52.73 0.23 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.55 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -83.07 146.77 28.51 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.317 -1.108 . . . . 0.0 109.693 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -135.77 125.16 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.325 -0.859 . . . . 0.0 109.187 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -58.82 -52.56 65.21 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.831 -0.543 . . . . 0.0 109.724 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.9 p -70.37 50.98 0.12 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.001 -1.062 . . . . 0.0 109.412 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.645 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -179.69 -50.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.41 56.99 20.29 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.645 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -72.14 164.42 26.22 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.834 -0.803 . . . . 0.0 110.784 -178.715 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.843 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 66.6 tp -178.64 -66.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.001 -1.062 . . . . 0.0 110.004 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.638 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -59.98 -23.12 63.36 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.098 -1.001 . . . . 0.0 109.711 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 5.5 p-10 -76.39 -64.11 1.18 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.003 0.906 . . . . 0.0 109.497 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.444 ' H ' HG22 ' A' ' 45' ' ' VAL . 15.3 m -76.21 -10.92 13.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.853 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.62 70.14 11.41 Favored Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.348 -0.845 . . . . 0.0 109.431 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -57.04 123.57 14.16 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 123.182 2.588 . . . . 0.0 113.673 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.487 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 73.88 36.45 52.51 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.487 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 8.5 mmtm -138.57 168.97 18.63 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 121.885 0.85 . . . . 0.0 111.205 -178.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.474 ' HG ' ' HD2' ' A' ' 78' ' ' TYR . 73.3 m -142.48 162.02 36.56 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.277 1.037 . . . . 0.0 111.089 -177.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.1 mm -84.47 126.93 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 122.1 0.952 . . . . 0.0 110.327 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.36 153.74 9.24 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.54 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 122.57 -20.46 7.82 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.329 -1.415 . . . . 0.0 110.782 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -68.33 -154.42 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 118.686 1.243 . . . . 0.0 109.01 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.66 139.65 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-O 121.864 0.84 . . . . 0.0 111.219 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.612 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.5 t80 -104.05 89.96 3.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.341 -0.85 . . . . 0.0 109.304 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.642 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.3 p -58.99 35.16 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.603 -0.686 . . . . 0.0 110.888 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.612 ' N ' ' O ' ' A' ' 56' ' ' PHE . 55.2 t30 38.34 39.7 0.3 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.107 -0.996 . . . . 0.0 109.878 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.642 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 8.9 mtm180 -70.29 43.33 0.06 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.562 -1.336 . . . . 0.0 110.087 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.61 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 21.7 mt-10 -149.38 -25.32 0.28 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.332 -0.855 . . . . 0.0 109.943 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.59 28.74 58.92 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.637 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.5 mttp -111.3 7.93 21.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.508 -0.995 . . . . 0.0 109.713 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mt -131.0 144.04 51.91 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.602 -0.686 . . . . 0.0 109.493 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.33 124.98 15.8 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.819 2.346 . . . . 0.0 112.408 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.543 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.1 -173.22 28.82 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.507 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 11.0 tttt 177.29 144.24 0.09 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.375 -1.074 . . . . 0.0 108.656 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.2 p -68.1 58.58 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.936 -1.102 . . . . 0.0 109.172 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.507 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 147.64 75.51 0.02 OUTLIER Glycine 0 N--CA 1.5 2.913 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.564 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.56 168.11 5.37 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.711 -0.876 . . . . 0.0 109.33 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 87.9 m -143.39 155.09 44.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.486 -0.759 . . . . 0.0 110.039 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.714 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 17.9 m95 -125.21 138.34 54.12 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.584 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -129.47 156.14 44.59 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 120.747 -1.221 . . . . 0.0 109.586 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.591 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -120.47 167.66 12.13 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.259 -0.901 . . . . 0.0 112.026 -179.37 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -166.65 135.71 2.94 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.135 -0.978 . . . . 0.0 110.714 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.646 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -58.59 153.33 16.53 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.343 0.592 . . . . 0.0 111.676 -179.436 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.686 HD11 ' CG2' ' A' ' 88' ' ' ILE . 39.9 mm -136.02 140.67 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.49 0.662 . . . . 0.0 110.37 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 60.49 68.98 0.72 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.679 -0.638 . . . . 0.0 110.403 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.843 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 61.2 t80 -126.13 159.45 32.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.349 -0.844 . . . . 0.0 109.636 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.601 ' OG1' ' N ' ' A' ' 80' ' ' SER . 31.2 p -139.8 -78.25 0.32 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.638 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -150.84 107.44 3.51 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.663 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.94 -107.41 0.31 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 52.1 t80 -139.29 -166.93 2.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.734 -0.862 . . . . 0.0 108.843 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.648 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.3 mtm180 -73.91 -157.31 0.05 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.0 -1.062 . . . . 0.0 109.53 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -166.64 -153.14 0.15 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 100' ' ' THR . 50.7 p -98.22 -9.64 25.3 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.457 -1.402 . . . . 0.0 110.727 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.538 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -86.06 117.71 25.07 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.066 -1.021 . . . . 0.0 111.096 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.826 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.65 148.45 42.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.405 -0.81 . . . . 0.0 109.552 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.686 ' CG2' HD11 ' A' ' 76' ' ' ILE . 3.5 tt -115.93 139.54 42.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.472 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.1 mm? -116.05 125.43 52.42 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.671 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -117.55 127.52 54.06 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.856 0.836 . . . . 0.0 109.355 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.714 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 8.6 p -94.58 157.7 15.86 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.122 0.963 . . . . 0.0 111.944 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.1 p -69.01 -20.1 64.14 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.564 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -82.18 9.72 8.15 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.3 -0.875 . . . . 0.0 110.033 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.451 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.25 29.35 0.45 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.714 -0.616 . . . . 0.0 110.449 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.437 HD12 HH21 ' A' ' 69' ' ' ARG . 29.2 mt -101.87 135.99 42.47 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.437 -0.79 . . . . 0.0 109.985 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.4 mm -110.2 119.74 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.515 -0.74 . . . . 0.0 110.115 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.435 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.3 m-85 -119.04 143.14 47.27 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.538 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 8.5 tptp -132.45 147.49 52.37 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.823 -1.173 . . . . 0.0 110.537 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.487 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.5 t -129.39 171.04 12.92 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.403 ' O ' ' OG ' ' A' ' 85' ' ' SER . 72.3 p -145.22 -3.65 0.74 Allowed 'General case' 0 N--CA 1.508 2.472 0 O-C-N 121.45 -0.781 . . . . 0.0 110.234 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -114.53 19.37 16.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.756 -1.215 . . . . 0.0 108.924 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 77.87 63.69 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.054 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.648 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 18.5 m-85 69.5 -14.48 0.33 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.813 -0.554 . . . . 0.0 111.87 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -49.96 -74.27 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.538 -1.351 . . . . 0.0 109.314 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.464 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 38.0 p -99.03 -177.17 3.54 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.791 -1.193 . . . . 0.0 108.319 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.472 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -160.23 134.33 7.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -0.983 . . . . 0.0 110.236 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.6 m -127.3 139.99 52.51 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.541 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.2 tttp -86.37 140.21 30.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.8 -1.187 . . . . 0.0 110.364 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.6 pt -113.68 -31.71 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.438 -0.788 . . . . 0.0 110.074 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.617 HH21 ' CG ' ' A' ' 8' ' ' ASP . 67.6 mtt180 . . . . . 0 N--CA 1.485 1.317 0 O-C-N 121.068 -1.02 . . . . 0.0 108.659 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.638 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.8 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 tt -169.4 159.69 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.365 -0.835 . . . . 0.0 109.342 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -146.67 31.07 0.97 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.512 -1.368 . . . . 0.0 111.357 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.7 p -106.08 155.97 18.88 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.599 -0.688 . . . . 0.0 109.865 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.3 p90 -58.44 -62.18 2.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.195 -0.941 . . . . 0.0 110.725 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.622 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.9 OUTLIER -58.15 -41.13 83.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.353 -0.842 . . . . 0.0 109.526 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.92 -44.91 87.56 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.692 HG22 ' HG2' ' A' ' 21' ' ' PRO . 53.3 t -67.95 -41.99 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.46 -57.02 12.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.473 -0.767 . . . . 0.0 109.21 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.08 -55.22 15.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.474 -0.766 . . . . 0.0 109.692 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.676 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 33.9 t80 -56.45 -49.88 73.32 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.249 0.547 . . . . 0.0 110.802 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -73.22 -44.55 59.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.376 -0.828 . . . . 0.0 110.709 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -62.26 -21.12 64.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.566 -1.334 . . . . 0.0 110.298 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.6 m -97.26 -40.92 8.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.174 -0.954 . . . . 0.0 110.742 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -109.16 14.42 23.9 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.118 -0.989 . . . . 0.0 111.908 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.1 m80 46.51 25.57 0.41 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 120.864 -1.147 . . . . 0.0 109.669 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.488 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 5.0 pttp -142.27 152.2 42.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.315 -0.866 . . . . 0.0 110.004 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.542 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.6 mp -76.88 149.36 80.24 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 109.066 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.692 ' HG2' HG22 ' A' ' 10' ' ' VAL . 66.1 Cg_exo -40.76 150.71 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.734 2.289 . . . . 0.0 113.23 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -62.59 47.14 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.601 0.715 . . . . 0.0 111.12 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -168.42 26.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.6 -1.313 . . . . 0.0 110.286 179.121 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -116.69 113.05 22.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.88 -1.137 . . . . 0.0 110.886 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 25' ' ' ILE . 28.3 pt -116.18 138.59 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.325 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.611 HG22 ' HA3' ' A' ' 53' ' ' GLY . 4.4 p -69.73 166.62 18.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.018 -1.051 . . . . 0.0 110.37 -176.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.586 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 18.7 mtmt -66.29 -35.4 80.29 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.441 ' HG ' ' CB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -41.89 -66.33 0.36 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.625 178.147 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.4 mt-10 -65.33 -49.3 69.95 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.301 -0.959 . . . . 0.0 109.192 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -44.24 -50.0 9.04 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.79 -1.194 . . . . 0.0 107.997 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.42 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 38.7 mt-30 -59.2 -57.6 12.33 Favored 'General case' 0 N--CA 1.509 2.506 0 O-C-N 121.36 -0.838 . . . . 0.0 110.733 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.34 -30.91 69.83 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.994 -1.066 . . . . 0.0 109.807 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.0 tp -63.11 -25.82 68.54 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.96 50.16 0.23 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.593 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.91 144.1 31.2 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.369 -1.077 . . . . 0.0 110.146 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.0 t -134.52 125.3 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.174 -0.954 . . . . 0.0 109.699 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -58.73 -52.83 64.02 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.55 -0.719 . . . . 0.0 109.812 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 59.6 p -68.56 50.2 0.07 Allowed 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.982 -1.073 . . . . 0.0 109.133 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.626 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.0 OUTLIER -179.34 -50.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -0.774 . . . . 0.0 108.964 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.95 56.86 18.4 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.626 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -74.27 162.76 28.59 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.443 -1.034 . . . . 0.0 110.773 -178.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.821 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 65.4 tp -176.12 -67.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.547 -0.72 . . . . 0.0 109.798 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.655 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.63 -18.86 55.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.962 -1.086 . . . . 0.0 109.935 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.8 p-10 -79.45 -65.1 1.04 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.843 0.83 . . . . 0.0 109.552 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.457 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 30.7 m -73.33 -10.89 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 O-C-N 121.743 -0.598 . . . . 0.0 110.353 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.83 71.87 9.59 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 109.785 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.36 122.56 12.0 Favored 'Trans proline' 0 N--CA 1.509 2.392 0 C-N-CA 123.977 3.118 . . . . 0.0 113.562 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.74 39.76 59.46 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 7.2 mmtt -136.6 176.08 9.03 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.052 0.929 . . . . 0.0 110.597 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.405 ' HA ' HD21 ' A' ' 42' ' ' LEU . 69.0 m -150.13 158.82 44.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.785 -1.197 . . . . 0.0 111.167 -177.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.3 mm -82.45 130.37 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.548 0.69 . . . . 0.0 110.121 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.4 154.83 8.5 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.611 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 119.89 -16.53 10.2 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 120.293 -0.956 . . . . 0.0 110.868 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -70.55 -152.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.748 -1.443 . . . . 0.0 109.603 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -128.93 138.84 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.522 0.677 . . . . 0.0 110.821 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.604 ' O ' ' N ' ' A' ' 58' ' ' ASN . 11.0 t80 -104.09 90.31 3.55 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.661 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.3 36.2 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.47 0.653 . . . . 0.0 111.182 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.604 ' N ' ' O ' ' A' ' 56' ' ' PHE . 53.5 t30 36.58 38.4 0.08 Allowed 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.94 -1.1 . . . . 0.0 110.541 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.661 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.8 mtm180 -69.51 39.07 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.614 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 18.9 mt-10 -149.05 -10.9 0.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.182 -0.949 . . . . 0.0 110.246 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.78 33.23 84.53 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.67 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.1 mttp -115.1 8.6 15.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.613 -0.934 . . . . 0.0 109.446 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -132.81 142.94 46.59 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.446 -0.784 . . . . 0.0 109.349 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.86 125.99 17.84 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.885 2.39 . . . . 0.0 112.394 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.539 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.0 -170.99 28.63 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.583 ' O ' ' N ' ' A' ' 68' ' ' GLY . 11.1 tttt 175.52 144.08 0.07 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.149 -1.206 . . . . 0.0 108.269 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 67' ' ' SER . 27.2 p -66.09 57.05 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.838 -1.164 . . . . 0.0 108.427 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 147.63 77.34 0.02 OUTLIER Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.539 ' NH1' ' O ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -173.54 167.78 4.56 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.551 -0.97 . . . . 0.0 108.974 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.431 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 85.6 m -144.36 155.87 43.98 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.811 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.737 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 25.6 m95 -126.32 138.73 53.61 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.615 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.38 154.31 47.81 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.544 -1.347 . . . . 0.0 109.606 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.586 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -118.35 167.0 11.97 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.195 -0.94 . . . . 0.0 111.815 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.13 136.13 3.97 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.797 0.808 . . . . 0.0 110.967 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.66 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -60.73 151.69 28.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.613 -0.679 . . . . 0.0 111.938 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.492 HG13 ' HB ' ' A' ' 88' ' ' ILE . 40.4 mm -137.15 143.82 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 121.476 0.655 . . . . 0.0 110.18 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 60.25 66.08 1.0 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.234 0.54 . . . . 0.0 110.576 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.821 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 58.0 t80 -126.79 161.63 27.74 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.156 -0.965 . . . . 0.0 109.122 178.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.634 ' OG1' ' N ' ' A' ' 80' ' ' SER . 27.2 p -141.38 -78.96 0.26 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.655 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -149.27 106.08 3.56 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.51 -107.09 0.3 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 49.1 t80 -135.82 -166.02 1.79 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.721 -0.87 . . . . 0.0 108.771 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.658 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.8 mtm180 -75.16 -153.04 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.916 -1.115 . . . . 0.0 109.077 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -168.41 -150.3 0.09 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.3 p -100.87 -8.36 22.64 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.464 -1.397 . . . . 0.0 110.335 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.455 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -86.5 116.75 24.85 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.386 -0.821 . . . . 0.0 110.741 -178.887 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.84 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.22 149.47 44.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.251 -0.906 . . . . 0.0 109.698 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.492 ' HB ' HG13 ' A' ' 76' ' ' ILE . 10.5 tt -119.64 136.1 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.621 0.724 . . . . 0.0 109.125 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 72' ' ' ARG . 2.8 mm? -112.66 124.65 53.03 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -116.69 127.84 54.78 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.691 0.758 . . . . 0.0 109.002 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.737 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 5.7 p -93.78 158.72 15.53 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.995 0.903 . . . . 0.0 111.91 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.7 p -69.39 -19.94 63.81 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.524 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.72 9.28 8.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.471 -0.768 . . . . 0.0 109.898 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.78 30.32 0.47 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.621 -0.674 . . . . 0.0 110.024 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.429 HD12 HH21 ' A' ' 69' ' ' ARG . 26.8 mt -102.87 137.57 40.9 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.342 -0.849 . . . . 0.0 110.388 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.52 ' CG2' HD11 ' A' ' 109' ' ' ILE . 35.9 mm -110.42 118.95 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.306 -0.872 . . . . 0.0 110.691 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.461 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 6.9 m-85 -119.09 141.61 48.61 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.455 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 6.2 tptp -131.37 148.26 52.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.417 -0.802 . . . . 0.0 110.896 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.7 t -128.66 172.46 11.2 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.9 p -146.87 -3.21 0.6 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.523 -0.735 . . . . 0.0 110.487 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.582 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.3 p30 -115.54 22.5 13.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.785 -1.197 . . . . 0.0 108.296 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 75.76 62.17 0.05 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.495 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.67 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 17.6 m-85 69.59 -10.87 0.55 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.701 -0.624 . . . . 0.0 111.414 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.72 -72.87 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.695 -1.253 . . . . 0.0 109.213 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.514 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 34.9 p -99.39 -178.37 3.88 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.477 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -160.65 133.48 6.41 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.071 -1.018 . . . . 0.0 109.794 -179.317 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.9 m -127.28 141.49 51.7 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.617 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 13.5 tttp -86.77 139.03 31.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.873 -1.142 . . . . 0.0 110.093 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.52 HD11 ' CG2' ' A' ' 96' ' ' ILE . 10.3 pt -112.11 -32.26 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.606 -0.684 . . . . 0.0 109.432 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.622 HH21 ' CG ' ' A' ' 8' ' ' ASP . 56.3 mtt180 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 118.086 -0.959 . . . . 0.0 109.049 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.622 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.2 t . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 tt -169.78 160.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.4 -0.812 . . . . 0.0 109.219 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -147.26 30.33 0.94 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.339 -1.475 . . . . 0.0 111.129 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 10' ' ' VAL . 19.9 p -104.86 156.25 18.18 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.744 0.783 . . . . 0.0 109.792 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.5 p90 -59.65 -61.38 2.66 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.729 -1.232 . . . . 0.0 110.143 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.647 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.74 -41.53 82.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.337 -0.852 . . . . 0.0 109.388 -179.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.5 -44.77 93.62 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.642 HG22 ' HG2' ' A' ' 21' ' ' PRO . 60.6 t -67.54 -41.66 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 121.43 -1.041 . . . . 0.0 108.662 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.47 -58.09 9.55 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.17 -54.86 14.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.362 -0.836 . . . . 0.0 109.633 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.571 ' CE1' ' HA ' ' A' ' 21' ' ' PRO . 34.1 t80 -57.6 -47.36 82.37 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.118 0.485 . . . . 0.0 110.754 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.2 tt -74.21 -44.37 53.52 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.246 -0.909 . . . . 0.0 110.717 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -62.98 -19.94 64.8 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.436 -1.415 . . . . 0.0 110.13 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.4 m -96.8 -43.33 7.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.987 -1.071 . . . . 0.0 111.01 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -107.77 13.12 26.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.153 -0.967 . . . . 0.0 111.894 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.2 m80 49.2 23.91 0.88 Allowed 'General case' 0 N--CA 1.508 2.426 0 O-C-N 120.692 -1.255 . . . . 0.0 109.902 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.487 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.5 pttp -141.48 153.63 45.06 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.526 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.2 mp -77.78 149.71 77.8 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.344 -0.847 . . . . 0.0 109.038 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.642 ' HG2' HG22 ' A' ' 10' ' ' VAL . 77.2 Cg_exo -39.34 151.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 123.133 2.555 . . . . 0.0 113.567 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -63.45 47.83 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.637 0.732 . . . . 0.0 110.538 179.581 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -169.88 26.95 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.846 -1.159 . . . . 0.0 110.328 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -118.48 114.01 22.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.482 -1.387 . . . . 0.0 110.227 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 35.4 pt -117.26 140.63 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.024 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.638 HG22 ' HA3' ' A' ' 53' ' ' GLY . 6.8 p -70.19 166.8 19.23 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.325 1.06 . . . . 0.0 111.684 -177.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.577 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 20.6 mtmt -68.58 -35.57 77.55 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.73 -65.47 0.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.425 176.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.458 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.6 mt-10 -64.4 -52.02 60.3 Favored 'General case' 0 C--O 1.201 -1.466 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.624 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -41.71 -51.65 4.06 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.858 -1.152 . . . . 0.0 109.047 177.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -60.0 -56.73 18.08 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.372 -0.83 . . . . 0.0 110.895 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.9 -30.61 69.14 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.589 -1.319 . . . . 0.0 109.024 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.1 tp -63.48 -29.83 71.04 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.405 0.621 . . . . 0.0 109.439 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.34 55.01 0.15 Allowed Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.595 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -88.08 145.61 25.86 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.294 -1.121 . . . . 0.0 109.505 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -135.45 124.31 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.427 -0.795 . . . . 0.0 109.414 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -56.89 -53.21 60.54 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.708 -0.62 . . . . 0.0 109.716 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 81.0 p -68.54 48.53 0.06 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.462 -0.774 . . . . 0.0 109.834 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.648 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.4 ttpm? -178.29 -50.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.53 56.05 23.78 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.648 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -73.24 161.24 30.76 Favored 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.517 -0.99 . . . . 0.0 111.155 -178.764 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.828 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.5 tp -173.17 -68.18 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.117 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.602 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.51 -18.93 55.09 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.169 -0.957 . . . . 0.0 109.779 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.2 p-10 -78.38 -63.9 1.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.66 0.743 . . . . 0.0 109.36 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.6 m -75.6 -10.13 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.919 -0.488 . . . . 0.0 110.381 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.74 71.21 9.65 Favored Pre-proline 0 N--CA 1.486 1.346 0 O-C-N 121.514 -0.741 . . . . 0.0 109.589 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.9 124.37 16.08 Favored 'Trans proline' 0 N--CA 1.505 2.185 0 C-N-CA 123.517 2.812 . . . . 0.0 113.872 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.536 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 72.15 38.69 59.15 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.9 mmtm -137.02 171.25 14.79 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 121.691 0.758 . . . . 0.0 110.167 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.0 m -144.35 162.24 36.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.146 -0.971 . . . . 0.0 110.302 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.7 mm -84.63 127.87 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.631 0.729 . . . . 0.0 110.156 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.97 155.34 10.9 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.638 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 120.63 -15.94 9.71 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.695 -1.24 . . . . 0.0 111.053 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -71.75 -155.14 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.766 -1.432 . . . . 0.0 109.321 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.16 140.27 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.76 0.791 . . . . 0.0 110.393 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.597 ' O ' ' N ' ' A' ' 58' ' ' ASN . 9.7 t80 -105.61 91.16 3.64 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.55 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -60.52 36.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.605 -0.684 . . . . 0.0 110.828 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 56' ' ' PHE . 51.7 t30 38.94 36.88 0.17 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.123 -0.985 . . . . 0.0 110.358 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.55 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.6 mtm180 -69.43 42.3 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.885 -1.134 . . . . 0.0 109.564 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.621 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 17.8 mt-10 -150.18 -15.46 0.25 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.411 -0.806 . . . . 0.0 110.254 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.43 32.1 83.08 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.668 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.1 mttp -113.63 6.53 16.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.717 -0.873 . . . . 0.0 109.304 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.7 144.01 51.66 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.659 -0.651 . . . . 0.0 109.39 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.48 124.52 14.38 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.984 2.456 . . . . 0.0 112.051 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.521 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -101.03 -172.5 28.81 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 68' ' ' GLY . 10.9 tttt 177.07 146.47 0.11 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.366 -1.079 . . . . 0.0 108.955 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 67' ' ' SER . 24.2 p -68.57 60.21 0.09 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.956 -1.09 . . . . 0.0 108.784 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 144.18 77.05 0.03 OUTLIER Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.541 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -173.69 167.29 4.51 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.586 -0.949 . . . . 0.0 109.208 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 92.4 m -143.81 156.67 44.56 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.23 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.727 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 22.6 m95 -127.11 138.21 53.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.052 -0.405 . . . . 0.0 109.947 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.561 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.04 154.19 47.67 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.89 -1.131 . . . . 0.0 109.733 179.32 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.577 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -118.28 166.9 12.07 Favored 'General case' 0 N--CA 1.509 2.488 0 CA-C-O 121.768 0.794 . . . . 0.0 112.064 -179.051 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.18 134.56 3.51 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.282 -0.886 . . . . 0.0 111.31 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.678 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.46 153.13 13.27 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.268 0.556 . . . . 0.0 111.372 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.726 HD11 ' CG2' ' A' ' 88' ' ' ILE . 42.3 mm -135.98 143.45 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.769 -0.582 . . . . 0.0 109.977 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 57.96 69.75 0.71 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.497 0.665 . . . . 0.0 110.576 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.828 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 65.8 t80 -127.88 160.19 32.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.375 -0.828 . . . . 0.0 109.344 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.613 ' OG1' ' N ' ' A' ' 80' ' ' SER . 29.9 p -141.5 -78.94 0.26 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.613 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.4 OUTLIER -150.5 105.21 3.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.787 -0.571 . . . . 0.0 110.2 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.5 -98.85 0.17 Allowed Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.473 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 46.0 t80 -144.81 -169.86 3.27 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.605 -0.938 . . . . 0.0 109.379 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.641 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.8 mtm180 -72.0 -156.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.045 -1.034 . . . . 0.0 109.531 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -167.17 -151.7 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 p -99.25 -6.31 28.28 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.725 -1.234 . . . . 0.0 110.38 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.466 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -89.05 118.61 28.89 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.122 -0.986 . . . . 0.0 110.451 -178.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.857 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.77 150.46 43.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.755 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.726 ' CG2' HD11 ' A' ' 76' ' ' ILE . 3.7 tt -118.35 136.63 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 72' ' ' ARG . 2.4 mm? -114.29 124.24 51.52 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.692 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -116.6 127.5 54.53 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.691 0.757 . . . . 0.0 109.09 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.727 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.9 p -93.69 157.96 15.91 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.143 0.973 . . . . 0.0 112.197 -178.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.1 p -68.86 -20.03 64.26 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.541 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -82.34 10.34 7.23 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.423 -0.798 . . . . 0.0 109.853 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.47 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.6 30.55 0.48 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.629 -0.669 . . . . 0.0 110.047 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.9 mt -102.79 138.68 39.36 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.384 -0.822 . . . . 0.0 109.94 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.468 HG22 HD11 ' A' ' 109' ' ' ILE . 33.4 mm -112.28 119.76 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.267 -0.896 . . . . 0.0 110.07 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.427 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.1 m-85 -119.95 142.61 48.59 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.466 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 9.3 tptp -130.62 147.67 52.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.761 . . . . 0.0 110.71 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.549 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.0 t -128.78 171.13 12.53 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.5 p -146.5 -2.62 0.66 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.36 -0.838 . . . . 0.0 110.488 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.636 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -115.63 19.34 15.37 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.653 -1.28 . . . . 0.0 108.549 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.97 62.01 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.534 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.668 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 21.5 m-85 69.89 -13.12 0.43 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.73 -0.606 . . . . 0.0 111.595 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -51.01 -72.39 0.05 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.735 -1.228 . . . . 0.0 109.557 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.458 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 34.5 p -99.96 -177.14 3.45 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -160.96 135.05 6.99 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.987 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.9 m -128.3 139.73 52.26 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.611 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 14.4 tttp -85.79 140.16 30.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.006 -1.059 . . . . 0.0 110.15 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.468 HD11 HG22 ' A' ' 96' ' ' ILE . 11.7 pt -113.23 -33.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.604 -0.685 . . . . 0.0 109.603 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.647 HH21 ' CG ' ' A' ' 8' ' ' ASP . 64.9 mtt180 . . . . . 0 N--CA 1.488 1.467 0 O-C-N 121.212 -0.93 . . . . 0.0 108.999 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.631 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.2 t . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 tt -171.31 161.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -145.94 28.2 1.15 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.43 -1.419 . . . . 0.0 111.083 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.5 p -104.16 156.12 18.15 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.729 0.776 . . . . 0.0 110.19 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.7 p90 -60.1 -60.78 3.28 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.758 -1.214 . . . . 0.0 110.759 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.63 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -58.57 -41.99 86.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 108.927 -179.381 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.19 -43.62 93.45 Favored Glycine 0 N--CA 1.501 2.993 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.733 HG22 ' HG2' ' A' ' 21' ' ' PRO . 50.5 t -68.78 -41.46 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.212 -1.169 . . . . 0.0 107.998 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.99 -59.1 5.91 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.61 -54.87 12.91 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.567 -0.708 . . . . 0.0 109.587 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.689 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 33.8 t80 -56.42 -49.51 74.35 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.174 0.511 . . . . 0.0 110.204 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.35 -47.41 56.57 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.164 -0.96 . . . . 0.0 111.567 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -61.4 -21.07 63.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.553 -1.342 . . . . 0.0 110.366 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 m -95.9 -41.01 9.02 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.986 -1.071 . . . . 0.0 111.652 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -110.8 16.2 21.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.457 -0.777 . . . . 0.0 111.566 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.6 m80 46.53 25.5 0.41 Allowed 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.563 -1.336 . . . . 0.0 110.248 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -142.95 152.62 42.2 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.203 -0.935 . . . . 0.0 110.695 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.551 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.3 mp -74.79 148.92 85.39 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.0 109.513 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.733 ' HG2' HG22 ' A' ' 10' ' ' VAL . 72.5 Cg_exo -40.48 151.56 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 123.4 2.734 . . . . 0.0 113.371 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.631 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -64.43 46.75 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 121.752 0.787 . . . . 0.0 110.997 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -167.62 24.87 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.937 -1.102 . . . . 0.0 110.545 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -116.27 116.02 27.01 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.692 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.8 pt -117.79 141.0 38.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.709 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.603 HG22 ' HA3' ' A' ' 53' ' ' GLY . 6.9 p -71.83 167.54 19.77 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 120.858 -1.151 . . . . 0.0 110.524 -177.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.568 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 22.5 mtmt -68.23 -35.92 78.68 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.414 ' HG ' ' CB ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -41.01 -66.23 0.35 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 122.829 1.299 . . . . 0.0 108.472 178.355 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.548 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.9 mt-10 -65.65 -52.83 48.63 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.612 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.548 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -40.8 -50.86 3.17 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.324 -1.485 . . . . 0.0 107.397 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -58.57 -58.79 6.98 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 120.898 -1.126 . . . . 0.0 111.63 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.93 -29.77 67.35 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.1 -1.625 . . . . 0.0 110.163 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.9 tp -63.17 -25.01 68.15 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.96 50.49 0.26 Allowed Glycine 0 N--CA 1.501 2.992 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.588 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.49 146.12 30.38 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.094 -1.239 . . . . 0.0 109.661 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.42 125.8 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.565 -0.709 . . . . 0.0 109.214 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -58.96 -52.53 65.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.843 -0.536 . . . . 0.0 109.744 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.6 p -69.71 50.12 0.1 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.697 -1.252 . . . . 0.0 109.342 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.64 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -178.46 -50.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.18 56.38 24.11 Favored Glycine 0 N--CA 1.503 3.1 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.64 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -71.94 164.99 25.1 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.629 -0.924 . . . . 0.0 110.387 -178.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.792 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 60.6 tp -177.35 -69.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.726 -0.609 . . . . 0.0 110.214 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -57.87 -20.46 36.85 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.616 -1.302 . . . . 0.0 109.414 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.5 p-10 -77.89 -63.08 1.47 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.424 1.107 . . . . 0.0 109.501 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.451 HG22 ' H ' ' A' ' 45' ' ' VAL . 17.0 m -77.46 -7.25 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.17 -0.956 . . . . 0.0 110.259 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.47 70.53 7.46 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.464 -0.772 . . . . 0.0 109.076 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.39 125.97 20.8 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 123.358 2.705 . . . . 0.0 113.719 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.32 40.13 70.04 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -137.56 176.21 8.91 Favored 'General case' 0 N--CA 1.516 2.851 0 CA-C-O 122.592 1.187 . . . . 0.0 111.85 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.404 ' HG ' ' HD2' ' A' ' 78' ' ' TYR . 73.1 m -148.72 160.41 43.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.614 -1.304 . . . . 0.0 111.639 -177.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.3 mm -83.24 127.76 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.436 -0.79 . . . . 0.0 109.833 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 170.44 153.23 8.59 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.603 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 121.71 -16.78 8.91 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.243 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.522 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 1.2 m-20 -70.48 -154.42 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.243 -1.151 . . . . 0.0 109.903 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mp -128.61 135.79 61.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.945 0.879 . . . . 0.0 110.202 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.606 ' O ' ' N ' ' A' ' 58' ' ' ASN . 10.9 t80 -101.75 91.16 4.28 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.654 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -60.57 37.27 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.632 -0.668 . . . . 0.0 110.456 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 56' ' ' PHE . 56.3 t30 37.82 36.69 0.1 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.208 -0.932 . . . . 0.0 110.444 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.654 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.9 mtm180 -68.35 44.93 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.804 -1.185 . . . . 0.0 109.885 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.62 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 20.1 mt-10 -151.51 -25.64 0.2 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.511 -0.743 . . . . 0.0 110.055 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.86 29.47 59.12 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.68 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.5 mttp -112.89 9.16 18.86 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.535 -0.979 . . . . 0.0 109.468 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mt -131.95 143.92 51.05 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.755 -0.591 . . . . 0.0 109.41 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.57 124.19 13.74 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 122.729 2.286 . . . . 0.0 112.3 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.541 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -100.76 -172.83 29.21 Favored Glycine 0 N--CA 1.505 3.235 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 68' ' ' GLY . 10.8 tttt 177.29 145.4 0.1 Allowed 'General case' 0 N--CA 1.508 2.465 0 O-C-N 121.559 -0.965 . . . . 0.0 108.73 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' A' ' 67' ' ' SER . 24.6 p -67.62 56.88 0.06 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.016 -1.052 . . . . 0.0 109.104 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 147.31 77.9 0.02 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.541 HH11 ' C ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -173.97 168.35 4.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.566 -0.961 . . . . 0.0 108.839 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.443 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.8 m -143.97 156.38 44.39 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.967 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.721 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 20.6 m95 -127.76 137.21 52.35 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.567 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -128.83 157.57 41.15 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 120.969 -1.082 . . . . 0.0 109.73 179.253 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.568 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -121.52 167.66 12.6 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.271 -0.893 . . . . 0.0 111.565 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.95 136.63 4.24 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.245 -0.909 . . . . 0.0 111.151 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.716 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -59.0 151.72 21.43 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.557 -0.714 . . . . 0.0 111.724 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.633 HD11 ' CG2' ' A' ' 88' ' ' ILE . 46.3 mm -135.69 144.58 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.489 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 58.31 70.36 0.66 Allowed 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.393 0.616 . . . . 0.0 110.407 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.792 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 61.6 t80 -129.54 161.1 31.26 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.076 -1.015 . . . . 0.0 109.455 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.611 ' OG1' ' N ' ' A' ' 80' ' ' SER . 28.5 p -140.9 -77.74 0.29 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.611 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -149.18 110.89 4.52 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.31 -104.04 0.24 Allowed Glycine 0 N--CA 1.502 3.038 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 44.2 t80 -141.32 -167.63 2.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.918 -0.754 . . . . 0.0 109.183 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.633 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.6 mtm180 -73.04 -153.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.165 -0.96 . . . . 0.0 109.415 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -168.35 -151.35 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.52 ' OG ' ' O ' ' A' ' 100' ' ' THR . 43.1 p -99.45 -4.16 32.05 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.645 -1.285 . . . . 0.0 110.114 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.457 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -91.04 118.14 30.16 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.287 -0.883 . . . . 0.0 110.492 -178.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.842 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.66 148.88 39.86 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.354 -0.841 . . . . 0.0 109.481 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.633 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.3 tt -116.59 136.65 52.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 72' ' ' ARG . 1.9 mm? -113.42 124.19 51.84 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.659 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -117.78 125.96 51.57 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.997 0.903 . . . . 0.0 109.466 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.721 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 5.1 p -92.12 158.54 16.14 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.852 0.834 . . . . 0.0 112.081 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.4 p -70.18 -19.69 63.17 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.533 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -82.43 10.12 7.78 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.347 -0.846 . . . . 0.0 109.928 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.453 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.85 30.22 0.47 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.712 -0.618 . . . . 0.0 110.099 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.423 HD12 HH21 ' A' ' 69' ' ' ARG . 29.6 mt -101.77 138.72 38.38 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.215 -0.928 . . . . 0.0 109.79 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.446 ' CG2' HD11 ' A' ' 109' ' ' ILE . 35.1 mm -113.23 119.51 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.469 -0.769 . . . . 0.0 110.024 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.428 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.9 m-85 -120.39 143.08 48.62 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.457 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 7.4 tptp -131.24 148.28 52.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.025 -1.047 . . . . 0.0 110.806 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.551 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.9 t -127.95 172.35 10.98 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.52 ' O ' ' OG ' ' A' ' 85' ' ' SER . 67.9 p -147.44 -1.45 0.62 Allowed 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.452 -0.78 . . . . 0.0 110.796 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.634 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -117.27 19.06 14.29 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.728 -1.232 . . . . 0.0 108.287 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.65 63.12 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.358 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.68 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 19.3 m-85 69.65 -13.23 0.41 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.873 -0.517 . . . . 0.0 111.334 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -50.72 -73.98 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.57 -1.331 . . . . 0.0 109.565 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.481 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 33.7 p -98.58 -177.42 3.67 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.67 134.81 7.15 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.968 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.4 m -128.39 139.0 52.6 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.615 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.7 tttp -86.26 140.21 30.32 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.937 -1.102 . . . . 0.0 109.904 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.446 HD11 ' CG2' ' A' ' 96' ' ' ILE . 12.8 pt -113.91 -31.26 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.689 -0.632 . . . . 0.0 109.642 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.63 HH21 ' CG ' ' A' ' 8' ' ' ASP . 66.7 mtt180 . . . . . 0 C--N 1.303 -1.426 0 O-C-N 121.126 -0.984 . . . . 0.0 108.846 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.621 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 20.2 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.399 0.618 . . . . 0.0 109.343 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 tt -170.13 159.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -146.17 30.14 1.05 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.766 -1.209 . . . . 0.0 111.306 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.4 p -104.8 158.14 16.73 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.594 0.712 . . . . 0.0 109.666 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.0 OUTLIER -60.68 -61.33 2.67 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.842 -1.161 . . . . 0.0 110.07 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.637 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.04 -41.48 78.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.213 -0.929 . . . . 0.0 109.659 -179.742 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.14 -44.83 94.62 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.676 HG22 ' HG2' ' A' ' 21' ' ' PRO . 53.3 t -67.31 -41.07 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.421 -1.047 . . . . 0.0 108.746 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.77 -57.86 9.45 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.17 -53.41 27.96 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.512 -0.742 . . . . 0.0 109.619 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.697 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 32.2 t80 -57.48 -50.6 72.52 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.454 0.645 . . . . 0.0 110.683 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tt -71.71 -45.14 62.75 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.3 -0.875 . . . . 0.0 110.886 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -62.12 -22.16 65.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.622 -1.299 . . . . 0.0 110.435 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 m -95.59 -40.93 9.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.077 -1.014 . . . . 0.0 111.021 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -110.28 17.06 21.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.958 -1.089 . . . . 0.0 112.002 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.2 m80 46.17 24.82 0.29 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.025 -1.047 . . . . 0.0 110.372 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.6 pttp -143.22 149.75 38.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.061 -1.024 . . . . 0.0 110.282 -178.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.6 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.6 mp -73.63 150.15 88.72 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.249 -0.907 . . . . 0.0 108.827 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.697 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 50.9 Cg_exo -38.94 153.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.333 2.688 . . . . 0.0 114.092 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.621 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -68.53 50.24 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.197 0.999 . . . . 0.0 110.692 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -171.32 25.77 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 109.928 179.015 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -117.81 116.39 26.89 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.46 -1.4 . . . . 0.0 110.399 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.0 pt -118.99 136.13 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 CA-C-O 122.167 0.984 . . . . 0.0 109.659 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.545 HG22 ' HA3' ' A' ' 53' ' ' GLY . 7.7 p -65.49 166.89 9.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.05 -1.031 . . . . 0.0 111.545 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.616 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 22.5 mtmt -68.48 -36.72 79.35 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.44 -65.17 0.52 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.109 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.9 mt-10 -63.72 -53.86 44.53 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 119.067 -1.053 . . . . 0.0 108.983 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -40.72 -51.56 3.05 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.653 -1.28 . . . . 0.0 108.597 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -57.38 -58.8 6.68 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.965 -1.084 . . . . 0.0 111.502 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.37 -32.23 68.38 Favored 'General case' 0 N--CA 1.51 2.562 0 O-C-N 120.663 -1.273 . . . . 0.0 108.811 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.412 HD21 ' HB ' ' A' ' 45' ' ' VAL . 27.8 tp -61.35 -23.43 65.75 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.49 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.49 50.98 0.36 Allowed Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.562 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -82.99 146.71 28.62 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.152 -1.205 . . . . 0.0 109.343 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.3 t -135.75 123.93 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.472 -0.768 . . . . 0.0 109.388 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -57.25 -52.61 64.63 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.846 -0.534 . . . . 0.0 109.763 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.3 p -69.79 48.7 0.09 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.389 -0.819 . . . . 0.0 109.72 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.645 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.3 ttpm? -178.31 -50.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.63 57.4 17.95 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.645 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -72.5 162.09 29.94 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.747 -0.855 . . . . 0.0 110.56 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.875 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.7 tp -175.62 -66.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.443 -0.785 . . . . 0.0 109.937 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.642 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -61.72 -18.96 61.75 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.77 -1.207 . . . . 0.0 109.988 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 45' ' ' VAL . 4.5 p-10 -79.18 -64.63 1.14 Allowed 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.912 0.863 . . . . 0.0 109.063 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.478 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 31.6 m -74.48 -12.07 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.918 -0.489 . . . . 0.0 110.158 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.4 71.07 13.01 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.47 -0.769 . . . . 0.0 109.412 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.48 123.58 13.91 Favored 'Trans proline' 0 N--CA 1.509 2.395 0 C-N-CA 122.919 2.413 . . . . 0.0 113.991 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.49 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 71.57 41.0 58.45 Favored Glycine 0 N--CA 1.502 3.049 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.5 mmtt -139.07 170.82 15.28 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 122.031 0.919 . . . . 0.0 110.962 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.417 ' HA ' HD21 ' A' ' 42' ' ' LEU . 74.8 m -144.81 160.63 40.96 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.204 1.002 . . . . 0.0 110.554 -177.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.8 mm -84.26 128.22 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.526 -0.734 . . . . 0.0 109.906 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.58 153.68 9.26 Favored Glycine 0 N--CA 1.499 2.88 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.545 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 121.75 -16.56 8.92 Favored Glycine 0 N--CA 1.5 2.925 0 C-N-CA 119.653 -1.26 . . . . 0.0 111.367 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -71.88 -150.64 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.795 -1.415 . . . . 0.0 110.037 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.93 140.7 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.561 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.624 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.3 t80 -106.68 90.1 3.22 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.514 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.3 p -60.0 38.22 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.388 0.613 . . . . 0.0 110.591 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 56' ' ' PHE . 63.8 t30 37.54 34.58 0.05 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.121 -0.987 . . . . 0.0 110.526 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.514 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.6 mtm180 -66.24 44.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.844 -1.16 . . . . 0.0 110.093 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.616 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 20.1 mt-10 -152.05 -26.42 0.18 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.483 -0.761 . . . . 0.0 109.918 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.6 28.08 62.0 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.671 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.0 mttp -110.31 5.11 21.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.527 -0.984 . . . . 0.0 109.102 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -127.98 144.46 51.57 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.792 -0.568 . . . . 0.0 109.673 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.52 124.89 15.02 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 123.048 2.499 . . . . 0.0 112.279 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.527 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -101.18 -173.94 28.8 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 68' ' ' GLY . 12.9 tttt 177.41 145.72 0.11 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.413 -1.051 . . . . 0.0 108.787 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 p -68.13 58.03 0.07 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.05 -1.031 . . . . 0.0 109.236 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 147.36 75.78 0.02 OUTLIER Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.531 ' NH2' ' OD1' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.46 169.92 5.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.684 -0.892 . . . . 0.0 109.225 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.454 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.9 m -145.23 155.39 43.22 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.829 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.721 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 20.3 m95 -126.13 138.78 53.7 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.573 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -129.35 155.8 45.05 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.789 -1.194 . . . . 0.0 109.58 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.616 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -120.28 166.25 13.75 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.255 -0.903 . . . . 0.0 111.551 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.53 134.66 3.34 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.197 -0.939 . . . . 0.0 110.69 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.712 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.91 152.14 16.71 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.359 0.599 . . . . 0.0 111.482 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.724 HD11 ' CG2' ' A' ' 88' ' ' ILE . 39.9 mm -134.9 142.85 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.559 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 57.8 71.69 0.56 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.288 0.566 . . . . 0.0 110.266 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.875 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 63.0 t80 -129.13 159.72 35.12 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.417 -0.802 . . . . 0.0 109.318 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.6 ' OG1' ' N ' ' A' ' 80' ' ' SER . 24.2 p -140.65 -78.33 0.29 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.642 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -150.05 107.58 3.65 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.66 -103.93 0.23 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.484 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 50.7 t80 -141.72 -170.02 3.03 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.638 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.5 mtm180 -70.41 -151.95 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.131 -0.981 . . . . 0.0 109.815 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -172.07 -151.89 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 100' ' ' THR . 43.8 p -98.9 -5.3 31.06 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.69 -1.256 . . . . 0.0 110.43 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -90.07 117.69 29.05 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.186 -0.946 . . . . 0.0 110.52 -178.638 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.856 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.31 149.64 43.03 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.724 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.8 tt -117.74 135.83 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.434 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.0 mm? -112.63 124.86 53.5 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.69 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.7 127.42 53.55 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.709 0.766 . . . . 0.0 109.205 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.721 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.1 p -94.35 158.95 15.33 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.173 0.987 . . . . 0.0 112.522 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.1 p -69.75 -19.08 63.54 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.531 ' OD1' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -83.24 10.46 8.4 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.762 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.443 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.46 29.97 0.52 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.634 -0.666 . . . . 0.0 110.025 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.41 HD12 HH21 ' A' ' 69' ' ' ARG . 23.4 mt -101.96 136.52 41.66 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.319 -0.863 . . . . 0.0 109.807 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.459 HG22 HD11 ' A' ' 109' ' ' ILE . 32.9 mm -110.38 119.92 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.576 -0.703 . . . . 0.0 110.251 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.429 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.3 m-85 -120.68 142.64 49.29 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.458 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 8.7 tptp -130.96 147.02 52.55 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.776 0.798 . . . . 0.0 111.005 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.573 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.4 t -127.51 171.53 11.52 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.442 ' O ' ' OG ' ' A' ' 85' ' ' SER . 74.6 p -146.85 -1.72 0.66 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.386 -0.821 . . . . 0.0 110.328 178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.627 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -116.68 18.75 14.83 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.806 -1.184 . . . . 0.0 108.353 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.53 63.27 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.449 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.671 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 19.9 m-85 69.99 -14.12 0.39 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.774 -0.579 . . . . 0.0 111.614 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -51.39 -73.33 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.754 -1.216 . . . . 0.0 109.578 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.504 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 33.2 p -98.65 -178.08 3.87 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.434 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -160.85 133.53 6.25 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.935 -1.103 . . . . 0.0 109.847 -179.245 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.7 m -127.87 140.05 52.25 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.615 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 16.3 tttp -86.01 139.71 30.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.123 -0.985 . . . . 0.0 109.971 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.459 HD11 HG22 ' A' ' 96' ' ' ILE . 12.0 pt -113.38 -32.43 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.637 HH21 ' CG ' ' A' ' 8' ' ' ASP . 62.2 mtt180 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.103 -0.998 . . . . 0.0 109.198 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.629 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 36.0 t . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 4' ' ' ILE . 1.6 tt -171.52 158.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.0 p30 -146.08 29.97 1.07 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.472 -1.392 . . . . 0.0 111.241 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 10' ' ' VAL . 24.9 p -105.69 155.94 18.77 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.2 p90 -58.66 -63.79 1.16 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.961 -1.087 . . . . 0.0 110.463 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.614 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -53.81 -43.46 69.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.516 -0.74 . . . . 0.0 109.449 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.39 -44.72 89.86 Favored Glycine 0 N--CA 1.5 2.965 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.682 HG22 ' HG2' ' A' ' 21' ' ' PRO . 63.2 t -67.3 -41.32 86.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 121.51 -0.994 . . . . 0.0 108.786 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.36 -58.84 6.19 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.82 -55.0 12.87 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.371 -0.83 . . . . 0.0 109.663 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.646 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 35.0 t80 -56.26 -50.76 70.43 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.284 0.564 . . . . 0.0 110.627 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.3 tt -72.26 -44.37 62.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.406 -0.809 . . . . 0.0 111.282 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -62.76 -21.31 65.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.605 -1.309 . . . . 0.0 110.08 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.0 m -95.9 -40.5 9.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.927 -1.108 . . . . 0.0 111.283 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -111.14 17.26 20.52 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.055 -1.028 . . . . 0.0 111.987 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.0 m80 45.78 25.01 0.25 Allowed 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.845 -1.159 . . . . 0.0 110.271 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.4 pttp -141.88 152.51 43.67 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.075 -1.016 . . . . 0.0 110.898 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.543 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.3 mp -76.78 148.73 79.72 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.224 -0.922 . . . . 0.0 109.303 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HG2' HG22 ' A' ' 10' ' ' VAL . 73.7 Cg_exo -38.23 152.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 122.904 2.403 . . . . 0.0 114.428 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -66.06 48.52 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 122.122 0.963 . . . . 0.0 110.094 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.7 OUTLIER -169.23 24.16 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.671 -1.268 . . . . 0.0 110.126 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -117.39 116.25 26.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.968 -1.082 . . . . 0.0 110.86 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.4 pt -118.03 141.01 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.833 0.825 . . . . 0.0 109.312 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.626 HG22 ' HA3' ' A' ' 53' ' ' GLY . 6.2 p -70.98 166.29 21.61 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.967 -1.083 . . . . 0.0 111.479 -177.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.629 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 20.2 mtmt -67.19 -36.39 81.64 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.78 -65.08 0.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.6 177.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.46 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.2 mt-10 -63.34 -52.47 61.66 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.025 -1.07 . . . . 0.0 108.342 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -41.69 -49.78 4.22 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.174 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 37.8 mt-30 -60.81 -55.72 29.69 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.36 -0.837 . . . . 0.0 111.755 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.49 -31.8 70.82 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.669 -1.269 . . . . 0.0 109.276 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 20.2 tp -60.83 -31.36 70.78 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.96 52.09 0.15 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.677 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -83.77 146.39 28.18 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.083 -1.245 . . . . 0.0 109.888 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -137.56 125.86 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.274 -0.891 . . . . 0.0 109.373 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -57.27 -53.28 59.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.924 -0.485 . . . . 0.0 110.501 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.7 p -69.08 48.75 0.07 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.979 -1.076 . . . . 0.0 109.716 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.648 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -178.81 -49.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.52 55.37 29.25 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.677 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -70.8 160.17 33.22 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 121.64 -0.918 . . . . 0.0 110.458 -179.063 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.813 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 58.9 tp -174.98 -67.29 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.497 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.653 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -58.52 -20.19 43.94 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.339 -0.851 . . . . 0.0 110.093 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.8 p-10 -79.63 -65.39 1.01 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.678 0.752 . . . . 0.0 109.874 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.457 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 28.9 m -75.98 -6.82 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.799 -0.563 . . . . 0.0 110.708 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.0 69.03 9.04 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -57.69 122.32 11.55 Favored 'Trans proline' 0 N--CA 1.508 2.324 0 C-N-CA 123.595 2.863 . . . . 0.0 113.853 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.95 38.99 55.61 Favored Glycine 0 N--CA 1.501 3.016 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 8.7 mmtm -138.38 178.16 7.34 Favored 'General case' 0 N--CA 1.51 2.546 0 CA-C-O 122.248 1.023 . . . . 0.0 111.455 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.419 ' HG ' ' HD2' ' A' ' 78' ' ' TYR . 63.9 m -150.53 161.0 43.38 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.857 -1.152 . . . . 0.0 111.417 -177.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.8 mm -83.37 126.17 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.092 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.72 152.97 8.74 Favored Glycine 0 N--CA 1.499 2.842 0 C-N-CA 119.981 -1.104 . . . . 0.0 110.38 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.626 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 122.43 -17.35 8.42 Favored Glycine 0 N--CA 1.498 2.778 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.052 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -69.95 -153.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.633 -1.51 . . . . 0.0 109.752 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.95 138.42 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.43 -0.794 . . . . 0.0 110.399 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.641 ' O ' ' N ' ' A' ' 58' ' ' ASN . 10.0 t80 -104.36 89.77 3.34 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.546 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -59.5 39.17 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.529 -0.732 . . . . 0.0 110.682 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.641 ' N ' ' O ' ' A' ' 56' ' ' PHE . 59.5 t30 36.83 34.88 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.069 -1.02 . . . . 0.0 110.483 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.546 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.2 mtm180 -66.71 45.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.822 -1.174 . . . . 0.0 109.602 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.61 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 18.9 mt-10 -151.74 -26.84 0.19 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.467 -0.771 . . . . 0.0 110.028 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.27 27.9 61.0 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.669 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.7 mttp -110.69 5.7 21.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.66 -0.906 . . . . 0.0 109.468 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.93 143.6 49.31 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.8 124.42 14.04 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.637 2.224 . . . . 0.0 112.239 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.519 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -99.81 -173.82 30.62 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 68' ' ' GLY . 11.1 tttt 177.92 146.27 0.13 Allowed 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.456 -1.026 . . . . 0.0 108.834 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.4 p -68.01 58.18 0.07 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.975 -1.078 . . . . 0.0 109.031 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 146.86 76.69 0.02 OUTLIER Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.542 ' NH2' ' OD1' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -173.35 168.89 4.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.597 -0.943 . . . . 0.0 109.161 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.454 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.3 m -145.65 155.2 42.85 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.834 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.726 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 21.5 m95 -125.39 138.8 54.04 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.558 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -129.72 156.06 44.9 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.798 -1.189 . . . . 0.0 109.517 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.629 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -120.03 167.54 12.07 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.3 -0.875 . . . . 0.0 112.136 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.46 135.59 3.62 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.237 -0.915 . . . . 0.0 111.153 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.692 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.93 154.7 11.88 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.743 -0.598 . . . . 0.0 111.546 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.706 HD11 ' CG2' ' A' ' 88' ' ' ILE . 45.2 mm -136.87 143.5 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.518 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 57.62 70.01 0.69 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.192 0.52 . . . . 0.0 110.589 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.813 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 59.5 t80 -128.37 161.33 29.68 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.02 -1.05 . . . . 0.0 109.331 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.608 ' OG1' ' N ' ' A' ' 80' ' ' SER . 26.9 p -141.43 -76.69 0.29 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.653 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -150.47 110.33 4.09 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.73 -103.67 0.24 Allowed Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 45.4 t80 -142.46 -169.96 3.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.89 -0.77 . . . . 0.0 109.156 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.657 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.2 mtm180 -71.47 -158.09 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.24 -0.912 . . . . 0.0 109.159 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -166.33 -150.9 0.12 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.505 ' OG ' ' O ' ' A' ' 100' ' ' THR . 53.8 p -99.0 -6.38 28.67 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.404 -1.435 . . . . 0.0 110.391 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.47 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -89.11 118.02 28.52 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.099 -1.001 . . . . 0.0 110.992 -178.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.857 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.03 149.97 42.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 0.0 109.685 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.706 ' CG2' HD11 ' A' ' 76' ' ' ILE . 5.2 tt -118.15 137.42 52.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 72' ' ' ARG . 1.9 mm? -113.85 124.88 53.29 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.63 127.67 53.81 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.724 0.773 . . . . 0.0 109.213 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.726 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.0 p -94.13 158.37 15.64 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 122.449 1.119 . . . . 0.0 112.382 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.8 p -68.93 -20.3 64.21 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.542 ' OD1' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -83.1 11.04 6.87 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.062 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.448 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.62 29.63 0.52 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.601 -0.687 . . . . 0.0 110.42 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.407 HD12 HH21 ' A' ' 69' ' ' ARG . 23.1 mt -102.78 136.86 41.83 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.501 HG22 HD11 ' A' ' 109' ' ' ILE . 31.7 mm -110.84 119.7 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.523 -0.736 . . . . 0.0 110.104 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.455 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.2 m-85 -119.88 142.81 48.34 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.47 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 8.2 tptp -130.7 147.29 52.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.847 -1.158 . . . . 0.0 110.691 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.493 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.5 t -128.46 171.43 12.08 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.505 ' O ' ' OG ' ' A' ' 85' ' ' SER . 76.5 p -146.51 -3.63 0.62 Allowed 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.491 -0.756 . . . . 0.0 110.459 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.639 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -114.36 19.52 16.19 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.792 -1.192 . . . . 0.0 108.455 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.11 62.41 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.15 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.669 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 21.6 m-85 70.36 -14.57 0.39 Allowed 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.826 -0.546 . . . . 0.0 111.66 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -49.98 -72.88 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.661 -1.275 . . . . 0.0 109.886 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.502 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 42.0 p -100.42 -178.31 3.77 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.65 135.19 8.39 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.045 -1.034 . . . . 0.0 110.332 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.1 m -128.13 139.14 52.66 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.601 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.8 tttp -86.02 139.15 31.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.835 -1.166 . . . . 0.0 110.003 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.501 HD11 HG22 ' A' ' 96' ' ' ILE . 10.8 pt -111.96 -32.91 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.63 -0.669 . . . . 0.0 109.791 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.614 HH21 ' CG ' ' A' ' 8' ' ' ASP . 69.0 mtt180 . . . . . 0 N--CA 1.487 1.412 0 O-C-N 121.281 -0.887 . . . . 0.0 108.678 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.633 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.8 t . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 tt -171.15 158.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -145.4 29.67 1.15 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.411 -1.431 . . . . 0.0 111.466 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.7 p -103.67 157.15 17.26 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.436 -0.79 . . . . 0.0 109.762 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.4 p90 -59.87 -63.13 1.41 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.211 -0.93 . . . . 0.0 109.897 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.586 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.8 OUTLIER -56.01 -42.25 76.15 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.165 -0.959 . . . . 0.0 109.679 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.4 -44.98 85.07 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.772 HG22 ' HG2' ' A' ' 21' ' ' PRO . 53.3 t -67.93 -42.51 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.24 -58.6 7.65 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.9 -53.13 27.92 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.766 -1.209 . . . . 0.0 110.103 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.672 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 36.6 t80 -57.24 -48.61 78.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.669 -0.644 . . . . 0.0 110.418 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -73.91 -43.89 56.94 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.493 -0.755 . . . . 0.0 110.974 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -63.7 -20.04 65.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.443 -1.411 . . . . 0.0 109.981 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 m -98.12 -40.29 8.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.697 -1.252 . . . . 0.0 110.544 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -109.66 14.62 23.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 112.022 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.8 m80 46.77 24.98 0.39 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.668 -1.27 . . . . 0.0 110.41 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -143.57 149.82 37.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.177 -0.952 . . . . 0.0 110.828 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.587 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.5 mp -72.72 149.48 90.52 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 120.98 -1.075 . . . . 0.0 109.565 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.772 ' HG2' HG22 ' A' ' 10' ' ' VAL . 51.3 Cg_exo -40.36 150.8 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 123.189 2.592 . . . . 0.0 113.716 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.633 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -63.95 48.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.541 0.686 . . . . 0.0 110.489 -179.205 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -171.43 28.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.02 -1.05 . . . . 0.0 110.67 179.103 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -119.11 115.08 23.53 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.191 -0.943 . . . . 0.0 110.719 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.5 pt -117.38 140.32 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.53 HG22 ' HA3' ' A' ' 53' ' ' GLY . 11.5 p -70.82 167.26 19.28 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.054 0.93 . . . . 0.0 111.75 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.568 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 23.6 mtmt -68.49 -37.32 80.01 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.406 ' HG ' ' CB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -40.43 -67.83 0.21 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 113.873 -1.512 . . . . 0.0 108.217 177.187 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.515 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.0 mt-10 -63.57 -54.43 36.14 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.233 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.515 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -39.18 -51.84 1.94 Allowed 'General case' 0 CA--C 1.566 1.569 0 O-C-N 120.318 -1.489 . . . . 0.0 109.033 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.439 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 41.2 mt-30 -58.93 -57.69 11.93 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.661 -0.649 . . . . 0.0 111.219 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.15 -32.84 71.41 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.819 -1.175 . . . . 0.0 110.006 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.1 tp -59.45 -27.78 66.38 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.96 52.5 0.21 Allowed Glycine 0 N--CA 1.502 3.09 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.605 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -85.04 146.2 27.3 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.549 -0.971 . . . . 0.0 111.007 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.6 t -137.14 124.59 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 O-C-N 121.394 -0.816 . . . . 0.0 109.79 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -57.27 -50.87 71.52 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 122.037 -0.414 . . . . 0.0 110.369 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.3 p -70.06 49.06 0.1 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.3 -0.875 . . . . 0.0 109.443 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.646 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -179.13 -52.97 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.69 57.05 13.5 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.646 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -71.79 162.29 29.68 Favored 'General case' 0 C--N 1.289 -2.058 0 O-C-N 121.728 -0.866 . . . . 0.0 111.067 -178.723 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.819 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 64.6 tp -174.44 -67.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.772 -1.205 . . . . 0.0 109.995 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -61.33 -18.96 61.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.509 -0.744 . . . . 0.0 109.827 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 3.9 p-10 -80.22 -62.1 1.78 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.091 0.948 . . . . 0.0 108.742 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 45' ' ' VAL . 16.3 m -75.65 -11.35 14.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.663 -1.273 . . . . 0.0 109.293 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.78 72.6 10.5 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 120.996 -1.065 . . . . 0.0 109.855 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.61 125.76 19.29 Favored 'Trans proline' 0 N--CA 1.509 2.415 0 C-N-CA 123.051 2.5 . . . . 0.0 114.323 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.571 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 72.74 40.15 53.67 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.571 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.8 mmtm -141.41 170.8 15.04 Favored 'General case' 0 N--CA 1.508 2.426 0 CA-C-O 121.674 0.749 . . . . 0.0 111.567 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.478 ' HG ' ' HD2' ' A' ' 78' ' ' TYR . 72.5 m -144.32 162.58 36.07 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 122.794 1.283 . . . . 0.0 110.935 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.6 mm -83.81 126.26 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.923 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 172.85 153.05 9.11 Favored Glycine 0 N--CA 1.501 3.021 0 O-C-N 120.575 -1.328 . . . . 0.0 109.98 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.53 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 120.38 -15.39 9.98 Favored Glycine 0 N--CA 1.499 2.866 0 O-C-N 121.145 -1.209 . . . . 0.0 111.166 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 1.6 m-20 -70.49 -154.9 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.547 -1.56 . . . . 0.0 109.473 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.0 mp -129.29 135.74 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 122.055 0.931 . . . . 0.0 110.169 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.633 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.7 t80 -101.8 89.16 3.58 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.67 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 2.2 p -59.3 40.25 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 121.306 0.574 . . . . 0.0 110.766 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.633 ' N ' ' O ' ' A' ' 56' ' ' PHE . 61.5 t30 34.13 37.12 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.372 -0.83 . . . . 0.0 110.4 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.67 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.1 mtm180 -68.02 40.1 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -0.951 . . . . 0.0 109.929 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.603 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 21.6 mt-10 -148.98 -19.38 0.3 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.024 -1.047 . . . . 0.0 110.44 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.45 31.45 68.35 Favored Glycine 0 N--CA 1.499 2.871 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.684 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.7 mttp -114.3 8.28 16.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.575 -0.956 . . . . 0.0 108.932 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mt -131.96 143.99 51.33 Favored Pre-proline 0 N--CA 1.491 1.583 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -63.37 124.3 13.57 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.681 2.254 . . . . 0.0 112.005 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.532 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -100.39 -172.04 29.56 Favored Glycine 0 N--CA 1.499 2.851 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 68' ' ' GLY . 10.3 tttt 177.03 146.55 0.1 Allowed 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.678 -0.895 . . . . 0.0 108.938 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.8 p -68.19 58.32 0.08 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.91 -1.119 . . . . 0.0 109.281 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 145.52 76.66 0.03 OUTLIER Glycine 0 N--CA 1.5 2.946 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.536 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.09 165.8 6.15 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.657 -0.908 . . . . 0.0 109.239 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.0 m -142.18 154.01 44.49 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.378 -0.826 . . . . 0.0 109.69 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.705 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 19.2 m95 -125.42 139.3 53.77 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.537 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -129.97 155.28 46.35 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.295 -0.878 . . . . 0.0 109.918 179.612 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.568 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -119.2 166.52 12.86 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.227 -0.921 . . . . 0.0 111.295 -179.144 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.85 134.8 3.19 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.182 -0.949 . . . . 0.0 110.955 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.703 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -57.04 152.43 13.21 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.457 0.646 . . . . 0.0 111.548 -179.338 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 75' ' ' ASP . 42.0 mm -135.53 142.58 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.08 -1.013 . . . . 0.0 110.084 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 58.62 71.24 0.59 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.403 0.621 . . . . 0.0 110.517 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.819 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 65.1 t80 -129.59 159.3 36.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.354 -0.841 . . . . 0.0 109.382 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 80' ' ' SER . 29.4 p -139.87 -78.94 0.31 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.642 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -149.86 106.65 3.54 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.84 -102.78 0.21 Allowed Glycine 0 N--CA 1.5 2.926 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.482 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 52.4 t80 -142.38 -168.0 2.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.86 -0.788 . . . . 0.0 108.977 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.652 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.8 mtm180 -73.09 -152.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.823 -1.173 . . . . 0.0 109.807 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -170.48 -150.61 0.07 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 100' ' ' THR . 40.6 p -100.75 -5.77 25.91 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.754 -1.216 . . . . 0.0 110.345 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.5 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -90.44 118.81 30.21 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.906 -1.121 . . . . 0.0 110.272 -178.706 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.865 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.52 150.42 42.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.187 -0.946 . . . . 0.0 109.346 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.662 ' CG2' HD11 ' A' ' 76' ' ' ILE . 3.6 tt -117.29 138.83 46.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.462 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.2 mm? -114.84 123.51 49.37 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.664 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -116.71 126.87 53.8 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.561 0.696 . . . . 0.0 109.357 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.705 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 3.1 p -93.07 158.94 15.52 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.163 0.983 . . . . 0.0 111.929 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.9 p -70.03 -20.33 63.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.446 -0.784 . . . . 0.0 108.913 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.536 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.47 10.2 6.19 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.468 -0.77 . . . . 0.0 109.867 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.475 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.76 30.07 0.48 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.654 -0.654 . . . . 0.0 110.148 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.4 HD12 HH21 ' A' ' 69' ' ' ARG . 26.5 mt -102.45 137.48 40.63 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.313 -0.867 . . . . 0.0 110.121 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.48 HG22 HD11 ' A' ' 109' ' ' ILE . 30.8 mm -110.75 119.14 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.28 -0.888 . . . . 0.0 110.951 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.448 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.5 m-85 -119.82 143.44 47.87 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.5 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 7.3 tptp -132.47 148.03 52.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.185 -0.947 . . . . 0.0 110.816 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.529 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.2 t -127.61 171.85 11.28 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.459 ' O ' ' OG ' ' A' ' 85' ' ' SER . 73.5 p -146.74 -1.82 0.67 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.274 -0.891 . . . . 0.0 110.358 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.631 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -117.36 19.31 14.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.823 -1.173 . . . . 0.0 108.681 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.94 61.63 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.237 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.684 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 19.6 m-85 70.01 -13.8 0.41 Allowed 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.711 -0.618 . . . . 0.0 111.529 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -49.83 -72.97 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.734 -1.228 . . . . 0.0 109.437 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.485 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 34.5 p -99.5 -176.18 3.21 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.462 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -161.8 135.07 6.28 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.174 -0.953 . . . . 0.0 109.666 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 55.0 m -128.33 140.7 51.72 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.615 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.4 tttp -87.25 139.91 30.08 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.7 -1.25 . . . . 0.0 110.306 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.48 HD11 HG22 ' A' ' 96' ' ' ILE . 13.6 pt -113.22 -32.72 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.485 -0.76 . . . . 0.0 109.75 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.615 ' O ' ' NZ ' ' A' ' 108' ' ' LYS . 60.5 mtt180 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 118.292 -0.861 . . . . 0.0 109.528 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.626 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.0 t . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 4' ' ' ILE . 1.7 tt -170.8 159.87 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -144.46 27.74 1.37 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.793 -1.192 . . . . 0.0 111.501 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 10' ' ' VAL . 18.0 p -105.54 158.03 16.97 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.859 0.837 . . . . 0.0 110.761 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.7 p90 -60.02 -61.16 2.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.595 -1.316 . . . . 0.0 110.997 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.651 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.81 -39.83 78.51 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.0 -1.062 . . . . 0.0 110.102 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.44 -44.25 96.81 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.667 HG22 ' HG2' ' A' ' 21' ' ' PRO . 54.5 t -67.66 -41.73 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.313 -1.11 . . . . 0.0 108.535 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.33 -58.94 5.86 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.98 -54.21 16.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.421 -0.8 . . . . 0.0 109.861 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.689 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 35.4 t80 -57.35 -49.62 75.55 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.569 -0.707 . . . . 0.0 110.737 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.89 -45.14 62.32 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.125 -0.985 . . . . 0.0 110.631 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -62.71 -20.11 64.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.23 -1.544 . . . . 0.0 110.615 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.0 m -98.07 -39.33 8.97 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.954 -1.091 . . . . 0.0 110.977 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -111.34 15.79 21.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.796 -1.19 . . . . 0.0 111.967 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.8 m80 46.75 23.74 0.28 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.109 -0.994 . . . . 0.0 110.867 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.2 pttp -141.16 150.81 43.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 109.792 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.568 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.7 mp -73.87 150.13 88.17 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.803 -1.186 . . . . 0.0 108.901 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.689 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 51.3 Cg_exo -38.07 150.66 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 124.016 3.144 . . . . 0.0 113.701 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.626 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -65.77 46.73 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.747 0.784 . . . . 0.0 111.405 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.7 OUTLIER -169.82 26.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 109.818 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -117.9 119.72 35.69 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.836 -1.165 . . . . 0.0 110.622 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.1 pt -121.12 139.52 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.818 0.818 . . . . 0.0 109.194 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.696 HG22 ' HA3' ' A' ' 53' ' ' GLY . 6.1 p -69.78 167.63 16.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.893 -1.129 . . . . 0.0 111.094 -177.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.554 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 19.1 mtmt -68.22 -33.04 73.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.12 -63.65 0.93 Allowed 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.493 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.7 mt-10 -66.44 -51.58 55.37 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -41.35 -51.41 3.68 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.662 -1.215 . . . . 0.0 108.686 177.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.415 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 39.3 mt-30 -60.14 -56.38 22.26 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.399 -0.813 . . . . 0.0 111.201 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.13 -27.85 68.68 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.263 -1.523 . . . . 0.0 109.147 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.1 tp -64.74 -23.35 67.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.706 -0.621 . . . . 0.0 110.233 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.4 51.78 0.28 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -84.43 144.18 28.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.29 -1.123 . . . . 0.0 109.853 179.393 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.2 t -136.14 125.18 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.226 -0.921 . . . . 0.0 109.627 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.5 -51.46 68.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.967 -0.458 . . . . 0.0 110.547 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.7 p -71.55 48.32 0.14 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.96 -1.088 . . . . 0.0 109.777 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.637 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.4 ttpm? -177.44 -49.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.76 54.79 31.08 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.637 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -71.21 160.27 33.14 Favored 'General case' 0 C--N 1.29 -2.021 0 O-C-N 121.479 -1.012 . . . . 0.0 110.311 -178.448 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.84 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 64.9 tp -174.94 -67.26 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.581 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.635 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -58.49 -21.29 51.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.817 -1.177 . . . . 0.0 109.467 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 3.2 p-10 -77.86 -63.42 1.39 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.684 0.754 . . . . 0.0 109.441 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.402 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 22.5 m -76.21 -8.78 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.724 -0.61 . . . . 0.0 109.734 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.13 68.79 8.87 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.148 -0.97 . . . . 0.0 109.292 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -57.26 124.51 16.34 Favored 'Trans proline' 0 N--CA 1.506 2.259 0 C-N-CA 123.306 2.67 . . . . 0.0 113.511 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.538 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 69.86 41.05 74.15 Favored Glycine 0 N--CA 1.501 3.033 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.4 mmtm -139.56 175.85 9.22 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.647 -0.914 . . . . 0.0 110.533 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.1 m -148.74 160.62 43.01 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.493 1.139 . . . . 0.0 110.957 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.0 mm -82.02 127.15 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.786 0.803 . . . . 0.0 110.493 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.33 153.55 9.08 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.696 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 122.31 -17.48 8.47 Favored Glycine 0 N--CA 1.507 3.433 0 O-C-N 121.57 -0.959 . . . . 0.0 110.799 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 1.2 m-20 -69.71 -156.21 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.629 -1.512 . . . . 0.0 109.619 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.83 140.72 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-O 121.604 0.716 . . . . 0.0 110.435 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.668 ' O ' ' N ' ' A' ' 58' ' ' ASN . 9.2 t80 -107.03 88.54 2.76 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.687 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -58.03 38.72 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.826 -0.546 . . . . 0.0 110.675 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.668 ' N ' ' O ' ' A' ' 56' ' ' PHE . 59.9 t30 35.76 38.75 0.06 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.074 -1.016 . . . . 0.0 110.001 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.687 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.2 mtm180 -69.61 41.79 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.745 -1.222 . . . . 0.0 109.832 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.611 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 17.5 mt-10 -148.0 -24.56 0.35 Allowed 'General case' 0 N--CA 1.485 1.285 0 O-C-N 120.698 -1.251 . . . . 0.0 109.717 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.3 27.66 61.37 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.68 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.8 mttp -111.84 7.51 20.15 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.921 -0.752 . . . . 0.0 109.637 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -129.61 143.79 50.36 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.83 123.54 12.48 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 122.613 2.209 . . . . 0.0 112.886 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.527 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -97.94 -174.17 33.3 Favored Glycine 0 N--CA 1.506 3.341 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.549 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 11.1 tttt 177.62 145.82 0.12 Allowed 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.447 -1.031 . . . . 0.0 108.707 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.0 p -68.71 58.85 0.09 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.888 -1.133 . . . . 0.0 108.767 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.549 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 146.67 74.39 0.02 OUTLIER Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.538 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -171.82 167.86 6.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.509 -0.995 . . . . 0.0 109.193 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.455 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 93.0 m -144.06 155.6 44.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 110.331 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.74 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 20.7 m95 -125.41 137.59 54.01 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.588 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -127.57 156.28 42.5 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.869 -1.144 . . . . 0.0 109.054 179.515 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.554 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -121.18 166.86 13.36 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.089 -1.007 . . . . 0.0 111.306 -179.613 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.52 134.71 3.36 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.313 -0.867 . . . . 0.0 110.979 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.66 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -56.23 152.23 11.27 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.611 0.719 . . . . 0.0 111.449 179.416 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.717 HD11 ' CG2' ' A' ' 88' ' ' ILE . 38.3 mm -135.5 143.58 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.563 -0.711 . . . . 0.0 110.106 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 58.41 69.47 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.365 0.603 . . . . 0.0 110.497 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.84 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 69.4 t80 -128.24 160.16 32.97 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.244 -0.91 . . . . 0.0 109.631 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.617 ' OG1' ' N ' ' A' ' 80' ' ' SER . 25.1 p -142.23 -78.5 0.25 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.635 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -148.67 107.95 3.93 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.85 -102.06 0.2 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 51.4 t80 -143.0 -168.52 2.81 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.635 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.4 mtm180 -72.99 -150.61 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.688 -1.257 . . . . 0.0 109.314 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.596 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 10.4 p30 -171.52 -151.28 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.6 p -99.83 -7.23 25.65 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.673 -1.267 . . . . 0.0 110.201 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.472 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -88.51 118.78 28.39 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.132 -0.98 . . . . 0.0 110.276 -178.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.859 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.77 150.32 43.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.429 -0.795 . . . . 0.0 110.014 179.038 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.717 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.0 tt -117.02 136.76 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 108.983 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.406 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.9 mm? -112.89 124.7 53.2 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.679 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.36 126.72 52.68 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.11 0.957 . . . . 0.0 109.494 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.74 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.7 p -94.39 158.34 15.61 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 122.292 1.044 . . . . 0.0 112.085 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.5 p -68.53 -21.17 64.58 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.538 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.61 10.77 5.45 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.196 -0.94 . . . . 0.0 110.144 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.435 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 76.97 31.12 0.53 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.927 -0.483 . . . . 0.0 110.051 179.513 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.409 HD12 HH21 ' A' ' 69' ' ' ARG . 26.8 mt -103.48 136.26 43.54 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.279 -0.888 . . . . 0.0 109.816 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.458 HG22 HD11 ' A' ' 109' ' ' ILE . 34.1 mm -110.37 120.02 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.248 -0.907 . . . . 0.0 110.204 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.448 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.3 m-85 -120.17 143.47 48.21 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.472 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 7.7 tptp -131.74 147.41 52.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 110.967 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.558 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.2 t -127.79 169.9 13.36 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.1 p -144.79 -2.99 0.8 Allowed 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.663 -0.648 . . . . 0.0 110.22 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.631 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -115.37 18.79 15.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.596 -1.315 . . . . 0.0 108.566 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.9 63.55 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.167 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.68 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 18.0 m-85 69.09 -13.64 0.34 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.899 -0.501 . . . . 0.0 111.736 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -51.46 -73.5 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.384 -1.448 . . . . 0.0 109.8 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.509 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 36.3 p -99.03 -178.48 3.95 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.32 134.24 7.15 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.845 -1.159 . . . . 0.0 110.0 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 78.3 m -127.38 140.66 52.03 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.628 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.8 tttp -86.22 139.33 31.14 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.063 -1.023 . . . . 0.0 109.928 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.458 HD11 HG22 ' A' ' 96' ' ' ILE . 13.2 pt -112.43 -31.66 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.695 -0.628 . . . . 0.0 109.728 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.651 HH21 ' CG ' ' A' ' 8' ' ' ASP . 61.8 mtt180 . . . . . 0 C--N 1.306 -1.298 0 O-C-N 120.962 -1.086 . . . . 0.0 108.756 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.638 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 24.1 t . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 tt -171.06 160.84 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -145.98 29.52 1.09 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.473 -1.392 . . . . 0.0 111.465 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 10' ' ' VAL . 22.0 p -106.18 156.84 18.04 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.785 0.802 . . . . 0.0 110.05 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.504 ' HA ' HD12 ' A' ' 88' ' ' ILE . 1.7 p90 -59.91 -62.45 1.86 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.899 -1.126 . . . . 0.0 110.745 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.653 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -55.74 -42.7 75.78 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.35 -0.844 . . . . 0.0 109.565 179.49 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.0 -44.75 87.96 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.678 HG22 ' HG2' ' A' ' 21' ' ' PRO . 75.0 t -68.22 -41.05 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 O-C-N 121.58 -0.953 . . . . 0.0 108.771 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.2 -58.29 8.32 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.26 -54.3 17.49 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.402 -0.811 . . . . 0.0 110.087 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.655 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 38.8 t80 -57.32 -50.1 74.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.911 -0.493 . . . . 0.0 110.429 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.85 -43.48 65.42 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.537 -0.727 . . . . 0.0 111.189 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -63.54 -20.1 65.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.31 -1.494 . . . . 0.0 110.314 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.5 m -97.28 -39.9 9.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.048 -1.032 . . . . 0.0 111.219 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.9 16.47 20.35 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.213 -0.93 . . . . 0.0 111.953 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.5 m80 46.82 24.38 0.34 Allowed 'General case' 0 N--CA 1.511 2.606 0 O-C-N 120.414 -1.429 . . . . 0.0 110.599 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 pttp -142.5 152.57 42.82 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.041 -1.037 . . . . 0.0 110.999 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.519 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.4 mp -75.45 148.53 83.29 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.313 -0.867 . . . . 0.0 109.442 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.678 ' HG2' HG22 ' A' ' 10' ' ' VAL . 54.0 Cg_exo -38.74 150.0 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.623 2.882 . . . . 0.0 113.58 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -63.64 46.62 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.572 0.701 . . . . 0.0 110.883 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -169.6 27.22 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.108 -0.995 . . . . 0.0 110.342 179.496 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -117.56 116.41 27.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.004 -1.06 . . . . 0.0 110.616 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 31.0 pt -119.11 139.36 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.313 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.581 HG22 ' HA3' ' A' ' 53' ' ' GLY . 5.1 p -70.33 166.35 20.41 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.056 -1.028 . . . . 0.0 111.206 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.604 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 20.5 mtmt -67.19 -37.41 83.64 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -40.91 -67.08 0.27 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.482 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.9 mt-10 -62.49 -54.46 39.61 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.297 -0.961 . . . . 0.0 108.994 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -39.18 -51.41 1.94 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.699 -1.251 . . . . 0.0 109.136 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.39 -57.63 12.16 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.549 -0.719 . . . . 0.0 111.019 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.9 -30.35 70.12 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 120.545 -1.347 . . . . 0.0 109.13 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.8 tp -61.51 -25.66 67.41 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.672 -0.642 . . . . 0.0 109.517 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.27 49.56 0.27 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.574 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -82.53 144.77 30.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -1.162 . . . . 0.0 109.72 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.0 t -136.73 125.21 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.34 -0.85 . . . . 0.0 109.392 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -57.19 -53.08 62.18 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.2 p -68.07 48.84 0.06 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.061 -1.025 . . . . 0.0 110.211 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.631 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -179.71 -51.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.91 58.15 11.83 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.631 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -72.85 161.98 30.05 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.714 -0.874 . . . . 0.0 110.782 -178.421 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.822 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.5 tp -174.85 -68.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.372 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -61.72 -18.65 60.52 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.721 -1.237 . . . . 0.0 109.793 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.9 p-10 -79.56 -60.86 2.19 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.842 0.829 . . . . 0.0 109.285 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.6 m -75.53 -13.24 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.85 -0.531 . . . . 0.0 109.983 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.57 72.62 9.83 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.46 -0.775 . . . . 0.0 110.011 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.29 124.72 16.83 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.809 2.34 . . . . 0.0 114.407 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.06 39.66 58.1 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 8.3 mmtt -138.65 172.69 12.51 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 122.195 0.998 . . . . 0.0 110.717 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.1 m -146.46 163.05 36.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.631 -1.293 . . . . 0.0 111.273 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.2 mm -83.8 130.02 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.452 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 167.81 154.35 8.62 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.581 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 118.67 -15.03 11.54 Favored Glycine 0 N--CA 1.501 3.031 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.269 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.488 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -72.93 -154.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.63 -1.512 . . . . 0.0 108.585 178.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -126.27 141.85 44.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.34 -0.85 . . . . 0.0 110.732 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.598 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.9 t80 -106.59 90.84 3.46 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.585 0.707 . . . . 0.0 109.106 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.508 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.5 p -61.34 38.94 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.579 0.704 . . . . 0.0 110.741 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.598 ' N ' ' O ' ' A' ' 56' ' ' PHE . 56.9 t30 36.33 35.73 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.131 -0.981 . . . . 0.0 110.505 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.508 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.5 mtm180 -67.17 43.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.915 -1.116 . . . . 0.0 109.872 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.61 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 18.2 mt-10 -150.58 -25.43 0.23 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.468 -0.77 . . . . 0.0 109.943 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.86 27.77 62.06 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.679 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.0 mttp -110.77 6.8 21.74 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.747 -0.855 . . . . 0.0 109.615 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mt -129.76 143.67 49.95 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.547 -0.721 . . . . 0.0 109.69 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.41 123.79 13.07 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.782 2.321 . . . . 0.0 111.913 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -100.48 -172.22 29.48 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 68' ' ' GLY . 9.8 tttt 177.37 146.63 0.12 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.624 -0.927 . . . . 0.0 109.092 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' A' ' 67' ' ' SER . 24.7 p -68.07 58.7 0.07 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.83 -1.169 . . . . 0.0 109.155 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 144.26 77.47 0.03 OUTLIER Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -171.82 168.04 6.19 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.701 -0.881 . . . . 0.0 108.988 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.442 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 86.6 m -144.18 154.53 43.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.454 -0.779 . . . . 0.0 110.116 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.703 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 18.5 m95 -125.4 139.21 53.86 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.531 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.21 155.06 46.89 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 121.01 -1.057 . . . . 0.0 109.578 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.604 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -119.74 167.85 11.65 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.088 -1.008 . . . . 0.0 111.761 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.59 136.21 3.71 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.746 -1.221 . . . . 0.0 110.753 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.705 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -59.19 152.49 20.46 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.236 0.541 . . . . 0.0 111.605 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.662 HD11 ' CG2' ' A' ' 88' ' ' ILE . 42.6 mm -135.74 144.95 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.595 -0.69 . . . . 0.0 110.462 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 57.35 68.53 0.84 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.523 0.677 . . . . 0.0 110.696 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.822 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 66.9 t80 -127.86 159.34 35.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.251 -0.906 . . . . 0.0 109.511 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.613 ' OG1' ' N ' ' A' ' 80' ' ' SER . 26.1 p -140.7 -77.35 0.3 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.613 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -150.09 108.23 3.75 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.19 -102.33 0.21 Allowed Glycine 0 N--CA 1.501 3.028 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.484 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 48.4 t80 -144.04 -169.78 3.19 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.646 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.9 mtm180 -71.66 -156.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.702 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -166.91 -150.06 0.1 Allowed 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 100' ' ' THR . 48.1 p -100.39 -6.84 25.1 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.646 -1.284 . . . . 0.0 110.151 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.46 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -88.03 117.53 26.96 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.285 -0.884 . . . . 0.0 110.764 -178.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.856 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.89 149.12 41.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.74 179.259 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.662 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.4 tt -117.56 137.39 51.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.465 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.1 mm? -113.97 125.44 54.02 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.682 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -117.92 126.48 52.45 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.791 0.805 . . . . 0.0 108.914 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.703 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 2.1 p -92.43 157.03 16.8 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.985 0.898 . . . . 0.0 111.298 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.1 p -69.92 -19.45 63.39 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.528 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.31 10.43 5.6 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.237 -0.914 . . . . 0.0 109.781 179.643 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.455 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.0 30.85 0.43 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.881 -0.512 . . . . 0.0 110.004 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.408 HD12 HH21 ' A' ' 69' ' ' ARG . 25.8 mt -103.26 138.68 39.71 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.134 -0.979 . . . . 0.0 109.938 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.0 mm -112.63 120.15 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.417 -0.802 . . . . 0.0 110.058 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.441 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.7 m-85 -120.36 142.96 48.68 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.46 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 8.5 tptp -131.0 147.78 52.67 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.167 -0.958 . . . . 0.0 110.835 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.516 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -128.22 171.14 12.24 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.442 ' O ' ' OG ' ' A' ' 85' ' ' SER . 73.9 p -146.69 -2.63 0.64 Allowed 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.443 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.638 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -115.95 20.02 14.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.741 -1.224 . . . . 0.0 108.397 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.14 61.75 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.619 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.679 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 20.0 m-85 70.45 -13.52 0.45 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.67 -0.644 . . . . 0.0 111.343 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -50.8 -73.62 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.517 -1.365 . . . . 0.0 109.31 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.494 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 37.1 p -99.11 -178.08 3.82 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.465 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -160.3 134.77 7.48 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.167 -0.958 . . . . 0.0 110.028 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 57.8 m -127.67 139.77 52.5 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.602 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 14.2 tttp -85.83 140.05 30.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.803 -1.185 . . . . 0.0 110.416 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.4 pt -113.2 -32.42 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.63 -0.669 . . . . 0.0 109.922 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.653 HH21 ' CG ' ' A' ' 8' ' ' ASP . 69.6 mtt180 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 109.112 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.577 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 39.9 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 tt -171.23 159.69 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -146.77 29.38 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.368 -1.458 . . . . 0.0 110.61 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 10' ' ' VAL . 24.9 p -105.48 157.42 17.37 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.545 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -60.06 -61.89 2.27 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.85 -1.156 . . . . 0.0 110.43 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.62 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.51 -40.75 79.41 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.053 -1.029 . . . . 0.0 109.317 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.13 -45.13 94.35 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.707 HG22 ' HG2' ' A' ' 21' ' ' PRO . 68.8 t -66.55 -40.73 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.388 -1.066 . . . . 0.0 109.179 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.06 -57.38 10.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.72 -0.612 . . . . 0.0 109.392 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.82 -52.1 51.71 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.672 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 33.3 t80 -58.45 -49.67 76.47 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.333 0.587 . . . . 0.0 111.188 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.2 tt -72.25 -45.89 58.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.561 -0.712 . . . . 0.0 110.749 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -61.0 -20.05 62.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.354 -1.466 . . . . 0.0 110.587 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 m -97.97 -40.77 8.31 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.486 -1.384 . . . . 0.0 111.194 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -110.36 16.12 21.84 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.781 -1.199 . . . . 0.0 111.714 -177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.0 m80 46.03 24.61 0.26 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.367 -0.833 . . . . 0.0 110.643 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 3.8 pttp -142.41 154.33 44.5 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.688 0.756 . . . . 0.0 110.511 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.473 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.4 mp -77.2 149.28 79.18 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.707 -0.62 . . . . 0.0 109.686 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.707 ' HG2' HG22 ' A' ' 10' ' ' VAL . 51.6 Cg_exo -39.67 147.68 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.556 2.837 . . . . 0.0 113.718 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -63.8 47.55 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.084 0.945 . . . . 0.0 110.936 -177.5 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -169.11 27.08 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.087 -1.008 . . . . 0.0 110.811 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -117.99 118.26 31.46 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.705 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.8 pt -120.12 137.39 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.566 HG22 ' HA3' ' A' ' 53' ' ' GLY . 7.2 p -67.78 169.8 9.04 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.498 1.142 . . . . 0.0 111.259 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.537 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 24.1 mtmt -71.61 -37.53 70.93 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -39.67 -70.43 0.1 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 175.376 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.522 ' O ' ' C ' ' A' ' 30' ' ' ALA . 3.5 mt-10 -58.57 -58.76 7.15 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.63 -51.55 1.21 Allowed 'General case' 0 N--CA 1.508 2.46 0 O-C-N 119.075 -2.265 . . . . 0.0 110.348 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -58.15 -58.64 7.55 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.091 -1.006 . . . . 0.0 110.171 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.48 69.81 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 121.119 -0.988 . . . . 0.0 110.452 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.6 tp -55.12 -28.61 53.93 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.504 0.669 . . . . 0.0 110.23 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.29 51.05 0.25 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.534 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.71 144.94 30.79 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.277 -1.131 . . . . 0.0 109.375 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.8 t -137.45 127.03 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.556 -0.715 . . . . 0.0 110.132 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -56.98 -52.55 64.82 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.991 -0.443 . . . . 0.0 110.581 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.6 p -70.05 47.31 0.08 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.196 -0.94 . . . . 0.0 110.377 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.631 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.5 ttpm? -176.35 -51.1 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.16 56.43 20.46 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.631 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -69.92 161.77 29.32 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.659 -0.907 . . . . 0.0 110.521 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.792 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 60.1 tp -176.26 -65.95 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.557 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -62.17 -19.4 63.05 Favored 'General case' 0 C--O 1.197 -1.666 0 O-C-N 121.305 -0.872 . . . . 0.0 109.504 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.6 p-10 -80.06 -64.42 1.19 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.993 0.902 . . . . 0.0 108.637 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.419 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 30.5 m -73.89 -11.45 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.705 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.57 72.15 11.68 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.506 -0.746 . . . . 0.0 109.939 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.4 122.43 11.66 Favored 'Trans proline' 0 N--CA 1.512 2.601 0 C-N-CA 123.472 2.781 . . . . 0.0 114.219 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.409 ' C ' ' HG2' ' A' ' 49' ' ' LYS . . . 73.41 39.46 50.83 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.49 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 8.6 mmtm -138.68 176.44 8.7 Favored 'General case' 0 N--CA 1.512 2.669 0 CA-C-O 122.513 1.149 . . . . 0.0 111.009 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.1 m -148.57 162.91 38.71 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 120.203 -1.56 . . . . 0.0 110.783 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.1 mm -85.59 125.31 40.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.128 -0.983 . . . . 0.0 109.77 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.22 154.02 10.45 Favored Glycine 0 N--CA 1.503 3.138 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.566 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 122.42 -17.42 8.41 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.906 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -69.79 -154.49 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.839 -1.389 . . . . 0.0 109.835 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.9 mp -127.69 139.8 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 121.805 0.812 . . . . 0.0 110.855 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.614 ' O ' ' N ' ' A' ' 58' ' ' ASN . 9.0 t80 -105.2 90.05 3.31 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.38 -0.825 . . . . 0.0 108.816 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.541 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.5 p -59.34 36.04 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 121.393 0.616 . . . . 0.0 110.524 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.614 ' N ' ' O ' ' A' ' 56' ' ' PHE . 59.2 t30 39.38 34.68 0.14 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.075 -1.016 . . . . 0.0 110.325 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.541 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.3 mtm180 -66.58 45.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.547 -1.345 . . . . 0.0 110.066 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.616 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 18.5 mt-10 -151.53 -27.07 0.19 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.526 -0.733 . . . . 0.0 110.142 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.32 27.76 59.11 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.674 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.6 mttp -111.13 7.79 21.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.723 -0.869 . . . . 0.0 109.757 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.31 144.88 55.04 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.608 -0.683 . . . . 0.0 109.247 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.57 125.15 14.97 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.672 2.248 . . . . 0.0 112.289 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.541 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.82 -171.41 27.7 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 68' ' ' GLY . 12.1 tttt 176.37 146.67 0.09 Allowed 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.405 -1.056 . . . . 0.0 109.144 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 67' ' ' SER . 24.1 p -68.88 61.29 0.1 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.763 -1.211 . . . . 0.0 108.951 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 142.99 76.73 0.04 OUTLIER Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.568 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.92 168.25 4.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.54 -0.976 . . . . 0.0 109.195 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.446 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 93.4 m -144.5 155.86 43.9 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.463 -0.773 . . . . 0.0 109.897 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.708 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 19.8 m95 -126.55 137.6 53.37 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.579 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -128.84 156.55 43.46 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.993 -1.067 . . . . 0.0 109.091 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.538 ' O ' ' OH ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -121.28 167.4 12.77 Favored 'General case' 0 N--CA 1.513 2.676 0 CA-C-O 122.274 1.035 . . . . 0.0 111.402 -179.322 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -166.29 136.84 3.42 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.276 -0.89 . . . . 0.0 111.308 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.693 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -59.5 153.69 18.93 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.648 0.737 . . . . 0.0 111.584 -179.344 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.649 HD11 ' CG2' ' A' ' 88' ' ' ILE . 40.6 mm -136.76 142.84 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.77 -0.581 . . . . 0.0 110.764 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 59.26 65.79 1.13 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.436 0.636 . . . . 0.0 110.665 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.792 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 63.1 t80 -125.2 159.78 30.75 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.298 -0.876 . . . . 0.0 109.566 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' A' ' 80' ' ' SER . 28.1 p -139.99 -77.38 0.32 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.594 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -149.53 112.12 4.76 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.06 -104.83 0.26 Allowed Glycine 0 N--CA 1.502 3.049 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.462 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 44.3 t80 -141.43 -169.77 2.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.861 -0.787 . . . . 0.0 109.286 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.668 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.7 mtm180 -71.1 -155.0 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 O-C-N 120.81 -1.181 . . . . 0.0 109.539 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -168.77 -151.99 0.1 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.5 p -99.72 -3.5 32.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.62 -1.3 . . . . 0.0 110.335 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.527 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -91.28 117.07 29.34 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.251 -0.906 . . . . 0.0 110.283 -179.134 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.853 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.1 150.22 44.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.329 -0.857 . . . . 0.0 109.56 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.649 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.2 tt -119.06 137.38 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 72' ' ' ARG . 2.2 mm? -114.47 125.72 54.14 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.7 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.56 127.83 53.99 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.752 0.786 . . . . 0.0 109.279 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.708 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.5 p -94.12 159.14 15.28 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.282 1.039 . . . . 0.0 112.329 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.5 p -69.87 -19.52 63.43 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.568 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -83.16 10.44 8.28 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.732 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.464 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.39 31.29 0.48 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.726 -0.609 . . . . 0.0 109.988 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.413 HD12 HH21 ' A' ' 69' ' ' ARG . 27.1 mt -103.43 138.34 40.29 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.46 -0.775 . . . . 0.0 109.833 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 109' ' ' ILE . 31.9 mm -112.35 119.51 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.794 -0.566 . . . . 0.0 110.139 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.413 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.0 m-85 -120.62 143.55 48.61 Favored 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.527 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 7.7 tptp -131.12 148.09 52.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.02 -1.05 . . . . 0.0 110.299 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.562 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -127.68 171.9 11.26 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.3 p -146.73 -1.85 0.67 Allowed 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.147 -0.971 . . . . 0.0 110.281 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.627 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -117.13 20.27 13.83 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.717 -1.239 . . . . 0.0 108.433 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 77.07 64.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.409 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.674 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 18.9 m-85 68.96 -12.87 0.37 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 122.195 -0.316 . . . . 0.0 111.793 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -51.66 -72.75 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.478 -1.389 . . . . 0.0 109.58 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.474 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 37.3 p -100.07 -179.12 4.05 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.415 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -159.12 135.42 9.1 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.038 -1.039 . . . . 0.0 109.954 -179.209 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 64.0 m -128.8 139.51 52.15 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.613 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.5 tttp -86.1 139.19 31.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.839 -1.163 . . . . 0.0 110.314 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 96' ' ' ILE . 13.5 pt -112.7 -31.55 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.831 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.62 HH21 ' CG ' ' A' ' 8' ' ' ASP . 68.2 mtt180 . . . . . 0 C--N 1.306 -1.298 0 O-C-N 121.131 -0.981 . . . . 0.0 109.167 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.592 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 22.0 t . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 tt -169.94 160.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -146.53 30.2 1.01 Allowed 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.255 -1.528 . . . . 0.0 111.637 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 10' ' ' VAL . 28.3 p -104.16 158.32 16.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.517 -0.739 . . . . 0.0 109.526 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.7 p90 -60.35 -61.67 2.43 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.617 -1.302 . . . . 0.0 110.872 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.617 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -56.69 -41.67 77.74 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.145 -0.972 . . . . 0.0 109.618 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.27 -45.21 94.46 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.676 HG22 ' HG2' ' A' ' 21' ' ' PRO . 54.7 t -66.72 -41.5 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 O-C-N 121.109 -1.23 . . . . 0.0 108.101 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.36 -59.38 5.37 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.48 -52.17 31.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.058 -1.026 . . . . 0.0 109.973 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.695 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 36.3 t80 -59.58 -47.98 83.46 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.291 -0.881 . . . . 0.0 110.628 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.7 tt -72.9 -44.38 61.34 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.382 -0.824 . . . . 0.0 110.841 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -62.73 -22.62 66.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.554 -1.341 . . . . 0.0 110.379 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.2 m -94.88 -42.11 8.85 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.957 -1.089 . . . . 0.0 111.048 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -109.49 16.83 21.98 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.127 -0.983 . . . . 0.0 112.214 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 m80 46.84 24.35 0.34 Allowed 'General case' 0 N--CA 1.51 2.56 0 O-C-N 120.94 -1.1 . . . . 0.0 110.584 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.2 pttp -141.39 151.45 43.49 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.241 1.02 . . . . 0.0 110.296 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.527 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.5 mp -75.44 150.39 84.75 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.033 -1.042 . . . . 0.0 108.725 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.695 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 50.7 Cg_exo -40.33 151.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 123.344 2.696 . . . . 0.0 114.35 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -66.38 47.6 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.6 0.714 . . . . 0.0 111.312 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -170.22 27.65 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 109.189 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -119.25 118.26 30.8 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.714 -1.241 . . . . 0.0 110.098 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.8 pt -119.89 138.73 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.307 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.54 HG22 ' HA3' ' A' ' 53' ' ' GLY . 12.0 p -69.01 166.97 16.91 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.936 -1.102 . . . . 0.0 110.875 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.591 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 22.9 mtmt -70.38 -34.59 72.75 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.31 -66.99 0.32 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' ' 30' ' ' ALA . 3.4 mt-10 -60.35 -58.3 9.1 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.439 -1.304 . . . . 0.0 108.288 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.66 -52.46 1.23 Allowed 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.007 -1.058 . . . . 0.0 109.241 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -59.0 -55.98 28.15 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.563 -0.711 . . . . 0.0 110.511 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.26 -29.1 70.17 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 120.652 -1.28 . . . . 0.0 108.964 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.413 HD21 ' HB ' ' A' ' 45' ' ' VAL . 33.9 tp -62.38 -27.36 69.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.648 -0.657 . . . . 0.0 109.471 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.84 52.73 0.23 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.55 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -83.07 146.77 28.51 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.317 -1.108 . . . . 0.0 109.693 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -135.77 125.16 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.325 -0.859 . . . . 0.0 109.187 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -58.82 -52.56 65.21 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.831 -0.543 . . . . 0.0 109.724 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.9 p -70.37 50.98 0.12 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.001 -1.062 . . . . 0.0 109.412 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.645 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -179.69 -50.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.41 56.99 20.29 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.645 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -72.14 164.42 26.22 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.834 -0.803 . . . . 0.0 110.784 -178.715 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.843 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 66.6 tp -178.64 -66.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.001 -1.062 . . . . 0.0 110.004 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.638 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -59.98 -23.12 63.36 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.098 -1.001 . . . . 0.0 109.711 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 5.5 p-10 -76.39 -64.11 1.18 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.003 0.906 . . . . 0.0 109.497 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.444 ' H ' HG22 ' A' ' 45' ' ' VAL . 15.3 m -76.21 -10.92 13.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.853 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.62 70.14 11.41 Favored Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.348 -0.845 . . . . 0.0 109.431 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -57.04 123.57 14.16 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 123.182 2.588 . . . . 0.0 113.673 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.487 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 73.88 36.45 52.51 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.487 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 8.5 mmtm -138.57 168.97 18.63 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 121.885 0.85 . . . . 0.0 111.205 -178.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.474 ' HG ' ' HD2' ' A' ' 78' ' ' TYR . 73.3 m -142.48 162.02 36.56 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.277 1.037 . . . . 0.0 111.089 -177.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.1 mm -84.47 126.93 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 122.1 0.952 . . . . 0.0 110.327 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.36 153.74 9.24 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.54 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 122.57 -20.46 7.82 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.329 -1.415 . . . . 0.0 110.782 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -68.33 -154.42 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 118.686 1.243 . . . . 0.0 109.01 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.66 139.65 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-O 121.864 0.84 . . . . 0.0 111.219 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.612 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.5 t80 -104.05 89.96 3.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.341 -0.85 . . . . 0.0 109.304 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.642 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.3 p -58.99 35.16 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.603 -0.686 . . . . 0.0 110.888 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.612 ' N ' ' O ' ' A' ' 56' ' ' PHE . 55.2 t30 38.34 39.7 0.3 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.107 -0.996 . . . . 0.0 109.878 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.642 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 8.9 mtm180 -70.29 43.33 0.06 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.562 -1.336 . . . . 0.0 110.087 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.61 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 21.7 mt-10 -149.38 -25.32 0.28 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.332 -0.855 . . . . 0.0 109.943 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.59 28.74 58.92 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.637 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.5 mttp -111.3 7.93 21.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.508 -0.995 . . . . 0.0 109.713 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mt -131.0 144.04 51.91 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.602 -0.686 . . . . 0.0 109.493 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.33 124.98 15.8 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.819 2.346 . . . . 0.0 112.408 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.543 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.1 -173.22 28.82 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.507 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 11.0 tttt 177.29 144.24 0.09 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.375 -1.074 . . . . 0.0 108.656 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.2 p -68.1 58.58 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.936 -1.102 . . . . 0.0 109.172 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.507 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 147.64 75.51 0.02 OUTLIER Glycine 0 N--CA 1.5 2.913 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.564 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.56 168.11 5.37 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.711 -0.876 . . . . 0.0 109.33 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 87.9 m -143.39 155.09 44.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.486 -0.759 . . . . 0.0 110.039 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.714 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 17.9 m95 -125.21 138.34 54.12 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.584 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -129.47 156.14 44.59 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 120.747 -1.221 . . . . 0.0 109.586 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.591 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -120.47 167.66 12.13 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.259 -0.901 . . . . 0.0 112.026 -179.37 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -166.65 135.71 2.94 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.135 -0.978 . . . . 0.0 110.714 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.646 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -58.59 153.33 16.53 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.343 0.592 . . . . 0.0 111.676 -179.436 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.686 HD11 ' CG2' ' A' ' 88' ' ' ILE . 39.9 mm -136.02 140.67 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.49 0.662 . . . . 0.0 110.37 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 60.49 68.98 0.72 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.679 -0.638 . . . . 0.0 110.403 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.843 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 61.2 t80 -126.13 159.45 32.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.349 -0.844 . . . . 0.0 109.636 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.601 ' OG1' ' N ' ' A' ' 80' ' ' SER . 31.2 p -139.8 -78.25 0.32 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.638 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -150.84 107.44 3.51 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.663 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.94 -107.41 0.31 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 52.1 t80 -139.29 -166.93 2.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.734 -0.862 . . . . 0.0 108.843 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.648 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.3 mtm180 -73.91 -157.31 0.05 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.0 -1.062 . . . . 0.0 109.53 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -166.64 -153.14 0.15 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 100' ' ' THR . 50.7 p -98.22 -9.64 25.3 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.457 -1.402 . . . . 0.0 110.727 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.538 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -86.06 117.71 25.07 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.066 -1.021 . . . . 0.0 111.096 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.826 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.65 148.45 42.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.405 -0.81 . . . . 0.0 109.552 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.686 ' CG2' HD11 ' A' ' 76' ' ' ILE . 3.5 tt -115.93 139.54 42.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.472 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.1 mm? -116.05 125.43 52.42 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.671 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -117.55 127.52 54.06 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.856 0.836 . . . . 0.0 109.355 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.714 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 8.6 p -94.58 157.7 15.86 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.122 0.963 . . . . 0.0 111.944 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.1 p -69.01 -20.1 64.14 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.564 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -82.18 9.72 8.15 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.3 -0.875 . . . . 0.0 110.033 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.451 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.25 29.35 0.45 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.714 -0.616 . . . . 0.0 110.449 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.437 HD12 HH21 ' A' ' 69' ' ' ARG . 29.2 mt -101.87 135.99 42.47 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.437 -0.79 . . . . 0.0 109.985 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.4 mm -110.2 119.74 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.515 -0.74 . . . . 0.0 110.115 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.435 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.3 m-85 -119.04 143.14 47.27 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.538 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 8.5 tptp -132.45 147.49 52.37 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.823 -1.173 . . . . 0.0 110.537 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.487 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.5 t -129.39 171.04 12.92 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.403 ' O ' ' OG ' ' A' ' 85' ' ' SER . 72.3 p -145.22 -3.65 0.74 Allowed 'General case' 0 N--CA 1.508 2.472 0 O-C-N 121.45 -0.781 . . . . 0.0 110.234 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -114.53 19.37 16.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.756 -1.215 . . . . 0.0 108.924 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 77.87 63.69 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.054 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.648 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 18.5 m-85 69.5 -14.48 0.33 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.813 -0.554 . . . . 0.0 111.87 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -49.96 -74.27 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.538 -1.351 . . . . 0.0 109.314 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.464 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 38.0 p -99.03 -177.17 3.54 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.791 -1.193 . . . . 0.0 108.319 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.472 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -160.23 134.33 7.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -0.983 . . . . 0.0 110.236 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.6 m -127.3 139.99 52.51 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.541 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.2 tttp -86.37 140.21 30.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.8 -1.187 . . . . 0.0 110.364 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.6 pt -113.68 -31.71 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.438 -0.788 . . . . 0.0 110.074 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.617 HH21 ' CG ' ' A' ' 8' ' ' ASP . 67.6 mtt180 . . . . . 0 N--CA 1.485 1.317 0 O-C-N 121.068 -1.02 . . . . 0.0 108.659 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.638 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.8 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 tt -169.4 159.69 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.365 -0.835 . . . . 0.0 109.342 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -146.67 31.07 0.97 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.512 -1.368 . . . . 0.0 111.357 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.7 p -106.08 155.97 18.88 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.599 -0.688 . . . . 0.0 109.865 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.3 p90 -58.44 -62.18 2.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.195 -0.941 . . . . 0.0 110.725 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.622 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.9 OUTLIER -58.15 -41.13 83.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.353 -0.842 . . . . 0.0 109.526 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.92 -44.91 87.56 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.692 HG22 ' HG2' ' A' ' 21' ' ' PRO . 53.3 t -67.95 -41.99 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.46 -57.02 12.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.473 -0.767 . . . . 0.0 109.21 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.08 -55.22 15.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.474 -0.766 . . . . 0.0 109.692 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.676 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 33.9 t80 -56.45 -49.88 73.32 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.249 0.547 . . . . 0.0 110.802 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -73.22 -44.55 59.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.376 -0.828 . . . . 0.0 110.709 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -62.26 -21.12 64.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.566 -1.334 . . . . 0.0 110.298 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.6 m -97.26 -40.92 8.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.174 -0.954 . . . . 0.0 110.742 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -109.16 14.42 23.9 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.118 -0.989 . . . . 0.0 111.908 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.1 m80 46.51 25.57 0.41 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 120.864 -1.147 . . . . 0.0 109.669 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.488 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 5.0 pttp -142.27 152.2 42.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.315 -0.866 . . . . 0.0 110.004 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.542 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.6 mp -76.88 149.36 80.24 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 109.066 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.692 ' HG2' HG22 ' A' ' 10' ' ' VAL . 66.1 Cg_exo -40.76 150.71 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.734 2.289 . . . . 0.0 113.23 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -62.59 47.14 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.601 0.715 . . . . 0.0 111.12 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -168.42 26.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.6 -1.313 . . . . 0.0 110.286 179.121 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -116.69 113.05 22.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.88 -1.137 . . . . 0.0 110.886 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 25' ' ' ILE . 28.3 pt -116.18 138.59 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.325 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.611 HG22 ' HA3' ' A' ' 53' ' ' GLY . 4.4 p -69.73 166.62 18.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.018 -1.051 . . . . 0.0 110.37 -176.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.586 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 18.7 mtmt -66.29 -35.4 80.29 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.441 ' HG ' ' CB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -41.89 -66.33 0.36 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.625 178.147 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.4 mt-10 -65.33 -49.3 69.95 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.301 -0.959 . . . . 0.0 109.192 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -44.24 -50.0 9.04 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.79 -1.194 . . . . 0.0 107.997 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.42 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 38.7 mt-30 -59.2 -57.6 12.33 Favored 'General case' 0 N--CA 1.509 2.506 0 O-C-N 121.36 -0.838 . . . . 0.0 110.733 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.34 -30.91 69.83 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.994 -1.066 . . . . 0.0 109.807 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.0 tp -63.11 -25.82 68.54 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.96 50.16 0.23 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.593 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.91 144.1 31.2 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.369 -1.077 . . . . 0.0 110.146 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.0 t -134.52 125.3 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.174 -0.954 . . . . 0.0 109.699 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -58.73 -52.83 64.02 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.55 -0.719 . . . . 0.0 109.812 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 59.6 p -68.56 50.2 0.07 Allowed 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.982 -1.073 . . . . 0.0 109.133 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.626 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.0 OUTLIER -179.34 -50.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -0.774 . . . . 0.0 108.964 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.95 56.86 18.4 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.626 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -74.27 162.76 28.59 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.443 -1.034 . . . . 0.0 110.773 -178.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.821 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 65.4 tp -176.12 -67.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.547 -0.72 . . . . 0.0 109.798 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.655 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.63 -18.86 55.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.962 -1.086 . . . . 0.0 109.935 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.8 p-10 -79.45 -65.1 1.04 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.843 0.83 . . . . 0.0 109.552 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.457 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 30.7 m -73.33 -10.89 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 O-C-N 121.743 -0.598 . . . . 0.0 110.353 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.83 71.87 9.59 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 109.785 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.36 122.56 12.0 Favored 'Trans proline' 0 N--CA 1.509 2.392 0 C-N-CA 123.977 3.118 . . . . 0.0 113.562 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.74 39.76 59.46 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 7.2 mmtt -136.6 176.08 9.03 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.052 0.929 . . . . 0.0 110.597 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.405 ' HA ' HD21 ' A' ' 42' ' ' LEU . 69.0 m -150.13 158.82 44.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.785 -1.197 . . . . 0.0 111.167 -177.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.3 mm -82.45 130.37 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.548 0.69 . . . . 0.0 110.121 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.4 154.83 8.5 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.611 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 119.89 -16.53 10.2 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 120.293 -0.956 . . . . 0.0 110.868 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -70.55 -152.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.748 -1.443 . . . . 0.0 109.603 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -128.93 138.84 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.522 0.677 . . . . 0.0 110.821 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.604 ' O ' ' N ' ' A' ' 58' ' ' ASN . 11.0 t80 -104.09 90.31 3.55 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.661 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.3 36.2 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.47 0.653 . . . . 0.0 111.182 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.604 ' N ' ' O ' ' A' ' 56' ' ' PHE . 53.5 t30 36.58 38.4 0.08 Allowed 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.94 -1.1 . . . . 0.0 110.541 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.661 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.8 mtm180 -69.51 39.07 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.614 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 18.9 mt-10 -149.05 -10.9 0.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.182 -0.949 . . . . 0.0 110.246 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.78 33.23 84.53 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.67 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.1 mttp -115.1 8.6 15.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.613 -0.934 . . . . 0.0 109.446 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -132.81 142.94 46.59 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.446 -0.784 . . . . 0.0 109.349 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.86 125.99 17.84 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.885 2.39 . . . . 0.0 112.394 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.539 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.0 -170.99 28.63 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.583 ' O ' ' N ' ' A' ' 68' ' ' GLY . 11.1 tttt 175.52 144.08 0.07 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.149 -1.206 . . . . 0.0 108.269 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 67' ' ' SER . 27.2 p -66.09 57.05 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.838 -1.164 . . . . 0.0 108.427 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 147.63 77.34 0.02 OUTLIER Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.539 ' NH1' ' O ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -173.54 167.78 4.56 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.551 -0.97 . . . . 0.0 108.974 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.431 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 85.6 m -144.36 155.87 43.98 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.811 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.737 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 25.6 m95 -126.32 138.73 53.61 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.615 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.38 154.31 47.81 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.544 -1.347 . . . . 0.0 109.606 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.586 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -118.35 167.0 11.97 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.195 -0.94 . . . . 0.0 111.815 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.13 136.13 3.97 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.797 0.808 . . . . 0.0 110.967 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.66 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -60.73 151.69 28.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.613 -0.679 . . . . 0.0 111.938 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.492 HG13 ' HB ' ' A' ' 88' ' ' ILE . 40.4 mm -137.15 143.82 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 121.476 0.655 . . . . 0.0 110.18 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 60.25 66.08 1.0 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.234 0.54 . . . . 0.0 110.576 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.821 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 58.0 t80 -126.79 161.63 27.74 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.156 -0.965 . . . . 0.0 109.122 178.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.634 ' OG1' ' N ' ' A' ' 80' ' ' SER . 27.2 p -141.38 -78.96 0.26 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.655 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -149.27 106.08 3.56 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.51 -107.09 0.3 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 49.1 t80 -135.82 -166.02 1.79 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.721 -0.87 . . . . 0.0 108.771 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.658 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.8 mtm180 -75.16 -153.04 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.916 -1.115 . . . . 0.0 109.077 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -168.41 -150.3 0.09 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.3 p -100.87 -8.36 22.64 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.464 -1.397 . . . . 0.0 110.335 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.455 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -86.5 116.75 24.85 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.386 -0.821 . . . . 0.0 110.741 -178.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.84 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.22 149.47 44.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.251 -0.906 . . . . 0.0 109.698 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.492 ' HB ' HG13 ' A' ' 76' ' ' ILE . 10.5 tt -119.64 136.1 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.621 0.724 . . . . 0.0 109.125 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 72' ' ' ARG . 2.8 mm? -112.66 124.65 53.03 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -116.69 127.84 54.78 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.691 0.758 . . . . 0.0 109.002 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.737 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 5.7 p -93.78 158.72 15.53 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.995 0.903 . . . . 0.0 111.91 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.7 p -69.39 -19.94 63.81 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.524 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.72 9.28 8.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.471 -0.768 . . . . 0.0 109.898 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.78 30.32 0.47 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.621 -0.674 . . . . 0.0 110.024 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.429 HD12 HH21 ' A' ' 69' ' ' ARG . 26.8 mt -102.87 137.57 40.9 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.342 -0.849 . . . . 0.0 110.388 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.52 ' CG2' HD11 ' A' ' 109' ' ' ILE . 35.9 mm -110.42 118.95 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.306 -0.872 . . . . 0.0 110.691 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.461 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 6.9 m-85 -119.09 141.61 48.61 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.455 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 6.2 tptp -131.37 148.26 52.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.417 -0.802 . . . . 0.0 110.896 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.7 t -128.66 172.46 11.2 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.9 p -146.87 -3.21 0.6 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.523 -0.735 . . . . 0.0 110.487 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.582 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.3 p30 -115.54 22.5 13.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.785 -1.197 . . . . 0.0 108.296 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 75.76 62.17 0.05 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.495 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.67 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 17.6 m-85 69.59 -10.87 0.55 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.701 -0.624 . . . . 0.0 111.414 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.72 -72.87 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.695 -1.253 . . . . 0.0 109.213 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.514 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 34.9 p -99.39 -178.37 3.88 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.477 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -160.65 133.48 6.41 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.071 -1.018 . . . . 0.0 109.794 -179.317 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.9 m -127.28 141.49 51.7 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.617 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 13.5 tttp -86.77 139.03 31.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.873 -1.142 . . . . 0.0 110.093 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.52 HD11 ' CG2' ' A' ' 96' ' ' ILE . 10.3 pt -112.11 -32.26 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.606 -0.684 . . . . 0.0 109.432 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.622 HH21 ' CG ' ' A' ' 8' ' ' ASP . 56.3 mtt180 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 118.086 -0.959 . . . . 0.0 109.049 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.622 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.2 t . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 tt -169.78 160.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.4 -0.812 . . . . 0.0 109.219 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -147.26 30.33 0.94 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.339 -1.475 . . . . 0.0 111.129 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 10' ' ' VAL . 19.9 p -104.86 156.25 18.18 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.744 0.783 . . . . 0.0 109.792 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.5 p90 -59.65 -61.38 2.66 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.729 -1.232 . . . . 0.0 110.143 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.647 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.74 -41.53 82.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.337 -0.852 . . . . 0.0 109.388 -179.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.5 -44.77 93.62 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.642 HG22 ' HG2' ' A' ' 21' ' ' PRO . 60.6 t -67.54 -41.66 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 121.43 -1.041 . . . . 0.0 108.662 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.47 -58.09 9.55 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.17 -54.86 14.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.362 -0.836 . . . . 0.0 109.633 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.571 ' CE1' ' HA ' ' A' ' 21' ' ' PRO . 34.1 t80 -57.6 -47.36 82.37 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.118 0.485 . . . . 0.0 110.754 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.2 tt -74.21 -44.37 53.52 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.246 -0.909 . . . . 0.0 110.717 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -62.98 -19.94 64.8 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.436 -1.415 . . . . 0.0 110.13 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.4 m -96.8 -43.33 7.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.987 -1.071 . . . . 0.0 111.01 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -107.77 13.12 26.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.153 -0.967 . . . . 0.0 111.894 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.2 m80 49.2 23.91 0.88 Allowed 'General case' 0 N--CA 1.508 2.426 0 O-C-N 120.692 -1.255 . . . . 0.0 109.902 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.487 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.5 pttp -141.48 153.63 45.06 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.526 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.2 mp -77.78 149.71 77.8 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.344 -0.847 . . . . 0.0 109.038 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.642 ' HG2' HG22 ' A' ' 10' ' ' VAL . 77.2 Cg_exo -39.34 151.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 123.133 2.555 . . . . 0.0 113.567 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -63.45 47.83 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.637 0.732 . . . . 0.0 110.538 179.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -169.88 26.95 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.846 -1.159 . . . . 0.0 110.328 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -118.48 114.01 22.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.482 -1.387 . . . . 0.0 110.227 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 35.4 pt -117.26 140.63 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.024 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.638 HG22 ' HA3' ' A' ' 53' ' ' GLY . 6.8 p -70.19 166.8 19.23 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.325 1.06 . . . . 0.0 111.684 -177.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.577 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 20.6 mtmt -68.58 -35.57 77.55 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.73 -65.47 0.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.425 176.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.458 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.6 mt-10 -64.4 -52.02 60.3 Favored 'General case' 0 C--O 1.201 -1.466 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.624 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -41.71 -51.65 4.06 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.858 -1.152 . . . . 0.0 109.047 177.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -60.0 -56.73 18.08 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.372 -0.83 . . . . 0.0 110.895 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.9 -30.61 69.14 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.589 -1.319 . . . . 0.0 109.024 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.1 tp -63.48 -29.83 71.04 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.405 0.621 . . . . 0.0 109.439 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.34 55.01 0.15 Allowed Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.595 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -88.08 145.61 25.86 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.294 -1.121 . . . . 0.0 109.505 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -135.45 124.31 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.427 -0.795 . . . . 0.0 109.414 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -56.89 -53.21 60.54 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.708 -0.62 . . . . 0.0 109.716 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 81.0 p -68.54 48.53 0.06 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.462 -0.774 . . . . 0.0 109.834 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.648 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.4 ttpm? -178.29 -50.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.53 56.05 23.78 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.648 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -73.24 161.24 30.76 Favored 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.517 -0.99 . . . . 0.0 111.155 -178.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.828 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.5 tp -173.17 -68.18 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.117 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.602 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.51 -18.93 55.09 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.169 -0.957 . . . . 0.0 109.779 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.2 p-10 -78.38 -63.9 1.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.66 0.743 . . . . 0.0 109.36 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.6 m -75.6 -10.13 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.919 -0.488 . . . . 0.0 110.381 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.74 71.21 9.65 Favored Pre-proline 0 N--CA 1.486 1.346 0 O-C-N 121.514 -0.741 . . . . 0.0 109.589 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.9 124.37 16.08 Favored 'Trans proline' 0 N--CA 1.505 2.185 0 C-N-CA 123.517 2.812 . . . . 0.0 113.872 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.536 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 72.15 38.69 59.15 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.9 mmtm -137.02 171.25 14.79 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 121.691 0.758 . . . . 0.0 110.167 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.0 m -144.35 162.24 36.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.146 -0.971 . . . . 0.0 110.302 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.7 mm -84.63 127.87 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.631 0.729 . . . . 0.0 110.156 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.97 155.34 10.9 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.638 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 120.63 -15.94 9.71 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.695 -1.24 . . . . 0.0 111.053 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -71.75 -155.14 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.766 -1.432 . . . . 0.0 109.321 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.16 140.27 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.76 0.791 . . . . 0.0 110.393 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.597 ' O ' ' N ' ' A' ' 58' ' ' ASN . 9.7 t80 -105.61 91.16 3.64 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.55 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -60.52 36.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.605 -0.684 . . . . 0.0 110.828 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 56' ' ' PHE . 51.7 t30 38.94 36.88 0.17 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.123 -0.985 . . . . 0.0 110.358 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.55 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.6 mtm180 -69.43 42.3 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.885 -1.134 . . . . 0.0 109.564 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.621 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 17.8 mt-10 -150.18 -15.46 0.25 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.411 -0.806 . . . . 0.0 110.254 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.43 32.1 83.08 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.668 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.1 mttp -113.63 6.53 16.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.717 -0.873 . . . . 0.0 109.304 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.7 144.01 51.66 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.659 -0.651 . . . . 0.0 109.39 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.48 124.52 14.38 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.984 2.456 . . . . 0.0 112.051 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.521 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -101.03 -172.5 28.81 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 68' ' ' GLY . 10.9 tttt 177.07 146.47 0.11 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.366 -1.079 . . . . 0.0 108.955 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 67' ' ' SER . 24.2 p -68.57 60.21 0.09 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.956 -1.09 . . . . 0.0 108.784 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 144.18 77.05 0.03 OUTLIER Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.541 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -173.69 167.29 4.51 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.586 -0.949 . . . . 0.0 109.208 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 92.4 m -143.81 156.67 44.56 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.23 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.727 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 22.6 m95 -127.11 138.21 53.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.052 -0.405 . . . . 0.0 109.947 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.561 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.04 154.19 47.67 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.89 -1.131 . . . . 0.0 109.733 179.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.577 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -118.28 166.9 12.07 Favored 'General case' 0 N--CA 1.509 2.488 0 CA-C-O 121.768 0.794 . . . . 0.0 112.064 -179.051 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.18 134.56 3.51 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.282 -0.886 . . . . 0.0 111.31 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.678 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.46 153.13 13.27 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.268 0.556 . . . . 0.0 111.372 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.726 HD11 ' CG2' ' A' ' 88' ' ' ILE . 42.3 mm -135.98 143.45 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.769 -0.582 . . . . 0.0 109.977 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 57.96 69.75 0.71 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.497 0.665 . . . . 0.0 110.576 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.828 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 65.8 t80 -127.88 160.19 32.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.375 -0.828 . . . . 0.0 109.344 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.613 ' OG1' ' N ' ' A' ' 80' ' ' SER . 29.9 p -141.5 -78.94 0.26 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.613 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.4 OUTLIER -150.5 105.21 3.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.787 -0.571 . . . . 0.0 110.2 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.5 -98.85 0.17 Allowed Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.473 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 46.0 t80 -144.81 -169.86 3.27 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.605 -0.938 . . . . 0.0 109.379 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.641 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.8 mtm180 -72.0 -156.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.045 -1.034 . . . . 0.0 109.531 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -167.17 -151.7 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 p -99.25 -6.31 28.28 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.725 -1.234 . . . . 0.0 110.38 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.466 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -89.05 118.61 28.89 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.122 -0.986 . . . . 0.0 110.451 -178.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.857 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.77 150.46 43.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.755 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.726 ' CG2' HD11 ' A' ' 76' ' ' ILE . 3.7 tt -118.35 136.63 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 72' ' ' ARG . 2.4 mm? -114.29 124.24 51.52 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.692 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -116.6 127.5 54.53 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.691 0.757 . . . . 0.0 109.09 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.727 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.9 p -93.69 157.96 15.91 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.143 0.973 . . . . 0.0 112.197 -178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.1 p -68.86 -20.03 64.26 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.541 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -82.34 10.34 7.23 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.423 -0.798 . . . . 0.0 109.853 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.47 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.6 30.55 0.48 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.629 -0.669 . . . . 0.0 110.047 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.9 mt -102.79 138.68 39.36 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.384 -0.822 . . . . 0.0 109.94 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.468 HG22 HD11 ' A' ' 109' ' ' ILE . 33.4 mm -112.28 119.76 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.267 -0.896 . . . . 0.0 110.07 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.427 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.1 m-85 -119.95 142.61 48.59 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.466 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 9.3 tptp -130.62 147.67 52.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.761 . . . . 0.0 110.71 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.549 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.0 t -128.78 171.13 12.53 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.5 p -146.5 -2.62 0.66 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.36 -0.838 . . . . 0.0 110.488 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.636 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -115.63 19.34 15.37 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.653 -1.28 . . . . 0.0 108.549 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.97 62.01 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.534 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.668 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 21.5 m-85 69.89 -13.12 0.43 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.73 -0.606 . . . . 0.0 111.595 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -51.01 -72.39 0.05 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.735 -1.228 . . . . 0.0 109.557 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.458 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 34.5 p -99.96 -177.14 3.45 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -160.96 135.05 6.99 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.987 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.9 m -128.3 139.73 52.26 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.611 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 14.4 tttp -85.79 140.16 30.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.006 -1.059 . . . . 0.0 110.15 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.468 HD11 HG22 ' A' ' 96' ' ' ILE . 11.7 pt -113.23 -33.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.604 -0.685 . . . . 0.0 109.603 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.647 HH21 ' CG ' ' A' ' 8' ' ' ASP . 64.9 mtt180 . . . . . 0 N--CA 1.488 1.467 0 O-C-N 121.212 -0.93 . . . . 0.0 108.999 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.631 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.2 t . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 tt -171.31 161.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -145.94 28.2 1.15 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.43 -1.419 . . . . 0.0 111.083 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.5 p -104.16 156.12 18.15 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.729 0.776 . . . . 0.0 110.19 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.7 p90 -60.1 -60.78 3.28 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.758 -1.214 . . . . 0.0 110.759 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.63 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -58.57 -41.99 86.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 108.927 -179.381 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.19 -43.62 93.45 Favored Glycine 0 N--CA 1.501 2.993 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.733 HG22 ' HG2' ' A' ' 21' ' ' PRO . 50.5 t -68.78 -41.46 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.212 -1.169 . . . . 0.0 107.998 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.99 -59.1 5.91 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.61 -54.87 12.91 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.567 -0.708 . . . . 0.0 109.587 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.689 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 33.8 t80 -56.42 -49.51 74.35 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.174 0.511 . . . . 0.0 110.204 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.35 -47.41 56.57 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.164 -0.96 . . . . 0.0 111.567 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -61.4 -21.07 63.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.553 -1.342 . . . . 0.0 110.366 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 m -95.9 -41.01 9.02 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.986 -1.071 . . . . 0.0 111.652 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -110.8 16.2 21.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.457 -0.777 . . . . 0.0 111.566 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.6 m80 46.53 25.5 0.41 Allowed 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.563 -1.336 . . . . 0.0 110.248 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -142.95 152.62 42.2 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.203 -0.935 . . . . 0.0 110.695 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.551 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.3 mp -74.79 148.92 85.39 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.0 109.513 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.733 ' HG2' HG22 ' A' ' 10' ' ' VAL . 72.5 Cg_exo -40.48 151.56 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 123.4 2.734 . . . . 0.0 113.371 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.631 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -64.43 46.75 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 121.752 0.787 . . . . 0.0 110.997 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -167.62 24.87 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.937 -1.102 . . . . 0.0 110.545 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -116.27 116.02 27.01 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.692 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.8 pt -117.79 141.0 38.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.709 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.603 HG22 ' HA3' ' A' ' 53' ' ' GLY . 6.9 p -71.83 167.54 19.77 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 120.858 -1.151 . . . . 0.0 110.524 -177.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.568 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 22.5 mtmt -68.23 -35.92 78.68 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.414 ' HG ' ' CB ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -41.01 -66.23 0.35 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 122.829 1.299 . . . . 0.0 108.472 178.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.548 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.9 mt-10 -65.65 -52.83 48.63 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.612 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.548 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -40.8 -50.86 3.17 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.324 -1.485 . . . . 0.0 107.397 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -58.57 -58.79 6.98 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 120.898 -1.126 . . . . 0.0 111.63 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.93 -29.77 67.35 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.1 -1.625 . . . . 0.0 110.163 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.9 tp -63.17 -25.01 68.15 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.96 50.49 0.26 Allowed Glycine 0 N--CA 1.501 2.992 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.588 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.49 146.12 30.38 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.094 -1.239 . . . . 0.0 109.661 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.42 125.8 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.565 -0.709 . . . . 0.0 109.214 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -58.96 -52.53 65.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.843 -0.536 . . . . 0.0 109.744 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.6 p -69.71 50.12 0.1 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.697 -1.252 . . . . 0.0 109.342 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.64 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -178.46 -50.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.18 56.38 24.11 Favored Glycine 0 N--CA 1.503 3.1 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.64 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -71.94 164.99 25.1 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.629 -0.924 . . . . 0.0 110.387 -178.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.792 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 60.6 tp -177.35 -69.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.726 -0.609 . . . . 0.0 110.214 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -57.87 -20.46 36.85 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.616 -1.302 . . . . 0.0 109.414 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.5 p-10 -77.89 -63.08 1.47 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.424 1.107 . . . . 0.0 109.501 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.451 HG22 ' H ' ' A' ' 45' ' ' VAL . 17.0 m -77.46 -7.25 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.17 -0.956 . . . . 0.0 110.259 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.47 70.53 7.46 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.464 -0.772 . . . . 0.0 109.076 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.39 125.97 20.8 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 123.358 2.705 . . . . 0.0 113.719 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.32 40.13 70.04 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -137.56 176.21 8.91 Favored 'General case' 0 N--CA 1.516 2.851 0 CA-C-O 122.592 1.187 . . . . 0.0 111.85 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.404 ' HG ' ' HD2' ' A' ' 78' ' ' TYR . 73.1 m -148.72 160.41 43.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.614 -1.304 . . . . 0.0 111.639 -177.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.3 mm -83.24 127.76 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.436 -0.79 . . . . 0.0 109.833 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 170.44 153.23 8.59 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.603 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 121.71 -16.78 8.91 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.243 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.522 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 1.2 m-20 -70.48 -154.42 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.243 -1.151 . . . . 0.0 109.903 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mp -128.61 135.79 61.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.945 0.879 . . . . 0.0 110.202 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.606 ' O ' ' N ' ' A' ' 58' ' ' ASN . 10.9 t80 -101.75 91.16 4.28 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.654 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -60.57 37.27 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.632 -0.668 . . . . 0.0 110.456 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 56' ' ' PHE . 56.3 t30 37.82 36.69 0.1 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.208 -0.932 . . . . 0.0 110.444 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.654 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.9 mtm180 -68.35 44.93 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.804 -1.185 . . . . 0.0 109.885 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.62 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 20.1 mt-10 -151.51 -25.64 0.2 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.511 -0.743 . . . . 0.0 110.055 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.86 29.47 59.12 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.68 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.5 mttp -112.89 9.16 18.86 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.535 -0.979 . . . . 0.0 109.468 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mt -131.95 143.92 51.05 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.755 -0.591 . . . . 0.0 109.41 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.57 124.19 13.74 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 122.729 2.286 . . . . 0.0 112.3 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.541 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -100.76 -172.83 29.21 Favored Glycine 0 N--CA 1.505 3.235 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 68' ' ' GLY . 10.8 tttt 177.29 145.4 0.1 Allowed 'General case' 0 N--CA 1.508 2.465 0 O-C-N 121.559 -0.965 . . . . 0.0 108.73 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' A' ' 67' ' ' SER . 24.6 p -67.62 56.88 0.06 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.016 -1.052 . . . . 0.0 109.104 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 147.31 77.9 0.02 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.541 HH11 ' C ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -173.97 168.35 4.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.566 -0.961 . . . . 0.0 108.839 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.443 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.8 m -143.97 156.38 44.39 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.967 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.721 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 20.6 m95 -127.76 137.21 52.35 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.567 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -128.83 157.57 41.15 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 120.969 -1.082 . . . . 0.0 109.73 179.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.568 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -121.52 167.66 12.6 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.271 -0.893 . . . . 0.0 111.565 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.95 136.63 4.24 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.245 -0.909 . . . . 0.0 111.151 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.716 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -59.0 151.72 21.43 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.557 -0.714 . . . . 0.0 111.724 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.633 HD11 ' CG2' ' A' ' 88' ' ' ILE . 46.3 mm -135.69 144.58 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.489 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 58.31 70.36 0.66 Allowed 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.393 0.616 . . . . 0.0 110.407 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.792 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 61.6 t80 -129.54 161.1 31.26 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.076 -1.015 . . . . 0.0 109.455 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.611 ' OG1' ' N ' ' A' ' 80' ' ' SER . 28.5 p -140.9 -77.74 0.29 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.611 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -149.18 110.89 4.52 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.31 -104.04 0.24 Allowed Glycine 0 N--CA 1.502 3.038 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 44.2 t80 -141.32 -167.63 2.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.918 -0.754 . . . . 0.0 109.183 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.633 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.6 mtm180 -73.04 -153.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.165 -0.96 . . . . 0.0 109.415 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -168.35 -151.35 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.52 ' OG ' ' O ' ' A' ' 100' ' ' THR . 43.1 p -99.45 -4.16 32.05 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.645 -1.285 . . . . 0.0 110.114 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.457 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -91.04 118.14 30.16 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.287 -0.883 . . . . 0.0 110.492 -178.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.842 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.66 148.88 39.86 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.354 -0.841 . . . . 0.0 109.481 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.633 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.3 tt -116.59 136.65 52.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 72' ' ' ARG . 1.9 mm? -113.42 124.19 51.84 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.659 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -117.78 125.96 51.57 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.997 0.903 . . . . 0.0 109.466 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.721 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 5.1 p -92.12 158.54 16.14 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.852 0.834 . . . . 0.0 112.081 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.4 p -70.18 -19.69 63.17 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.533 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -82.43 10.12 7.78 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.347 -0.846 . . . . 0.0 109.928 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.453 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.85 30.22 0.47 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.712 -0.618 . . . . 0.0 110.099 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.423 HD12 HH21 ' A' ' 69' ' ' ARG . 29.6 mt -101.77 138.72 38.38 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.215 -0.928 . . . . 0.0 109.79 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.446 HG22 HD11 ' A' ' 109' ' ' ILE . 35.1 mm -113.23 119.51 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.469 -0.769 . . . . 0.0 110.024 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.428 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.9 m-85 -120.39 143.08 48.62 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.457 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 7.4 tptp -131.24 148.28 52.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.025 -1.047 . . . . 0.0 110.806 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.551 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.9 t -127.95 172.35 10.98 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.52 ' O ' ' OG ' ' A' ' 85' ' ' SER . 67.9 p -147.44 -1.45 0.62 Allowed 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.452 -0.78 . . . . 0.0 110.796 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.634 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -117.27 19.06 14.29 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.728 -1.232 . . . . 0.0 108.287 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.65 63.12 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.358 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.68 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 19.3 m-85 69.65 -13.23 0.41 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.873 -0.517 . . . . 0.0 111.334 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -50.72 -73.98 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.57 -1.331 . . . . 0.0 109.565 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.481 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 33.7 p -98.58 -177.42 3.67 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.67 134.81 7.15 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.968 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.4 m -128.39 139.0 52.6 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.615 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.7 tttp -86.26 140.21 30.32 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.937 -1.102 . . . . 0.0 109.904 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.446 HD11 HG22 ' A' ' 96' ' ' ILE . 12.8 pt -113.91 -31.26 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.689 -0.632 . . . . 0.0 109.642 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.63 HH21 ' CG ' ' A' ' 8' ' ' ASP . 66.7 mtt180 . . . . . 0 C--N 1.303 -1.426 0 O-C-N 121.126 -0.984 . . . . 0.0 108.846 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.621 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 20.2 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.399 0.618 . . . . 0.0 109.343 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 tt -170.13 159.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -146.17 30.14 1.05 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.766 -1.209 . . . . 0.0 111.306 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.4 p -104.8 158.14 16.73 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.594 0.712 . . . . 0.0 109.666 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.0 OUTLIER -60.68 -61.33 2.67 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.842 -1.161 . . . . 0.0 110.07 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.637 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.04 -41.48 78.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.213 -0.929 . . . . 0.0 109.659 -179.742 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.14 -44.83 94.62 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.676 HG22 ' HG2' ' A' ' 21' ' ' PRO . 53.3 t -67.31 -41.07 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.421 -1.047 . . . . 0.0 108.746 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.77 -57.86 9.45 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.17 -53.41 27.96 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.512 -0.742 . . . . 0.0 109.619 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.697 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 32.2 t80 -57.48 -50.6 72.52 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.454 0.645 . . . . 0.0 110.683 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tt -71.71 -45.14 62.75 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.3 -0.875 . . . . 0.0 110.886 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -62.12 -22.16 65.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.622 -1.299 . . . . 0.0 110.435 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 m -95.59 -40.93 9.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.077 -1.014 . . . . 0.0 111.021 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -110.28 17.06 21.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.958 -1.089 . . . . 0.0 112.002 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.2 m80 46.17 24.82 0.29 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.025 -1.047 . . . . 0.0 110.372 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.451 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.6 pttp -143.22 149.75 38.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.061 -1.024 . . . . 0.0 110.282 -178.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.6 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.6 mp -73.63 150.15 88.72 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.249 -0.907 . . . . 0.0 108.827 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.697 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 50.9 Cg_exo -38.94 153.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.333 2.688 . . . . 0.0 114.092 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.621 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -68.53 50.24 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.197 0.999 . . . . 0.0 110.692 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -171.32 25.77 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 109.928 179.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -117.81 116.39 26.89 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.46 -1.4 . . . . 0.0 110.399 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.0 pt -118.99 136.13 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 CA-C-O 122.167 0.984 . . . . 0.0 109.659 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.545 HG22 ' HA3' ' A' ' 53' ' ' GLY . 7.7 p -65.49 166.89 9.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.05 -1.031 . . . . 0.0 111.545 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.616 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 22.5 mtmt -68.48 -36.72 79.35 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.44 -65.17 0.52 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.109 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.9 mt-10 -63.72 -53.86 44.53 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 119.067 -1.053 . . . . 0.0 108.983 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -40.72 -51.56 3.05 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.653 -1.28 . . . . 0.0 108.597 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -57.38 -58.8 6.68 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.965 -1.084 . . . . 0.0 111.502 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.37 -32.23 68.38 Favored 'General case' 0 N--CA 1.51 2.562 0 O-C-N 120.663 -1.273 . . . . 0.0 108.811 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.412 HD21 ' HB ' ' A' ' 45' ' ' VAL . 27.8 tp -61.35 -23.43 65.75 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.49 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.49 50.98 0.36 Allowed Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.562 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -82.99 146.71 28.62 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.152 -1.205 . . . . 0.0 109.343 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.3 t -135.75 123.93 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.472 -0.768 . . . . 0.0 109.388 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -57.25 -52.61 64.63 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.846 -0.534 . . . . 0.0 109.763 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.3 p -69.79 48.7 0.09 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.389 -0.819 . . . . 0.0 109.72 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.645 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.3 ttpm? -178.31 -50.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.63 57.4 17.95 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.645 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -72.5 162.09 29.94 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.747 -0.855 . . . . 0.0 110.56 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.875 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.7 tp -175.62 -66.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.443 -0.785 . . . . 0.0 109.937 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.642 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -61.72 -18.96 61.75 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.77 -1.207 . . . . 0.0 109.988 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 45' ' ' VAL . 4.5 p-10 -79.18 -64.63 1.14 Allowed 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.912 0.863 . . . . 0.0 109.063 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.478 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 31.6 m -74.48 -12.07 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.918 -0.489 . . . . 0.0 110.158 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.4 71.07 13.01 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.47 -0.769 . . . . 0.0 109.412 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.48 123.58 13.91 Favored 'Trans proline' 0 N--CA 1.509 2.395 0 C-N-CA 122.919 2.413 . . . . 0.0 113.991 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.49 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 71.57 41.0 58.45 Favored Glycine 0 N--CA 1.502 3.049 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.5 mmtt -139.07 170.82 15.28 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 122.031 0.919 . . . . 0.0 110.962 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.417 ' HA ' HD21 ' A' ' 42' ' ' LEU . 74.8 m -144.81 160.63 40.96 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.204 1.002 . . . . 0.0 110.554 -177.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.8 mm -84.26 128.22 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.526 -0.734 . . . . 0.0 109.906 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.58 153.68 9.26 Favored Glycine 0 N--CA 1.499 2.88 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.545 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 121.75 -16.56 8.92 Favored Glycine 0 N--CA 1.5 2.925 0 C-N-CA 119.653 -1.26 . . . . 0.0 111.367 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -71.88 -150.64 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.795 -1.415 . . . . 0.0 110.037 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.93 140.7 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.561 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.624 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.3 t80 -106.68 90.1 3.22 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.514 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.3 p -60.0 38.22 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.388 0.613 . . . . 0.0 110.591 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 56' ' ' PHE . 63.8 t30 37.54 34.58 0.05 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.121 -0.987 . . . . 0.0 110.526 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.514 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.6 mtm180 -66.24 44.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.844 -1.16 . . . . 0.0 110.093 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.616 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 20.1 mt-10 -152.05 -26.42 0.18 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.483 -0.761 . . . . 0.0 109.918 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.6 28.08 62.0 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.671 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.0 mttp -110.31 5.11 21.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.527 -0.984 . . . . 0.0 109.102 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -127.98 144.46 51.57 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.792 -0.568 . . . . 0.0 109.673 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.52 124.89 15.02 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 123.048 2.499 . . . . 0.0 112.279 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.527 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -101.18 -173.94 28.8 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 68' ' ' GLY . 12.9 tttt 177.41 145.72 0.11 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.413 -1.051 . . . . 0.0 108.787 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 p -68.13 58.03 0.07 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.05 -1.031 . . . . 0.0 109.236 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 147.36 75.78 0.02 OUTLIER Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.531 ' NH2' ' OD1' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.46 169.92 5.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.684 -0.892 . . . . 0.0 109.225 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.454 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.9 m -145.23 155.39 43.22 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.829 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.721 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 20.3 m95 -126.13 138.78 53.7 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.573 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -129.35 155.8 45.05 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.789 -1.194 . . . . 0.0 109.58 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.616 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -120.28 166.25 13.75 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.255 -0.903 . . . . 0.0 111.551 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.53 134.66 3.34 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.197 -0.939 . . . . 0.0 110.69 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.712 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.91 152.14 16.71 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.359 0.599 . . . . 0.0 111.482 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.724 HD11 ' CG2' ' A' ' 88' ' ' ILE . 39.9 mm -134.9 142.85 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.559 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 57.8 71.69 0.56 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.288 0.566 . . . . 0.0 110.266 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.875 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 63.0 t80 -129.13 159.72 35.12 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.417 -0.802 . . . . 0.0 109.318 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.6 ' OG1' ' N ' ' A' ' 80' ' ' SER . 24.2 p -140.65 -78.33 0.29 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.642 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -150.05 107.58 3.65 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.66 -103.93 0.23 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.484 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 50.7 t80 -141.72 -170.02 3.03 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.638 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.5 mtm180 -70.41 -151.95 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.131 -0.981 . . . . 0.0 109.815 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -172.07 -151.89 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 100' ' ' THR . 43.8 p -98.9 -5.3 31.06 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.69 -1.256 . . . . 0.0 110.43 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -90.07 117.69 29.05 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.186 -0.946 . . . . 0.0 110.52 -178.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.856 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.31 149.64 43.03 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.724 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.8 tt -117.74 135.83 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.434 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.0 mm? -112.63 124.86 53.5 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.69 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.7 127.42 53.55 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.709 0.766 . . . . 0.0 109.205 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.721 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.1 p -94.35 158.95 15.33 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.173 0.987 . . . . 0.0 112.522 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.1 p -69.75 -19.08 63.54 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.531 ' OD1' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -83.24 10.46 8.4 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.762 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.443 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.46 29.97 0.52 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.634 -0.666 . . . . 0.0 110.025 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.41 HD12 HH21 ' A' ' 69' ' ' ARG . 23.4 mt -101.96 136.52 41.66 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.319 -0.863 . . . . 0.0 109.807 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.459 HG22 HD11 ' A' ' 109' ' ' ILE . 32.9 mm -110.38 119.92 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.576 -0.703 . . . . 0.0 110.251 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.429 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.3 m-85 -120.68 142.64 49.29 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.458 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 8.7 tptp -130.96 147.02 52.55 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.776 0.798 . . . . 0.0 111.005 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.573 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.4 t -127.51 171.53 11.52 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.442 ' O ' ' OG ' ' A' ' 85' ' ' SER . 74.6 p -146.85 -1.72 0.66 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.386 -0.821 . . . . 0.0 110.328 178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.627 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -116.68 18.75 14.83 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.806 -1.184 . . . . 0.0 108.353 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.53 63.27 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.449 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.671 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 19.9 m-85 69.99 -14.12 0.39 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.774 -0.579 . . . . 0.0 111.614 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -51.39 -73.33 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.754 -1.216 . . . . 0.0 109.578 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.504 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 33.2 p -98.65 -178.08 3.87 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.434 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -160.85 133.53 6.25 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.935 -1.103 . . . . 0.0 109.847 -179.245 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.7 m -127.87 140.05 52.25 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.615 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 16.3 tttp -86.01 139.71 30.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.123 -0.985 . . . . 0.0 109.971 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.459 HD11 HG22 ' A' ' 96' ' ' ILE . 12.0 pt -113.38 -32.43 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.637 HH21 ' CG ' ' A' ' 8' ' ' ASP . 62.2 mtt180 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.103 -0.998 . . . . 0.0 109.198 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.629 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 36.0 t . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 4' ' ' ILE . 1.6 tt -171.52 158.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.0 p30 -146.08 29.97 1.07 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.472 -1.392 . . . . 0.0 111.241 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 10' ' ' VAL . 24.9 p -105.69 155.94 18.77 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.2 p90 -58.66 -63.79 1.16 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.961 -1.087 . . . . 0.0 110.463 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.614 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -53.81 -43.46 69.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.516 -0.74 . . . . 0.0 109.449 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.39 -44.72 89.86 Favored Glycine 0 N--CA 1.5 2.965 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.682 HG22 ' HG2' ' A' ' 21' ' ' PRO . 63.2 t -67.3 -41.32 86.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 121.51 -0.994 . . . . 0.0 108.786 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.36 -58.84 6.19 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.82 -55.0 12.87 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.371 -0.83 . . . . 0.0 109.663 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.646 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 35.0 t80 -56.26 -50.76 70.43 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.284 0.564 . . . . 0.0 110.627 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.3 tt -72.26 -44.37 62.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.406 -0.809 . . . . 0.0 111.282 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -62.76 -21.31 65.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.605 -1.309 . . . . 0.0 110.08 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.0 m -95.9 -40.5 9.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.927 -1.108 . . . . 0.0 111.283 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -111.14 17.26 20.52 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.055 -1.028 . . . . 0.0 111.987 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.0 m80 45.78 25.01 0.25 Allowed 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.845 -1.159 . . . . 0.0 110.271 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.453 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.4 pttp -141.88 152.51 43.67 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.075 -1.016 . . . . 0.0 110.898 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.543 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.3 mp -76.78 148.73 79.72 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.224 -0.922 . . . . 0.0 109.303 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HG2' HG22 ' A' ' 10' ' ' VAL . 73.7 Cg_exo -38.23 152.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 122.904 2.403 . . . . 0.0 114.428 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -66.06 48.52 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 122.122 0.963 . . . . 0.0 110.094 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.7 OUTLIER -169.23 24.16 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.671 -1.268 . . . . 0.0 110.126 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -117.39 116.25 26.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.968 -1.082 . . . . 0.0 110.86 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.4 pt -118.03 141.01 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.833 0.825 . . . . 0.0 109.312 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.626 HG22 ' HA3' ' A' ' 53' ' ' GLY . 6.2 p -70.98 166.29 21.61 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.967 -1.083 . . . . 0.0 111.479 -177.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.629 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 20.2 mtmt -67.19 -36.39 81.64 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.78 -65.08 0.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.6 177.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.46 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.2 mt-10 -63.34 -52.47 61.66 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.025 -1.07 . . . . 0.0 108.342 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -41.69 -49.78 4.22 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.174 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 37.8 mt-30 -60.81 -55.72 29.69 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.36 -0.837 . . . . 0.0 111.755 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.49 -31.8 70.82 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.669 -1.269 . . . . 0.0 109.276 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 20.2 tp -60.83 -31.36 70.78 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.96 52.09 0.15 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.677 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -83.77 146.39 28.18 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.083 -1.245 . . . . 0.0 109.888 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -137.56 125.86 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.274 -0.891 . . . . 0.0 109.373 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -57.27 -53.28 59.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.924 -0.485 . . . . 0.0 110.501 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.7 p -69.08 48.75 0.07 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.979 -1.076 . . . . 0.0 109.716 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.648 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -178.81 -49.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.52 55.37 29.25 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.677 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -70.8 160.17 33.22 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 121.64 -0.918 . . . . 0.0 110.458 -179.063 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.813 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 58.9 tp -174.98 -67.29 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.497 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.653 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -58.52 -20.19 43.94 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.339 -0.851 . . . . 0.0 110.093 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.8 p-10 -79.63 -65.39 1.01 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.678 0.752 . . . . 0.0 109.874 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.457 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 28.9 m -75.98 -6.82 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.799 -0.563 . . . . 0.0 110.708 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.0 69.03 9.04 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -57.69 122.32 11.55 Favored 'Trans proline' 0 N--CA 1.508 2.324 0 C-N-CA 123.595 2.863 . . . . 0.0 113.853 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.95 38.99 55.61 Favored Glycine 0 N--CA 1.501 3.016 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 8.7 mmtm -138.38 178.16 7.34 Favored 'General case' 0 N--CA 1.51 2.546 0 CA-C-O 122.248 1.023 . . . . 0.0 111.455 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.419 ' HG ' ' HD2' ' A' ' 78' ' ' TYR . 63.9 m -150.53 161.0 43.38 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.857 -1.152 . . . . 0.0 111.417 -177.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.8 mm -83.37 126.17 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.092 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.72 152.97 8.74 Favored Glycine 0 N--CA 1.499 2.842 0 C-N-CA 119.981 -1.104 . . . . 0.0 110.38 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.626 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 122.43 -17.35 8.42 Favored Glycine 0 N--CA 1.498 2.778 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.052 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -69.95 -153.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.633 -1.51 . . . . 0.0 109.752 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.95 138.42 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.43 -0.794 . . . . 0.0 110.399 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.641 ' O ' ' N ' ' A' ' 58' ' ' ASN . 10.0 t80 -104.36 89.77 3.34 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.546 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -59.5 39.17 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.529 -0.732 . . . . 0.0 110.682 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.641 ' N ' ' O ' ' A' ' 56' ' ' PHE . 59.5 t30 36.83 34.88 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.069 -1.02 . . . . 0.0 110.483 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.546 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.2 mtm180 -66.71 45.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.822 -1.174 . . . . 0.0 109.602 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.61 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 18.9 mt-10 -151.74 -26.84 0.19 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.467 -0.771 . . . . 0.0 110.028 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.27 27.9 61.0 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.669 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.7 mttp -110.69 5.7 21.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.66 -0.906 . . . . 0.0 109.468 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.93 143.6 49.31 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.8 124.42 14.04 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.637 2.224 . . . . 0.0 112.239 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.519 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -99.81 -173.82 30.62 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 68' ' ' GLY . 11.1 tttt 177.92 146.27 0.13 Allowed 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.456 -1.026 . . . . 0.0 108.834 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.4 p -68.01 58.18 0.07 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.975 -1.078 . . . . 0.0 109.031 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 146.86 76.69 0.02 OUTLIER Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.542 ' NH2' ' OD1' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -173.35 168.89 4.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.597 -0.943 . . . . 0.0 109.161 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.454 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.3 m -145.65 155.2 42.85 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.834 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.726 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 21.5 m95 -125.39 138.8 54.04 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.558 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -129.72 156.06 44.9 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.798 -1.189 . . . . 0.0 109.517 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.629 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -120.03 167.54 12.07 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.3 -0.875 . . . . 0.0 112.136 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.46 135.59 3.62 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.237 -0.915 . . . . 0.0 111.153 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.692 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.93 154.7 11.88 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.743 -0.598 . . . . 0.0 111.546 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.706 HD11 ' CG2' ' A' ' 88' ' ' ILE . 45.2 mm -136.87 143.5 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.518 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 57.62 70.01 0.69 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.192 0.52 . . . . 0.0 110.589 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.813 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 59.5 t80 -128.37 161.33 29.68 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.02 -1.05 . . . . 0.0 109.331 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.608 ' OG1' ' N ' ' A' ' 80' ' ' SER . 26.9 p -141.43 -76.69 0.29 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.653 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -150.47 110.33 4.09 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.73 -103.67 0.24 Allowed Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 45.4 t80 -142.46 -169.96 3.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.89 -0.77 . . . . 0.0 109.156 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.657 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.2 mtm180 -71.47 -158.09 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.24 -0.912 . . . . 0.0 109.159 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -166.33 -150.9 0.12 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.505 ' OG ' ' O ' ' A' ' 100' ' ' THR . 53.8 p -99.0 -6.38 28.67 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.404 -1.435 . . . . 0.0 110.391 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.47 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -89.11 118.02 28.52 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.099 -1.001 . . . . 0.0 110.992 -178.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.857 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.03 149.97 42.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 0.0 109.685 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.706 ' CG2' HD11 ' A' ' 76' ' ' ILE . 5.2 tt -118.15 137.42 52.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 72' ' ' ARG . 1.9 mm? -113.85 124.88 53.29 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.63 127.67 53.81 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.724 0.773 . . . . 0.0 109.213 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.726 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.0 p -94.13 158.37 15.64 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 122.449 1.119 . . . . 0.0 112.382 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.8 p -68.93 -20.3 64.21 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.542 ' OD1' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -83.1 11.04 6.87 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.062 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.448 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.62 29.63 0.52 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.601 -0.687 . . . . 0.0 110.42 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.407 HD12 HH21 ' A' ' 69' ' ' ARG . 23.1 mt -102.78 136.86 41.83 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.501 HG22 HD11 ' A' ' 109' ' ' ILE . 31.7 mm -110.84 119.7 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.523 -0.736 . . . . 0.0 110.104 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.455 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.2 m-85 -119.88 142.81 48.34 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.47 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 8.2 tptp -130.7 147.29 52.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.847 -1.158 . . . . 0.0 110.691 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.493 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.5 t -128.46 171.43 12.08 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.505 ' O ' ' OG ' ' A' ' 85' ' ' SER . 76.5 p -146.51 -3.63 0.62 Allowed 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.491 -0.756 . . . . 0.0 110.459 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.639 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -114.36 19.52 16.19 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.792 -1.192 . . . . 0.0 108.455 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.11 62.41 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.15 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.669 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 21.6 m-85 70.36 -14.57 0.39 Allowed 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.826 -0.546 . . . . 0.0 111.66 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -49.98 -72.88 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.661 -1.275 . . . . 0.0 109.886 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.502 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 42.0 p -100.42 -178.31 3.77 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.65 135.19 8.39 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.045 -1.034 . . . . 0.0 110.332 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.1 m -128.13 139.14 52.66 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.601 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.8 tttp -86.02 139.15 31.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.835 -1.166 . . . . 0.0 110.003 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.501 HD11 HG22 ' A' ' 96' ' ' ILE . 10.8 pt -111.96 -32.91 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.63 -0.669 . . . . 0.0 109.791 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.614 HH21 ' CG ' ' A' ' 8' ' ' ASP . 69.0 mtt180 . . . . . 0 N--CA 1.487 1.412 0 O-C-N 121.281 -0.887 . . . . 0.0 108.678 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.633 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.8 t . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 tt -171.15 158.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -145.4 29.67 1.15 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.411 -1.431 . . . . 0.0 111.466 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.7 p -103.67 157.15 17.26 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.436 -0.79 . . . . 0.0 109.762 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.4 p90 -59.87 -63.13 1.41 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.211 -0.93 . . . . 0.0 109.897 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.586 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.8 OUTLIER -56.01 -42.25 76.15 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.165 -0.959 . . . . 0.0 109.679 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.4 -44.98 85.07 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.772 HG22 ' HG2' ' A' ' 21' ' ' PRO . 53.3 t -67.93 -42.51 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.24 -58.6 7.65 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.9 -53.13 27.92 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.766 -1.209 . . . . 0.0 110.103 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.672 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 36.6 t80 -57.24 -48.61 78.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.669 -0.644 . . . . 0.0 110.418 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -73.91 -43.89 56.94 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.493 -0.755 . . . . 0.0 110.974 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -63.7 -20.04 65.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.443 -1.411 . . . . 0.0 109.981 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 m -98.12 -40.29 8.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.697 -1.252 . . . . 0.0 110.544 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -109.66 14.62 23.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 112.022 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.8 m80 46.77 24.98 0.39 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.668 -1.27 . . . . 0.0 110.41 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -143.57 149.82 37.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.177 -0.952 . . . . 0.0 110.828 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.587 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.5 mp -72.72 149.48 90.52 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 120.98 -1.075 . . . . 0.0 109.565 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.772 ' HG2' HG22 ' A' ' 10' ' ' VAL . 51.3 Cg_exo -40.36 150.8 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 123.189 2.592 . . . . 0.0 113.716 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.633 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -63.95 48.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.541 0.686 . . . . 0.0 110.489 -179.205 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -171.43 28.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.02 -1.05 . . . . 0.0 110.67 179.103 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -119.11 115.08 23.53 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.191 -0.943 . . . . 0.0 110.719 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.5 pt -117.38 140.32 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.53 HG22 ' HA3' ' A' ' 53' ' ' GLY . 11.5 p -70.82 167.26 19.28 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.054 0.93 . . . . 0.0 111.75 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.568 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 23.6 mtmt -68.49 -37.32 80.01 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.406 ' HG ' ' CB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -40.43 -67.83 0.21 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 113.873 -1.512 . . . . 0.0 108.217 177.187 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.515 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.0 mt-10 -63.57 -54.43 36.14 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.233 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.515 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -39.18 -51.84 1.94 Allowed 'General case' 0 CA--C 1.566 1.569 0 O-C-N 120.318 -1.489 . . . . 0.0 109.033 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.439 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 41.2 mt-30 -58.93 -57.69 11.93 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.661 -0.649 . . . . 0.0 111.219 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.15 -32.84 71.41 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.819 -1.175 . . . . 0.0 110.006 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.1 tp -59.45 -27.78 66.38 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.96 52.5 0.21 Allowed Glycine 0 N--CA 1.502 3.09 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.605 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -85.04 146.2 27.3 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.549 -0.971 . . . . 0.0 111.007 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.6 t -137.14 124.59 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 O-C-N 121.394 -0.816 . . . . 0.0 109.79 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -57.27 -50.87 71.52 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 122.037 -0.414 . . . . 0.0 110.369 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.3 p -70.06 49.06 0.1 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.3 -0.875 . . . . 0.0 109.443 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.646 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -179.13 -52.97 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.69 57.05 13.5 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.646 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -71.79 162.29 29.68 Favored 'General case' 0 C--N 1.289 -2.058 0 O-C-N 121.728 -0.866 . . . . 0.0 111.067 -178.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.819 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 64.6 tp -174.44 -67.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.772 -1.205 . . . . 0.0 109.995 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -61.33 -18.96 61.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.509 -0.744 . . . . 0.0 109.827 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 3.9 p-10 -80.22 -62.1 1.78 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.091 0.948 . . . . 0.0 108.742 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 45' ' ' VAL . 16.3 m -75.65 -11.35 14.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.663 -1.273 . . . . 0.0 109.293 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.78 72.6 10.5 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 120.996 -1.065 . . . . 0.0 109.855 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.61 125.76 19.29 Favored 'Trans proline' 0 N--CA 1.509 2.415 0 C-N-CA 123.051 2.5 . . . . 0.0 114.323 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.571 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 72.74 40.15 53.67 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.571 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.8 mmtm -141.41 170.8 15.04 Favored 'General case' 0 N--CA 1.508 2.426 0 CA-C-O 121.674 0.749 . . . . 0.0 111.567 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.478 ' HG ' ' HD2' ' A' ' 78' ' ' TYR . 72.5 m -144.32 162.58 36.07 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 122.794 1.283 . . . . 0.0 110.935 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.6 mm -83.81 126.26 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.923 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 172.85 153.05 9.11 Favored Glycine 0 N--CA 1.501 3.021 0 O-C-N 120.575 -1.328 . . . . 0.0 109.98 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.53 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 120.38 -15.39 9.98 Favored Glycine 0 N--CA 1.499 2.866 0 O-C-N 121.145 -1.209 . . . . 0.0 111.166 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 1.6 m-20 -70.49 -154.9 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.547 -1.56 . . . . 0.0 109.473 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.0 mp -129.29 135.74 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 122.055 0.931 . . . . 0.0 110.169 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.633 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.7 t80 -101.8 89.16 3.58 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.67 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 2.2 p -59.3 40.25 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 121.306 0.574 . . . . 0.0 110.766 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.633 ' N ' ' O ' ' A' ' 56' ' ' PHE . 61.5 t30 34.13 37.12 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.372 -0.83 . . . . 0.0 110.4 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.67 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.1 mtm180 -68.02 40.1 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -0.951 . . . . 0.0 109.929 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.603 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 21.6 mt-10 -148.98 -19.38 0.3 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.024 -1.047 . . . . 0.0 110.44 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.45 31.45 68.35 Favored Glycine 0 N--CA 1.499 2.871 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.684 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.7 mttp -114.3 8.28 16.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.575 -0.956 . . . . 0.0 108.932 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mt -131.96 143.99 51.33 Favored Pre-proline 0 N--CA 1.491 1.583 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -63.37 124.3 13.57 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.681 2.254 . . . . 0.0 112.005 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.532 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -100.39 -172.04 29.56 Favored Glycine 0 N--CA 1.499 2.851 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 68' ' ' GLY . 10.3 tttt 177.03 146.55 0.1 Allowed 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.678 -0.895 . . . . 0.0 108.938 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.8 p -68.19 58.32 0.08 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.91 -1.119 . . . . 0.0 109.281 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 145.52 76.66 0.03 OUTLIER Glycine 0 N--CA 1.5 2.946 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.536 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.09 165.8 6.15 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.657 -0.908 . . . . 0.0 109.239 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.0 m -142.18 154.01 44.49 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.378 -0.826 . . . . 0.0 109.69 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.705 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 19.2 m95 -125.42 139.3 53.77 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.537 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -129.97 155.28 46.35 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.295 -0.878 . . . . 0.0 109.918 179.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.568 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -119.2 166.52 12.86 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.227 -0.921 . . . . 0.0 111.295 -179.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.85 134.8 3.19 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.182 -0.949 . . . . 0.0 110.955 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.703 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -57.04 152.43 13.21 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.457 0.646 . . . . 0.0 111.548 -179.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 75' ' ' ASP . 42.0 mm -135.53 142.58 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.08 -1.013 . . . . 0.0 110.084 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 58.62 71.24 0.59 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.403 0.621 . . . . 0.0 110.517 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.819 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 65.1 t80 -129.59 159.3 36.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.354 -0.841 . . . . 0.0 109.382 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 80' ' ' SER . 29.4 p -139.87 -78.94 0.31 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.642 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -149.86 106.65 3.54 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.84 -102.78 0.21 Allowed Glycine 0 N--CA 1.5 2.926 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.482 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 52.4 t80 -142.38 -168.0 2.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.86 -0.788 . . . . 0.0 108.977 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.652 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.8 mtm180 -73.09 -152.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.823 -1.173 . . . . 0.0 109.807 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -170.48 -150.61 0.07 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 100' ' ' THR . 40.6 p -100.75 -5.77 25.91 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.754 -1.216 . . . . 0.0 110.345 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.5 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -90.44 118.81 30.21 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.906 -1.121 . . . . 0.0 110.272 -178.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.865 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.52 150.42 42.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.187 -0.946 . . . . 0.0 109.346 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.662 ' CG2' HD11 ' A' ' 76' ' ' ILE . 3.6 tt -117.29 138.83 46.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.462 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.2 mm? -114.84 123.51 49.37 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.664 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -116.71 126.87 53.8 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.561 0.696 . . . . 0.0 109.357 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.705 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 3.1 p -93.07 158.94 15.52 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.163 0.983 . . . . 0.0 111.929 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.9 p -70.03 -20.33 63.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.446 -0.784 . . . . 0.0 108.913 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.536 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.47 10.2 6.19 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.468 -0.77 . . . . 0.0 109.867 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.475 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.76 30.07 0.48 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.654 -0.654 . . . . 0.0 110.148 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.4 HD12 HH21 ' A' ' 69' ' ' ARG . 26.5 mt -102.45 137.48 40.63 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.313 -0.867 . . . . 0.0 110.121 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.48 HG22 HD11 ' A' ' 109' ' ' ILE . 30.8 mm -110.75 119.14 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.28 -0.888 . . . . 0.0 110.951 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.448 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.5 m-85 -119.82 143.44 47.87 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.5 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 7.3 tptp -132.47 148.03 52.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.185 -0.947 . . . . 0.0 110.816 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.529 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.2 t -127.61 171.85 11.28 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.459 ' O ' ' OG ' ' A' ' 85' ' ' SER . 73.5 p -146.74 -1.82 0.67 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.274 -0.891 . . . . 0.0 110.358 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.631 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -117.36 19.31 14.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.823 -1.173 . . . . 0.0 108.681 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.94 61.63 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.237 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.684 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 19.6 m-85 70.01 -13.8 0.41 Allowed 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.711 -0.618 . . . . 0.0 111.529 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -49.83 -72.97 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.734 -1.228 . . . . 0.0 109.437 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.485 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 34.5 p -99.5 -176.18 3.21 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.462 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -161.8 135.07 6.28 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.174 -0.953 . . . . 0.0 109.666 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 55.0 m -128.33 140.7 51.72 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.615 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.4 tttp -87.25 139.91 30.08 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.7 -1.25 . . . . 0.0 110.306 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.48 HD11 HG22 ' A' ' 96' ' ' ILE . 13.6 pt -113.22 -32.72 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.485 -0.76 . . . . 0.0 109.75 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.615 ' O ' ' NZ ' ' A' ' 108' ' ' LYS . 60.5 mtt180 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 118.292 -0.861 . . . . 0.0 109.528 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.626 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.0 t . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 4' ' ' ILE . 1.7 tt -170.8 159.87 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -144.46 27.74 1.37 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.793 -1.192 . . . . 0.0 111.501 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 10' ' ' VAL . 18.0 p -105.54 158.03 16.97 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.859 0.837 . . . . 0.0 110.761 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.7 p90 -60.02 -61.16 2.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.595 -1.316 . . . . 0.0 110.997 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.651 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.81 -39.83 78.51 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.0 -1.062 . . . . 0.0 110.102 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.44 -44.25 96.81 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.667 HG22 ' HG2' ' A' ' 21' ' ' PRO . 54.5 t -67.66 -41.73 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.313 -1.11 . . . . 0.0 108.535 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.33 -58.94 5.86 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.98 -54.21 16.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.421 -0.8 . . . . 0.0 109.861 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.689 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 35.4 t80 -57.35 -49.62 75.55 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.569 -0.707 . . . . 0.0 110.737 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.89 -45.14 62.32 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.125 -0.985 . . . . 0.0 110.631 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -62.71 -20.11 64.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.23 -1.544 . . . . 0.0 110.615 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.0 m -98.07 -39.33 8.97 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.954 -1.091 . . . . 0.0 110.977 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -111.34 15.79 21.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.796 -1.19 . . . . 0.0 111.967 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.8 m80 46.75 23.74 0.28 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.109 -0.994 . . . . 0.0 110.867 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.2 pttp -141.16 150.81 43.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 109.792 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.568 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.7 mp -73.87 150.13 88.17 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.803 -1.186 . . . . 0.0 108.901 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.689 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 51.3 Cg_exo -38.07 150.66 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 124.016 3.144 . . . . 0.0 113.701 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.626 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -65.77 46.73 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.747 0.784 . . . . 0.0 111.405 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.7 OUTLIER -169.82 26.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 109.818 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -117.9 119.72 35.69 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.836 -1.165 . . . . 0.0 110.622 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.1 pt -121.12 139.52 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.818 0.818 . . . . 0.0 109.194 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.696 HG22 ' HA3' ' A' ' 53' ' ' GLY . 6.1 p -69.78 167.63 16.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.893 -1.129 . . . . 0.0 111.094 -177.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.554 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 19.1 mtmt -68.22 -33.04 73.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.12 -63.65 0.93 Allowed 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.493 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.7 mt-10 -66.44 -51.58 55.37 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -41.35 -51.41 3.68 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.662 -1.215 . . . . 0.0 108.686 177.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.415 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 39.3 mt-30 -60.14 -56.38 22.26 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.399 -0.813 . . . . 0.0 111.201 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.13 -27.85 68.68 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.263 -1.523 . . . . 0.0 109.147 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.1 tp -64.74 -23.35 67.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.706 -0.621 . . . . 0.0 110.233 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.4 51.78 0.28 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -84.43 144.18 28.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.29 -1.123 . . . . 0.0 109.853 179.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.2 t -136.14 125.18 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.226 -0.921 . . . . 0.0 109.627 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.5 -51.46 68.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.967 -0.458 . . . . 0.0 110.547 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.7 p -71.55 48.32 0.14 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.96 -1.088 . . . . 0.0 109.777 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.637 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.4 ttpm? -177.44 -49.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.76 54.79 31.08 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.637 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -71.21 160.27 33.14 Favored 'General case' 0 C--N 1.29 -2.021 0 O-C-N 121.479 -1.012 . . . . 0.0 110.311 -178.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.84 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 64.9 tp -174.94 -67.26 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.581 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.635 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -58.49 -21.29 51.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.817 -1.177 . . . . 0.0 109.467 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 3.2 p-10 -77.86 -63.42 1.39 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.684 0.754 . . . . 0.0 109.441 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.402 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 22.5 m -76.21 -8.78 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.724 -0.61 . . . . 0.0 109.734 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.13 68.79 8.87 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.148 -0.97 . . . . 0.0 109.292 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -57.26 124.51 16.34 Favored 'Trans proline' 0 N--CA 1.506 2.259 0 C-N-CA 123.306 2.67 . . . . 0.0 113.511 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.538 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 69.86 41.05 74.15 Favored Glycine 0 N--CA 1.501 3.033 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.4 mmtm -139.56 175.85 9.22 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.647 -0.914 . . . . 0.0 110.533 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.1 m -148.74 160.62 43.01 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.493 1.139 . . . . 0.0 110.957 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.0 mm -82.02 127.15 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.786 0.803 . . . . 0.0 110.493 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.33 153.55 9.08 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.696 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 122.31 -17.48 8.47 Favored Glycine 0 N--CA 1.507 3.433 0 O-C-N 121.57 -0.959 . . . . 0.0 110.799 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 1.2 m-20 -69.71 -156.21 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.629 -1.512 . . . . 0.0 109.619 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.83 140.72 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-O 121.604 0.716 . . . . 0.0 110.435 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.668 ' O ' ' N ' ' A' ' 58' ' ' ASN . 9.2 t80 -107.03 88.54 2.76 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.687 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -58.03 38.72 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.826 -0.546 . . . . 0.0 110.675 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.668 ' N ' ' O ' ' A' ' 56' ' ' PHE . 59.9 t30 35.76 38.75 0.06 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.074 -1.016 . . . . 0.0 110.001 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.687 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.2 mtm180 -69.61 41.79 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.745 -1.222 . . . . 0.0 109.832 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.611 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 17.5 mt-10 -148.0 -24.56 0.35 Allowed 'General case' 0 N--CA 1.485 1.285 0 O-C-N 120.698 -1.251 . . . . 0.0 109.717 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.3 27.66 61.37 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.68 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.8 mttp -111.84 7.51 20.15 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.921 -0.752 . . . . 0.0 109.637 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -129.61 143.79 50.36 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.83 123.54 12.48 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 122.613 2.209 . . . . 0.0 112.886 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.527 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -97.94 -174.17 33.3 Favored Glycine 0 N--CA 1.506 3.341 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.549 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 11.1 tttt 177.62 145.82 0.12 Allowed 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.447 -1.031 . . . . 0.0 108.707 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.0 p -68.71 58.85 0.09 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.888 -1.133 . . . . 0.0 108.767 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.549 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 146.67 74.39 0.02 OUTLIER Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.538 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -171.82 167.86 6.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.509 -0.995 . . . . 0.0 109.193 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.455 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 93.0 m -144.06 155.6 44.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 110.331 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.74 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 20.7 m95 -125.41 137.59 54.01 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.588 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -127.57 156.28 42.5 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.869 -1.144 . . . . 0.0 109.054 179.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.554 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -121.18 166.86 13.36 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.089 -1.007 . . . . 0.0 111.306 -179.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.52 134.71 3.36 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.313 -0.867 . . . . 0.0 110.979 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.66 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -56.23 152.23 11.27 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.611 0.719 . . . . 0.0 111.449 179.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.717 HD11 ' CG2' ' A' ' 88' ' ' ILE . 38.3 mm -135.5 143.58 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.563 -0.711 . . . . 0.0 110.106 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 58.41 69.47 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.365 0.603 . . . . 0.0 110.497 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.84 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 69.4 t80 -128.24 160.16 32.97 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.244 -0.91 . . . . 0.0 109.631 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.617 ' OG1' ' N ' ' A' ' 80' ' ' SER . 25.1 p -142.23 -78.5 0.25 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.635 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -148.67 107.95 3.93 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.85 -102.06 0.2 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 51.4 t80 -143.0 -168.52 2.81 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.635 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.4 mtm180 -72.99 -150.61 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.688 -1.257 . . . . 0.0 109.314 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.596 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 10.4 p30 -171.52 -151.28 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.6 p -99.83 -7.23 25.65 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.673 -1.267 . . . . 0.0 110.201 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.472 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -88.51 118.78 28.39 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.132 -0.98 . . . . 0.0 110.276 -178.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.859 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.77 150.32 43.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.429 -0.795 . . . . 0.0 110.014 179.038 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.717 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.0 tt -117.02 136.76 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 108.983 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.406 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.9 mm? -112.89 124.7 53.2 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.679 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.36 126.72 52.68 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.11 0.957 . . . . 0.0 109.494 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.74 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.7 p -94.39 158.34 15.61 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 122.292 1.044 . . . . 0.0 112.085 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.5 p -68.53 -21.17 64.58 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.538 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.61 10.77 5.45 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.196 -0.94 . . . . 0.0 110.144 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.435 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 76.97 31.12 0.53 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.927 -0.483 . . . . 0.0 110.051 179.513 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.409 HD12 HH21 ' A' ' 69' ' ' ARG . 26.8 mt -103.48 136.26 43.54 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.279 -0.888 . . . . 0.0 109.816 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.458 HG22 HD11 ' A' ' 109' ' ' ILE . 34.1 mm -110.37 120.02 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.248 -0.907 . . . . 0.0 110.204 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.448 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.3 m-85 -120.17 143.47 48.21 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.472 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 7.7 tptp -131.74 147.41 52.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 110.967 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.558 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.2 t -127.79 169.9 13.36 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.1 p -144.79 -2.99 0.8 Allowed 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.663 -0.648 . . . . 0.0 110.22 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.631 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -115.37 18.79 15.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.596 -1.315 . . . . 0.0 108.566 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.9 63.55 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.167 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.68 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 18.0 m-85 69.09 -13.64 0.34 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.899 -0.501 . . . . 0.0 111.736 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -51.46 -73.5 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.384 -1.448 . . . . 0.0 109.8 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.509 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 36.3 p -99.03 -178.48 3.95 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.32 134.24 7.15 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.845 -1.159 . . . . 0.0 110.0 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 78.3 m -127.38 140.66 52.03 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.628 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.8 tttp -86.22 139.33 31.14 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.063 -1.023 . . . . 0.0 109.928 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.458 HD11 HG22 ' A' ' 96' ' ' ILE . 13.2 pt -112.43 -31.66 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.695 -0.628 . . . . 0.0 109.728 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.651 HH21 ' CG ' ' A' ' 8' ' ' ASP . 61.8 mtt180 . . . . . 0 C--N 1.306 -1.298 0 O-C-N 120.962 -1.086 . . . . 0.0 108.756 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.638 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 24.1 t . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 tt -171.06 160.84 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -145.98 29.52 1.09 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.473 -1.392 . . . . 0.0 111.465 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 10' ' ' VAL . 22.0 p -106.18 156.84 18.04 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.785 0.802 . . . . 0.0 110.05 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.504 ' HA ' HD12 ' A' ' 88' ' ' ILE . 1.7 p90 -59.91 -62.45 1.86 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.899 -1.126 . . . . 0.0 110.745 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.653 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -55.74 -42.7 75.78 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.35 -0.844 . . . . 0.0 109.565 179.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.0 -44.75 87.96 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.678 HG22 ' HG2' ' A' ' 21' ' ' PRO . 75.0 t -68.22 -41.05 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 O-C-N 121.58 -0.953 . . . . 0.0 108.771 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.2 -58.29 8.32 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.26 -54.3 17.49 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.402 -0.811 . . . . 0.0 110.087 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.655 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 38.8 t80 -57.32 -50.1 74.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.911 -0.493 . . . . 0.0 110.429 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.85 -43.48 65.42 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.537 -0.727 . . . . 0.0 111.189 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -63.54 -20.1 65.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.31 -1.494 . . . . 0.0 110.314 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.5 m -97.28 -39.9 9.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.048 -1.032 . . . . 0.0 111.219 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.9 16.47 20.35 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.213 -0.93 . . . . 0.0 111.953 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.5 m80 46.82 24.38 0.34 Allowed 'General case' 0 N--CA 1.511 2.606 0 O-C-N 120.414 -1.429 . . . . 0.0 110.599 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 pttp -142.5 152.57 42.82 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.041 -1.037 . . . . 0.0 110.999 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.519 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.4 mp -75.45 148.53 83.29 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.313 -0.867 . . . . 0.0 109.442 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.678 ' HG2' HG22 ' A' ' 10' ' ' VAL . 54.0 Cg_exo -38.74 150.0 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.623 2.882 . . . . 0.0 113.58 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -63.64 46.62 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.572 0.701 . . . . 0.0 110.883 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -169.6 27.22 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.108 -0.995 . . . . 0.0 110.342 179.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -117.56 116.41 27.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.004 -1.06 . . . . 0.0 110.616 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 31.0 pt -119.11 139.36 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.313 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.581 HG22 ' HA3' ' A' ' 53' ' ' GLY . 5.1 p -70.33 166.35 20.41 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.056 -1.028 . . . . 0.0 111.206 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.604 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 20.5 mtmt -67.19 -37.41 83.64 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -40.91 -67.08 0.27 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.482 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.9 mt-10 -62.49 -54.46 39.61 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.297 -0.961 . . . . 0.0 108.994 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -39.18 -51.41 1.94 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.699 -1.251 . . . . 0.0 109.136 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.39 -57.63 12.16 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.549 -0.719 . . . . 0.0 111.019 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.9 -30.35 70.12 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 120.545 -1.347 . . . . 0.0 109.13 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.8 tp -61.51 -25.66 67.41 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.672 -0.642 . . . . 0.0 109.517 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.27 49.56 0.27 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.574 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -82.53 144.77 30.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -1.162 . . . . 0.0 109.72 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.0 t -136.73 125.21 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.34 -0.85 . . . . 0.0 109.392 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -57.19 -53.08 62.18 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.2 p -68.07 48.84 0.06 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.061 -1.025 . . . . 0.0 110.211 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.631 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -179.71 -51.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.91 58.15 11.83 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.631 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -72.85 161.98 30.05 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.714 -0.874 . . . . 0.0 110.782 -178.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.822 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.5 tp -174.85 -68.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.372 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -61.72 -18.65 60.52 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.721 -1.237 . . . . 0.0 109.793 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.9 p-10 -79.56 -60.86 2.19 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.842 0.829 . . . . 0.0 109.285 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.6 m -75.53 -13.24 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.85 -0.531 . . . . 0.0 109.983 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.57 72.62 9.83 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.46 -0.775 . . . . 0.0 110.011 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.29 124.72 16.83 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.809 2.34 . . . . 0.0 114.407 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.06 39.66 58.1 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 8.3 mmtt -138.65 172.69 12.51 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 122.195 0.998 . . . . 0.0 110.717 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.1 m -146.46 163.05 36.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.631 -1.293 . . . . 0.0 111.273 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.2 mm -83.8 130.02 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.452 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 167.81 154.35 8.62 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.581 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 118.67 -15.03 11.54 Favored Glycine 0 N--CA 1.501 3.031 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.269 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.488 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -72.93 -154.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.63 -1.512 . . . . 0.0 108.585 178.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -126.27 141.85 44.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.34 -0.85 . . . . 0.0 110.732 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.598 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.9 t80 -106.59 90.84 3.46 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.585 0.707 . . . . 0.0 109.106 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.508 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.5 p -61.34 38.94 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.579 0.704 . . . . 0.0 110.741 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.598 ' N ' ' O ' ' A' ' 56' ' ' PHE . 56.9 t30 36.33 35.73 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.131 -0.981 . . . . 0.0 110.505 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.508 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.5 mtm180 -67.17 43.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.915 -1.116 . . . . 0.0 109.872 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.61 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 18.2 mt-10 -150.58 -25.43 0.23 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.468 -0.77 . . . . 0.0 109.943 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.86 27.77 62.06 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.679 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.0 mttp -110.77 6.8 21.74 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.747 -0.855 . . . . 0.0 109.615 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mt -129.76 143.67 49.95 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.547 -0.721 . . . . 0.0 109.69 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.41 123.79 13.07 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.782 2.321 . . . . 0.0 111.913 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -100.48 -172.22 29.48 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 68' ' ' GLY . 9.8 tttt 177.37 146.63 0.12 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.624 -0.927 . . . . 0.0 109.092 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' A' ' 67' ' ' SER . 24.7 p -68.07 58.7 0.07 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.83 -1.169 . . . . 0.0 109.155 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 144.26 77.47 0.03 OUTLIER Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -171.82 168.04 6.19 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.701 -0.881 . . . . 0.0 108.988 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.442 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 86.6 m -144.18 154.53 43.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.454 -0.779 . . . . 0.0 110.116 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.703 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 18.5 m95 -125.4 139.21 53.86 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.531 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.21 155.06 46.89 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 121.01 -1.057 . . . . 0.0 109.578 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.604 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -119.74 167.85 11.65 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.088 -1.008 . . . . 0.0 111.761 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.59 136.21 3.71 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.746 -1.221 . . . . 0.0 110.753 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.705 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -59.19 152.49 20.46 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.236 0.541 . . . . 0.0 111.605 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.662 HD11 ' CG2' ' A' ' 88' ' ' ILE . 42.6 mm -135.74 144.95 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.595 -0.69 . . . . 0.0 110.462 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 57.35 68.53 0.84 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.523 0.677 . . . . 0.0 110.696 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.822 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 66.9 t80 -127.86 159.34 35.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.251 -0.906 . . . . 0.0 109.511 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.613 ' OG1' ' N ' ' A' ' 80' ' ' SER . 26.1 p -140.7 -77.35 0.3 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.613 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -150.09 108.23 3.75 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.19 -102.33 0.21 Allowed Glycine 0 N--CA 1.501 3.028 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.484 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 48.4 t80 -144.04 -169.78 3.19 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.646 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.9 mtm180 -71.66 -156.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.702 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -166.91 -150.06 0.1 Allowed 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 100' ' ' THR . 48.1 p -100.39 -6.84 25.1 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.646 -1.284 . . . . 0.0 110.151 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.46 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -88.03 117.53 26.96 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.285 -0.884 . . . . 0.0 110.764 -178.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.856 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.89 149.12 41.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.74 179.259 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.662 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.4 tt -117.56 137.39 51.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.465 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.1 mm? -113.97 125.44 54.02 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.682 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -117.92 126.48 52.45 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.791 0.805 . . . . 0.0 108.914 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.703 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 2.1 p -92.43 157.03 16.8 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.985 0.898 . . . . 0.0 111.298 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.1 p -69.92 -19.45 63.39 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.528 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.31 10.43 5.6 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.237 -0.914 . . . . 0.0 109.781 179.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.455 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.0 30.85 0.43 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.881 -0.512 . . . . 0.0 110.004 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.408 HD12 HH21 ' A' ' 69' ' ' ARG . 25.8 mt -103.26 138.68 39.71 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.134 -0.979 . . . . 0.0 109.938 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.0 mm -112.63 120.15 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.417 -0.802 . . . . 0.0 110.058 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.441 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.7 m-85 -120.36 142.96 48.68 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.46 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 8.5 tptp -131.0 147.78 52.67 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.167 -0.958 . . . . 0.0 110.835 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.516 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -128.22 171.14 12.24 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.442 ' O ' ' OG ' ' A' ' 85' ' ' SER . 73.9 p -146.69 -2.63 0.64 Allowed 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.443 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.638 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -115.95 20.02 14.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.741 -1.224 . . . . 0.0 108.397 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.14 61.75 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.619 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.679 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 20.0 m-85 70.45 -13.52 0.45 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.67 -0.644 . . . . 0.0 111.343 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -50.8 -73.62 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.517 -1.365 . . . . 0.0 109.31 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.494 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 37.1 p -99.11 -178.08 3.82 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.465 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -160.3 134.77 7.48 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.167 -0.958 . . . . 0.0 110.028 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 57.8 m -127.67 139.77 52.5 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.602 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 14.2 tttp -85.83 140.05 30.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.803 -1.185 . . . . 0.0 110.416 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.4 pt -113.2 -32.42 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.63 -0.669 . . . . 0.0 109.922 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.653 HH21 ' CG ' ' A' ' 8' ' ' ASP . 69.6 mtt180 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 109.112 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.577 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 39.9 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 tt -171.23 159.69 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -146.77 29.38 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.368 -1.458 . . . . 0.0 110.61 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 10' ' ' VAL . 24.9 p -105.48 157.42 17.37 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.545 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -60.06 -61.89 2.27 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.85 -1.156 . . . . 0.0 110.43 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.62 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.51 -40.75 79.41 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.053 -1.029 . . . . 0.0 109.317 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.13 -45.13 94.35 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.707 HG22 ' HG2' ' A' ' 21' ' ' PRO . 68.8 t -66.55 -40.73 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.388 -1.066 . . . . 0.0 109.179 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.06 -57.38 10.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.72 -0.612 . . . . 0.0 109.392 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.82 -52.1 51.71 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.672 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 33.3 t80 -58.45 -49.67 76.47 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.333 0.587 . . . . 0.0 111.188 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.2 tt -72.25 -45.89 58.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.561 -0.712 . . . . 0.0 110.749 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -61.0 -20.05 62.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.354 -1.466 . . . . 0.0 110.587 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 m -97.97 -40.77 8.31 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.486 -1.384 . . . . 0.0 111.194 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -110.36 16.12 21.84 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.781 -1.199 . . . . 0.0 111.714 -177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.0 m80 46.03 24.61 0.26 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.367 -0.833 . . . . 0.0 110.643 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 3.8 pttp -142.41 154.33 44.5 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.688 0.756 . . . . 0.0 110.511 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.473 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.4 mp -77.2 149.28 79.18 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.707 -0.62 . . . . 0.0 109.686 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.707 ' HG2' HG22 ' A' ' 10' ' ' VAL . 51.6 Cg_exo -39.67 147.68 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.556 2.837 . . . . 0.0 113.718 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -63.8 47.55 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.084 0.945 . . . . 0.0 110.936 -177.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -169.11 27.08 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.087 -1.008 . . . . 0.0 110.811 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -117.99 118.26 31.46 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.705 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.8 pt -120.12 137.39 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.566 HG22 ' HA3' ' A' ' 53' ' ' GLY . 7.2 p -67.78 169.8 9.04 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.498 1.142 . . . . 0.0 111.259 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.537 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 24.1 mtmt -71.61 -37.53 70.93 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -39.67 -70.43 0.1 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 175.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.522 ' O ' ' C ' ' A' ' 30' ' ' ALA . 3.5 mt-10 -58.57 -58.76 7.15 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.63 -51.55 1.21 Allowed 'General case' 0 N--CA 1.508 2.46 0 O-C-N 119.075 -2.265 . . . . 0.0 110.348 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -58.15 -58.64 7.55 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.091 -1.006 . . . . 0.0 110.171 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.48 69.81 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 121.119 -0.988 . . . . 0.0 110.452 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.6 tp -55.12 -28.61 53.93 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.504 0.669 . . . . 0.0 110.23 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.29 51.05 0.25 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.534 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.71 144.94 30.79 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.277 -1.131 . . . . 0.0 109.375 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.8 t -137.45 127.03 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.556 -0.715 . . . . 0.0 110.132 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -56.98 -52.55 64.82 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.991 -0.443 . . . . 0.0 110.581 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.6 p -70.05 47.31 0.08 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.196 -0.94 . . . . 0.0 110.377 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.631 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.5 ttpm? -176.35 -51.1 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.16 56.43 20.46 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.631 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -69.92 161.77 29.32 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.659 -0.907 . . . . 0.0 110.521 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.792 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 60.1 tp -176.26 -65.95 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.557 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -62.17 -19.4 63.05 Favored 'General case' 0 C--O 1.197 -1.666 0 O-C-N 121.305 -0.872 . . . . 0.0 109.504 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.6 p-10 -80.06 -64.42 1.19 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.993 0.902 . . . . 0.0 108.637 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.419 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 30.5 m -73.89 -11.45 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.705 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.57 72.15 11.68 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.506 -0.746 . . . . 0.0 109.939 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.4 122.43 11.66 Favored 'Trans proline' 0 N--CA 1.512 2.601 0 C-N-CA 123.472 2.781 . . . . 0.0 114.219 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.409 ' C ' ' HG2' ' A' ' 49' ' ' LYS . . . 73.41 39.46 50.83 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.49 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 8.6 mmtm -138.68 176.44 8.7 Favored 'General case' 0 N--CA 1.512 2.669 0 CA-C-O 122.513 1.149 . . . . 0.0 111.009 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.1 m -148.57 162.91 38.71 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 120.203 -1.56 . . . . 0.0 110.783 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.1 mm -85.59 125.31 40.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.128 -0.983 . . . . 0.0 109.77 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.22 154.02 10.45 Favored Glycine 0 N--CA 1.503 3.138 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.566 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 122.42 -17.42 8.41 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.906 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -69.79 -154.49 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.839 -1.389 . . . . 0.0 109.835 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.9 mp -127.69 139.8 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 121.805 0.812 . . . . 0.0 110.855 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.614 ' O ' ' N ' ' A' ' 58' ' ' ASN . 9.0 t80 -105.2 90.05 3.31 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.38 -0.825 . . . . 0.0 108.816 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.541 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.5 p -59.34 36.04 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 121.393 0.616 . . . . 0.0 110.524 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.614 ' N ' ' O ' ' A' ' 56' ' ' PHE . 59.2 t30 39.38 34.68 0.14 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.075 -1.016 . . . . 0.0 110.325 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.541 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.3 mtm180 -66.58 45.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.547 -1.345 . . . . 0.0 110.066 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.616 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 18.5 mt-10 -151.53 -27.07 0.19 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.526 -0.733 . . . . 0.0 110.142 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.32 27.76 59.11 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.674 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.6 mttp -111.13 7.79 21.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.723 -0.869 . . . . 0.0 109.757 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.31 144.88 55.04 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.608 -0.683 . . . . 0.0 109.247 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.57 125.15 14.97 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.672 2.248 . . . . 0.0 112.289 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.541 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.82 -171.41 27.7 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 68' ' ' GLY . 12.1 tttt 176.37 146.67 0.09 Allowed 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.405 -1.056 . . . . 0.0 109.144 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 67' ' ' SER . 24.1 p -68.88 61.29 0.1 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.763 -1.211 . . . . 0.0 108.951 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 142.99 76.73 0.04 OUTLIER Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.568 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.92 168.25 4.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.54 -0.976 . . . . 0.0 109.195 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.446 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 93.4 m -144.5 155.86 43.9 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.463 -0.773 . . . . 0.0 109.897 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.708 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 19.8 m95 -126.55 137.6 53.37 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.579 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -128.84 156.55 43.46 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.993 -1.067 . . . . 0.0 109.091 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.538 ' O ' ' OH ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -121.28 167.4 12.77 Favored 'General case' 0 N--CA 1.513 2.676 0 CA-C-O 122.274 1.035 . . . . 0.0 111.402 -179.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -166.29 136.84 3.42 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.276 -0.89 . . . . 0.0 111.308 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.693 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -59.5 153.69 18.93 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.648 0.737 . . . . 0.0 111.584 -179.344 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.649 HD11 ' CG2' ' A' ' 88' ' ' ILE . 40.6 mm -136.76 142.84 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.77 -0.581 . . . . 0.0 110.764 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 59.26 65.79 1.13 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.436 0.636 . . . . 0.0 110.665 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.792 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 63.1 t80 -125.2 159.78 30.75 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.298 -0.876 . . . . 0.0 109.566 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' A' ' 80' ' ' SER . 28.1 p -139.99 -77.38 0.32 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.594 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -149.53 112.12 4.76 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.06 -104.83 0.26 Allowed Glycine 0 N--CA 1.502 3.049 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.462 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 44.3 t80 -141.43 -169.77 2.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.861 -0.787 . . . . 0.0 109.286 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.668 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.7 mtm180 -71.1 -155.0 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 O-C-N 120.81 -1.181 . . . . 0.0 109.539 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -168.77 -151.99 0.1 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.5 p -99.72 -3.5 32.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.62 -1.3 . . . . 0.0 110.335 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.527 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -91.28 117.07 29.34 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.251 -0.906 . . . . 0.0 110.283 -179.134 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.853 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.1 150.22 44.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.329 -0.857 . . . . 0.0 109.56 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.649 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.2 tt -119.06 137.38 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 72' ' ' ARG . 2.2 mm? -114.47 125.72 54.14 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.7 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.56 127.83 53.99 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.752 0.786 . . . . 0.0 109.279 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.708 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.5 p -94.12 159.14 15.28 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.282 1.039 . . . . 0.0 112.329 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.5 p -69.87 -19.52 63.43 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.568 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -83.16 10.44 8.28 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.732 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.464 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.39 31.29 0.48 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.726 -0.609 . . . . 0.0 109.988 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.413 HD12 HH21 ' A' ' 69' ' ' ARG . 27.1 mt -103.43 138.34 40.29 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.46 -0.775 . . . . 0.0 109.833 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 109' ' ' ILE . 31.9 mm -112.35 119.51 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.794 -0.566 . . . . 0.0 110.139 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.413 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.0 m-85 -120.62 143.55 48.61 Favored 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.527 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 7.7 tptp -131.12 148.09 52.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.02 -1.05 . . . . 0.0 110.299 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.562 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -127.68 171.9 11.26 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.3 p -146.73 -1.85 0.67 Allowed 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.147 -0.971 . . . . 0.0 110.281 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.627 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -117.13 20.27 13.83 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.717 -1.239 . . . . 0.0 108.433 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 77.07 64.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.409 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.674 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 18.9 m-85 68.96 -12.87 0.37 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 122.195 -0.316 . . . . 0.0 111.793 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -51.66 -72.75 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.478 -1.389 . . . . 0.0 109.58 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.474 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 37.3 p -100.07 -179.12 4.05 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.415 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -159.12 135.42 9.1 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.038 -1.039 . . . . 0.0 109.954 -179.209 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 64.0 m -128.8 139.51 52.15 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.613 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.5 tttp -86.1 139.19 31.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.839 -1.163 . . . . 0.0 110.314 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 96' ' ' ILE . 13.5 pt -112.7 -31.55 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.831 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.62 HH21 ' CG ' ' A' ' 8' ' ' ASP . 68.2 mtt180 . . . . . 0 C--N 1.306 -1.298 0 O-C-N 121.131 -0.981 . . . . 0.0 109.167 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.592 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 22.0 t . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 tt -169.94 160.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -146.53 30.2 1.01 Allowed 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.255 -1.528 . . . . 0.0 111.637 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 10' ' ' VAL . 28.3 p -104.16 158.32 16.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.517 -0.739 . . . . 0.0 109.526 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.7 p90 -60.35 -61.67 2.43 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.617 -1.302 . . . . 0.0 110.872 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.617 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -56.69 -41.67 77.74 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.145 -0.972 . . . . 0.0 109.618 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.27 -45.21 94.46 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.676 HG22 ' HG2' ' A' ' 21' ' ' PRO . 54.7 t -66.72 -41.5 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 O-C-N 121.109 -1.23 . . . . 0.0 108.101 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.36 -59.38 5.37 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.48 -52.17 31.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.058 -1.026 . . . . 0.0 109.973 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.695 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 36.3 t80 -59.58 -47.98 83.46 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.291 -0.881 . . . . 0.0 110.628 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.7 tt -72.9 -44.38 61.34 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.382 -0.824 . . . . 0.0 110.841 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -62.73 -22.62 66.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.554 -1.341 . . . . 0.0 110.379 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.2 m -94.88 -42.11 8.85 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.957 -1.089 . . . . 0.0 111.048 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -109.49 16.83 21.98 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.127 -0.983 . . . . 0.0 112.214 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 m80 46.84 24.35 0.34 Allowed 'General case' 0 N--CA 1.51 2.56 0 O-C-N 120.94 -1.1 . . . . 0.0 110.584 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.2 pttp -141.39 151.45 43.49 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.241 1.02 . . . . 0.0 110.296 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.527 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.5 mp -75.44 150.39 84.75 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.033 -1.042 . . . . 0.0 108.725 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.695 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 50.7 Cg_exo -40.33 151.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 123.344 2.696 . . . . 0.0 114.35 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -66.38 47.6 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.6 0.714 . . . . 0.0 111.312 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -170.22 27.65 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 109.189 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -119.25 118.26 30.8 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.714 -1.241 . . . . 0.0 110.098 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.8 pt -119.89 138.73 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.307 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.54 HG22 ' HA3' ' A' ' 53' ' ' GLY . 12.0 p -69.01 166.97 16.91 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.936 -1.102 . . . . 0.0 110.875 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.591 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 22.9 mtmt -70.38 -34.59 72.75 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.31 -66.99 0.32 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' ' 30' ' ' ALA . 3.4 mt-10 -60.35 -58.3 9.1 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.439 -1.304 . . . . 0.0 108.288 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.66 -52.46 1.23 Allowed 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.007 -1.058 . . . . 0.0 109.241 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -59.0 -55.98 28.15 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.563 -0.711 . . . . 0.0 110.511 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.26 -29.1 70.17 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 120.652 -1.28 . . . . 0.0 108.964 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.413 HD21 ' HB ' ' A' ' 45' ' ' VAL . 33.9 tp -62.38 -27.36 69.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.648 -0.657 . . . . 0.0 109.471 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.84 52.73 0.23 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.55 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -83.07 146.77 28.51 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.317 -1.108 . . . . 0.0 109.693 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -135.77 125.16 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.325 -0.859 . . . . 0.0 109.187 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -58.82 -52.56 65.21 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.831 -0.543 . . . . 0.0 109.724 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.9 p -70.37 50.98 0.12 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.001 -1.062 . . . . 0.0 109.412 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.645 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -179.69 -50.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.41 56.99 20.29 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.645 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -72.14 164.42 26.22 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.834 -0.803 . . . . 0.0 110.784 -178.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.843 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 66.6 tp -178.64 -66.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.001 -1.062 . . . . 0.0 110.004 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.638 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -59.98 -23.12 63.36 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.098 -1.001 . . . . 0.0 109.711 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 5.5 p-10 -76.39 -64.11 1.18 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.003 0.906 . . . . 0.0 109.497 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.444 ' H ' HG22 ' A' ' 45' ' ' VAL . 15.3 m -76.21 -10.92 13.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.853 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.62 70.14 11.41 Favored Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.348 -0.845 . . . . 0.0 109.431 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -57.04 123.57 14.16 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 123.182 2.588 . . . . 0.0 113.673 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.487 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 73.88 36.45 52.51 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.487 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 8.5 mmtm -138.57 168.97 18.63 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 121.885 0.85 . . . . 0.0 111.205 -178.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.474 ' HG ' ' HD2' ' A' ' 78' ' ' TYR . 73.3 m -142.48 162.02 36.56 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.277 1.037 . . . . 0.0 111.089 -177.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.1 mm -84.47 126.93 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 122.1 0.952 . . . . 0.0 110.327 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.36 153.74 9.24 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.54 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 122.57 -20.46 7.82 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.329 -1.415 . . . . 0.0 110.782 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -68.33 -154.42 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 118.686 1.243 . . . . 0.0 109.01 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.66 139.65 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-O 121.864 0.84 . . . . 0.0 111.219 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.612 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.5 t80 -104.05 89.96 3.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.341 -0.85 . . . . 0.0 109.304 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.642 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.3 p -58.99 35.16 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.603 -0.686 . . . . 0.0 110.888 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.612 ' N ' ' O ' ' A' ' 56' ' ' PHE . 55.2 t30 38.34 39.7 0.3 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.107 -0.996 . . . . 0.0 109.878 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.642 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 8.9 mtm180 -70.29 43.33 0.06 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.562 -1.336 . . . . 0.0 110.087 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.61 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 21.7 mt-10 -149.38 -25.32 0.28 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.332 -0.855 . . . . 0.0 109.943 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.59 28.74 58.92 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.637 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.5 mttp -111.3 7.93 21.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.508 -0.995 . . . . 0.0 109.713 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mt -131.0 144.04 51.91 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.602 -0.686 . . . . 0.0 109.493 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.33 124.98 15.8 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.819 2.346 . . . . 0.0 112.408 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.543 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.1 -173.22 28.82 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.507 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 11.0 tttt 177.29 144.24 0.09 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.375 -1.074 . . . . 0.0 108.656 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.2 p -68.1 58.58 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.936 -1.102 . . . . 0.0 109.172 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.507 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 147.64 75.51 0.02 OUTLIER Glycine 0 N--CA 1.5 2.913 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.564 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.56 168.11 5.37 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.711 -0.876 . . . . 0.0 109.33 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 87.9 m -143.39 155.09 44.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.486 -0.759 . . . . 0.0 110.039 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.714 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 17.9 m95 -125.21 138.34 54.12 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.584 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -129.47 156.14 44.59 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 120.747 -1.221 . . . . 0.0 109.586 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.591 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -120.47 167.66 12.13 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.259 -0.901 . . . . 0.0 112.026 -179.37 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -166.65 135.71 2.94 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.135 -0.978 . . . . 0.0 110.714 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.646 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -58.59 153.33 16.53 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.343 0.592 . . . . 0.0 111.676 -179.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.686 HD11 ' CG2' ' A' ' 88' ' ' ILE . 39.9 mm -136.02 140.67 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.49 0.662 . . . . 0.0 110.37 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 60.49 68.98 0.72 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.679 -0.638 . . . . 0.0 110.403 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.843 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 61.2 t80 -126.13 159.45 32.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.349 -0.844 . . . . 0.0 109.636 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.601 ' OG1' ' N ' ' A' ' 80' ' ' SER . 31.2 p -139.8 -78.25 0.32 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.638 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -150.84 107.44 3.51 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.94 -107.41 0.31 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 52.1 t80 -139.29 -166.93 2.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.734 -0.862 . . . . 0.0 108.843 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.648 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.3 mtm180 -73.91 -157.31 0.05 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.0 -1.062 . . . . 0.0 109.53 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -166.64 -153.14 0.15 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 100' ' ' THR . 50.7 p -98.22 -9.64 25.3 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.457 -1.402 . . . . 0.0 110.727 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.538 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -86.06 117.71 25.07 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.066 -1.021 . . . . 0.0 111.096 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.826 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.65 148.45 42.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.405 -0.81 . . . . 0.0 109.552 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.686 ' CG2' HD11 ' A' ' 76' ' ' ILE . 3.5 tt -115.93 139.54 42.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.472 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.1 mm? -116.05 125.43 52.42 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.671 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -117.55 127.52 54.06 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.856 0.836 . . . . 0.0 109.355 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.714 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 8.6 p -94.58 157.7 15.86 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.122 0.963 . . . . 0.0 111.944 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.1 p -69.01 -20.1 64.14 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.564 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -82.18 9.72 8.15 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.3 -0.875 . . . . 0.0 110.033 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.451 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.25 29.35 0.45 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.714 -0.616 . . . . 0.0 110.449 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.437 HD12 HH21 ' A' ' 69' ' ' ARG . 29.2 mt -101.87 135.99 42.47 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.437 -0.79 . . . . 0.0 109.985 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.4 mm -110.2 119.74 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.515 -0.74 . . . . 0.0 110.115 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.435 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.3 m-85 -119.04 143.14 47.27 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.538 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 8.5 tptp -132.45 147.49 52.37 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.823 -1.173 . . . . 0.0 110.537 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.487 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.5 t -129.39 171.04 12.92 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.403 ' O ' ' OG ' ' A' ' 85' ' ' SER . 72.3 p -145.22 -3.65 0.74 Allowed 'General case' 0 N--CA 1.508 2.472 0 O-C-N 121.45 -0.781 . . . . 0.0 110.234 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -114.53 19.37 16.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.756 -1.215 . . . . 0.0 108.924 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 77.87 63.69 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.054 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.648 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 18.5 m-85 69.5 -14.48 0.33 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.813 -0.554 . . . . 0.0 111.87 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -49.96 -74.27 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.538 -1.351 . . . . 0.0 109.314 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.464 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 38.0 p -99.03 -177.17 3.54 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.791 -1.193 . . . . 0.0 108.319 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.472 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -160.23 134.33 7.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -0.983 . . . . 0.0 110.236 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.6 m -127.3 139.99 52.51 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.541 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.2 tttp -86.37 140.21 30.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.8 -1.187 . . . . 0.0 110.364 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.6 pt -113.68 -31.71 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.438 -0.788 . . . . 0.0 110.074 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.617 HH21 ' CG ' ' A' ' 8' ' ' ASP . 67.6 mtt180 . . . . . 0 N--CA 1.485 1.317 0 O-C-N 121.068 -1.02 . . . . 0.0 108.659 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.638 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.8 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 tt -169.4 159.69 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.365 -0.835 . . . . 0.0 109.342 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -146.67 31.07 0.97 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.512 -1.368 . . . . 0.0 111.357 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.7 p -106.08 155.97 18.88 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.599 -0.688 . . . . 0.0 109.865 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.3 p90 -58.44 -62.18 2.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.195 -0.941 . . . . 0.0 110.725 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.622 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.9 OUTLIER -58.15 -41.13 83.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.353 -0.842 . . . . 0.0 109.526 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.92 -44.91 87.56 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.692 HG22 ' HG2' ' A' ' 21' ' ' PRO . 53.3 t -67.95 -41.99 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.46 -57.02 12.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.473 -0.767 . . . . 0.0 109.21 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.08 -55.22 15.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.474 -0.766 . . . . 0.0 109.692 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.676 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 33.9 t80 -56.45 -49.88 73.32 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.249 0.547 . . . . 0.0 110.802 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -73.22 -44.55 59.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.376 -0.828 . . . . 0.0 110.709 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -62.26 -21.12 64.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.566 -1.334 . . . . 0.0 110.298 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.6 m -97.26 -40.92 8.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.174 -0.954 . . . . 0.0 110.742 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -109.16 14.42 23.9 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.118 -0.989 . . . . 0.0 111.908 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.1 m80 46.51 25.57 0.41 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 120.864 -1.147 . . . . 0.0 109.669 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.488 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 5.0 pttp -142.27 152.2 42.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.315 -0.866 . . . . 0.0 110.004 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.542 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.6 mp -76.88 149.36 80.24 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 109.066 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.692 ' HG2' HG22 ' A' ' 10' ' ' VAL . 66.1 Cg_exo -40.76 150.71 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.734 2.289 . . . . 0.0 113.23 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -62.59 47.14 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.601 0.715 . . . . 0.0 111.12 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -168.42 26.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.6 -1.313 . . . . 0.0 110.286 179.121 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -116.69 113.05 22.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.88 -1.137 . . . . 0.0 110.886 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.432 HG21 HD13 ' A' ' 25' ' ' ILE . 28.3 pt -116.18 138.59 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.325 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.611 HG22 ' HA3' ' A' ' 53' ' ' GLY . 4.4 p -69.73 166.62 18.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.018 -1.051 . . . . 0.0 110.37 -176.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.586 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 18.7 mtmt -66.29 -35.4 80.29 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.441 ' HG ' ' CB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -41.89 -66.33 0.36 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.625 178.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.4 mt-10 -65.33 -49.3 69.95 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.301 -0.959 . . . . 0.0 109.192 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -44.24 -50.0 9.04 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.79 -1.194 . . . . 0.0 107.997 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.42 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 38.7 mt-30 -59.2 -57.6 12.33 Favored 'General case' 0 N--CA 1.509 2.506 0 O-C-N 121.36 -0.838 . . . . 0.0 110.733 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.34 -30.91 69.83 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.994 -1.066 . . . . 0.0 109.807 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.0 tp -63.11 -25.82 68.54 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.96 50.16 0.23 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.593 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.91 144.1 31.2 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.369 -1.077 . . . . 0.0 110.146 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.0 t -134.52 125.3 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.174 -0.954 . . . . 0.0 109.699 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -58.73 -52.83 64.02 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.55 -0.719 . . . . 0.0 109.812 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 59.6 p -68.56 50.2 0.07 Allowed 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.982 -1.073 . . . . 0.0 109.133 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.626 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.0 OUTLIER -179.34 -50.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -0.774 . . . . 0.0 108.964 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.95 56.86 18.4 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.626 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -74.27 162.76 28.59 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.443 -1.034 . . . . 0.0 110.773 -178.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.821 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 65.4 tp -176.12 -67.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.547 -0.72 . . . . 0.0 109.798 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.655 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.63 -18.86 55.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.962 -1.086 . . . . 0.0 109.935 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.8 p-10 -79.45 -65.1 1.04 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.843 0.83 . . . . 0.0 109.552 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.457 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 30.7 m -73.33 -10.89 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 O-C-N 121.743 -0.598 . . . . 0.0 110.353 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.83 71.87 9.59 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 109.785 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.36 122.56 12.0 Favored 'Trans proline' 0 N--CA 1.509 2.392 0 C-N-CA 123.977 3.118 . . . . 0.0 113.562 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.74 39.76 59.46 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 7.2 mmtt -136.6 176.08 9.03 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.052 0.929 . . . . 0.0 110.597 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.405 ' HA ' HD21 ' A' ' 42' ' ' LEU . 69.0 m -150.13 158.82 44.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.785 -1.197 . . . . 0.0 111.167 -177.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.3 mm -82.45 130.37 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.548 0.69 . . . . 0.0 110.121 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.4 154.83 8.5 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.611 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 119.89 -16.53 10.2 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 120.293 -0.956 . . . . 0.0 110.868 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -70.55 -152.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.748 -1.443 . . . . 0.0 109.603 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -128.93 138.84 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.522 0.677 . . . . 0.0 110.821 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.604 ' O ' ' N ' ' A' ' 58' ' ' ASN . 11.0 t80 -104.09 90.31 3.55 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.661 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.3 36.2 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.47 0.653 . . . . 0.0 111.182 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.604 ' N ' ' O ' ' A' ' 56' ' ' PHE . 53.5 t30 36.58 38.4 0.08 Allowed 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.94 -1.1 . . . . 0.0 110.541 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.661 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.8 mtm180 -69.51 39.07 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.614 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 18.9 mt-10 -149.05 -10.9 0.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.182 -0.949 . . . . 0.0 110.246 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.78 33.23 84.53 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.67 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.1 mttp -115.1 8.6 15.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.613 -0.934 . . . . 0.0 109.446 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -132.81 142.94 46.59 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.446 -0.784 . . . . 0.0 109.349 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.86 125.99 17.84 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.885 2.39 . . . . 0.0 112.394 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.539 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.0 -170.99 28.63 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.583 ' O ' ' N ' ' A' ' 68' ' ' GLY . 11.1 tttt 175.52 144.08 0.07 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.149 -1.206 . . . . 0.0 108.269 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 67' ' ' SER . 27.2 p -66.09 57.05 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.838 -1.164 . . . . 0.0 108.427 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 147.63 77.34 0.02 OUTLIER Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.539 ' NH1' ' O ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -173.54 167.78 4.56 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.551 -0.97 . . . . 0.0 108.974 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.431 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 85.6 m -144.36 155.87 43.98 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.811 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.737 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 25.6 m95 -126.32 138.73 53.61 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.615 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.38 154.31 47.81 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.544 -1.347 . . . . 0.0 109.606 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.586 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -118.35 167.0 11.97 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.195 -0.94 . . . . 0.0 111.815 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.13 136.13 3.97 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.797 0.808 . . . . 0.0 110.967 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.66 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -60.73 151.69 28.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.613 -0.679 . . . . 0.0 111.938 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.492 HG13 ' HB ' ' A' ' 88' ' ' ILE . 40.4 mm -137.15 143.82 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 121.476 0.655 . . . . 0.0 110.18 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 60.25 66.08 1.0 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.234 0.54 . . . . 0.0 110.576 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.821 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 58.0 t80 -126.79 161.63 27.74 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.156 -0.965 . . . . 0.0 109.122 178.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.634 ' OG1' ' N ' ' A' ' 80' ' ' SER . 27.2 p -141.38 -78.96 0.26 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.655 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -149.27 106.08 3.56 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.51 -107.09 0.3 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 49.1 t80 -135.82 -166.02 1.79 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.721 -0.87 . . . . 0.0 108.771 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.658 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.8 mtm180 -75.16 -153.04 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.916 -1.115 . . . . 0.0 109.077 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -168.41 -150.3 0.09 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.3 p -100.87 -8.36 22.64 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.464 -1.397 . . . . 0.0 110.335 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.455 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -86.5 116.75 24.85 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.386 -0.821 . . . . 0.0 110.741 -178.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.84 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.22 149.47 44.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.251 -0.906 . . . . 0.0 109.698 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.492 ' HB ' HG13 ' A' ' 76' ' ' ILE . 10.5 tt -119.64 136.1 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.621 0.724 . . . . 0.0 109.125 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 72' ' ' ARG . 2.8 mm? -112.66 124.65 53.03 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -116.69 127.84 54.78 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.691 0.758 . . . . 0.0 109.002 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.737 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 5.7 p -93.78 158.72 15.53 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.995 0.903 . . . . 0.0 111.91 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.7 p -69.39 -19.94 63.81 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.524 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.72 9.28 8.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.471 -0.768 . . . . 0.0 109.898 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.78 30.32 0.47 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.621 -0.674 . . . . 0.0 110.024 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.429 HD12 HH21 ' A' ' 69' ' ' ARG . 26.8 mt -102.87 137.57 40.9 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.342 -0.849 . . . . 0.0 110.388 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.52 ' CG2' HD11 ' A' ' 109' ' ' ILE . 35.9 mm -110.42 118.95 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.306 -0.872 . . . . 0.0 110.691 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.461 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 6.9 m-85 -119.09 141.61 48.61 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.455 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 6.2 tptp -131.37 148.26 52.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.417 -0.802 . . . . 0.0 110.896 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.7 t -128.66 172.46 11.2 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.9 p -146.87 -3.21 0.6 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.523 -0.735 . . . . 0.0 110.487 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.582 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.3 p30 -115.54 22.5 13.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.785 -1.197 . . . . 0.0 108.296 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 75.76 62.17 0.05 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.495 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.67 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 17.6 m-85 69.59 -10.87 0.55 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.701 -0.624 . . . . 0.0 111.414 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.72 -72.87 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.695 -1.253 . . . . 0.0 109.213 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.514 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 34.9 p -99.39 -178.37 3.88 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.477 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -160.65 133.48 6.41 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.071 -1.018 . . . . 0.0 109.794 -179.317 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.9 m -127.28 141.49 51.7 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.617 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 13.5 tttp -86.77 139.03 31.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.873 -1.142 . . . . 0.0 110.093 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.52 HD11 ' CG2' ' A' ' 96' ' ' ILE . 10.3 pt -112.11 -32.26 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.606 -0.684 . . . . 0.0 109.432 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.622 HH21 ' CG ' ' A' ' 8' ' ' ASP . 56.3 mtt180 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 118.086 -0.959 . . . . 0.0 109.049 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.622 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.2 t . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 tt -169.78 160.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.4 -0.812 . . . . 0.0 109.219 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.0 p30 -147.26 30.33 0.94 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.339 -1.475 . . . . 0.0 111.129 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 10' ' ' VAL . 19.9 p -104.86 156.25 18.18 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.744 0.783 . . . . 0.0 109.792 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.5 p90 -59.65 -61.38 2.66 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.729 -1.232 . . . . 0.0 110.143 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.647 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.74 -41.53 82.08 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.337 -0.852 . . . . 0.0 109.388 -179.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.5 -44.77 93.62 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.642 HG22 ' HG2' ' A' ' 21' ' ' PRO . 60.6 t -67.54 -41.66 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 O-C-N 121.43 -1.041 . . . . 0.0 108.662 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.47 -58.09 9.55 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.17 -54.86 14.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.362 -0.836 . . . . 0.0 109.633 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.571 ' CE1' ' HA ' ' A' ' 21' ' ' PRO . 34.1 t80 -57.6 -47.36 82.37 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.118 0.485 . . . . 0.0 110.754 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.2 tt -74.21 -44.37 53.52 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.246 -0.909 . . . . 0.0 110.717 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -62.98 -19.94 64.8 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.436 -1.415 . . . . 0.0 110.13 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.4 m -96.8 -43.33 7.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.987 -1.071 . . . . 0.0 111.01 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -107.77 13.12 26.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.153 -0.967 . . . . 0.0 111.894 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.2 m80 49.2 23.91 0.88 Allowed 'General case' 0 N--CA 1.508 2.426 0 O-C-N 120.692 -1.255 . . . . 0.0 109.902 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.487 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.5 pttp -141.48 153.63 45.06 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.526 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.2 mp -77.78 149.71 77.8 Favored Pre-proline 0 N--CA 1.496 1.863 0 O-C-N 121.344 -0.847 . . . . 0.0 109.038 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.642 ' HG2' HG22 ' A' ' 10' ' ' VAL . 77.2 Cg_exo -39.34 151.07 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.801 0 C-N-CA 123.133 2.555 . . . . 0.0 113.567 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -63.45 47.83 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.637 0.732 . . . . 0.0 110.538 179.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -169.88 26.95 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.846 -1.159 . . . . 0.0 110.328 179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -118.48 114.01 22.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.482 -1.387 . . . . 0.0 110.227 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 35.4 pt -117.26 140.63 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 119.052 -1.059 . . . . 0.0 110.024 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.638 HG22 ' HA3' ' A' ' 53' ' ' GLY . 6.8 p -70.19 166.8 19.23 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.325 1.06 . . . . 0.0 111.684 -177.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.577 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 20.6 mtmt -68.58 -35.57 77.55 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -44.73 -65.47 0.52 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.425 176.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.458 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.6 mt-10 -64.4 -52.02 60.3 Favored 'General case' 0 C--O 1.201 -1.466 0 C-N-CA 118.854 -1.138 . . . . 0.0 108.624 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -41.71 -51.65 4.06 Favored 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.858 -1.152 . . . . 0.0 109.047 177.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -60.0 -56.73 18.08 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.372 -0.83 . . . . 0.0 110.895 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.9 -30.61 69.14 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.589 -1.319 . . . . 0.0 109.024 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 25.1 tp -63.48 -29.83 71.04 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.405 0.621 . . . . 0.0 109.439 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.34 55.01 0.15 Allowed Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.084 -1.207 . . . . 0.0 110.084 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.595 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -88.08 145.61 25.86 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.294 -1.121 . . . . 0.0 109.505 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.2 t -135.45 124.31 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.427 -0.795 . . . . 0.0 109.414 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -56.89 -53.21 60.54 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.708 -0.62 . . . . 0.0 109.716 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 81.0 p -68.54 48.53 0.06 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.462 -0.774 . . . . 0.0 109.834 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.648 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.4 ttpm? -178.29 -50.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.53 56.05 23.78 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.648 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -73.24 161.24 30.76 Favored 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.517 -0.99 . . . . 0.0 111.155 -178.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.828 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.5 tp -173.17 -68.18 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.117 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.602 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.51 -18.93 55.09 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.169 -0.957 . . . . 0.0 109.779 -177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.2 p-10 -78.38 -63.9 1.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.66 0.743 . . . . 0.0 109.36 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.6 m -75.6 -10.13 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.919 -0.488 . . . . 0.0 110.381 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.74 71.21 9.65 Favored Pre-proline 0 N--CA 1.486 1.346 0 O-C-N 121.514 -0.741 . . . . 0.0 109.589 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.9 124.37 16.08 Favored 'Trans proline' 0 N--CA 1.505 2.185 0 C-N-CA 123.517 2.812 . . . . 0.0 113.872 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.536 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 72.15 38.69 59.15 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.9 mmtm -137.02 171.25 14.79 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 121.691 0.758 . . . . 0.0 110.167 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.0 m -144.35 162.24 36.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.146 -0.971 . . . . 0.0 110.302 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.7 mm -84.63 127.87 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 121.631 0.729 . . . . 0.0 110.156 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.97 155.34 10.9 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.638 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 120.63 -15.94 9.71 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.695 -1.24 . . . . 0.0 111.053 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -71.75 -155.14 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.766 -1.432 . . . . 0.0 109.321 179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -127.16 140.27 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.76 0.791 . . . . 0.0 110.393 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.597 ' O ' ' N ' ' A' ' 58' ' ' ASN . 9.7 t80 -105.61 91.16 3.64 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.55 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -60.52 36.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.605 -0.684 . . . . 0.0 110.828 -179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.597 ' N ' ' O ' ' A' ' 56' ' ' PHE . 51.7 t30 38.94 36.88 0.17 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.123 -0.985 . . . . 0.0 110.358 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.55 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.6 mtm180 -69.43 42.3 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.885 -1.134 . . . . 0.0 109.564 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.621 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 17.8 mt-10 -150.18 -15.46 0.25 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.411 -0.806 . . . . 0.0 110.254 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 64.43 32.1 83.08 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.668 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.1 mttp -113.63 6.53 16.98 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.717 -0.873 . . . . 0.0 109.304 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.7 144.01 51.66 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.659 -0.651 . . . . 0.0 109.39 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.48 124.52 14.38 Favored 'Trans proline' 0 N--CA 1.499 1.841 0 C-N-CA 122.984 2.456 . . . . 0.0 112.051 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.521 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -101.03 -172.5 28.81 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.486 ' O ' ' N ' ' A' ' 68' ' ' GLY . 10.9 tttt 177.07 146.47 0.11 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.366 -1.079 . . . . 0.0 108.955 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 67' ' ' SER . 24.2 p -68.57 60.21 0.09 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.956 -1.09 . . . . 0.0 108.784 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 144.18 77.05 0.03 OUTLIER Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.541 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -173.69 167.29 4.51 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.586 -0.949 . . . . 0.0 109.208 179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 92.4 m -143.81 156.67 44.56 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.23 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.727 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 22.6 m95 -127.11 138.21 53.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.052 -0.405 . . . . 0.0 109.947 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.561 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.04 154.19 47.67 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.89 -1.131 . . . . 0.0 109.733 179.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.577 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -118.28 166.9 12.07 Favored 'General case' 0 N--CA 1.509 2.488 0 CA-C-O 121.768 0.794 . . . . 0.0 112.064 -179.051 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.18 134.56 3.51 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.282 -0.886 . . . . 0.0 111.31 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.678 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.46 153.13 13.27 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.268 0.556 . . . . 0.0 111.372 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.726 HD11 ' CG2' ' A' ' 88' ' ' ILE . 42.3 mm -135.98 143.45 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.769 -0.582 . . . . 0.0 109.977 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 57.96 69.75 0.71 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.497 0.665 . . . . 0.0 110.576 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.828 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 65.8 t80 -127.88 160.19 32.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.375 -0.828 . . . . 0.0 109.344 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.613 ' OG1' ' N ' ' A' ' 80' ' ' SER . 29.9 p -141.5 -78.94 0.26 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.613 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.4 OUTLIER -150.5 105.21 3.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.787 -0.571 . . . . 0.0 110.2 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.5 -98.85 0.17 Allowed Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.473 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 46.0 t80 -144.81 -169.86 3.27 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.605 -0.938 . . . . 0.0 109.379 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.641 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.8 mtm180 -72.0 -156.27 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.045 -1.034 . . . . 0.0 109.531 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.3 p30 -167.17 -151.7 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 p -99.25 -6.31 28.28 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.725 -1.234 . . . . 0.0 110.38 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.466 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -89.05 118.61 28.89 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.122 -0.986 . . . . 0.0 110.451 -178.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.857 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.77 150.46 43.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.755 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.726 ' CG2' HD11 ' A' ' 76' ' ' ILE . 3.7 tt -118.35 136.63 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.45 HD13 ' O ' ' A' ' 72' ' ' ARG . 2.4 mm? -114.29 124.24 51.52 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.692 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -116.6 127.5 54.53 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.691 0.757 . . . . 0.0 109.09 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.727 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.9 p -93.69 157.96 15.91 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.143 0.973 . . . . 0.0 112.197 -178.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.1 p -68.86 -20.03 64.26 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.541 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -82.34 10.34 7.23 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.423 -0.798 . . . . 0.0 109.853 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.47 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.6 30.55 0.48 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.629 -0.669 . . . . 0.0 110.047 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 29.9 mt -102.79 138.68 39.36 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.384 -0.822 . . . . 0.0 109.94 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.468 HG22 HD11 ' A' ' 109' ' ' ILE . 33.4 mm -112.28 119.76 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.267 -0.896 . . . . 0.0 110.07 -179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.427 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.1 m-85 -119.95 142.61 48.59 Favored 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.466 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 9.3 tptp -130.62 147.67 52.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.482 -0.761 . . . . 0.0 110.71 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.549 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.0 t -128.78 171.13 12.53 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.5 p -146.5 -2.62 0.66 Allowed 'General case' 0 N--CA 1.508 2.463 0 O-C-N 121.36 -0.838 . . . . 0.0 110.488 178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.636 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -115.63 19.34 15.37 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.653 -1.28 . . . . 0.0 108.549 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.97 62.01 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.534 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.668 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 21.5 m-85 69.89 -13.12 0.43 Allowed 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.73 -0.606 . . . . 0.0 111.595 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -51.01 -72.39 0.05 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.735 -1.228 . . . . 0.0 109.557 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.458 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 34.5 p -99.96 -177.14 3.45 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.423 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -160.96 135.05 6.99 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.052 -1.03 . . . . 0.0 109.987 -179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 59.9 m -128.3 139.73 52.26 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.611 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 14.4 tttp -85.79 140.16 30.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.006 -1.059 . . . . 0.0 110.15 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.468 HD11 HG22 ' A' ' 96' ' ' ILE . 11.7 pt -113.23 -33.2 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.604 -0.685 . . . . 0.0 109.603 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.647 HH21 ' CG ' ' A' ' 8' ' ' ASP . 64.9 mtt180 . . . . . 0 N--CA 1.488 1.467 0 O-C-N 121.212 -0.93 . . . . 0.0 108.999 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.631 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.2 t . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 tt -171.31 161.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -145.94 28.2 1.15 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.43 -1.419 . . . . 0.0 111.083 -178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.5 p -104.16 156.12 18.15 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 121.729 0.776 . . . . 0.0 110.19 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.7 p90 -60.1 -60.78 3.28 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.758 -1.214 . . . . 0.0 110.759 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.63 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -58.57 -41.99 86.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.34 -0.85 . . . . 0.0 108.927 -179.381 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.19 -43.62 93.45 Favored Glycine 0 N--CA 1.501 2.993 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.733 HG22 ' HG2' ' A' ' 21' ' ' PRO . 50.5 t -68.78 -41.46 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.212 -1.169 . . . . 0.0 107.998 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.99 -59.1 5.91 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.61 -54.87 12.91 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.567 -0.708 . . . . 0.0 109.587 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.689 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 33.8 t80 -56.42 -49.51 74.35 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.174 0.511 . . . . 0.0 110.204 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.35 -47.41 56.57 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.164 -0.96 . . . . 0.0 111.567 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -61.4 -21.07 63.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.553 -1.342 . . . . 0.0 110.366 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.4 m -95.9 -41.01 9.02 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.986 -1.071 . . . . 0.0 111.652 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -110.8 16.2 21.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.457 -0.777 . . . . 0.0 111.566 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.6 m80 46.53 25.5 0.41 Allowed 'General case' 0 N--CA 1.506 2.345 0 O-C-N 120.563 -1.336 . . . . 0.0 110.248 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -142.95 152.62 42.2 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.203 -0.935 . . . . 0.0 110.695 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.551 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.3 mp -74.79 148.92 85.39 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.0 109.513 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.733 ' HG2' HG22 ' A' ' 10' ' ' VAL . 72.5 Cg_exo -40.48 151.56 0.1 OUTLIER 'Trans proline' 0 N--CA 1.497 1.696 0 C-N-CA 123.4 2.734 . . . . 0.0 113.371 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.631 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -64.43 46.75 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 121.752 0.787 . . . . 0.0 110.997 -179.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -167.62 24.87 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.937 -1.102 . . . . 0.0 110.545 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -116.27 116.02 27.01 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.692 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.8 pt -117.79 141.0 38.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.709 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.603 HG22 ' HA3' ' A' ' 53' ' ' GLY . 6.9 p -71.83 167.54 19.77 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 120.858 -1.151 . . . . 0.0 110.524 -177.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.568 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 22.5 mtmt -68.23 -35.92 78.68 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.414 ' HG ' ' CB ' ' A' ' 26' ' ' THR . 0.4 OUTLIER -41.01 -66.23 0.35 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 122.829 1.299 . . . . 0.0 108.472 178.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.548 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.9 mt-10 -65.65 -52.83 48.63 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.132 -0.94 . . . . 0.0 108.612 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.548 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -40.8 -50.86 3.17 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.324 -1.485 . . . . 0.0 107.397 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -58.57 -58.79 6.98 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 120.898 -1.126 . . . . 0.0 111.63 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.93 -29.77 67.35 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.1 -1.625 . . . . 0.0 110.163 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 27.9 tp -63.17 -25.01 68.15 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.96 50.49 0.26 Allowed Glycine 0 N--CA 1.501 2.992 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.588 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.49 146.12 30.38 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.094 -1.239 . . . . 0.0 109.661 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.1 t -135.42 125.8 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.565 -0.709 . . . . 0.0 109.214 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -58.96 -52.53 65.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.843 -0.536 . . . . 0.0 109.744 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.6 p -69.71 50.12 0.1 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.697 -1.252 . . . . 0.0 109.342 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.64 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -178.46 -50.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.18 56.38 24.11 Favored Glycine 0 N--CA 1.503 3.1 0 N-CA-C 108.389 -1.884 . . . . 0.0 108.389 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.64 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -71.94 164.99 25.1 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.629 -0.924 . . . . 0.0 110.387 -178.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.792 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 60.6 tp -177.35 -69.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.726 -0.609 . . . . 0.0 110.214 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -57.87 -20.46 36.85 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.616 -1.302 . . . . 0.0 109.414 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.5 p-10 -77.89 -63.08 1.47 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 122.424 1.107 . . . . 0.0 109.501 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.451 HG22 ' H ' ' A' ' 45' ' ' VAL . 17.0 m -77.46 -7.25 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.17 -0.956 . . . . 0.0 110.259 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.47 70.53 7.46 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.464 -0.772 . . . . 0.0 109.076 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -56.39 125.97 20.8 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 123.358 2.705 . . . . 0.0 113.719 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.32 40.13 70.04 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -137.56 176.21 8.91 Favored 'General case' 0 N--CA 1.516 2.851 0 CA-C-O 122.592 1.187 . . . . 0.0 111.85 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.404 ' HG ' ' HD2' ' A' ' 78' ' ' TYR . 73.1 m -148.72 160.41 43.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.614 -1.304 . . . . 0.0 111.639 -177.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.3 mm -83.24 127.76 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.436 -0.79 . . . . 0.0 109.833 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 170.44 153.23 8.59 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.603 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 121.71 -16.78 8.91 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.243 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.522 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 1.2 m-20 -70.48 -154.42 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.243 -1.151 . . . . 0.0 109.903 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.2 mp -128.61 135.79 61.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.945 0.879 . . . . 0.0 110.202 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.606 ' O ' ' N ' ' A' ' 58' ' ' ASN . 10.9 t80 -101.75 91.16 4.28 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.654 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -60.57 37.27 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.632 -0.668 . . . . 0.0 110.456 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.606 ' N ' ' O ' ' A' ' 56' ' ' PHE . 56.3 t30 37.82 36.69 0.1 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.208 -0.932 . . . . 0.0 110.444 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.654 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.9 mtm180 -68.35 44.93 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.804 -1.185 . . . . 0.0 109.885 179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.62 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 20.1 mt-10 -151.51 -25.64 0.2 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.511 -0.743 . . . . 0.0 110.055 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.86 29.47 59.12 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.384 -1.487 . . . . 0.0 109.384 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.68 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.5 mttp -112.89 9.16 18.86 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.535 -0.979 . . . . 0.0 109.468 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mt -131.95 143.92 51.05 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.755 -0.591 . . . . 0.0 109.41 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.57 124.19 13.74 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 122.729 2.286 . . . . 0.0 112.3 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.541 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -100.76 -172.83 29.21 Favored Glycine 0 N--CA 1.505 3.235 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.5 ' O ' ' N ' ' A' ' 68' ' ' GLY . 10.8 tttt 177.29 145.4 0.1 Allowed 'General case' 0 N--CA 1.508 2.465 0 O-C-N 121.559 -0.965 . . . . 0.0 108.73 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' A' ' 67' ' ' SER . 24.6 p -67.62 56.88 0.06 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.016 -1.052 . . . . 0.0 109.104 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 147.31 77.9 0.02 OUTLIER Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.541 HH11 ' C ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -173.97 168.35 4.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.566 -0.961 . . . . 0.0 108.839 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.443 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.8 m -143.97 156.38 44.39 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.967 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.721 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 20.6 m95 -127.76 137.21 52.35 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.567 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -128.83 157.57 41.15 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 120.969 -1.082 . . . . 0.0 109.73 179.253 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.568 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -121.52 167.66 12.6 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.271 -0.893 . . . . 0.0 111.565 -179.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.95 136.63 4.24 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.245 -0.909 . . . . 0.0 111.151 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.716 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -59.0 151.72 21.43 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.557 -0.714 . . . . 0.0 111.724 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.633 HD11 ' CG2' ' A' ' 88' ' ' ILE . 46.3 mm -135.69 144.58 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.489 179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 58.31 70.36 0.66 Allowed 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.393 0.616 . . . . 0.0 110.407 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.792 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 61.6 t80 -129.54 161.1 31.26 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.076 -1.015 . . . . 0.0 109.455 178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.611 ' OG1' ' N ' ' A' ' 80' ' ' SER . 28.5 p -140.9 -77.74 0.29 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.611 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -149.18 110.89 4.52 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.31 -104.04 0.24 Allowed Glycine 0 N--CA 1.502 3.038 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 44.2 t80 -141.32 -167.63 2.45 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.918 -0.754 . . . . 0.0 109.183 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.633 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.6 mtm180 -73.04 -153.58 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.165 -0.96 . . . . 0.0 109.415 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -168.35 -151.35 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.52 ' OG ' ' O ' ' A' ' 100' ' ' THR . 43.1 p -99.45 -4.16 32.05 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.645 -1.285 . . . . 0.0 110.114 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.457 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -91.04 118.14 30.16 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.287 -0.883 . . . . 0.0 110.492 -178.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.842 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.66 148.88 39.86 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.354 -0.841 . . . . 0.0 109.481 179.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.633 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.3 tt -116.59 136.65 52.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.402 HD13 ' O ' ' A' ' 72' ' ' ARG . 1.9 mm? -113.42 124.19 51.84 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.659 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -117.78 125.96 51.57 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.997 0.903 . . . . 0.0 109.466 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.721 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 5.1 p -92.12 158.54 16.14 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-O 121.852 0.834 . . . . 0.0 112.081 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.4 p -70.18 -19.69 63.17 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.533 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -82.43 10.12 7.78 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.347 -0.846 . . . . 0.0 109.928 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.453 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.85 30.22 0.47 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.712 -0.618 . . . . 0.0 110.099 179.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.423 HD12 HH21 ' A' ' 69' ' ' ARG . 29.6 mt -101.77 138.72 38.38 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.215 -0.928 . . . . 0.0 109.79 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.446 HG22 HD11 ' A' ' 109' ' ' ILE . 35.1 mm -113.23 119.51 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.469 -0.769 . . . . 0.0 110.024 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.428 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.9 m-85 -120.39 143.08 48.62 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.457 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 7.4 tptp -131.24 148.28 52.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.025 -1.047 . . . . 0.0 110.806 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.551 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.9 t -127.95 172.35 10.98 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.52 ' O ' ' OG ' ' A' ' 85' ' ' SER . 67.9 p -147.44 -1.45 0.62 Allowed 'General case' 0 N--CA 1.507 2.408 0 O-C-N 121.452 -0.78 . . . . 0.0 110.796 178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.634 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -117.27 19.06 14.29 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.728 -1.232 . . . . 0.0 108.287 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.65 63.12 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.358 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.68 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 19.3 m-85 69.65 -13.23 0.41 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.873 -0.517 . . . . 0.0 111.334 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -50.72 -73.98 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.57 -1.331 . . . . 0.0 109.565 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.481 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 33.7 p -98.58 -177.42 3.67 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.67 134.81 7.15 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.126 -0.984 . . . . 0.0 109.968 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.4 m -128.39 139.0 52.6 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.615 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.7 tttp -86.26 140.21 30.32 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.937 -1.102 . . . . 0.0 109.904 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.446 HD11 HG22 ' A' ' 96' ' ' ILE . 12.8 pt -113.91 -31.26 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.689 -0.632 . . . . 0.0 109.642 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.63 HH21 ' CG ' ' A' ' 8' ' ' ASP . 66.7 mtt180 . . . . . 0 C--N 1.303 -1.426 0 O-C-N 121.126 -0.984 . . . . 0.0 108.846 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.621 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 20.2 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.399 0.618 . . . . 0.0 109.343 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 tt -170.13 159.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -146.17 30.14 1.05 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.766 -1.209 . . . . 0.0 111.306 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.4 p -104.8 158.14 16.73 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.594 0.712 . . . . 0.0 109.666 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.0 OUTLIER -60.68 -61.33 2.67 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.842 -1.161 . . . . 0.0 110.07 -179.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.637 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.04 -41.48 78.71 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.213 -0.929 . . . . 0.0 109.659 -179.742 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.14 -44.83 94.62 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.676 HG22 ' HG2' ' A' ' 21' ' ' PRO . 53.3 t -67.31 -41.07 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.421 -1.047 . . . . 0.0 108.746 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.77 -57.86 9.45 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.17 -53.41 27.96 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.512 -0.742 . . . . 0.0 109.619 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.697 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 32.2 t80 -57.48 -50.6 72.52 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.454 0.645 . . . . 0.0 110.683 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tt -71.71 -45.14 62.75 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.3 -0.875 . . . . 0.0 110.886 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -62.12 -22.16 65.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.622 -1.299 . . . . 0.0 110.435 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 m -95.59 -40.93 9.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.077 -1.014 . . . . 0.0 111.021 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -110.28 17.06 21.29 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.958 -1.089 . . . . 0.0 112.002 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.2 m80 46.17 24.82 0.29 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.025 -1.047 . . . . 0.0 110.372 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.6 pttp -143.22 149.75 38.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.061 -1.024 . . . . 0.0 110.282 -178.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.6 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.6 mp -73.63 150.15 88.72 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.249 -0.907 . . . . 0.0 108.827 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.697 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 50.9 Cg_exo -38.94 153.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 123.333 2.688 . . . . 0.0 114.092 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.621 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -68.53 50.24 0.07 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.197 0.999 . . . . 0.0 110.692 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -171.32 25.77 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 109.928 179.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -117.81 116.39 26.89 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.46 -1.4 . . . . 0.0 110.399 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.0 pt -118.99 136.13 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 CA-C-O 122.167 0.984 . . . . 0.0 109.659 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.545 HG22 ' HA3' ' A' ' 53' ' ' GLY . 7.7 p -65.49 166.89 9.62 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.05 -1.031 . . . . 0.0 111.545 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.616 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 22.5 mtmt -68.48 -36.72 79.35 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.44 -65.17 0.52 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 114.836 -1.075 . . . . 0.0 108.109 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.9 mt-10 -63.72 -53.86 44.53 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 119.067 -1.053 . . . . 0.0 108.983 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.494 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -40.72 -51.56 3.05 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.653 -1.28 . . . . 0.0 108.597 178.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -57.38 -58.8 6.68 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.965 -1.084 . . . . 0.0 111.502 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.37 -32.23 68.38 Favored 'General case' 0 N--CA 1.51 2.562 0 O-C-N 120.663 -1.273 . . . . 0.0 108.811 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.412 HD21 ' HB ' ' A' ' 45' ' ' VAL . 27.8 tp -61.35 -23.43 65.75 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.49 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.49 50.98 0.36 Allowed Glycine 0 N--CA 1.496 2.675 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.562 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -82.99 146.71 28.62 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.152 -1.205 . . . . 0.0 109.343 179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.3 t -135.75 123.93 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.472 -0.768 . . . . 0.0 109.388 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.44 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -57.25 -52.61 64.63 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.846 -0.534 . . . . 0.0 109.763 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 77.3 p -69.79 48.7 0.09 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.389 -0.819 . . . . 0.0 109.72 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.645 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.3 ttpm? -178.31 -50.35 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.63 57.4 17.95 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.645 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -72.5 162.09 29.94 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.747 -0.855 . . . . 0.0 110.56 -179.196 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.875 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.7 tp -175.62 -66.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.443 -0.785 . . . . 0.0 109.937 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.642 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -61.72 -18.96 61.75 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.77 -1.207 . . . . 0.0 109.988 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 45' ' ' VAL . 4.5 p-10 -79.18 -64.63 1.14 Allowed 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.912 0.863 . . . . 0.0 109.063 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.478 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 31.6 m -74.48 -12.07 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.918 -0.489 . . . . 0.0 110.158 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.4 71.07 13.01 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.47 -0.769 . . . . 0.0 109.412 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.48 123.58 13.91 Favored 'Trans proline' 0 N--CA 1.509 2.395 0 C-N-CA 122.919 2.413 . . . . 0.0 113.991 -179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.49 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 71.57 41.0 58.45 Favored Glycine 0 N--CA 1.502 3.049 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.5 mmtt -139.07 170.82 15.28 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 122.031 0.919 . . . . 0.0 110.962 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.417 ' HA ' HD21 ' A' ' 42' ' ' LEU . 74.8 m -144.81 160.63 40.96 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 122.204 1.002 . . . . 0.0 110.554 -177.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.8 mm -84.26 128.22 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.526 -0.734 . . . . 0.0 109.906 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.58 153.68 9.26 Favored Glycine 0 N--CA 1.499 2.88 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.545 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 121.75 -16.56 8.92 Favored Glycine 0 N--CA 1.5 2.925 0 C-N-CA 119.653 -1.26 . . . . 0.0 111.367 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.456 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -71.88 -150.64 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.795 -1.415 . . . . 0.0 110.037 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -129.93 140.7 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.561 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.624 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.3 t80 -106.68 90.1 3.22 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.514 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.3 p -60.0 38.22 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.388 0.613 . . . . 0.0 110.591 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 56' ' ' PHE . 63.8 t30 37.54 34.58 0.05 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.121 -0.987 . . . . 0.0 110.526 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.514 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.6 mtm180 -66.24 44.72 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.844 -1.16 . . . . 0.0 110.093 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.616 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 20.1 mt-10 -152.05 -26.42 0.18 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.483 -0.761 . . . . 0.0 109.918 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.6 28.08 62.0 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.671 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.0 mttp -110.31 5.11 21.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.527 -0.984 . . . . 0.0 109.102 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -127.98 144.46 51.57 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.792 -0.568 . . . . 0.0 109.673 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.52 124.89 15.02 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 123.048 2.499 . . . . 0.0 112.279 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.527 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -101.18 -173.94 28.8 Favored Glycine 0 N--CA 1.498 2.826 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' O ' ' N ' ' A' ' 68' ' ' GLY . 12.9 tttt 177.41 145.72 0.11 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.413 -1.051 . . . . 0.0 108.787 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.3 p -68.13 58.03 0.07 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.05 -1.031 . . . . 0.0 109.236 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 147.36 75.78 0.02 OUTLIER Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.531 ' NH2' ' OD1' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.46 169.92 5.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.684 -0.892 . . . . 0.0 109.225 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.454 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.9 m -145.23 155.39 43.22 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.911 -0.716 . . . . 0.0 109.829 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.721 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 20.3 m95 -126.13 138.78 53.7 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.573 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -129.35 155.8 45.05 Favored 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.789 -1.194 . . . . 0.0 109.58 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.616 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -120.28 166.25 13.75 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 121.255 -0.903 . . . . 0.0 111.551 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.53 134.66 3.34 Favored 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.197 -0.939 . . . . 0.0 110.69 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.712 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.91 152.14 16.71 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.359 0.599 . . . . 0.0 111.482 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.724 HD11 ' CG2' ' A' ' 88' ' ' ILE . 39.9 mm -134.9 142.85 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.559 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.9 m-20 57.8 71.69 0.56 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.288 0.566 . . . . 0.0 110.266 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.875 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 63.0 t80 -129.13 159.72 35.12 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 121.417 -0.802 . . . . 0.0 109.318 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.6 ' OG1' ' N ' ' A' ' 80' ' ' SER . 24.2 p -140.65 -78.33 0.29 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.642 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -150.05 107.58 3.65 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.66 -103.93 0.23 Allowed Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.484 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 50.7 t80 -141.72 -170.02 3.03 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.638 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.5 mtm180 -70.41 -151.95 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.131 -0.981 . . . . 0.0 109.815 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -172.07 -151.89 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 100' ' ' THR . 43.8 p -98.9 -5.3 31.06 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.69 -1.256 . . . . 0.0 110.43 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.458 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -90.07 117.69 29.05 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.186 -0.946 . . . . 0.0 110.52 -178.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.856 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.31 149.64 43.03 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.214 -0.929 . . . . 0.0 109.573 179.349 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.724 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.8 tt -117.74 135.83 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.434 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.0 mm? -112.63 124.86 53.5 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.69 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.7 127.42 53.55 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.709 0.766 . . . . 0.0 109.205 -179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.721 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.1 p -94.35 158.95 15.33 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.173 0.987 . . . . 0.0 112.522 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.1 p -69.75 -19.08 63.54 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.531 ' OD1' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -83.24 10.46 8.4 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.762 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.443 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.46 29.97 0.52 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.634 -0.666 . . . . 0.0 110.025 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.41 HD12 HH21 ' A' ' 69' ' ' ARG . 23.4 mt -101.96 136.52 41.66 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.319 -0.863 . . . . 0.0 109.807 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.459 HG22 HD11 ' A' ' 109' ' ' ILE . 32.9 mm -110.38 119.92 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.576 -0.703 . . . . 0.0 110.251 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.429 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.3 m-85 -120.68 142.64 49.29 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.458 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 8.7 tptp -130.96 147.02 52.55 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.776 0.798 . . . . 0.0 111.005 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.573 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.4 t -127.51 171.53 11.52 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.442 ' O ' ' OG ' ' A' ' 85' ' ' SER . 74.6 p -146.85 -1.72 0.66 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 121.386 -0.821 . . . . 0.0 110.328 178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.627 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -116.68 18.75 14.83 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.806 -1.184 . . . . 0.0 108.353 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.53 63.27 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.449 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.671 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 19.9 m-85 69.99 -14.12 0.39 Allowed 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.774 -0.579 . . . . 0.0 111.614 178.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -51.39 -73.33 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.754 -1.216 . . . . 0.0 109.578 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.504 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 33.2 p -98.65 -178.08 3.87 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.434 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -160.85 133.53 6.25 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.935 -1.103 . . . . 0.0 109.847 -179.245 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.7 m -127.87 140.05 52.25 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.615 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 16.3 tttp -86.01 139.71 30.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.123 -0.985 . . . . 0.0 109.971 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.459 HD11 HG22 ' A' ' 96' ' ' ILE . 12.0 pt -113.38 -32.43 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.637 HH21 ' CG ' ' A' ' 8' ' ' ASP . 62.2 mtt180 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.103 -0.998 . . . . 0.0 109.198 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.629 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 36.0 t . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 4' ' ' ILE . 1.6 tt -171.52 158.82 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 40.0 p30 -146.08 29.97 1.07 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.472 -1.392 . . . . 0.0 111.241 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.405 ' O ' HG23 ' A' ' 10' ' ' VAL . 24.9 p -105.69 155.94 18.77 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.2 p90 -58.66 -63.79 1.16 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.961 -1.087 . . . . 0.0 110.463 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.614 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -53.81 -43.46 69.37 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.516 -0.74 . . . . 0.0 109.449 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.39 -44.72 89.86 Favored Glycine 0 N--CA 1.5 2.965 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.682 HG22 ' HG2' ' A' ' 21' ' ' PRO . 63.2 t -67.3 -41.32 86.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 121.51 -0.994 . . . . 0.0 108.786 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.36 -58.84 6.19 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.82 -55.0 12.87 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.371 -0.83 . . . . 0.0 109.663 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.646 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 35.0 t80 -56.26 -50.76 70.43 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.284 0.564 . . . . 0.0 110.627 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.3 tt -72.26 -44.37 62.93 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.406 -0.809 . . . . 0.0 111.282 -179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -62.76 -21.31 65.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.605 -1.309 . . . . 0.0 110.08 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.0 m -95.9 -40.5 9.27 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.927 -1.108 . . . . 0.0 111.283 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -111.14 17.26 20.52 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.055 -1.028 . . . . 0.0 111.987 -177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.0 m80 45.78 25.01 0.25 Allowed 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.845 -1.159 . . . . 0.0 110.271 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.453 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.4 pttp -141.88 152.51 43.67 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.075 -1.016 . . . . 0.0 110.898 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.543 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.3 mp -76.78 148.73 79.72 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.224 -0.922 . . . . 0.0 109.303 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.682 ' HG2' HG22 ' A' ' 10' ' ' VAL . 73.7 Cg_exo -38.23 152.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.503 2.032 0 C-N-CA 122.904 2.403 . . . . 0.0 114.428 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.629 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -66.06 48.52 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 122.122 0.963 . . . . 0.0 110.094 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.7 OUTLIER -169.23 24.16 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.671 -1.268 . . . . 0.0 110.126 179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -117.39 116.25 26.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.968 -1.082 . . . . 0.0 110.86 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 34.4 pt -118.03 141.01 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.833 0.825 . . . . 0.0 109.312 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.626 HG22 ' HA3' ' A' ' 53' ' ' GLY . 6.2 p -70.98 166.29 21.61 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.967 -1.083 . . . . 0.0 111.479 -177.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.629 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 20.2 mtmt -67.19 -36.39 81.64 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.78 -65.08 0.54 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 114.834 -1.076 . . . . 0.0 108.6 177.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.46 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.2 mt-10 -63.34 -52.47 61.66 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.025 -1.07 . . . . 0.0 108.342 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.46 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -41.69 -49.78 4.22 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.174 178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 37.8 mt-30 -60.81 -55.72 29.69 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.36 -0.837 . . . . 0.0 111.755 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.49 -31.8 70.82 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.669 -1.269 . . . . 0.0 109.276 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 20.2 tp -60.83 -31.36 70.78 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.96 52.09 0.15 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.677 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -83.77 146.39 28.18 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.083 -1.245 . . . . 0.0 109.888 -179.802 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.3 t -137.56 125.86 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.274 -0.891 . . . . 0.0 109.373 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -57.27 -53.28 59.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.924 -0.485 . . . . 0.0 110.501 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.7 p -69.08 48.75 0.07 Allowed 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.979 -1.076 . . . . 0.0 109.716 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.648 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -178.81 -49.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.52 55.37 29.25 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.677 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -70.8 160.17 33.22 Favored 'General case' 0 C--N 1.292 -1.931 0 O-C-N 121.64 -0.918 . . . . 0.0 110.458 -179.063 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.813 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 58.9 tp -174.98 -67.29 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.497 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.653 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -58.52 -20.19 43.94 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.339 -0.851 . . . . 0.0 110.093 -178.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.8 p-10 -79.63 -65.39 1.01 Allowed 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.678 0.752 . . . . 0.0 109.874 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.457 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 28.9 m -75.98 -6.82 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.799 -0.563 . . . . 0.0 110.708 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.0 69.03 9.04 Favored Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -57.69 122.32 11.55 Favored 'Trans proline' 0 N--CA 1.508 2.324 0 C-N-CA 123.595 2.863 . . . . 0.0 113.853 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.95 38.99 55.61 Favored Glycine 0 N--CA 1.501 3.016 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.41 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 8.7 mmtm -138.38 178.16 7.34 Favored 'General case' 0 N--CA 1.51 2.546 0 CA-C-O 122.248 1.023 . . . . 0.0 111.455 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.419 ' HG ' ' HD2' ' A' ' 78' ' ' TYR . 63.9 m -150.53 161.0 43.38 Favored 'General case' 0 N--CA 1.483 1.207 0 O-C-N 120.857 -1.152 . . . . 0.0 111.417 -177.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.8 mm -83.37 126.17 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.092 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.72 152.97 8.74 Favored Glycine 0 N--CA 1.499 2.842 0 C-N-CA 119.981 -1.104 . . . . 0.0 110.38 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.626 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 122.43 -17.35 8.42 Favored Glycine 0 N--CA 1.498 2.778 0 C-N-CA 119.944 -1.122 . . . . 0.0 111.052 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -69.95 -153.24 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.633 -1.51 . . . . 0.0 109.752 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.95 138.42 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.43 -0.794 . . . . 0.0 110.399 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.641 ' O ' ' N ' ' A' ' 58' ' ' ASN . 10.0 t80 -104.36 89.77 3.34 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.546 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -59.5 39.17 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.529 -0.732 . . . . 0.0 110.682 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.641 ' N ' ' O ' ' A' ' 56' ' ' PHE . 59.5 t30 36.83 34.88 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.069 -1.02 . . . . 0.0 110.483 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.546 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.2 mtm180 -66.71 45.25 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.822 -1.174 . . . . 0.0 109.602 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.61 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 18.9 mt-10 -151.74 -26.84 0.19 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.467 -0.771 . . . . 0.0 110.028 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.27 27.9 61.0 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.669 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.7 mttp -110.69 5.7 21.09 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.66 -0.906 . . . . 0.0 109.468 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -128.93 143.6 49.31 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.8 124.42 14.04 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 122.637 2.224 . . . . 0.0 112.239 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.519 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -99.81 -173.82 30.62 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 68' ' ' GLY . 11.1 tttt 177.92 146.27 0.13 Allowed 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.456 -1.026 . . . . 0.0 108.834 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.4 p -68.01 58.18 0.07 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.975 -1.078 . . . . 0.0 109.031 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 146.86 76.69 0.02 OUTLIER Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.542 ' NH2' ' OD1' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -173.35 168.89 4.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.597 -0.943 . . . . 0.0 109.161 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.454 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.3 m -145.65 155.2 42.85 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.834 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.726 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 21.5 m95 -125.39 138.8 54.04 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.558 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -129.72 156.06 44.9 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.798 -1.189 . . . . 0.0 109.517 179.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.629 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -120.03 167.54 12.07 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.3 -0.875 . . . . 0.0 112.136 -179.215 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.46 135.59 3.62 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.237 -0.915 . . . . 0.0 111.153 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.692 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.93 154.7 11.88 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.743 -0.598 . . . . 0.0 111.546 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.706 HD11 ' CG2' ' A' ' 88' ' ' ILE . 45.2 mm -136.87 143.5 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.789 -0.764 . . . . 0.0 110.518 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.8 m-20 57.62 70.01 0.69 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.192 0.52 . . . . 0.0 110.589 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.813 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 59.5 t80 -128.37 161.33 29.68 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.02 -1.05 . . . . 0.0 109.331 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.608 ' OG1' ' N ' ' A' ' 80' ' ' SER . 26.9 p -141.43 -76.69 0.29 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.653 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -150.47 110.33 4.09 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.73 -103.67 0.24 Allowed Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 45.4 t80 -142.46 -169.96 3.09 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.89 -0.77 . . . . 0.0 109.156 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.657 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.2 mtm180 -71.47 -158.09 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.24 -0.912 . . . . 0.0 109.159 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 19.1 p30 -166.33 -150.9 0.12 Allowed 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.505 ' OG ' ' O ' ' A' ' 100' ' ' THR . 53.8 p -99.0 -6.38 28.67 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.404 -1.435 . . . . 0.0 110.391 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.47 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -89.11 118.02 28.52 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.099 -1.001 . . . . 0.0 110.992 -178.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.857 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.03 149.97 42.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 0.0 109.685 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.706 ' CG2' HD11 ' A' ' 76' ' ' ILE . 5.2 tt -118.15 137.42 52.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.403 HD13 ' O ' ' A' ' 72' ' ' ARG . 1.9 mm? -113.85 124.88 53.29 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.63 127.67 53.81 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.724 0.773 . . . . 0.0 109.213 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.726 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.0 p -94.13 158.37 15.64 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 122.449 1.119 . . . . 0.0 112.382 -178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.8 p -68.93 -20.3 64.21 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.542 ' OD1' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -83.1 11.04 6.87 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.062 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.448 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.62 29.63 0.52 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.601 -0.687 . . . . 0.0 110.42 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.407 HD12 HH21 ' A' ' 69' ' ' ARG . 23.1 mt -102.78 136.86 41.83 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.258 -0.901 . . . . 0.0 110.189 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.501 HG22 HD11 ' A' ' 109' ' ' ILE . 31.7 mm -110.84 119.7 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.523 -0.736 . . . . 0.0 110.104 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.455 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.2 m-85 -119.88 142.81 48.34 Favored 'General case' 0 N--CA 1.505 2.286 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.47 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 8.2 tptp -130.7 147.29 52.35 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.847 -1.158 . . . . 0.0 110.691 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.493 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.5 t -128.46 171.43 12.08 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.505 ' O ' ' OG ' ' A' ' 85' ' ' SER . 76.5 p -146.51 -3.63 0.62 Allowed 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.491 -0.756 . . . . 0.0 110.459 179.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.639 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -114.36 19.52 16.19 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.792 -1.192 . . . . 0.0 108.455 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.11 62.41 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.15 179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.669 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 21.6 m-85 70.36 -14.57 0.39 Allowed 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.826 -0.546 . . . . 0.0 111.66 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -49.98 -72.88 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.247 0 O-C-N 120.661 -1.275 . . . . 0.0 109.886 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.502 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 42.0 p -100.42 -178.31 3.77 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -159.65 135.19 8.39 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.045 -1.034 . . . . 0.0 110.332 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.1 m -128.13 139.14 52.66 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.601 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.8 tttp -86.02 139.15 31.42 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.835 -1.166 . . . . 0.0 110.003 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.501 HD11 HG22 ' A' ' 96' ' ' ILE . 10.8 pt -111.96 -32.91 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.63 -0.669 . . . . 0.0 109.791 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.614 HH21 ' CG ' ' A' ' 8' ' ' ASP . 69.0 mtt180 . . . . . 0 N--CA 1.487 1.412 0 O-C-N 121.281 -0.887 . . . . 0.0 108.678 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.633 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.8 t . . . . . 0 N--CA 1.487 1.391 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.5 tt -171.15 158.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -179.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.4 p30 -145.4 29.67 1.15 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.411 -1.431 . . . . 0.0 111.466 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.7 p -103.67 157.15 17.26 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.436 -0.79 . . . . 0.0 109.762 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.4 p90 -59.87 -63.13 1.41 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.211 -0.93 . . . . 0.0 109.897 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.586 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.8 OUTLIER -56.01 -42.25 76.15 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.165 -0.959 . . . . 0.0 109.679 -179.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.4 -44.98 85.07 Favored Glycine 0 N--CA 1.5 2.957 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.772 HG22 ' HG2' ' A' ' 21' ' ' PRO . 53.3 t -67.93 -42.51 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.24 -58.6 7.65 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.9 -53.13 27.92 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.766 -1.209 . . . . 0.0 110.103 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.672 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 36.6 t80 -57.24 -48.61 78.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.669 -0.644 . . . . 0.0 110.418 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.6 tt -73.91 -43.89 56.94 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.493 -0.755 . . . . 0.0 110.974 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -63.7 -20.04 65.4 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.443 -1.411 . . . . 0.0 109.981 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.6 m -98.12 -40.29 8.48 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.697 -1.252 . . . . 0.0 110.544 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -109.66 14.62 23.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.165 -0.959 . . . . 0.0 112.022 -177.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.8 m80 46.77 24.98 0.39 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 120.668 -1.27 . . . . 0.0 110.41 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -143.57 149.82 37.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.177 -0.952 . . . . 0.0 110.828 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.587 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.5 mp -72.72 149.48 90.52 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 120.98 -1.075 . . . . 0.0 109.565 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.772 ' HG2' HG22 ' A' ' 10' ' ' VAL . 51.3 Cg_exo -40.36 150.8 0.11 Allowed 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 123.189 2.592 . . . . 0.0 113.716 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.633 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -63.95 48.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.541 0.686 . . . . 0.0 110.489 -179.205 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -171.43 28.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.02 -1.05 . . . . 0.0 110.67 179.103 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -119.11 115.08 23.53 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.191 -0.943 . . . . 0.0 110.719 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 30.5 pt -117.38 140.32 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.53 HG22 ' HA3' ' A' ' 53' ' ' GLY . 11.5 p -70.82 167.26 19.28 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.054 0.93 . . . . 0.0 111.75 -177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.568 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 23.6 mtmt -68.49 -37.32 80.01 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.406 ' HG ' ' CB ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -40.43 -67.83 0.21 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 113.873 -1.512 . . . . 0.0 108.217 177.187 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.515 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.0 mt-10 -63.57 -54.43 36.14 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.233 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.515 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -39.18 -51.84 1.94 Allowed 'General case' 0 CA--C 1.566 1.569 0 O-C-N 120.318 -1.489 . . . . 0.0 109.033 177.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.439 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 41.2 mt-30 -58.93 -57.69 11.93 Favored 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.661 -0.649 . . . . 0.0 111.219 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.15 -32.84 71.41 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.819 -1.175 . . . . 0.0 110.006 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.1 tp -59.45 -27.78 66.38 Favored 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.96 52.5 0.21 Allowed Glycine 0 N--CA 1.502 3.09 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.605 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -85.04 146.2 27.3 Favored 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.549 -0.971 . . . . 0.0 111.007 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.6 t -137.14 124.59 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 O-C-N 121.394 -0.816 . . . . 0.0 109.79 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -57.27 -50.87 71.52 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 122.037 -0.414 . . . . 0.0 110.369 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 54.3 p -70.06 49.06 0.1 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.3 -0.875 . . . . 0.0 109.443 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.646 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -179.13 -52.97 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.69 57.05 13.5 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 108.916 -1.674 . . . . 0.0 108.916 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.646 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -71.79 162.29 29.68 Favored 'General case' 0 C--N 1.289 -2.058 0 O-C-N 121.728 -0.866 . . . . 0.0 111.067 -178.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.819 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 64.6 tp -174.44 -67.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.772 -1.205 . . . . 0.0 109.995 178.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -61.33 -18.96 61.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.509 -0.744 . . . . 0.0 109.827 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.451 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 3.9 p-10 -80.22 -62.1 1.78 Allowed 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 122.091 0.948 . . . . 0.0 108.742 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.434 ' H ' HG22 ' A' ' 45' ' ' VAL . 16.3 m -75.65 -11.35 14.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.663 -1.273 . . . . 0.0 109.293 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -148.78 72.6 10.5 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 120.996 -1.065 . . . . 0.0 109.855 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.61 125.76 19.29 Favored 'Trans proline' 0 N--CA 1.509 2.415 0 C-N-CA 123.051 2.5 . . . . 0.0 114.323 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.571 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 72.74 40.15 53.67 Favored Glycine 0 N--CA 1.495 2.605 0 N-CA-C 109.023 -1.631 . . . . 0.0 109.023 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.571 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.8 mmtm -141.41 170.8 15.04 Favored 'General case' 0 N--CA 1.508 2.426 0 CA-C-O 121.674 0.749 . . . . 0.0 111.567 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.478 ' HG ' ' HD2' ' A' ' 78' ' ' TYR . 72.5 m -144.32 162.58 36.07 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 122.794 1.283 . . . . 0.0 110.935 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.6 mm -83.81 126.26 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.923 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 172.85 153.05 9.11 Favored Glycine 0 N--CA 1.501 3.021 0 O-C-N 120.575 -1.328 . . . . 0.0 109.98 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.53 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 120.38 -15.39 9.98 Favored Glycine 0 N--CA 1.499 2.866 0 O-C-N 121.145 -1.209 . . . . 0.0 111.166 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 1.6 m-20 -70.49 -154.9 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.547 -1.56 . . . . 0.0 109.473 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.0 mp -129.29 135.74 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 122.055 0.931 . . . . 0.0 110.169 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.633 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.7 t80 -101.8 89.16 3.58 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.67 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 2.2 p -59.3 40.25 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 CA-C-O 121.306 0.574 . . . . 0.0 110.766 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.633 ' N ' ' O ' ' A' ' 56' ' ' PHE . 61.5 t30 34.13 37.12 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.372 -0.83 . . . . 0.0 110.4 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.67 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.1 mtm180 -68.02 40.1 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.178 -0.951 . . . . 0.0 109.929 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.603 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 21.6 mt-10 -148.98 -19.38 0.3 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.024 -1.047 . . . . 0.0 110.44 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 70.45 31.45 68.35 Favored Glycine 0 N--CA 1.499 2.871 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.684 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.7 mttp -114.3 8.28 16.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.575 -0.956 . . . . 0.0 108.932 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mt -131.96 143.99 51.33 Favored Pre-proline 0 N--CA 1.491 1.583 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -63.37 124.3 13.57 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.681 2.254 . . . . 0.0 112.005 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.532 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -100.39 -172.04 29.56 Favored Glycine 0 N--CA 1.499 2.851 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 68' ' ' GLY . 10.3 tttt 177.03 146.55 0.1 Allowed 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.678 -0.895 . . . . 0.0 108.938 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.8 p -68.19 58.32 0.08 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.91 -1.119 . . . . 0.0 109.281 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 145.52 76.66 0.03 OUTLIER Glycine 0 N--CA 1.5 2.946 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.536 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.09 165.8 6.15 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.657 -0.908 . . . . 0.0 109.239 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 89.0 m -142.18 154.01 44.49 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.378 -0.826 . . . . 0.0 109.69 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.705 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 19.2 m95 -125.42 139.3 53.77 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.537 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -129.97 155.28 46.35 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.295 -0.878 . . . . 0.0 109.918 179.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.568 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -119.2 166.52 12.86 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.227 -0.921 . . . . 0.0 111.295 -179.144 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.85 134.8 3.19 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.182 -0.949 . . . . 0.0 110.955 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.703 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.5 OUTLIER -57.04 152.43 13.21 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.457 0.646 . . . . 0.0 111.548 -179.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 75' ' ' ASP . 42.0 mm -135.53 142.58 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.08 -1.013 . . . . 0.0 110.084 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 58.62 71.24 0.59 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.403 0.621 . . . . 0.0 110.517 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.819 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 65.1 t80 -129.59 159.3 36.8 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.354 -0.841 . . . . 0.0 109.382 178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 80' ' ' SER . 29.4 p -139.87 -78.94 0.31 Allowed 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.642 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -149.86 106.65 3.54 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.84 -102.78 0.21 Allowed Glycine 0 N--CA 1.5 2.926 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.482 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 52.4 t80 -142.38 -168.0 2.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.86 -0.788 . . . . 0.0 108.977 179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.652 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.8 mtm180 -73.09 -152.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.823 -1.173 . . . . 0.0 109.807 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -170.48 -150.61 0.07 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' A' ' 100' ' ' THR . 40.6 p -100.75 -5.77 25.91 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.754 -1.216 . . . . 0.0 110.345 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.5 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -90.44 118.81 30.21 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.906 -1.121 . . . . 0.0 110.272 -178.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.865 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -141.52 150.42 42.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.187 -0.946 . . . . 0.0 109.346 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.662 ' CG2' HD11 ' A' ' 76' ' ' ILE . 3.6 tt -117.29 138.83 46.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.462 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.2 mm? -114.84 123.51 49.37 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.664 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -116.71 126.87 53.8 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.561 0.696 . . . . 0.0 109.357 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.705 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 3.1 p -93.07 158.94 15.52 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 122.163 0.983 . . . . 0.0 111.929 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.9 p -70.03 -20.33 63.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.446 -0.784 . . . . 0.0 108.913 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.536 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.47 10.2 6.19 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.468 -0.77 . . . . 0.0 109.867 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.475 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.76 30.07 0.48 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.654 -0.654 . . . . 0.0 110.148 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.4 HD12 HH21 ' A' ' 69' ' ' ARG . 26.5 mt -102.45 137.48 40.63 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.313 -0.867 . . . . 0.0 110.121 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.48 HG22 HD11 ' A' ' 109' ' ' ILE . 30.8 mm -110.75 119.14 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.28 -0.888 . . . . 0.0 110.951 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.448 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.5 m-85 -119.82 143.44 47.87 Favored 'General case' 0 N--CA 1.504 2.238 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.5 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 7.3 tptp -132.47 148.03 52.39 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.185 -0.947 . . . . 0.0 110.816 -178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.529 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.2 t -127.61 171.85 11.28 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.459 ' O ' ' OG ' ' A' ' 85' ' ' SER . 73.5 p -146.74 -1.82 0.67 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.274 -0.891 . . . . 0.0 110.358 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.631 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -117.36 19.31 14.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.823 -1.173 . . . . 0.0 108.681 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.94 61.63 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.237 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.684 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 19.6 m-85 70.01 -13.8 0.41 Allowed 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.711 -0.618 . . . . 0.0 111.529 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -49.83 -72.97 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.734 -1.228 . . . . 0.0 109.437 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.485 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 34.5 p -99.5 -176.18 3.21 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.462 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -161.8 135.07 6.28 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.174 -0.953 . . . . 0.0 109.666 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 55.0 m -128.33 140.7 51.72 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.615 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.4 tttp -87.25 139.91 30.08 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.7 -1.25 . . . . 0.0 110.306 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.48 HD11 HG22 ' A' ' 96' ' ' ILE . 13.6 pt -113.22 -32.72 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.485 -0.76 . . . . 0.0 109.75 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.615 ' O ' ' NZ ' ' A' ' 108' ' ' LYS . 60.5 mtt180 . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 118.292 -0.861 . . . . 0.0 109.528 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.626 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 21.0 t . . . . . 0 N--CA 1.494 1.768 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 4' ' ' ILE . 1.7 tt -170.8 159.87 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -144.46 27.74 1.37 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.793 -1.192 . . . . 0.0 111.501 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 10' ' ' VAL . 18.0 p -105.54 158.03 16.97 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.859 0.837 . . . . 0.0 110.761 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.7 p90 -60.02 -61.16 2.82 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.595 -1.316 . . . . 0.0 110.997 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.651 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.81 -39.83 78.51 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.0 -1.062 . . . . 0.0 110.102 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -59.44 -44.25 96.81 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.667 HG22 ' HG2' ' A' ' 21' ' ' PRO . 54.5 t -67.66 -41.73 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.313 -1.11 . . . . 0.0 108.535 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.33 -58.94 5.86 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.98 -54.21 16.57 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.421 -0.8 . . . . 0.0 109.861 178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.689 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 35.4 t80 -57.35 -49.62 75.55 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.569 -0.707 . . . . 0.0 110.737 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.89 -45.14 62.32 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.125 -0.985 . . . . 0.0 110.631 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -62.71 -20.11 64.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.23 -1.544 . . . . 0.0 110.615 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.0 m -98.07 -39.33 8.97 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.954 -1.091 . . . . 0.0 110.977 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -111.34 15.79 21.19 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.796 -1.19 . . . . 0.0 111.967 -177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 21.8 m80 46.75 23.74 0.28 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.109 -0.994 . . . . 0.0 110.867 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.2 pttp -141.16 150.81 43.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 109.792 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.568 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.7 mp -73.87 150.13 88.17 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.803 -1.186 . . . . 0.0 108.901 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.689 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 51.3 Cg_exo -38.07 150.66 0.06 OUTLIER 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 124.016 3.144 . . . . 0.0 113.701 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.626 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -65.77 46.73 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.747 0.784 . . . . 0.0 111.405 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.7 OUTLIER -169.82 26.6 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 109.818 -179.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -117.9 119.72 35.69 Favored 'General case' 0 N--CA 1.506 2.354 0 O-C-N 120.836 -1.165 . . . . 0.0 110.622 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.1 pt -121.12 139.52 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.818 0.818 . . . . 0.0 109.194 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.696 HG22 ' HA3' ' A' ' 53' ' ' GLY . 6.1 p -69.78 167.63 16.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.893 -1.129 . . . . 0.0 111.094 -177.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.554 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 19.1 mtmt -68.22 -33.04 73.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -46.12 -63.65 0.93 Allowed 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.493 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.7 mt-10 -66.44 -51.58 55.37 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -41.35 -51.41 3.68 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.662 -1.215 . . . . 0.0 108.686 177.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.415 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 39.3 mt-30 -60.14 -56.38 22.26 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.399 -0.813 . . . . 0.0 111.201 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.13 -27.85 68.68 Favored 'General case' 0 N--CA 1.511 2.577 0 O-C-N 120.263 -1.523 . . . . 0.0 109.147 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.1 tp -64.74 -23.35 67.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.706 -0.621 . . . . 0.0 110.233 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.4 51.78 0.28 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -84.43 144.18 28.93 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.29 -1.123 . . . . 0.0 109.853 179.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.2 t -136.14 125.18 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.304 0 O-C-N 121.226 -0.921 . . . . 0.0 109.627 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -56.5 -51.46 68.43 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.967 -0.458 . . . . 0.0 110.547 -179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.7 p -71.55 48.32 0.14 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.96 -1.088 . . . . 0.0 109.777 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.637 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.4 ttpm? -177.44 -49.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.76 54.79 31.08 Favored Glycine 0 N--CA 1.496 2.661 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.637 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -71.21 160.27 33.14 Favored 'General case' 0 C--N 1.29 -2.021 0 O-C-N 121.479 -1.012 . . . . 0.0 110.311 -178.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.84 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 64.9 tp -174.94 -67.26 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.581 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.635 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -58.49 -21.29 51.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.817 -1.177 . . . . 0.0 109.467 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 3.2 p-10 -77.86 -63.42 1.39 Allowed 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.684 0.754 . . . . 0.0 109.441 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.402 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 22.5 m -76.21 -8.78 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.724 -0.61 . . . . 0.0 109.734 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.13 68.79 8.87 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.148 -0.97 . . . . 0.0 109.292 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -57.26 124.51 16.34 Favored 'Trans proline' 0 N--CA 1.506 2.259 0 C-N-CA 123.306 2.67 . . . . 0.0 113.511 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.538 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 69.86 41.05 74.15 Favored Glycine 0 N--CA 1.501 3.033 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.4 mmtm -139.56 175.85 9.22 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.647 -0.914 . . . . 0.0 110.533 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.1 m -148.74 160.62 43.01 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.493 1.139 . . . . 0.0 110.957 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.0 mm -82.02 127.15 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 CA-C-O 121.786 0.803 . . . . 0.0 110.493 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.33 153.55 9.08 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 178.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.696 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 122.31 -17.48 8.47 Favored Glycine 0 N--CA 1.507 3.433 0 O-C-N 121.57 -0.959 . . . . 0.0 110.799 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.479 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 1.2 m-20 -69.71 -156.21 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.629 -1.512 . . . . 0.0 109.619 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.83 140.72 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-O 121.604 0.716 . . . . 0.0 110.435 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.668 ' O ' ' N ' ' A' ' 58' ' ' ASN . 9.2 t80 -107.03 88.54 2.76 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.687 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -58.03 38.72 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.826 -0.546 . . . . 0.0 110.675 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.668 ' N ' ' O ' ' A' ' 56' ' ' PHE . 59.9 t30 35.76 38.75 0.06 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.074 -1.016 . . . . 0.0 110.001 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.687 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.2 mtm180 -69.61 41.79 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.745 -1.222 . . . . 0.0 109.832 177.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.611 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 17.5 mt-10 -148.0 -24.56 0.35 Allowed 'General case' 0 N--CA 1.485 1.285 0 O-C-N 120.698 -1.251 . . . . 0.0 109.717 179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.3 27.66 61.37 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.68 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.8 mttp -111.84 7.51 20.15 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.921 -0.752 . . . . 0.0 109.637 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -129.61 143.79 50.36 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.83 123.54 12.48 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 122.613 2.209 . . . . 0.0 112.886 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.527 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -97.94 -174.17 33.3 Favored Glycine 0 N--CA 1.506 3.341 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.549 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 11.1 tttt 177.62 145.82 0.12 Allowed 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.447 -1.031 . . . . 0.0 108.707 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 41.0 p -68.71 58.85 0.09 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.888 -1.133 . . . . 0.0 108.767 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.549 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 146.67 74.39 0.02 OUTLIER Glycine 0 N--CA 1.495 2.608 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.538 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -171.82 167.86 6.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.509 -0.995 . . . . 0.0 109.193 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.455 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 93.0 m -144.06 155.6 44.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.273 -0.892 . . . . 0.0 110.331 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.74 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 20.7 m95 -125.41 137.59 54.01 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.588 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -127.57 156.28 42.5 Favored 'General case' 0 N--CA 1.506 2.338 0 O-C-N 120.869 -1.144 . . . . 0.0 109.054 179.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.554 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -121.18 166.86 13.36 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.089 -1.007 . . . . 0.0 111.306 -179.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.52 134.71 3.36 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.313 -0.867 . . . . 0.0 110.979 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.66 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -56.23 152.23 11.27 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.611 0.719 . . . . 0.0 111.449 179.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.717 HD11 ' CG2' ' A' ' 88' ' ' ILE . 38.3 mm -135.5 143.58 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.563 -0.711 . . . . 0.0 110.106 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 28.0 m-20 58.41 69.47 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.365 0.603 . . . . 0.0 110.497 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.84 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 69.4 t80 -128.24 160.16 32.97 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.244 -0.91 . . . . 0.0 109.631 178.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.617 ' OG1' ' N ' ' A' ' 80' ' ' SER . 25.1 p -142.23 -78.5 0.25 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.635 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -148.67 107.95 3.93 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.85 -102.06 0.2 Allowed Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 51.4 t80 -143.0 -168.52 2.81 Favored 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 178.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.635 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.4 mtm180 -72.99 -150.61 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.688 -1.257 . . . . 0.0 109.314 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.596 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 10.4 p30 -171.52 -151.28 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.6 p -99.83 -7.23 25.65 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.673 -1.267 . . . . 0.0 110.201 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.472 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -88.51 118.78 28.39 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.132 -0.98 . . . . 0.0 110.276 -178.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.859 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.77 150.32 43.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.429 -0.795 . . . . 0.0 110.014 179.038 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.717 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.0 tt -117.02 136.76 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 108.983 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.406 ' HA ' HD22 ' A' ' 89' ' ' LEU . 1.9 mm? -112.89 124.7 53.2 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.679 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.36 126.72 52.68 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-O 122.11 0.957 . . . . 0.0 109.494 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.74 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.7 p -94.39 158.34 15.61 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 122.292 1.044 . . . . 0.0 112.085 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.5 p -68.53 -21.17 64.58 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 177.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.538 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.61 10.77 5.45 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.196 -0.94 . . . . 0.0 110.144 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.435 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 76.97 31.12 0.53 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.927 -0.483 . . . . 0.0 110.051 179.513 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.409 HD12 HH21 ' A' ' 69' ' ' ARG . 26.8 mt -103.48 136.26 43.54 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.279 -0.888 . . . . 0.0 109.816 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.458 HG22 HD11 ' A' ' 109' ' ' ILE . 34.1 mm -110.37 120.02 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.248 -0.907 . . . . 0.0 110.204 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.448 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.3 m-85 -120.17 143.47 48.21 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.472 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 7.7 tptp -131.74 147.41 52.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 110.967 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.558 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 2.2 t -127.79 169.9 13.36 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 70.1 p -144.79 -2.99 0.8 Allowed 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.663 -0.648 . . . . 0.0 110.22 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.631 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -115.37 18.79 15.9 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.596 -1.315 . . . . 0.0 108.566 -179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.9 63.55 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.167 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.68 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 18.0 m-85 69.09 -13.64 0.34 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.899 -0.501 . . . . 0.0 111.736 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -51.46 -73.5 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.384 -1.448 . . . . 0.0 109.8 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.509 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 36.3 p -99.03 -178.48 3.95 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.32 134.24 7.15 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.845 -1.159 . . . . 0.0 110.0 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 78.3 m -127.38 140.66 52.03 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.628 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.8 tttp -86.22 139.33 31.14 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.063 -1.023 . . . . 0.0 109.928 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.458 HD11 HG22 ' A' ' 96' ' ' ILE . 13.2 pt -112.43 -31.66 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.695 -0.628 . . . . 0.0 109.728 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.651 HH21 ' CG ' ' A' ' 8' ' ' ASP . 61.8 mtt180 . . . . . 0 C--N 1.306 -1.298 0 O-C-N 120.962 -1.086 . . . . 0.0 108.756 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.638 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 24.1 t . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 tt -171.06 160.84 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -145.98 29.52 1.09 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.473 -1.392 . . . . 0.0 111.465 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.441 ' O ' HG23 ' A' ' 10' ' ' VAL . 22.0 p -106.18 156.84 18.04 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-O 121.785 0.802 . . . . 0.0 110.05 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.504 ' HA ' HD12 ' A' ' 88' ' ' ILE . 1.7 p90 -59.91 -62.45 1.86 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.899 -1.126 . . . . 0.0 110.745 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.653 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -55.74 -42.7 75.78 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.35 -0.844 . . . . 0.0 109.565 179.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.0 -44.75 87.96 Favored Glycine 0 N--CA 1.5 2.903 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.678 HG22 ' HG2' ' A' ' 21' ' ' PRO . 75.0 t -68.22 -41.05 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 O-C-N 121.58 -0.953 . . . . 0.0 108.771 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.2 -58.29 8.32 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.26 -54.3 17.49 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.402 -0.811 . . . . 0.0 110.087 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.655 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 38.8 t80 -57.32 -50.1 74.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.911 -0.493 . . . . 0.0 110.429 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.85 -43.48 65.42 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.537 -0.727 . . . . 0.0 111.189 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -63.54 -20.1 65.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.31 -1.494 . . . . 0.0 110.314 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.5 m -97.28 -39.9 9.01 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.048 -1.032 . . . . 0.0 111.219 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.9 16.47 20.35 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.213 -0.93 . . . . 0.0 111.953 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 20.5 m80 46.82 24.38 0.34 Allowed 'General case' 0 N--CA 1.511 2.606 0 O-C-N 120.414 -1.429 . . . . 0.0 110.599 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 pttp -142.5 152.57 42.82 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.041 -1.037 . . . . 0.0 110.999 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.519 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.4 mp -75.45 148.53 83.29 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.313 -0.867 . . . . 0.0 109.442 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.678 ' HG2' HG22 ' A' ' 10' ' ' VAL . 54.0 Cg_exo -38.74 150.0 0.07 OUTLIER 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 123.623 2.882 . . . . 0.0 113.58 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -63.64 46.62 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.572 0.701 . . . . 0.0 110.883 -179.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.526 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -169.6 27.22 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.108 -0.995 . . . . 0.0 110.342 179.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -117.56 116.41 27.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.004 -1.06 . . . . 0.0 110.616 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 31.0 pt -119.11 139.36 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.313 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.581 HG22 ' HA3' ' A' ' 53' ' ' GLY . 5.1 p -70.33 166.35 20.41 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.056 -1.028 . . . . 0.0 111.206 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.604 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 20.5 mtmt -67.19 -37.41 83.64 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -40.91 -67.08 0.27 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.482 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.9 mt-10 -62.49 -54.46 39.61 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.297 -0.961 . . . . 0.0 108.994 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -39.18 -51.41 1.94 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.699 -1.251 . . . . 0.0 109.136 177.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -59.39 -57.63 12.16 Favored 'General case' 0 N--CA 1.508 2.433 0 O-C-N 121.549 -0.719 . . . . 0.0 111.019 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.9 -30.35 70.12 Favored 'General case' 0 N--CA 1.51 2.531 0 O-C-N 120.545 -1.347 . . . . 0.0 109.13 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.8 tp -61.51 -25.66 67.41 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 121.672 -0.642 . . . . 0.0 109.517 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.27 49.56 0.27 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.574 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -82.53 144.77 30.15 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -1.162 . . . . 0.0 109.72 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.0 t -136.73 125.21 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.34 -0.85 . . . . 0.0 109.392 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -57.19 -53.08 62.18 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.2 p -68.07 48.84 0.06 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.061 -1.025 . . . . 0.0 110.211 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.631 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -179.71 -51.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.91 58.15 11.83 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.631 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -72.85 161.98 30.05 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.714 -0.874 . . . . 0.0 110.782 -178.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.822 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.5 tp -174.85 -68.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.372 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -61.72 -18.65 60.52 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.721 -1.237 . . . . 0.0 109.793 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.9 p-10 -79.56 -60.86 2.19 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.842 0.829 . . . . 0.0 109.285 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.6 m -75.53 -13.24 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.85 -0.531 . . . . 0.0 109.983 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.57 72.62 9.83 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.46 -0.775 . . . . 0.0 110.011 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.29 124.72 16.83 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.809 2.34 . . . . 0.0 114.407 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.06 39.66 58.1 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.405 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 8.3 mmtt -138.65 172.69 12.51 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-O 122.195 0.998 . . . . 0.0 110.717 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.1 m -146.46 163.05 36.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.631 -1.293 . . . . 0.0 111.273 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.2 mm -83.8 130.02 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.452 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 167.81 154.35 8.62 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.581 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 118.67 -15.03 11.54 Favored Glycine 0 N--CA 1.501 3.031 0 C-N-CA 120.102 -1.047 . . . . 0.0 111.269 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.488 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -72.93 -154.59 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.63 -1.512 . . . . 0.0 108.585 178.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -126.27 141.85 44.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.34 -0.85 . . . . 0.0 110.732 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.598 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.9 t80 -106.59 90.84 3.46 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.585 0.707 . . . . 0.0 109.106 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.508 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.5 p -61.34 38.94 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.579 0.704 . . . . 0.0 110.741 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.598 ' N ' ' O ' ' A' ' 56' ' ' PHE . 56.9 t30 36.33 35.73 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.131 -0.981 . . . . 0.0 110.505 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.508 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.5 mtm180 -67.17 43.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.915 -1.116 . . . . 0.0 109.872 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.61 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 18.2 mt-10 -150.58 -25.43 0.23 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.468 -0.77 . . . . 0.0 109.943 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.86 27.77 62.06 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.679 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.0 mttp -110.77 6.8 21.74 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.747 -0.855 . . . . 0.0 109.615 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mt -129.76 143.67 49.95 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.547 -0.721 . . . . 0.0 109.69 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -62.41 123.79 13.07 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.782 2.321 . . . . 0.0 111.913 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.529 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -100.48 -172.22 29.48 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.497 ' O ' ' N ' ' A' ' 68' ' ' GLY . 9.8 tttt 177.37 146.63 0.12 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.624 -0.927 . . . . 0.0 109.092 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' A' ' 67' ' ' SER . 24.7 p -68.07 58.7 0.07 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.83 -1.169 . . . . 0.0 109.155 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 144.26 77.47 0.03 OUTLIER Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.529 ' NH1' ' O ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -171.82 168.04 6.19 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.701 -0.881 . . . . 0.0 108.988 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.442 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 86.6 m -144.18 154.53 43.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.454 -0.779 . . . . 0.0 110.116 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.703 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 18.5 m95 -125.4 139.21 53.86 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.531 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.21 155.06 46.89 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 121.01 -1.057 . . . . 0.0 109.578 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.604 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -119.74 167.85 11.65 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.088 -1.008 . . . . 0.0 111.761 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.59 136.21 3.71 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.746 -1.221 . . . . 0.0 110.753 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.705 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -59.19 152.49 20.46 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.236 0.541 . . . . 0.0 111.605 -179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.662 HD11 ' CG2' ' A' ' 88' ' ' ILE . 42.6 mm -135.74 144.95 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.595 -0.69 . . . . 0.0 110.462 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 31.1 m-20 57.35 68.53 0.84 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.523 0.677 . . . . 0.0 110.696 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.822 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 66.9 t80 -127.86 159.34 35.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.251 -0.906 . . . . 0.0 109.511 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.613 ' OG1' ' N ' ' A' ' 80' ' ' SER . 26.1 p -140.7 -77.35 0.3 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.613 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.2 OUTLIER -150.09 108.23 3.75 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.19 -102.33 0.21 Allowed Glycine 0 N--CA 1.501 3.028 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.484 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 48.4 t80 -144.04 -169.78 3.19 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.646 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.9 mtm180 -71.66 -156.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.702 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.8 p30 -166.91 -150.06 0.1 Allowed 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 100' ' ' THR . 48.1 p -100.39 -6.84 25.1 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.646 -1.284 . . . . 0.0 110.151 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.46 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -88.03 117.53 26.96 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.285 -0.884 . . . . 0.0 110.764 -178.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.856 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.89 149.12 41.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -0.915 . . . . 0.0 109.74 179.259 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.662 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.4 tt -117.56 137.39 51.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.465 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.1 mm? -113.97 125.44 54.02 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.682 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -117.92 126.48 52.45 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.791 0.805 . . . . 0.0 108.914 179.651 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.703 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 2.1 p -92.43 157.03 16.8 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 121.985 0.898 . . . . 0.0 111.298 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.1 p -69.92 -19.45 63.39 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.528 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.31 10.43 5.6 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.237 -0.914 . . . . 0.0 109.781 179.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.455 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.0 30.85 0.43 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.881 -0.512 . . . . 0.0 110.004 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.408 HD12 HH21 ' A' ' 69' ' ' ARG . 25.8 mt -103.26 138.68 39.71 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.134 -0.979 . . . . 0.0 109.938 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.0 mm -112.63 120.15 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.417 -0.802 . . . . 0.0 110.058 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.441 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.7 m-85 -120.36 142.96 48.68 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.46 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 8.5 tptp -131.0 147.78 52.67 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.167 -0.958 . . . . 0.0 110.835 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.516 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -128.22 171.14 12.24 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.442 ' O ' ' OG ' ' A' ' 85' ' ' SER . 73.9 p -146.69 -2.63 0.64 Allowed 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.443 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.638 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -115.95 20.02 14.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.741 -1.224 . . . . 0.0 108.397 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 78.14 61.75 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.619 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.679 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 20.0 m-85 70.45 -13.52 0.45 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.67 -0.644 . . . . 0.0 111.343 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -50.8 -73.62 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.517 -1.365 . . . . 0.0 109.31 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.494 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 37.1 p -99.11 -178.08 3.82 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.465 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -160.3 134.77 7.48 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.167 -0.958 . . . . 0.0 110.028 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 57.8 m -127.67 139.77 52.5 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.602 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 14.2 tttp -85.83 140.05 30.76 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.803 -1.185 . . . . 0.0 110.416 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.4 pt -113.2 -32.42 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.63 -0.669 . . . . 0.0 109.922 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.653 HH21 ' CG ' ' A' ' 8' ' ' ASP . 69.6 mtt180 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 109.112 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.577 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 39.9 t . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.0 tt -171.23 159.69 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -146.77 29.38 1.01 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.368 -1.458 . . . . 0.0 110.61 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 10' ' ' VAL . 24.9 p -105.48 157.42 17.37 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.545 -178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.8 OUTLIER -60.06 -61.89 2.27 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.85 -1.156 . . . . 0.0 110.43 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.62 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.51 -40.75 79.41 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.053 -1.029 . . . . 0.0 109.317 -179.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.13 -45.13 94.35 Favored Glycine 0 N--CA 1.482 1.75 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.707 HG22 ' HG2' ' A' ' 21' ' ' PRO . 68.8 t -66.55 -40.73 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.388 -1.066 . . . . 0.0 109.179 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.06 -57.38 10.85 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.72 -0.612 . . . . 0.0 109.392 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.82 -52.1 51.71 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.672 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 33.3 t80 -58.45 -49.67 76.47 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.333 0.587 . . . . 0.0 111.188 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.2 tt -72.25 -45.89 58.24 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.561 -0.712 . . . . 0.0 110.749 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -61.0 -20.05 62.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.354 -1.466 . . . . 0.0 110.587 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 m -97.97 -40.77 8.31 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.486 -1.384 . . . . 0.0 111.194 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -110.36 16.12 21.84 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 120.781 -1.199 . . . . 0.0 111.714 -177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.0 m80 46.03 24.61 0.26 Allowed 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.367 -0.833 . . . . 0.0 110.643 178.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 14' ' ' LEU . 3.8 pttp -142.41 154.33 44.5 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.688 0.756 . . . . 0.0 110.511 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.473 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.4 mp -77.2 149.28 79.18 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.707 -0.62 . . . . 0.0 109.686 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.707 ' HG2' HG22 ' A' ' 10' ' ' VAL . 51.6 Cg_exo -39.67 147.68 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.556 2.837 . . . . 0.0 113.718 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.577 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -63.8 47.55 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.084 0.945 . . . . 0.0 110.936 -177.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.541 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -169.11 27.08 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.087 -1.008 . . . . 0.0 110.811 179.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -117.99 118.26 31.46 Favored 'General case' 0 N--CA 1.496 1.869 0 C-N-CA 119.141 -1.024 . . . . 0.0 109.705 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.8 pt -120.12 137.39 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.566 HG22 ' HA3' ' A' ' 53' ' ' GLY . 7.2 p -67.78 169.8 9.04 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.498 1.142 . . . . 0.0 111.259 -178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.537 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 24.1 mtmt -71.61 -37.53 70.93 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 178.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -39.67 -70.43 0.1 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 175.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.522 ' O ' ' C ' ' A' ' 30' ' ' ALA . 3.5 mt-10 -58.57 -58.76 7.15 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.522 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.63 -51.55 1.21 Allowed 'General case' 0 N--CA 1.508 2.46 0 O-C-N 119.075 -2.265 . . . . 0.0 110.348 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -58.15 -58.64 7.55 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 121.091 -1.006 . . . . 0.0 110.171 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.24 -37.48 69.81 Favored 'General case' 0 N--CA 1.51 2.561 0 O-C-N 121.119 -0.988 . . . . 0.0 110.452 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.6 tp -55.12 -28.61 53.93 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.504 0.669 . . . . 0.0 110.23 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.29 51.05 0.25 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.534 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.71 144.94 30.79 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.277 -1.131 . . . . 0.0 109.375 178.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.8 t -137.45 127.03 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.556 -0.715 . . . . 0.0 110.132 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -56.98 -52.55 64.82 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.991 -0.443 . . . . 0.0 110.581 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.6 p -70.05 47.31 0.08 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.196 -0.94 . . . . 0.0 110.377 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.631 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.5 ttpm? -176.35 -51.1 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.16 56.43 20.46 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.404 -1.878 . . . . 0.0 108.404 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.631 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -69.92 161.77 29.32 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.659 -0.907 . . . . 0.0 110.521 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.792 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 60.1 tp -176.26 -65.95 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.557 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.594 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -62.17 -19.4 63.05 Favored 'General case' 0 C--O 1.197 -1.666 0 O-C-N 121.305 -0.872 . . . . 0.0 109.504 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.6 p-10 -80.06 -64.42 1.19 Allowed 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.993 0.902 . . . . 0.0 108.637 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.419 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 30.5 m -73.89 -11.45 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 119.501 -0.879 . . . . 0.0 110.705 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.57 72.15 11.68 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.506 -0.746 . . . . 0.0 109.939 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.4 122.43 11.66 Favored 'Trans proline' 0 N--CA 1.512 2.601 0 C-N-CA 123.472 2.781 . . . . 0.0 114.219 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.409 ' C ' ' HG2' ' A' ' 49' ' ' LYS . . . 73.41 39.46 50.83 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.49 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 8.6 mmtm -138.68 176.44 8.7 Favored 'General case' 0 N--CA 1.512 2.669 0 CA-C-O 122.513 1.149 . . . . 0.0 111.009 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.1 m -148.57 162.91 38.71 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 120.203 -1.56 . . . . 0.0 110.783 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.1 mm -85.59 125.31 40.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.128 -0.983 . . . . 0.0 109.77 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.22 154.02 10.45 Favored Glycine 0 N--CA 1.503 3.138 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 178.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.566 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 122.42 -17.42 8.41 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.906 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -69.79 -154.49 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.348 0 O-C-N 120.839 -1.389 . . . . 0.0 109.835 179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 2.9 mp -127.69 139.8 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 121.805 0.812 . . . . 0.0 110.855 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.614 ' O ' ' N ' ' A' ' 58' ' ' ASN . 9.0 t80 -105.2 90.05 3.31 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.38 -0.825 . . . . 0.0 108.816 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.541 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.5 p -59.34 36.04 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 121.393 0.616 . . . . 0.0 110.524 -179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.614 ' N ' ' O ' ' A' ' 56' ' ' PHE . 59.2 t30 39.38 34.68 0.14 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.075 -1.016 . . . . 0.0 110.325 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.541 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.3 mtm180 -66.58 45.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.547 -1.345 . . . . 0.0 110.066 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.616 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 18.5 mt-10 -151.53 -27.07 0.19 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.526 -0.733 . . . . 0.0 110.142 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.32 27.76 59.11 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.674 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.6 mttp -111.13 7.79 21.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.723 -0.869 . . . . 0.0 109.757 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.31 144.88 55.04 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.608 -0.683 . . . . 0.0 109.247 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -63.57 125.15 14.97 Favored 'Trans proline' 0 N--CA 1.498 1.759 0 C-N-CA 122.672 2.248 . . . . 0.0 112.289 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.541 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.82 -171.41 27.7 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 68' ' ' GLY . 12.1 tttt 176.37 146.67 0.09 Allowed 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.405 -1.056 . . . . 0.0 109.144 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 67' ' ' SER . 24.1 p -68.88 61.29 0.1 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.763 -1.211 . . . . 0.0 108.951 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 142.99 76.73 0.04 OUTLIER Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.568 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.92 168.25 4.97 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.54 -0.976 . . . . 0.0 109.195 179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.446 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 93.4 m -144.5 155.86 43.9 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.463 -0.773 . . . . 0.0 109.897 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.708 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 19.8 m95 -126.55 137.6 53.37 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.579 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -128.84 156.55 43.46 Favored 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.993 -1.067 . . . . 0.0 109.091 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.538 ' O ' ' OH ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -121.28 167.4 12.77 Favored 'General case' 0 N--CA 1.513 2.676 0 CA-C-O 122.274 1.035 . . . . 0.0 111.402 -179.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -166.29 136.84 3.42 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.276 -0.89 . . . . 0.0 111.308 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.693 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -59.5 153.69 18.93 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.648 0.737 . . . . 0.0 111.584 -179.344 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.649 HD11 ' CG2' ' A' ' 88' ' ' ILE . 40.6 mm -136.76 142.84 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.77 -0.581 . . . . 0.0 110.764 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 59.26 65.79 1.13 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.436 0.636 . . . . 0.0 110.665 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.792 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 63.1 t80 -125.2 159.78 30.75 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.298 -0.876 . . . . 0.0 109.566 179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.583 ' OG1' ' N ' ' A' ' 80' ' ' SER . 28.1 p -139.99 -77.38 0.32 Allowed 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.594 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -149.53 112.12 4.76 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.06 -104.83 0.26 Allowed Glycine 0 N--CA 1.502 3.049 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.462 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 44.3 t80 -141.43 -169.77 2.94 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.861 -0.787 . . . . 0.0 109.286 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.668 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.7 mtm180 -71.1 -155.0 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.214 0 O-C-N 120.81 -1.181 . . . . 0.0 109.539 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -168.77 -151.99 0.1 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 51.5 p -99.72 -3.5 32.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.62 -1.3 . . . . 0.0 110.335 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.527 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -91.28 117.07 29.34 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.251 -0.906 . . . . 0.0 110.283 -179.134 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.853 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -140.1 150.22 44.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.329 -0.857 . . . . 0.0 109.56 179.363 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.649 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.2 tt -119.06 137.38 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.44 HD13 ' O ' ' A' ' 72' ' ' ARG . 2.2 mm? -114.47 125.72 54.14 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.7 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.56 127.83 53.99 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.752 0.786 . . . . 0.0 109.279 179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.708 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 6.5 p -94.12 159.14 15.28 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.282 1.039 . . . . 0.0 112.329 -178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.5 p -69.87 -19.52 63.43 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.568 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -83.16 10.44 8.28 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.732 179.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.464 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.39 31.29 0.48 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.726 -0.609 . . . . 0.0 109.988 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.413 HD12 HH21 ' A' ' 69' ' ' ARG . 27.1 mt -103.43 138.34 40.29 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.46 -0.775 . . . . 0.0 109.833 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 109' ' ' ILE . 31.9 mm -112.35 119.51 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.794 -0.566 . . . . 0.0 110.139 -179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.413 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.0 m-85 -120.62 143.55 48.61 Favored 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.527 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 7.7 tptp -131.12 148.09 52.69 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.02 -1.05 . . . . 0.0 110.299 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.562 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -127.68 171.9 11.26 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.3 p -146.73 -1.85 0.67 Allowed 'General case' 0 N--CA 1.507 2.421 0 O-C-N 121.147 -0.971 . . . . 0.0 110.281 178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.627 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -117.13 20.27 13.83 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.717 -1.239 . . . . 0.0 108.433 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 77.07 64.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.409 179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.674 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 18.9 m-85 68.96 -12.87 0.37 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 122.195 -0.316 . . . . 0.0 111.793 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -51.66 -72.75 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.478 -1.389 . . . . 0.0 109.58 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.474 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 37.3 p -100.07 -179.12 4.05 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.415 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -159.12 135.42 9.1 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.038 -1.039 . . . . 0.0 109.954 -179.209 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 64.0 m -128.8 139.51 52.15 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.613 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.5 tttp -86.1 139.19 31.34 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.839 -1.163 . . . . 0.0 110.314 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 96' ' ' ILE . 13.5 pt -112.7 -31.55 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.831 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.62 HH21 ' CG ' ' A' ' 8' ' ' ASP . 68.2 mtt180 . . . . . 0 C--N 1.306 -1.298 0 O-C-N 121.131 -0.981 . . . . 0.0 109.167 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.592 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 22.0 t . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.6 tt -169.94 160.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 32.7 p30 -146.53 30.2 1.01 Allowed 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.255 -1.528 . . . . 0.0 111.637 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 10' ' ' VAL . 28.3 p -104.16 158.32 16.52 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.517 -0.739 . . . . 0.0 109.526 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.7 p90 -60.35 -61.67 2.43 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.617 -1.302 . . . . 0.0 110.872 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.617 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -56.69 -41.67 77.74 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.145 -0.972 . . . . 0.0 109.618 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -58.27 -45.21 94.46 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.676 HG22 ' HG2' ' A' ' 21' ' ' PRO . 54.7 t -66.72 -41.5 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 O-C-N 121.109 -1.23 . . . . 0.0 108.101 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.36 -59.38 5.37 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.48 -52.17 31.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.058 -1.026 . . . . 0.0 109.973 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.695 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 36.3 t80 -59.58 -47.98 83.46 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.291 -0.881 . . . . 0.0 110.628 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 1.7 tt -72.9 -44.38 61.34 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.382 -0.824 . . . . 0.0 110.841 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -62.73 -22.62 66.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.554 -1.341 . . . . 0.0 110.379 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.2 m -94.88 -42.11 8.85 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.957 -1.089 . . . . 0.0 111.048 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -109.49 16.83 21.98 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.127 -0.983 . . . . 0.0 112.214 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.9 m80 46.84 24.35 0.34 Allowed 'General case' 0 N--CA 1.51 2.56 0 O-C-N 120.94 -1.1 . . . . 0.0 110.584 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 4.2 pttp -141.39 151.45 43.49 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.241 1.02 . . . . 0.0 110.296 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.527 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.5 mp -75.44 150.39 84.75 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.033 -1.042 . . . . 0.0 108.725 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.695 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 50.7 Cg_exo -40.33 151.91 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 123.344 2.696 . . . . 0.0 114.35 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.592 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -66.38 47.6 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.6 0.714 . . . . 0.0 111.312 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.443 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -170.22 27.65 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.378 -0.826 . . . . 0.0 109.189 179.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -119.25 118.26 30.8 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.714 -1.241 . . . . 0.0 110.098 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 33.8 pt -119.89 138.73 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.307 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.54 HG22 ' HA3' ' A' ' 53' ' ' GLY . 12.0 p -69.01 166.97 16.91 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.936 -1.102 . . . . 0.0 110.875 -177.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.591 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 22.9 mtmt -70.38 -34.59 72.75 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.31 -66.99 0.32 Allowed 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 175.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' ' 30' ' ' ALA . 3.4 mt-10 -60.35 -58.3 9.1 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.439 -1.304 . . . . 0.0 108.288 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.66 -52.46 1.23 Allowed 'General case' 0 N--CA 1.509 2.502 0 O-C-N 121.007 -1.058 . . . . 0.0 109.241 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -59.0 -55.98 28.15 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.563 -0.711 . . . . 0.0 110.511 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.26 -29.1 70.17 Favored 'General case' 0 N--CA 1.508 2.446 0 O-C-N 120.652 -1.28 . . . . 0.0 108.964 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.413 HD21 ' HB ' ' A' ' 45' ' ' VAL . 33.9 tp -62.38 -27.36 69.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.648 -0.657 . . . . 0.0 109.471 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.84 52.73 0.23 Allowed Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.55 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -83.07 146.77 28.51 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.317 -1.108 . . . . 0.0 109.693 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.8 t -135.77 125.16 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 121.325 -0.859 . . . . 0.0 109.187 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -58.82 -52.56 65.21 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.831 -0.543 . . . . 0.0 109.724 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.9 p -70.37 50.98 0.12 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.001 -1.062 . . . . 0.0 109.412 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.645 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -179.69 -50.18 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.41 56.99 20.29 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.645 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -72.14 164.42 26.22 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 121.834 -0.803 . . . . 0.0 110.784 -178.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.843 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 66.6 tp -178.64 -66.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.001 -1.062 . . . . 0.0 110.004 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.638 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -59.98 -23.12 63.36 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.098 -1.001 . . . . 0.0 109.711 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 5.5 p-10 -76.39 -64.11 1.18 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.003 0.906 . . . . 0.0 109.497 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.444 ' H ' HG22 ' A' ' 45' ' ' VAL . 15.3 m -76.21 -10.92 13.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.853 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.62 70.14 11.41 Favored Pre-proline 0 N--CA 1.502 2.148 0 O-C-N 121.348 -0.845 . . . . 0.0 109.431 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -57.04 123.57 14.16 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 123.182 2.588 . . . . 0.0 113.673 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.487 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 73.88 36.45 52.51 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.487 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 8.5 mmtm -138.57 168.97 18.63 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 121.885 0.85 . . . . 0.0 111.205 -178.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.474 ' HG ' ' HD2' ' A' ' 78' ' ' TYR . 73.3 m -142.48 162.02 36.56 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.277 1.037 . . . . 0.0 111.089 -177.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.1 mm -84.47 126.93 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 122.1 0.952 . . . . 0.0 110.327 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 171.36 153.74 9.24 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.54 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 122.57 -20.46 7.82 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.329 -1.415 . . . . 0.0 110.782 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -68.33 -154.42 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 118.686 1.243 . . . . 0.0 109.01 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.3 mp -128.66 139.65 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 CA-C-O 121.864 0.84 . . . . 0.0 111.219 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.612 ' O ' ' N ' ' A' ' 58' ' ' ASN . 8.5 t80 -104.05 89.96 3.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.341 -0.85 . . . . 0.0 109.304 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.642 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.3 p -58.99 35.16 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.603 -0.686 . . . . 0.0 110.888 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.612 ' N ' ' O ' ' A' ' 56' ' ' PHE . 55.2 t30 38.34 39.7 0.3 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.107 -0.996 . . . . 0.0 109.878 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.642 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 8.9 mtm180 -70.29 43.33 0.06 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.562 -1.336 . . . . 0.0 110.087 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.61 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 21.7 mt-10 -149.38 -25.32 0.28 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.332 -0.855 . . . . 0.0 109.943 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.59 28.74 58.92 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.637 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 8.5 mttp -111.3 7.93 21.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.508 -0.995 . . . . 0.0 109.713 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 mt -131.0 144.04 51.91 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.602 -0.686 . . . . 0.0 109.493 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.33 124.98 15.8 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.819 2.346 . . . . 0.0 112.408 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.543 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.1 -173.22 28.82 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.507 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 11.0 tttt 177.29 144.24 0.09 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.375 -1.074 . . . . 0.0 108.656 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.2 p -68.1 58.58 0.07 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.936 -1.102 . . . . 0.0 109.172 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.507 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 147.64 75.51 0.02 OUTLIER Glycine 0 N--CA 1.5 2.913 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.564 ' NH2' ' OD2' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -172.56 168.11 5.37 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.711 -0.876 . . . . 0.0 109.33 -179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.429 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 87.9 m -143.39 155.09 44.32 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.486 -0.759 . . . . 0.0 110.039 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.714 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 17.9 m95 -125.21 138.34 54.12 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.584 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -129.47 156.14 44.59 Favored 'General case' 0 N--CA 1.509 2.477 0 O-C-N 120.747 -1.221 . . . . 0.0 109.586 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.591 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -120.47 167.66 12.13 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.259 -0.901 . . . . 0.0 112.026 -179.37 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -166.65 135.71 2.94 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.135 -0.978 . . . . 0.0 110.714 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.646 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.5 OUTLIER -58.59 153.33 16.53 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.343 0.592 . . . . 0.0 111.676 -179.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.686 HD11 ' CG2' ' A' ' 88' ' ' ILE . 39.9 mm -136.02 140.67 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 CA-C-O 121.49 0.662 . . . . 0.0 110.37 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 32.9 m-20 60.49 68.98 0.72 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.679 -0.638 . . . . 0.0 110.403 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.843 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 61.2 t80 -126.13 159.45 32.87 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.349 -0.844 . . . . 0.0 109.636 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.601 ' OG1' ' N ' ' A' ' 80' ' ' SER . 31.2 p -139.8 -78.25 0.32 Allowed 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.638 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -150.84 107.44 3.51 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.94 -107.41 0.31 Allowed Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.493 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 52.1 t80 -139.29 -166.93 2.14 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.734 -0.862 . . . . 0.0 108.843 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.648 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.3 mtm180 -73.91 -157.31 0.05 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.0 -1.062 . . . . 0.0 109.53 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -166.64 -153.14 0.15 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 100' ' ' THR . 50.7 p -98.22 -9.64 25.3 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.457 -1.402 . . . . 0.0 110.727 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.538 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -86.06 117.71 25.07 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.066 -1.021 . . . . 0.0 111.096 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.826 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.65 148.45 42.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.405 -0.81 . . . . 0.0 109.552 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.686 ' CG2' HD11 ' A' ' 76' ' ' ILE . 3.5 tt -115.93 139.54 42.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.472 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.1 mm? -116.05 125.43 52.42 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.671 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -117.55 127.52 54.06 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-O 121.856 0.836 . . . . 0.0 109.355 -179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.714 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 8.6 p -94.58 157.7 15.86 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.122 0.963 . . . . 0.0 111.944 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.1 p -69.01 -20.1 64.14 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.564 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -82.18 9.72 8.15 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.3 -0.875 . . . . 0.0 110.033 179.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.451 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.25 29.35 0.45 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.714 -0.616 . . . . 0.0 110.449 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.437 HD12 HH21 ' A' ' 69' ' ' ARG . 29.2 mt -101.87 135.99 42.47 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.437 -0.79 . . . . 0.0 109.985 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.4 mm -110.2 119.74 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.515 -0.74 . . . . 0.0 110.115 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.435 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.3 m-85 -119.04 143.14 47.27 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.538 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 8.5 tptp -132.45 147.49 52.37 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.823 -1.173 . . . . 0.0 110.537 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.487 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.5 t -129.39 171.04 12.92 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.403 ' O ' ' OG ' ' A' ' 85' ' ' SER . 72.3 p -145.22 -3.65 0.74 Allowed 'General case' 0 N--CA 1.508 2.472 0 O-C-N 121.45 -0.781 . . . . 0.0 110.234 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.616 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -114.53 19.37 16.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.756 -1.215 . . . . 0.0 108.924 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.616 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 77.87 63.69 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.054 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.648 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 18.5 m-85 69.5 -14.48 0.33 Allowed 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.813 -0.554 . . . . 0.0 111.87 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -49.96 -74.27 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.538 -1.351 . . . . 0.0 109.314 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.464 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 38.0 p -99.03 -177.17 3.54 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.791 -1.193 . . . . 0.0 108.319 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.472 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -160.23 134.33 7.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.127 -0.983 . . . . 0.0 110.236 -179.682 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.6 m -127.3 139.99 52.51 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.541 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 15.2 tttp -86.37 140.21 30.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.8 -1.187 . . . . 0.0 110.364 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.6 pt -113.68 -31.71 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.438 -0.788 . . . . 0.0 110.074 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.617 HH21 ' CG ' ' A' ' 8' ' ' ASP . 67.6 mtt180 . . . . . 0 N--CA 1.485 1.317 0 O-C-N 121.068 -1.02 . . . . 0.0 108.659 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.638 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.8 t . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 tt -169.4 159.69 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.365 -0.835 . . . . 0.0 109.342 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.3 p30 -146.67 31.07 0.97 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.512 -1.368 . . . . 0.0 111.357 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 23.7 p -106.08 155.97 18.88 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.599 -0.688 . . . . 0.0 109.865 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.402 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 1.3 p90 -58.44 -62.18 2.04 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.195 -0.941 . . . . 0.0 110.725 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.622 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.9 OUTLIER -58.15 -41.13 83.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.353 -0.842 . . . . 0.0 109.526 -179.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.92 -44.91 87.56 Favored Glycine 0 N--CA 1.502 3.045 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.692 HG22 ' HG2' ' A' ' 21' ' ' PRO . 53.3 t -67.95 -41.99 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.46 -57.02 12.72 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.473 -0.767 . . . . 0.0 109.21 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.08 -55.22 15.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.474 -0.766 . . . . 0.0 109.692 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.676 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 33.9 t80 -56.45 -49.88 73.32 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.249 0.547 . . . . 0.0 110.802 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 tt -73.22 -44.55 59.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.376 -0.828 . . . . 0.0 110.709 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -62.26 -21.12 64.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.566 -1.334 . . . . 0.0 110.298 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.6 m -97.26 -40.92 8.52 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.174 -0.954 . . . . 0.0 110.742 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -109.16 14.42 23.9 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.118 -0.989 . . . . 0.0 111.908 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 19.1 m80 46.51 25.57 0.41 Allowed 'General case' 0 N--CA 1.509 2.48 0 O-C-N 120.864 -1.147 . . . . 0.0 109.669 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.488 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 5.0 pttp -142.27 152.2 42.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.315 -0.866 . . . . 0.0 110.004 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.542 ' H ' HD12 ' A' ' 20' ' ' LEU . 5.6 mp -76.88 149.36 80.24 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 109.066 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.692 ' HG2' HG22 ' A' ' 10' ' ' VAL . 66.1 Cg_exo -40.76 150.71 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.734 2.289 . . . . 0.0 113.23 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -62.59 47.14 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.601 0.715 . . . . 0.0 111.12 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -168.42 26.22 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.6 -1.313 . . . . 0.0 110.286 179.121 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -116.69 113.05 22.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.88 -1.137 . . . . 0.0 110.886 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.432 HG21 HD13 ' A' ' 25' ' ' ILE . 28.3 pt -116.18 138.59 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.325 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.611 HG22 ' HA3' ' A' ' 53' ' ' GLY . 4.4 p -69.73 166.62 18.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.018 -1.051 . . . . 0.0 110.37 -176.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.586 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 18.7 mtmt -66.29 -35.4 80.29 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.441 ' HG ' ' CB ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -41.89 -66.33 0.36 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.647 -1.16 . . . . 0.0 108.625 178.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 30' ' ' ALA . 1.4 mt-10 -65.33 -49.3 69.95 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.301 -0.959 . . . . 0.0 109.192 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -44.24 -50.0 9.04 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.79 -1.194 . . . . 0.0 107.997 177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.42 ' HA ' ' HB2' ' A' ' 35' ' ' TRP . 38.7 mt-30 -59.2 -57.6 12.33 Favored 'General case' 0 N--CA 1.509 2.506 0 O-C-N 121.36 -0.838 . . . . 0.0 110.733 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.34 -30.91 69.83 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.994 -1.066 . . . . 0.0 109.807 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 15.0 tp -63.11 -25.82 68.54 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.96 50.16 0.23 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.593 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.91 144.1 31.2 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.369 -1.077 . . . . 0.0 110.146 179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.0 t -134.52 125.3 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.441 0 O-C-N 121.174 -0.954 . . . . 0.0 109.699 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.503 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -58.73 -52.83 64.02 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.55 -0.719 . . . . 0.0 109.812 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 59.6 p -68.56 50.2 0.07 Allowed 'General case' 0 N--CA 1.501 2.125 0 O-C-N 120.982 -1.073 . . . . 0.0 109.133 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.626 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.0 OUTLIER -179.34 -50.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.462 -0.774 . . . . 0.0 108.964 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.95 56.86 18.4 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.626 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -74.27 162.76 28.59 Favored 'General case' 0 C--N 1.292 -1.894 0 O-C-N 121.443 -1.034 . . . . 0.0 110.773 -178.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.821 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 65.4 tp -176.12 -67.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.547 -0.72 . . . . 0.0 109.798 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.655 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.63 -18.86 55.94 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.962 -1.086 . . . . 0.0 109.935 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.8 p-10 -79.45 -65.1 1.04 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.843 0.83 . . . . 0.0 109.552 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.457 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 30.7 m -73.33 -10.89 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 O-C-N 121.743 -0.598 . . . . 0.0 110.353 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.83 71.87 9.59 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 109.785 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.36 122.56 12.0 Favored 'Trans proline' 0 N--CA 1.509 2.392 0 C-N-CA 123.977 3.118 . . . . 0.0 113.562 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.74 39.76 59.46 Favored Glycine 0 N--CA 1.501 2.983 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 23' ' ' ASN . 7.2 mmtt -136.6 176.08 9.03 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 122.052 0.929 . . . . 0.0 110.597 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.405 ' HA ' HD21 ' A' ' 42' ' ' LEU . 69.0 m -150.13 158.82 44.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.785 -1.197 . . . . 0.0 111.167 -177.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.3 mm -82.45 130.37 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.548 0.69 . . . . 0.0 110.121 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.4 154.83 8.5 Favored Glycine 0 N--CA 1.499 2.895 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.611 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 119.89 -16.53 10.2 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 120.293 -0.956 . . . . 0.0 110.868 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -70.55 -152.71 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.748 -1.443 . . . . 0.0 109.603 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -128.93 138.84 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-O 121.522 0.677 . . . . 0.0 110.821 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.604 ' O ' ' N ' ' A' ' 58' ' ' ASN . 11.0 t80 -104.09 90.31 3.55 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.661 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.3 36.2 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.47 0.653 . . . . 0.0 111.182 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.604 ' N ' ' O ' ' A' ' 56' ' ' PHE . 53.5 t30 36.58 38.4 0.08 Allowed 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.94 -1.1 . . . . 0.0 110.541 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.661 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.8 mtm180 -69.51 39.07 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.245 -0.909 . . . . 0.0 109.412 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.614 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 18.9 mt-10 -149.05 -10.9 0.32 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.182 -0.949 . . . . 0.0 110.246 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 61.78 33.23 84.53 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.67 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 7.1 mttp -115.1 8.6 15.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.613 -0.934 . . . . 0.0 109.446 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -132.81 142.94 46.59 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.446 -0.784 . . . . 0.0 109.349 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.86 125.99 17.84 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.885 2.39 . . . . 0.0 112.394 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.539 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . -101.0 -170.99 28.63 Favored Glycine 0 N--CA 1.5 2.935 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.583 ' O ' ' N ' ' A' ' 68' ' ' GLY . 11.1 tttt 175.52 144.08 0.07 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.149 -1.206 . . . . 0.0 108.269 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 67' ' ' SER . 27.2 p -66.09 57.05 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.838 -1.164 . . . . 0.0 108.427 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 147.63 77.34 0.02 OUTLIER Glycine 0 N--CA 1.495 2.598 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.539 ' NH1' ' O ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -173.54 167.78 4.56 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.551 -0.97 . . . . 0.0 108.974 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.431 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 85.6 m -144.36 155.87 43.98 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.811 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.737 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 25.6 m95 -126.32 138.73 53.61 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.615 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.38 154.31 47.81 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.544 -1.347 . . . . 0.0 109.606 179.596 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.586 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -118.35 167.0 11.97 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.195 -0.94 . . . . 0.0 111.815 -179.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.13 136.13 3.97 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.797 0.808 . . . . 0.0 110.967 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.66 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.6 OUTLIER -60.73 151.69 28.75 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.613 -0.679 . . . . 0.0 111.938 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.492 HG13 ' HB ' ' A' ' 88' ' ' ILE . 40.4 mm -137.15 143.82 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-O 121.476 0.655 . . . . 0.0 110.18 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 60.25 66.08 1.0 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.234 0.54 . . . . 0.0 110.576 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.821 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 58.0 t80 -126.79 161.63 27.74 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.156 -0.965 . . . . 0.0 109.122 178.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.634 ' OG1' ' N ' ' A' ' 80' ' ' SER . 27.2 p -141.38 -78.96 0.26 Allowed 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.655 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -149.27 106.08 3.56 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.51 -107.09 0.3 Allowed Glycine 0 N--CA 1.495 2.606 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 49.1 t80 -135.82 -166.02 1.79 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.721 -0.87 . . . . 0.0 108.771 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.658 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.8 mtm180 -75.16 -153.04 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.916 -1.115 . . . . 0.0 109.077 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -168.41 -150.3 0.09 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 55.3 p -100.87 -8.36 22.64 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.464 -1.397 . . . . 0.0 110.335 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.455 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -86.5 116.75 24.85 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.386 -0.821 . . . . 0.0 110.741 -178.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.84 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.22 149.47 44.41 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.251 -0.906 . . . . 0.0 109.698 179.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.492 ' HB ' HG13 ' A' ' 76' ' ' ILE . 10.5 tt -119.64 136.1 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-O 121.621 0.724 . . . . 0.0 109.125 178.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 72' ' ' ARG . 2.8 mm? -112.66 124.65 53.03 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.67 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -116.69 127.84 54.78 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.691 0.758 . . . . 0.0 109.002 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.737 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 5.7 p -93.78 158.72 15.53 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.995 0.903 . . . . 0.0 111.91 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.7 p -69.39 -19.94 63.81 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.524 ' OD2' ' NH2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -81.72 9.28 8.13 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.471 -0.768 . . . . 0.0 109.898 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.78 30.32 0.47 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.621 -0.674 . . . . 0.0 110.024 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.429 HD12 HH21 ' A' ' 69' ' ' ARG . 26.8 mt -102.87 137.57 40.9 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.342 -0.849 . . . . 0.0 110.388 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.52 ' CG2' HD11 ' A' ' 109' ' ' ILE . 35.9 mm -110.42 118.95 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.306 -0.872 . . . . 0.0 110.691 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.461 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 6.9 m-85 -119.09 141.61 48.61 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.455 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 6.2 tptp -131.37 148.26 52.65 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.417 -0.802 . . . . 0.0 110.896 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.528 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.7 t -128.66 172.46 11.2 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.9 p -146.87 -3.21 0.6 Allowed 'General case' 0 N--CA 1.505 2.292 0 O-C-N 121.523 -0.735 . . . . 0.0 110.487 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.582 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.3 p30 -115.54 22.5 13.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.785 -1.197 . . . . 0.0 108.296 -179.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 75.76 62.17 0.05 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.495 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.67 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 17.6 m-85 69.59 -10.87 0.55 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.701 -0.624 . . . . 0.0 111.414 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.72 -72.87 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.695 -1.253 . . . . 0.0 109.213 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.514 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 34.9 p -99.39 -178.37 3.88 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.477 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -160.65 133.48 6.41 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.071 -1.018 . . . . 0.0 109.794 -179.317 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 51.9 m -127.28 141.49 51.7 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.617 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 13.5 tttp -86.77 139.03 31.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.873 -1.142 . . . . 0.0 110.093 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.52 HD11 ' CG2' ' A' ' 96' ' ' ILE . 10.3 pt -112.11 -32.26 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.606 -0.684 . . . . 0.0 109.432 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.622 HH21 ' CG ' ' A' ' 8' ' ' ASP . 56.3 mtt180 . . . . . 0 N--CA 1.488 1.435 0 CA-C-O 118.086 -0.959 . . . . 0.0 109.049 179.382 . . . . . . . . 1 1 . 1 stop_ save_